{"meta":{"query_hash":"d7116a3a9363","filters":{"venue":"Leukemia Research"},"cohort_total":253,"direct_labels_cover":0,"predictions_cover":253,"exported":253,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/d7116a3a9363","api":"https://metacan.xera.ac/api/v1/cohort?venue=Leukemia+Research"},"results":[{"id":"W10996203","doi":"10.1016/s0145-2126(00)00059-x","title":"Designing an International Greenhouse Gas Emissions Trading System","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Climate Change Policy and Economics","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; National Heart, Lung, and Blood Institute","keywords":"Kyoto Protocol; Clean Development Mechanism; Greenhouse gas; Emissions trading; United Nations Framework Convention on Climate Change; Business; Montreal Protocol; Carbon offset; Natural resource economics; European union; International trade; Climate change mitigation; Environmental economics; Economics","score_opus":0.2966553023168457,"score_gpt":0.36064517112069233,"score_spread":0.0639898688038466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W10996203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9061227,0.00013934923,0.003192689,0.0016405107,0.00053263496,0.00020720756,0.00024388058,0.00013328501,0.08778776],"genre_scores_gemma":[0.99590445,0.00037141473,0.00084897876,0.000056841047,0.0006191266,0.000052582665,0.000012348324,0.000043480042,0.0020907982],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99832505,0.00005003995,0.00046743947,0.0004760094,0.00007665442,0.00060480624],"domain_scores_gemma":[0.998858,0.00026922862,0.00011854775,0.00045387502,0.000048175632,0.00025221184],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019248257,0.00012092254,0.00023609282,0.000528066,0.00029014796,0.00015634387,0.0006020518,0.00013279337,0.00088208355],"category_scores_gemma":[0.00028294037,0.000110891066,0.00007793269,0.0001985067,0.000095080635,0.0005917598,0.00014629879,0.00023978515,0.0016790644],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001647739,0.00015028067,0.062741,0.0001423901,0.00013474331,0.000070774004,0.0041661733,0.00004327589,0.008781987,0.89863175,0.008364912,0.016607957],"study_design_scores_gemma":[0.014014113,0.0014360629,0.024926074,0.0020325272,0.000025857737,0.00041063677,0.013300525,0.18394011,0.025681784,0.23326448,0.49689794,0.004069894],"about_ca_topic_score_codex":0.0006628362,"about_ca_topic_score_gemma":0.000066660024,"teacher_disagreement_score":0.66536725,"about_ca_system_score_codex":0.0021888698,"about_ca_system_score_gemma":0.00007181238,"threshold_uncertainty_score":0.99909824},"labels":[],"label_agreement":null},{"id":"W1142333440","doi":"10.1016/j.leukres.2015.08.012","title":"A phase II exercise randomized controlled trial for patients with acute myeloid leukemia undergoing induction chemotherapy","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Randomized controlled trial; Aerobic exercise; Induction chemotherapy; Quality of life (healthcare); Physical therapy; Internal medicine; Grip strength; Myeloid leukemia; Chemotherapy","score_opus":0.04461839989931244,"score_gpt":0.3640978572054129,"score_spread":0.31947945730610045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1142333440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9806971,0.00027999343,0.00055874867,0.0008567374,0.00069869735,0.014771696,0.000016496238,0.00009514044,0.0020254236],"genre_scores_gemma":[0.9836501,0.0003014471,0.0003415003,0.0001934215,0.00091042113,0.005053352,0.00018324317,0.000087660155,0.009278852],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9963118,0.00038466355,0.00055975816,0.00052839855,0.0015250043,0.0006903755],"domain_scores_gemma":[0.9966767,0.00076012075,0.0001720817,0.0005013447,0.0014369905,0.000452769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034812258,0.0002802258,0.0015708825,0.00040233356,0.00030615542,0.00008471364,0.00019096745,0.00024852835,0.00007288452],"category_scores_gemma":[0.0010152137,0.00018802282,0.0003764947,0.0005752599,0.0002717365,0.00019414673,0.00006591865,0.0006188205,0.000015527758],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97919106,0.0006125664,0.000019033218,0.00007418397,0.0005140243,0.000013467782,0.0022091921,0.0000061707624,0.00016162987,0.0000918797,0.0058567016,0.011250095],"study_design_scores_gemma":[0.9833801,0.009508917,0.000005789357,0.00022512299,0.0003732884,0.0000055030587,0.00067250925,0.0007925843,0.0009532126,0.0004768842,0.00339491,0.00021119988],"about_ca_topic_score_codex":0.0006229158,"about_ca_topic_score_gemma":0.00019197568,"teacher_disagreement_score":0.011038896,"about_ca_system_score_codex":0.0030937393,"about_ca_system_score_gemma":0.005479149,"threshold_uncertainty_score":0.97197753},"labels":[],"label_agreement":null},{"id":"W1608094604","doi":"10.1016/j.leukres.2015.04.018","title":"Identification of prognostic subgroups among acute myeloid leukemia patients with intermediate risk cytogenetics using a flow-cytometry-based assessment of ABC-transporter function","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Cytogenetics; Mitoxantrone; Internal medicine; Myeloid leukemia; NPM1; Oncology; Medicine; Leukemia; Multivariate analysis; Flow cytometry; Chemotherapy; Biology; Immunology; Karyotype; Gene; Chromosome; Genetics","score_opus":0.0411452183642174,"score_gpt":0.34695582293462646,"score_spread":0.30581060457040904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1608094604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96232516,0.000065074746,0.03445909,0.00003685802,0.00015487666,0.002488752,0.00022102604,0.000065693996,0.00018345386],"genre_scores_gemma":[0.99150914,0.00006453256,0.0072168433,0.000027301116,0.00014568024,0.0001730641,0.0005686926,0.00013632116,0.00015842298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916186,0.000731849,0.0014057053,0.00090228295,0.004245983,0.0010955821],"domain_scores_gemma":[0.9922263,0.0005028674,0.00070102065,0.0013370982,0.0045382194,0.0006945103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041751126,0.0004323176,0.0008827051,0.0018504224,0.00019748141,0.0000739496,0.00059709203,0.0004150194,0.000065227854],"category_scores_gemma":[0.0008263692,0.0003599454,0.0002091023,0.0029318926,0.0012493711,0.0003479995,0.00020654513,0.0017779561,0.000023484721],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0034281702,0.00042327313,0.9585787,0.00068861904,0.00054201786,0.00007205199,0.0004186399,0.0053926883,0.027797187,0.000012604096,0.00027193624,0.0023741063],"study_design_scores_gemma":[0.009744618,0.002767296,0.8000932,0.00045452395,0.0005827889,0.000007752063,0.00031329936,0.16152978,0.0241311,0.000052350602,0.00003441339,0.00028888253],"about_ca_topic_score_codex":0.00081165874,"about_ca_topic_score_gemma":0.00009864649,"teacher_disagreement_score":0.1584855,"about_ca_system_score_codex":0.006959019,"about_ca_system_score_gemma":0.008776146,"threshold_uncertainty_score":0.99988526},"labels":[],"label_agreement":null},{"id":"W1963543962","doi":"10.1016/j.leukres.2009.02.015","title":"Pronostic significance of angiogenic/lymphangiogenic, anti-apoptotic, inflammatory and viral factors in 88 cases with diffuse large B cell lymphoma and review of the literature","year":2009,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Survivin; Medicine; Lymphoma; Angiogenesis; Vascular endothelial growth factor; Diffuse large B-cell lymphoma; Internal medicine; Beta-2 microglobulin; Gastroenterology; Proportional hazards model; Pathology; VEGF receptors; Cancer","score_opus":0.032765040611274596,"score_gpt":0.3325268069805384,"score_spread":0.29976176636926377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963543962","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22691926,0.7699023,7.404025e-8,0.000029188055,0.000017926044,0.0028476897,0.00020704973,0.000008352249,0.000068150075],"genre_scores_gemma":[0.102893285,0.8964964,0.000027984479,0.000036111232,0.000041528543,0.00018285656,0.0001162001,0.000048659578,0.00015696137],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99645907,0.00062920805,0.00082878256,0.00064409577,0.0008357137,0.000603126],"domain_scores_gemma":[0.9973158,0.0009573668,0.00039514605,0.0008569262,0.00026002576,0.00021473723],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00074213766,0.0005198102,0.0022324182,0.00043739862,0.00009110186,0.000035677254,0.00028313277,0.00033832222,0.000009924743],"category_scores_gemma":[0.00033649165,0.00027535207,0.00041274377,0.0011068402,0.0003730918,0.00008394091,0.00022559051,0.00029956637,0.0000023535245],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027373212,0.004353364,0.04414583,0.6379754,0.00094551133,0.0021392882,0.0010770371,2.5200538e-7,0.00008622933,0.00023454188,0.0011430598,0.30762574],"study_design_scores_gemma":[0.017155461,0.0020178377,0.08013736,0.76260674,0.0035772016,0.0011217273,0.00014616309,0.0000052244886,0.0021167297,0.000021408317,0.13017043,0.0009237005],"about_ca_topic_score_codex":0.00017143652,"about_ca_topic_score_gemma":0.000053532847,"teacher_disagreement_score":0.30670205,"about_ca_system_score_codex":0.0010268094,"about_ca_system_score_gemma":0.0025003816,"threshold_uncertainty_score":0.99996984},"labels":[],"label_agreement":null},{"id":"W1964125608","doi":"10.1016/j.leukres.2012.11.013","title":"Correlation between cytokine levels and changes in fatigue and quality of life in patients with acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University; University Health Network","funders":"Canadian Institutes of Health Research; Ministerul Cercetării, Inovării şi Digitalizării","keywords":"Myeloid leukemia; Cancer-related fatigue; Medicine; Cytokine; Tumor necrosis factor alpha; Internal medicine; Chemokine; Myeloid; Oncology; Leukemia; Immunology; Cancer; Gastroenterology; Inflammation","score_opus":0.1157119307328995,"score_gpt":0.3813353205692868,"score_spread":0.26562338983638734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964125608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966747,0.00035792365,0.00008023207,0.0005976983,0.000024532254,0.0013998635,0.00008223724,0.000023055833,0.00075976714],"genre_scores_gemma":[0.9984159,0.00020206622,0.0005921334,0.00007477584,0.00014915715,0.000084476735,0.00012451253,0.000052918123,0.00030407292],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99540466,0.00071104406,0.0006676308,0.00053307135,0.0015563237,0.0011272827],"domain_scores_gemma":[0.9972242,0.0011254017,0.00011988147,0.00051588647,0.0004293386,0.0005852945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004324647,0.00027409487,0.00084629835,0.001168603,0.00010079487,0.000031725816,0.00017671369,0.00036136273,0.000051321385],"category_scores_gemma":[0.0012179044,0.00022537267,0.00003067752,0.0014177784,0.00060523074,0.00039487763,0.0003927697,0.0016224037,0.000011039864],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016351538,0.000092888964,0.9891608,0.00038532875,0.00008395312,0.0000135876,0.0013988792,0.0000101052565,0.0019862591,0.00020305745,0.00012423495,0.00490575],"study_design_scores_gemma":[0.010041334,0.00065010594,0.9859615,0.00028960968,0.000024355248,0.000005197088,0.0003517845,0.00037752226,0.0019035707,0.00004547926,0.0001367334,0.0002127816],"about_ca_topic_score_codex":0.0038572908,"about_ca_topic_score_gemma":0.00087973836,"teacher_disagreement_score":0.00840618,"about_ca_system_score_codex":0.0029561922,"about_ca_system_score_gemma":0.0014171338,"threshold_uncertainty_score":0.91904306},"labels":[],"label_agreement":null},{"id":"W1964315239","doi":"10.1016/s0145-2126(02)00062-0","title":"Differentiation of monoclonal B lymphocytosis of undetermined significance (MLUS) and chronic lymphocytic leukemia (CLL) with weak CD5 expression from CD5− CLL","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto","funders":"","keywords":"CD5; Lymphocytosis; Chronic lymphocytic leukemia; Prolymphocytic leukemia; Medicine; Leukemia; Monoclonal; Pathology; Immunology; Lymphoma; Antibody; Monoclonal antibody","score_opus":0.05402939586775175,"score_gpt":0.3108194792010493,"score_spread":0.25679008333329756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964315239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914042,0.0034212347,0.00036359942,0.00010708781,0.00008051753,0.0014556207,0.00009095658,0.00009024626,0.00298657],"genre_scores_gemma":[0.99308765,0.002201925,0.0012378223,0.00003184466,0.00033415214,0.000209726,0.00010176876,0.00013167477,0.0026634093],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9924286,0.0005410997,0.0011205444,0.0012661776,0.0032650882,0.0013784599],"domain_scores_gemma":[0.9947378,0.0017577027,0.00040567576,0.001606098,0.000846495,0.0006462526],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009880711,0.0005456934,0.0012286432,0.0008293743,0.00026675448,0.000079182064,0.0007045722,0.00052830373,0.0010358365],"category_scores_gemma":[0.0005289695,0.0004428412,0.00020795947,0.0013643242,0.0014792824,0.0003395706,0.000558391,0.0008741975,0.00008467279],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.007153985,0.00037202076,0.0052683377,0.0032018842,0.00065186946,0.00038808686,0.002051457,0.0015194782,0.95617926,0.00039206338,0.004102029,0.01871953],"study_design_scores_gemma":[0.04267439,0.002267511,0.006698327,0.0022729735,0.00018512766,0.00017878004,0.0005047592,0.35720053,0.5865547,0.00032829065,0.00059962075,0.0005349882],"about_ca_topic_score_codex":0.011080718,"about_ca_topic_score_gemma":0.00035937206,"teacher_disagreement_score":0.36962456,"about_ca_system_score_codex":0.121614456,"about_ca_system_score_gemma":0.028556535,"threshold_uncertainty_score":0.99987733},"labels":[],"label_agreement":null},{"id":"W1966423882","doi":"10.1016/j.leukres.2008.06.027","title":"Genetic aberrations including chromosome 1 abnormalities and clinical features of plasma cell leukemia","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Leukemia and Lymphoma Research; State Key Laboratory of Polymer Physics and Chemistry; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Plasma cell leukemia; Leukemia; Chromosome; Cancer research; Biology; Genetics; Medicine; Immunology; Bone marrow; Gene","score_opus":0.12189593627991017,"score_gpt":0.4022160662119751,"score_spread":0.2803201299320649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966423882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96747464,0.0017400599,0.000021843136,0.00024561322,0.00013391428,0.00088363036,0.000021837504,0.00007924343,0.029399231],"genre_scores_gemma":[0.98082554,0.0044932566,0.0023383107,0.00009161717,0.0006238089,0.00007977214,0.00002852738,0.00007796156,0.011441188],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9941303,0.0006040899,0.0010424302,0.00080078613,0.0021927853,0.0012296166],"domain_scores_gemma":[0.9950913,0.0022366676,0.000110141445,0.0010543067,0.00081039063,0.0006971904],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022150395,0.00031603043,0.0008068977,0.0006838505,0.00065248343,0.000055643937,0.00049240544,0.0005006716,0.00025806465],"category_scores_gemma":[0.0014430134,0.00028084934,0.00022761477,0.0010122441,0.0025373248,0.00020966426,0.00078892364,0.0019294135,0.00013644001],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.012685623,0.0035689701,0.2411209,0.01581121,0.0031305633,0.022078143,0.039138757,0.0017336997,0.21321154,0.008035101,0.37906635,0.060419165],"study_design_scores_gemma":[0.10577777,0.007707032,0.50458443,0.0018172022,0.00045097506,0.018106628,0.006612036,0.0841457,0.22746399,0.0013144963,0.039856855,0.002162872],"about_ca_topic_score_codex":0.0038062453,"about_ca_topic_score_gemma":0.00023360897,"teacher_disagreement_score":0.33920947,"about_ca_system_score_codex":0.018165411,"about_ca_system_score_gemma":0.032322578,"threshold_uncertainty_score":0.99996436},"labels":[],"label_agreement":null},{"id":"W1968363559","doi":"10.1016/j.leukres.2013.08.001","title":"Adhesion of ZAP-70+ chronic lymphocytic leukemia cells to stromal cells is enhanced by cytokines and blocked by inhibitors of the PI3-kinase pathway","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Stromal cell; PI3K/AKT/mTOR pathway; Cytokine; Cancer research; Chronic lymphocytic leukemia; Signal transduction; Cell biology; CD40; Focal adhesion; Biology; Immunology; Chemistry; Leukemia; Cytotoxic T cell; In vitro","score_opus":0.016017212918031244,"score_gpt":0.2880966235796338,"score_spread":0.2720794106616025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968363559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326,0.0016090673,0.000026070671,0.00052337383,0.00020267874,0.0030432593,0.00015169177,0.000057183348,0.001126665],"genre_scores_gemma":[0.98799014,0.0008092965,0.0001449422,0.000254635,0.00025723217,0.00028244357,0.000028314022,0.00013355345,0.010099445],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9909324,0.0005833082,0.0012405139,0.001190128,0.004248947,0.001804674],"domain_scores_gemma":[0.9944237,0.0011502022,0.00029244795,0.0019200547,0.0011420132,0.0010715907],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0018221434,0.00056583295,0.0010638546,0.0005362872,0.0003042798,0.00009365281,0.0012501159,0.0006462119,0.0011611835],"category_scores_gemma":[0.00072986423,0.00041769072,0.0002949441,0.0018164626,0.0013352588,0.00023290451,0.001466682,0.0012030298,0.00035024327],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00043757545,0.00009441593,0.000076102864,0.0010960456,0.000087417604,0.000024717318,0.00070788315,0.000065907996,0.8878942,0.000016697917,0.1041882,0.005310818],"study_design_scores_gemma":[0.013380681,0.0015104072,0.00016332642,0.0010740986,0.00003962785,0.000033423992,0.00047095199,0.009363749,0.9694026,0.000052711846,0.0041546104,0.00035379294],"about_ca_topic_score_codex":0.017828437,"about_ca_topic_score_gemma":0.00012302521,"teacher_disagreement_score":0.10003358,"about_ca_system_score_codex":0.07476454,"about_ca_system_score_gemma":0.052958805,"threshold_uncertainty_score":0.9998275},"labels":[],"label_agreement":null},{"id":"W1969714189","doi":"10.1016/j.leukres.2009.03.019","title":"Reduction in multi-lineage and erythroid progenitors distinguishes myelodysplastic syndromes from non-malignant cytopenias","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Vancouver General Hospital","funders":"BC Cancer Agency","keywords":"Cytopenia; Myelodysplastic syndromes; Progenitor cell; Bone marrow; Haematopoiesis; Dysplasia; Lineage (genetic); Progenitor; Peripheral blood; Medicine; Cancer research; Pathology; Internal medicine; Immunology; Stem cell; Biology; Genetics; Gene","score_opus":0.08105111945671498,"score_gpt":0.3819588372743892,"score_spread":0.3009077178176742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969714189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994537,0.0007544859,0.00013020588,0.0014925317,0.00015182287,0.0016721821,0.000025347017,0.0001092723,0.0011271699],"genre_scores_gemma":[0.9902803,0.0004887384,0.0056249644,0.00006814334,0.0005971865,0.00013333892,0.00010634046,0.00006992754,0.0026310608],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9950085,0.00039057888,0.00067116745,0.0011281073,0.001423257,0.0013783701],"domain_scores_gemma":[0.9973958,0.00066038215,0.000087222536,0.0007880556,0.0004752969,0.0005932235],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018970484,0.00037694362,0.0007183846,0.0009283764,0.0003287303,0.00018079448,0.0004107082,0.00038031032,0.000108515895],"category_scores_gemma":[0.002450065,0.00032573013,0.00010125797,0.0014747218,0.00057702017,0.00027732144,0.00030674826,0.0021296632,0.00021428033],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059628277,0.0018284408,0.095401876,0.00091561425,0.00040525116,0.013496141,0.0088950405,0.00021371199,0.76903087,0.00037352153,0.011557649,0.09191907],"study_design_scores_gemma":[0.018731315,0.0034478703,0.78649825,0.0023838314,0.00013154397,0.0019948436,0.0049450193,0.056644563,0.11992962,0.00086051103,0.0031771653,0.0012554958],"about_ca_topic_score_codex":0.0027516636,"about_ca_topic_score_gemma":0.0001819154,"teacher_disagreement_score":0.69109637,"about_ca_system_score_codex":0.002990435,"about_ca_system_score_gemma":0.0017717164,"threshold_uncertainty_score":0.9999195},"labels":[],"label_agreement":null},{"id":"W1971236526","doi":"10.1016/j.leukres.2013.01.001","title":"High-dose cytarabine-based consolidation shows superior results for older AML patients with intermediate risk cytogenetics in first complete remission","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Cytarabine; Mitoxantrone; Etoposide; Medicine; Internal medicine; Daunorubicin; Cytogenetics; Regimen; Multivariate analysis; Oncology; Leukemia; Surgery; Gastroenterology; Chemotherapy; Biology","score_opus":0.03875802131210687,"score_gpt":0.3175527483247753,"score_spread":0.27879472701266844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971236526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897277,0.00004277409,0.00045855186,0.0022829496,0.00009464063,0.0064530256,0.00045579698,0.00008335437,0.0004012348],"genre_scores_gemma":[0.9889053,0.00011004999,0.0066080857,0.00026998064,0.00022977487,0.0012729408,0.0016288904,0.00011178489,0.00086319994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99403304,0.0005541621,0.00091579056,0.0010837367,0.0018530685,0.0015601838],"domain_scores_gemma":[0.99393797,0.0019402121,0.0001868666,0.0012075697,0.0020502396,0.00067714177],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020295186,0.00042116517,0.00068358745,0.0010331774,0.00041140307,0.00017354748,0.00057963084,0.00038987395,0.000287895],"category_scores_gemma":[0.0030088255,0.00032617876,0.0001212384,0.001143263,0.00062971923,0.00026088284,0.00022884028,0.0017395342,0.00026614201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05771843,0.002150421,0.71910363,0.0023662145,0.00038873314,0.00041866046,0.0028749644,0.0030631213,0.035225924,0.000095770374,0.12317014,0.053423986],"study_design_scores_gemma":[0.058079023,0.003225791,0.8682404,0.00096783467,0.000054865544,0.0000112323605,0.00029142678,0.04684101,0.016161274,0.00012551883,0.0054517845,0.00054983364],"about_ca_topic_score_codex":0.003433974,"about_ca_topic_score_gemma":0.00073526596,"teacher_disagreement_score":0.14913677,"about_ca_system_score_codex":0.004098215,"about_ca_system_score_gemma":0.0026091721,"threshold_uncertainty_score":0.999919},"labels":[],"label_agreement":null},{"id":"W1971888832","doi":"10.1016/j.leukres.2010.07.015","title":"What are RBC-transfusion-dependence and -independence?","year":2010,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Independence (probability theory); Medicine; Erythropoiesis; Anemia; Intensive care medicine; Interval (graph theory); Transfusion therapy; Blood transfusion; Internal medicine; Statistics; Mathematics","score_opus":0.06272011493768677,"score_gpt":0.36454207019617724,"score_spread":0.3018219552584905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971888832","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12762001,0.004180749,0.000009679702,0.85916466,0.001126557,0.0026319171,0.00006891364,0.00011244298,0.0050851065],"genre_scores_gemma":[0.104071245,0.096301936,0.0014446724,0.6722732,0.015457614,0.0028804136,0.0008986783,0.0005381157,0.106134124],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99312687,0.0003895808,0.0004606228,0.001441705,0.0033335194,0.0012477039],"domain_scores_gemma":[0.99594855,0.0013445846,0.00012788118,0.0011662348,0.0009791043,0.0004336318],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0012117631,0.00058310427,0.0009564132,0.00065436854,0.00051166175,0.0005656393,0.0004173342,0.0035279528,0.0015278545],"category_scores_gemma":[0.00044125813,0.0004460426,0.00020228897,0.00047232446,0.00055721414,0.00036234452,0.00030726712,0.018138992,0.0006734915],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018304962,0.00013799056,0.015801664,0.00081679865,0.00025596813,0.014696629,0.00047567041,3.7971958e-7,0.0007879573,0.000093068724,0.95428604,0.012464804],"study_design_scores_gemma":[0.0029704394,0.00083237287,0.014550662,0.0027529646,0.00018756364,0.0013732938,0.00050923374,0.00007366413,0.0054820077,0.0010836166,0.96952164,0.0006625361],"about_ca_topic_score_codex":0.0009999553,"about_ca_topic_score_gemma":0.0008360243,"teacher_disagreement_score":0.18689144,"about_ca_system_score_codex":0.0010571975,"about_ca_system_score_gemma":0.0018395944,"threshold_uncertainty_score":0.99979913},"labels":[],"label_agreement":null},{"id":"W1972241790","doi":"10.1016/j.leukres.2015.01.015","title":"Incidence of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis in Calgary, Alberta, Canada","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"Health Research Board; University of Calgary; World Health Organization","keywords":"Lymphocytosis; Incidence (geometry); Chronic lymphocytic leukemia; Medicine; Population; Leukemia; Demography; Immunology; Internal medicine; Environmental health","score_opus":0.04314567899309261,"score_gpt":0.32430468315694544,"score_spread":0.2811590041638528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972241790","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761744,0.0041246307,0.00001670565,0.00024349823,0.00014193579,0.0011137621,0.000012012705,0.000031514315,0.018141536],"genre_scores_gemma":[0.9894213,0.0007467749,0.00038272186,0.00017746427,0.00022113802,0.00016538866,0.00003569788,0.0000934397,0.008756065],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9919571,0.000508302,0.0010044777,0.001065272,0.0035757069,0.0018891161],"domain_scores_gemma":[0.9944949,0.0018227845,0.00014951716,0.0012419169,0.000908022,0.0013828557],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028173113,0.0004427252,0.0009870145,0.0008428731,0.00014363414,0.00006122386,0.00076097436,0.00041120622,0.00017775202],"category_scores_gemma":[0.0019430004,0.00041712864,0.00010705069,0.001981415,0.0009549423,0.00024352326,0.0009235552,0.0011687586,0.00009759385],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.03783111,0.0019666962,0.1890893,0.029846657,0.0017451848,0.04471851,0.021273889,0.050293338,0.10117566,0.00849646,0.4066656,0.106897585],"study_design_scores_gemma":[0.09522716,0.002305085,0.008301003,0.0015506702,0.000097497876,0.002293826,0.0017208997,0.7822375,0.0868364,0.000558187,0.017775083,0.001096653],"about_ca_topic_score_codex":0.9824125,"about_ca_topic_score_gemma":0.82433605,"teacher_disagreement_score":0.7319442,"about_ca_system_score_codex":0.54181457,"about_ca_system_score_gemma":0.52757335,"threshold_uncertainty_score":0.99982804},"labels":[],"label_agreement":null},{"id":"W1972578692","doi":"10.1016/j.leukres.2009.04.009","title":"Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Methylation; CDKN2A; CpG site; Cancer research; DNA methylation; Biology; Biomarker; Oncology; Medicine; Internal medicine; Genetics; Cancer; Gene; Gene expression","score_opus":0.03828348548014472,"score_gpt":0.3431067613303727,"score_spread":0.304823275850228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972578692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99132913,0.0005329022,0.0000875199,0.0003692181,0.00007573849,0.0012577105,0.000036499707,0.000006136853,0.0063051395],"genre_scores_gemma":[0.9988473,0.00020607117,0.00016818597,0.00001889712,0.000044882247,0.000039199927,0.000008167286,0.000018569299,0.00064869976],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99437755,0.000874699,0.00086850015,0.00041662896,0.0027191604,0.00074346014],"domain_scores_gemma":[0.99680483,0.0015212832,0.00022371381,0.00073306554,0.0006005023,0.00011658185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028744496,0.00017595428,0.000476078,0.00063689135,0.00008463587,0.000013000257,0.0005412673,0.00021448782,0.00014447741],"category_scores_gemma":[0.0014720162,0.000117211275,0.0001659388,0.0022561343,0.00049220776,0.00014400792,0.00014695071,0.0012234015,0.0000052460005],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0019068795,0.00039226282,0.028755466,0.0005434392,0.000042044092,0.000028542843,0.011028821,0.014010144,0.93785584,0.0019182696,0.000113966365,0.0034043326],"study_design_scores_gemma":[0.012245067,0.00034340867,0.33729485,0.0006139015,0.00001736619,0.000018434042,0.0021659178,0.03054962,0.61348486,0.0030761904,0.00007702942,0.00011333005],"about_ca_topic_score_codex":0.0101320585,"about_ca_topic_score_gemma":0.0040466157,"teacher_disagreement_score":0.32437095,"about_ca_system_score_codex":0.01799335,"about_ca_system_score_gemma":0.016813258,"threshold_uncertainty_score":0.99645954},"labels":[],"label_agreement":null},{"id":"W1972727429","doi":"10.1016/j.leukres.2011.06.035","title":"Induction of apoptosis in pediatric acute lymphoblastic leukemia (ALL) cells by the therapeutic opioid methadone and effective synergy with Bcl-2 inhibition","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer, Stress, Anesthesia, and Immune Response","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Children's Hospital","funders":"","keywords":"Methadone; Apoptosis; Medicine; Leukemia; Pharmacology; Programmed cell death; Opioid; Cytotoxicity; Population; Cancer research; Oncology; Immunology; Internal medicine; Biology; Receptor; In vitro","score_opus":0.027659181922956765,"score_gpt":0.29046731096596873,"score_spread":0.262808129043012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972727429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955419,0.0025515112,0.00007792918,0.00014269455,0.00006594851,0.0009999528,0.000007452134,0.000024801282,0.0005878229],"genre_scores_gemma":[0.9928781,0.006007969,0.00007144617,0.00007259175,0.00015593124,0.00027430887,0.0000143856405,0.000043267348,0.00048203437],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99734473,0.00068236975,0.00033496242,0.00042131677,0.000700062,0.0005165431],"domain_scores_gemma":[0.9983512,0.00074698846,0.0001222831,0.00042398123,0.00023115802,0.00012438213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012318214,0.00022320244,0.00042041202,0.0005341972,0.00012700973,0.000025858079,0.0001485957,0.00020873174,0.00003643538],"category_scores_gemma":[0.00009076642,0.00014671836,0.00006856745,0.0010684483,0.0004971165,0.0001622351,0.00007563846,0.00068134174,0.000012473955],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030669086,0.0007734024,0.013695605,0.0016229587,0.0008090272,0.00014706483,0.014281068,0.000058706963,0.83693045,0.00031786348,0.0029770317,0.097717725],"study_design_scores_gemma":[0.008899517,0.0044285003,0.1321581,0.0004936664,0.0005410054,0.00031028988,0.0023292883,0.0004415537,0.84858364,0.00028801302,0.0011214012,0.00040503955],"about_ca_topic_score_codex":0.003880012,"about_ca_topic_score_gemma":0.00007767048,"teacher_disagreement_score":0.1184625,"about_ca_system_score_codex":0.0014309,"about_ca_system_score_gemma":0.0009207553,"threshold_uncertainty_score":0.59830016},"labels":[],"label_agreement":null},{"id":"W1974101399","doi":"10.1016/j.leukres.2011.05.001","title":"Validation of a scoring system to establish the probability of myelodysplastic syndrome in patients with unexplained cytopenias or macrocytosis","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Macrocytosis; Medicine; Myelodysplastic syndromes; Internal medicine; Bone marrow; Red blood cell distribution width; International Prognostic Scoring System; Bone marrow examination; Gastroenterology; Anemia","score_opus":0.06880836050930669,"score_gpt":0.31004931206278535,"score_spread":0.24124095155347866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974101399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942835,0.000010371146,0.00010913276,0.00012064603,0.000035064906,0.0036086114,0.000027145183,0.000033947974,0.0017715968],"genre_scores_gemma":[0.99709105,0.000004491649,0.0021186608,0.000013168735,0.000021875141,0.00036516637,0.000019503746,0.000049821894,0.00031624376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951138,0.00062109204,0.00077117234,0.0005817521,0.0020853719,0.00082681834],"domain_scores_gemma":[0.9959928,0.00090456044,0.00015672288,0.0011324061,0.001529435,0.00028409134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036172797,0.00022393183,0.00065856456,0.00086378347,0.00012528768,0.000030178187,0.0006965242,0.00015672315,0.00011808476],"category_scores_gemma":[0.0020946255,0.00013229162,0.00006558934,0.0033100827,0.00041198375,0.00022911625,0.00047291323,0.00087590044,0.000042474283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04667799,0.0011961957,0.9201109,0.0073385173,0.00034153674,0.0005072369,0.010089333,0.0005027998,0.008206574,0.001588247,0.00041042402,0.0030302533],"study_design_scores_gemma":[0.009026747,0.0058025825,0.9205056,0.0028681564,0.000072011,0.00008532449,0.0026475477,0.0008246322,0.057795964,0.00006207861,0.000040590487,0.00026879404],"about_ca_topic_score_codex":0.0028634735,"about_ca_topic_score_gemma":0.00021813271,"teacher_disagreement_score":0.04958939,"about_ca_system_score_codex":0.0035358036,"about_ca_system_score_gemma":0.002398978,"threshold_uncertainty_score":0.92460036},"labels":[],"label_agreement":null},{"id":"W1974511383","doi":"10.1016/j.leukres.2010.05.002","title":"Impact of cytogenetics in patients with relapsed or refractory multiple myeloma treated with bortezomib: Adverse effect of 1q21 gains","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Bortezomib; Multiple myeloma; Internal medicine; Refractory (planetary science); Medicine; Fluorescence in situ hybridization; Cytogenetics; Oncology; Adverse effect; Gastroenterology; Biology; Chromosome","score_opus":0.030969004063272687,"score_gpt":0.3650718684054194,"score_spread":0.3341028643421467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974511383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968643,0.000021792523,0.000002438574,0.0000102928425,0.00001412725,0.0022849706,0.00010906942,0.000026748998,0.0006662705],"genre_scores_gemma":[0.99848616,0.000030802483,0.00060262444,0.0000027838169,0.000030269235,0.000115859264,0.00020057648,0.00007781872,0.0004531275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959997,0.00042757162,0.00045965982,0.00050702394,0.0016868046,0.000919228],"domain_scores_gemma":[0.9963297,0.0011360303,0.00015628427,0.000998982,0.00086619385,0.00051278365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008346107,0.00033000624,0.0007729693,0.00083822553,0.00008188011,0.000010876909,0.0002642678,0.00025823398,0.00021864363],"category_scores_gemma":[0.0013514209,0.00017599639,0.00013870842,0.0013098471,0.0005909477,0.00011736092,0.00010500889,0.0012226602,0.000024239807],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068099976,0.0010315789,0.9006935,0.00025422493,0.00040273237,0.00042361353,0.00014730741,0.000036642192,0.02200573,0.0000013341877,0.00007435172,0.006829041],"study_design_scores_gemma":[0.041279707,0.02749948,0.8910885,0.00031203436,0.000053717275,0.000012684954,0.000035045126,0.0005532675,0.038990095,8.8271895e-7,0.000028018756,0.00014659908],"about_ca_topic_score_codex":0.0037025379,"about_ca_topic_score_gemma":0.0017132517,"teacher_disagreement_score":0.026820265,"about_ca_system_score_codex":0.0010105717,"about_ca_system_score_gemma":0.00192695,"threshold_uncertainty_score":0.7176925},"labels":[],"label_agreement":null},{"id":"W1974934205","doi":"10.1016/j.leukres.2008.06.030","title":"Investigation of an NQO1 polymorphism as a possible risk and prognostic factor for chronic lymphocytic leukemia","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"","keywords":"Chronic lymphocytic leukemia; Genotype; Apoptosis; Internal medicine; Oncology; Immunology; Leukemia; Cancer research; Medicine; Biology; Genetics; Gene","score_opus":0.08583140411174466,"score_gpt":0.3598572648351422,"score_spread":0.2740258607233975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974934205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933485,0.0020727797,0.00012426247,0.00011731059,0.00008812346,0.0032084465,0.000100276804,0.00014778768,0.0007925375],"genre_scores_gemma":[0.9927435,0.0011418153,0.0018355333,0.00008255662,0.00053440063,0.000478181,0.00010996098,0.00013806002,0.002935997],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9938013,0.00052100344,0.0008083567,0.0011007482,0.0021919934,0.0015766183],"domain_scores_gemma":[0.99448174,0.0019108301,0.00016648106,0.0012313448,0.0010998034,0.0011097995],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018563236,0.00041834527,0.0007990193,0.000994085,0.0006924939,0.00007628769,0.000526975,0.0005027876,0.00020612116],"category_scores_gemma":[0.0033337502,0.0003748515,0.00019257226,0.0013651978,0.0019701156,0.00043348465,0.00033488843,0.0010292273,0.00012930536],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.024019012,0.00059526705,0.124747396,0.021001969,0.0025149777,0.005635977,0.03851573,0.0023875954,0.63563275,0.0062512495,0.015182964,0.12351514],"study_design_scores_gemma":[0.08644461,0.014168548,0.09500061,0.0014471776,0.00031316406,0.005914256,0.00084929535,0.43281037,0.35473853,0.004802695,0.002284116,0.0012266185],"about_ca_topic_score_codex":0.012371544,"about_ca_topic_score_gemma":0.00020542977,"teacher_disagreement_score":0.43042278,"about_ca_system_score_codex":0.12110029,"about_ca_system_score_gemma":0.15350427,"threshold_uncertainty_score":0.99987036},"labels":[],"label_agreement":null},{"id":"W1978209348","doi":"10.1016/j.leukres.2011.01.002","title":"Prevalence and clinical characteristics of N-terminally truncated WT1 expression in acute myeloid leukemia","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Renal and related cancers","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Biomedical Innovation; Ministry of Health, Labour and Welfare; Ministry of Education, Culture, Sports, Science and Technology; Institut national de la recherche scientifique","keywords":"Myeloid leukemia; Acute promyelocytic leukemia; Gene isoform; Leukemia; Cancer research; Myeloid; Medicine; Wilms' tumor; Gene; Biology; Internal medicine; Immunology; Genetics; Retinoic acid","score_opus":0.044220017657999246,"score_gpt":0.3507350368077484,"score_spread":0.30651501914974916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978209348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755186,0.0004976408,0.00002396465,0.00001812581,0.00008323051,0.00020053382,0.000015665872,0.0000058021733,0.0016031533],"genre_scores_gemma":[0.9880599,0.010016742,0.00032137556,0.000029428624,0.00008626616,0.000019196865,0.000026051013,0.000017692702,0.0014233679],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9982518,0.00026216137,0.00043649727,0.00042018894,0.00027218272,0.00035716497],"domain_scores_gemma":[0.9992215,0.00004683068,0.00007673797,0.00035132343,0.0001654864,0.00013811176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090720516,0.00012708866,0.00021583166,0.00010450231,0.000054642253,0.000011576117,0.00032034708,0.00037572123,0.000029767549],"category_scores_gemma":[0.00016086838,0.00010241438,0.0000659465,0.00017240633,0.0004357968,0.000007635663,0.00027725322,0.00053499284,0.000009232261],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016343145,0.00008530833,0.14722444,0.00023580315,0.00008134872,0.0001174076,0.00028217235,0.0000018238009,0.83456206,0.000025316604,0.0007202083,0.015029777],"study_design_scores_gemma":[0.0013728373,0.0009829298,0.5287538,0.00031887708,0.000025861262,0.000039651124,0.000056051576,0.00018167363,0.46694875,0.0000949354,0.001013841,0.00021075523],"about_ca_topic_score_codex":0.00011561058,"about_ca_topic_score_gemma":0.00001364868,"teacher_disagreement_score":0.38152942,"about_ca_system_score_codex":0.00012224267,"about_ca_system_score_gemma":0.0006197227,"threshold_uncertainty_score":0.4176337},"labels":[],"label_agreement":null},{"id":"W1978698022","doi":"10.1016/s0145-2126(02)00078-4","title":"Microsatellite mutations of transforming growth factor-β receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Calgary; University of Saskatchewan","funders":"","keywords":"Biology; DNA mismatch repair; DNA methylation; Frameshift mutation; Microsatellite instability; Molecular biology; CpG site; Coding region; Epigenetics; Genetics; Microsatellite; Gene; Cancer research; Mutation; DNA repair; Gene expression; Allele","score_opus":0.07022919313065507,"score_gpt":0.3229667732685162,"score_spread":0.25273758013786113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978698022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965906,0.00034277036,0.0000098497385,0.00014460774,0.000058238584,0.0014630286,0.00010881224,0.00003540557,0.0012466882],"genre_scores_gemma":[0.996282,0.00016194803,0.00038382979,0.00003544599,0.000037282774,0.00012051144,0.00004096773,0.00006585807,0.0028721963],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969136,0.00033409128,0.00056265394,0.00058764516,0.0008915608,0.00071046123],"domain_scores_gemma":[0.9980591,0.0007353136,0.00016520538,0.00028988443,0.00055339135,0.00019711863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006911252,0.00029134372,0.0005572007,0.00077144266,0.000171712,0.000036744936,0.00018094502,0.00034784278,0.000734336],"category_scores_gemma":[0.00086279307,0.00023912593,0.00005268964,0.0016037103,0.00033252654,0.00015674498,0.00005981404,0.0006233504,0.000011528795],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021298989,0.000602078,0.062106397,0.0008568516,0.00008873251,0.00016643977,0.014326247,0.00012698525,0.91722226,0.000011080802,0.00029699324,0.002066056],"study_design_scores_gemma":[0.010448729,0.0032487996,0.081226565,0.0013624779,0.00005753729,0.00003827116,0.0011585889,0.0029241021,0.8988994,0.000044812627,0.0001620067,0.00042875065],"about_ca_topic_score_codex":0.0011051887,"about_ca_topic_score_gemma":0.0022486942,"teacher_disagreement_score":0.019120168,"about_ca_system_score_codex":0.0038542717,"about_ca_system_score_gemma":0.0008857218,"threshold_uncertainty_score":0.9999698},"labels":[],"label_agreement":null},{"id":"W1980393873","doi":"10.1016/j.leukres.2013.02.009","title":"Symptom burden and supportive care in patients with acute leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":145,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto; Ontario Institute for Cancer Research","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Sadness; Referral; Psychosocial; Acute leukemia; Population; Palliative care; Anger; Leukemia; Psychiatry; Physical therapy; Pediatrics; Intensive care medicine; Internal medicine; Family medicine; Nursing","score_opus":0.05923042890475087,"score_gpt":0.40838790978477907,"score_spread":0.3491574808800282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980393873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992103,0.0006044483,0.0000038153157,0.00025102,0.000020182111,0.00077193073,0.000017508488,0.000018525947,0.006209615],"genre_scores_gemma":[0.99797446,0.00032953452,0.0005350174,0.00005252463,0.00008443116,0.000084570456,0.00007133815,0.00002591763,0.00084223115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980994,0.00010112386,0.00023157569,0.00032897337,0.00075096654,0.0004879764],"domain_scores_gemma":[0.9983608,0.00020924305,0.00003472785,0.0003066353,0.000879648,0.00020895079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020212984,0.00014546239,0.00034264565,0.00030537607,0.00005335981,0.000025112453,0.00012788,0.00012664468,0.00015642037],"category_scores_gemma":[0.00017660517,0.00010644133,0.00003240422,0.0004369666,0.00028028802,0.00015656605,0.0001243692,0.0005168964,0.00008091254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006714866,0.000025872825,0.9752883,0.00027229878,0.00013052276,0.00010757117,0.008916164,0.0000057156753,0.00068614667,0.000060792496,0.0022156993,0.011619467],"study_design_scores_gemma":[0.0068679657,0.0018651631,0.9724255,0.0011650209,0.000044030305,0.000003841751,0.006925865,0.00015010423,0.00561682,0.00008827098,0.0046420223,0.00020536485],"about_ca_topic_score_codex":0.0033758145,"about_ca_topic_score_gemma":0.000088510846,"teacher_disagreement_score":0.011414102,"about_ca_system_score_codex":0.0013233516,"about_ca_system_score_gemma":0.00086316146,"threshold_uncertainty_score":0.5103244},"labels":[],"label_agreement":null},{"id":"W1980590287","doi":"10.1016/j.leukres.2012.07.013","title":"Dasatinib inhibits leukaemic cell survival by decreasing PRH/Hhex phosphorylation resulting in increased repression of VEGF signalling genes","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Wellcome Trust","keywords":"Dasatinib; Psychological repression; Phosphorylation; Cell biology; Proto-oncogene tyrosine-protein kinase Src; Transcription factor; Cancer research; Biology; Myeloid leukemia; Chemistry; Signal transduction; Molecular biology; Gene; Tyrosine kinase; Gene expression; Biochemistry","score_opus":0.06927618701549326,"score_gpt":0.36445768919430604,"score_spread":0.2951815021788128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980590287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878513,0.005350321,0.00005783185,0.000056021312,0.00010245878,0.0010401175,0.000017531398,0.00006891538,0.005455464],"genre_scores_gemma":[0.9955761,0.00050131994,0.0024754754,0.000024286854,0.00027743328,0.00008010645,0.00026519113,0.00008654577,0.00071358506],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99462926,0.0008074044,0.00096314575,0.00066829415,0.0016815112,0.0012503878],"domain_scores_gemma":[0.9967445,0.0014123584,0.00029665956,0.0007029771,0.00037790427,0.00046561536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047717863,0.0003218027,0.0006244883,0.0005283073,0.00021142382,0.000037949776,0.00025773837,0.00037908964,0.00012416749],"category_scores_gemma":[0.0016370172,0.00030004553,0.000119986114,0.001125195,0.00018597745,0.00037927492,0.0002712763,0.0011394443,0.000060425686],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012891439,0.00040674995,0.21547471,0.00044341473,0.000040364463,0.00003462237,0.0015270418,0.00012988097,0.77067316,0.000026872043,0.0005392636,0.009414805],"study_design_scores_gemma":[0.009741751,0.00024159478,0.033650715,0.0015738603,0.0000525417,0.000027846607,0.0008951644,0.0068833977,0.9458498,0.000050599345,0.00073029567,0.00030248147],"about_ca_topic_score_codex":0.008245244,"about_ca_topic_score_gemma":0.00007731701,"teacher_disagreement_score":0.181824,"about_ca_system_score_codex":0.005883746,"about_ca_system_score_gemma":0.001904261,"threshold_uncertainty_score":0.99994516},"labels":[],"label_agreement":null},{"id":"W1980656001","doi":"10.1016/j.leukres.2011.05.023","title":"CASP8AP2 is a promising prognostic indicator in pediatric acute lymphoblastic leukemia","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"","keywords":"Medicine; Minimal residual disease; Bone marrow; Oncology; Internal medicine; Cohort; Disease; Overall survival","score_opus":0.06316909539166278,"score_gpt":0.34194616434308045,"score_spread":0.2787770689514177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980656001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735023,0.0004494294,0.00016922884,0.00040674294,0.00018374031,0.0029289469,0.000032081236,0.00024286259,0.022084719],"genre_scores_gemma":[0.9914694,0.0006495176,0.0026762073,0.00042323215,0.0006538673,0.0006981249,0.000041579668,0.000229543,0.0031585514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9896832,0.0006203364,0.0012084752,0.0017189176,0.0035630642,0.0032059734],"domain_scores_gemma":[0.9949311,0.0012085154,0.00014622809,0.0016052275,0.0007467873,0.0013621375],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0031917482,0.0006570515,0.0010247425,0.0032143537,0.00040509857,0.00014891193,0.0012140118,0.00080416386,0.0014626625],"category_scores_gemma":[0.0023998162,0.000586843,0.0002658188,0.004633736,0.0008281603,0.00042754444,0.0009859997,0.0029245599,0.0034428493],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008451685,0.0018970923,0.8596055,0.0033647337,0.00086775876,0.028958257,0.020487178,0.000020902218,0.013091998,0.0013423812,0.04991317,0.011999324],"study_design_scores_gemma":[0.03251781,0.0047663315,0.89208037,0.001395618,0.00083048927,0.004047454,0.0014866563,0.022606142,0.03280373,0.0025921883,0.002731206,0.0021420028],"about_ca_topic_score_codex":0.002051737,"about_ca_topic_score_gemma":0.0000721555,"teacher_disagreement_score":0.047181964,"about_ca_system_score_codex":0.019739974,"about_ca_system_score_gemma":0.021462498,"threshold_uncertainty_score":0.9996583},"labels":[],"label_agreement":null},{"id":"W1980663284","doi":"10.1016/j.leukres.2008.07.015","title":"Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib plasma levels","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia; BC Cancer Agency","funders":"BC Cancer Agency; Michael Smith Health Research BC","keywords":"Imatinib; Myeloid leukemia; Internal medicine; Medicine; Odds ratio; Gastroenterology; Trough (economics); Trough level; Oncology","score_opus":0.061519008866460737,"score_gpt":0.34157451335812333,"score_spread":0.2800555044916626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980663284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471396,0.0019287235,0.00012076542,0.00032135754,0.000027985332,0.002419511,0.00020930731,0.000059563503,0.00019882125],"genre_scores_gemma":[0.99285,0.0028661394,0.0032667888,0.00007929457,0.00006133118,0.0002454015,0.000040538267,0.00009915381,0.00049132033],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9950973,0.00070642796,0.0008221332,0.00090391934,0.0015533123,0.0009169043],"domain_scores_gemma":[0.99715024,0.00089431665,0.00028315285,0.00077583664,0.000492167,0.0004042803],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012258935,0.00045673797,0.00088522874,0.00077665533,0.0003141538,0.000055765213,0.0002251417,0.0003008168,0.00007713517],"category_scores_gemma":[0.0009617398,0.0003723259,0.000073936,0.0010309834,0.00081301894,0.00018603752,0.00019258009,0.0010524674,0.000022117527],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.06916568,0.00029272021,0.21385354,0.00094097375,0.0007254977,0.004215035,0.010304663,0.0027297942,0.6630527,0.0001208785,0.00049402204,0.034104496],"study_design_scores_gemma":[0.03687789,0.006045182,0.53410447,0.0011943665,0.00007250478,0.00094262185,0.0008136121,0.008398668,0.4108248,0.00007672095,0.00018146122,0.00046771142],"about_ca_topic_score_codex":0.002128836,"about_ca_topic_score_gemma":0.00051480765,"teacher_disagreement_score":0.32025093,"about_ca_system_score_codex":0.007669998,"about_ca_system_score_gemma":0.007481933,"threshold_uncertainty_score":0.99987286},"labels":[],"label_agreement":null},{"id":"W1981161460","doi":"10.1016/j.leukres.2009.01.010","title":"p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Leukemia and Lymphoma Research; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Intramedullary rod; Multiple myeloma; Bone marrow; Medicine; Pathology; Medullary cavity; Proliferation index; Plasmacytoma; Immunohistochemistry; Internal medicine; Anatomy","score_opus":0.09732688832183028,"score_gpt":0.4157256430816742,"score_spread":0.3183987547598439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981161460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99266297,0.0001924405,0.000018811956,0.0010870544,0.000014473483,0.0011918987,0.000019186145,0.00009009276,0.0047230613],"genre_scores_gemma":[0.99683857,0.00007247283,0.0016141037,0.0001131136,0.000066757835,0.000029980825,0.0001346173,0.000039177085,0.0010911828],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961923,0.0002573418,0.00031560622,0.00043692597,0.002015584,0.0007822856],"domain_scores_gemma":[0.9977831,0.00040148763,0.00009778584,0.00054823497,0.0007741348,0.00039526128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008227453,0.00019032137,0.00037836994,0.0004115053,0.00023857935,0.000045820998,0.00020399332,0.00022696397,0.00029070448],"category_scores_gemma":[0.0011283354,0.00013630178,0.000096317504,0.0009361603,0.00024220545,0.0001712662,0.0000751467,0.00070819823,0.00009675275],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014685131,0.0032143453,0.34517455,0.0003478794,0.00072734884,0.0021319122,0.0022387416,0.00004878818,0.13116565,0.00044771878,0.009212678,0.49060524],"study_design_scores_gemma":[0.010886932,0.0051618232,0.92595565,0.0010043096,0.000043141583,0.00006104872,0.00023655644,0.02139848,0.03341566,0.00024513103,0.001380251,0.00021103868],"about_ca_topic_score_codex":0.00014550793,"about_ca_topic_score_gemma":0.000022229404,"teacher_disagreement_score":0.58078104,"about_ca_system_score_codex":0.0009174683,"about_ca_system_score_gemma":0.00065107533,"threshold_uncertainty_score":0.55582255},"labels":[],"label_agreement":null},{"id":"W1981572464","doi":"10.1016/j.leukres.2006.03.029","title":"Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Cytotoxic T cell; Daunorubicin; Cytarabine; Etoposide; Bone marrow; Troglitazone; Pharmacology; Leukemia; Chemistry; Medicine; In vitro; Immunology; Internal medicine; Chemotherapy; Biochemistry","score_opus":0.024792458038532843,"score_gpt":0.3256734553512945,"score_spread":0.30088099731276163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981572464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928223,0.0002965594,0.00015837034,0.00030992556,0.000057809324,0.0025239792,0.000011710685,0.000050614224,0.0037687547],"genre_scores_gemma":[0.994594,0.00017258221,0.00090325344,0.000051028106,0.00009264435,0.00035396972,0.00009476014,0.00009430367,0.003643482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99412245,0.00071650086,0.000768478,0.0007707199,0.0021152433,0.0015066206],"domain_scores_gemma":[0.99702287,0.0012204412,0.00012265843,0.00086696644,0.0005109968,0.00025609482],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020470368,0.0003406182,0.0008435676,0.0021344554,0.000107143365,0.00004124233,0.00051966944,0.0003815503,0.000059810234],"category_scores_gemma":[0.00042239396,0.0002936255,0.00010031329,0.003264269,0.0006071773,0.00017588721,0.00024791164,0.0019287589,0.00013131752],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034840885,0.0016112305,0.050901495,0.0020686097,0.00015416484,0.010339016,0.00068872486,0.00091636943,0.9221503,0.0015613418,0.0030837294,0.003040931],"study_design_scores_gemma":[0.027050251,0.0036617315,0.32904276,0.0014403078,0.00008173304,0.00010839809,0.00026561914,0.009144831,0.62712187,0.0012752076,0.00031004855,0.0004972176],"about_ca_topic_score_codex":0.0082189655,"about_ca_topic_score_gemma":0.001024068,"teacher_disagreement_score":0.29502842,"about_ca_system_score_codex":0.008418513,"about_ca_system_score_gemma":0.002618357,"threshold_uncertainty_score":0.9999516},"labels":[],"label_agreement":null},{"id":"W1983100070","doi":"10.1016/s0145-2126(06)80002-0","title":"Principles of maintenance therapy","year":2006,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Maintenance therapy; Medicine; Rituximab; Asymptomatic; Follicular lymphoma; Disease; Randomized controlled trial; Internal medicine; Oncology; Intensive care medicine; Lymphoma; Surgery; Chemotherapy","score_opus":0.3289401216310138,"score_gpt":0.481570942499759,"score_spread":0.1526308208687452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983100070","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000121136596,0.94807005,7.487e-7,0.000060097926,0.000047322934,0.0014753153,0.000038265305,0.0000238653,0.050163224],"genre_scores_gemma":[0.000089033085,0.9795498,0.00020023069,0.0000151283975,0.00022052239,0.00049850164,0.00014921636,0.00005624538,0.019221285],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99724764,0.0002440897,0.0006053438,0.00044922868,0.0009084671,0.0005452472],"domain_scores_gemma":[0.99799895,0.0005630988,0.000170771,0.00082979293,0.00030259258,0.00013479448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008055643,0.00028442236,0.0016141164,0.00037426985,0.00006645798,0.000021230775,0.0002731672,0.0003153802,0.00011847274],"category_scores_gemma":[0.0001364051,0.00016938076,0.000550714,0.00061511673,0.00023417588,0.000021730038,0.00012392603,0.00051087554,0.0002225008],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032768683,0.00029612897,0.00017014844,0.010181981,0.00024229097,0.00026783487,0.000012895934,2.4345803e-7,7.9799764e-7,0.002542065,0.008248355,0.9780045],"study_design_scores_gemma":[0.0012510498,0.00031351918,0.00038561106,0.014610435,0.00011722151,0.00008066752,0.0000051414213,0.000002912752,0.000045740435,0.000024992525,0.983044,0.00011868133],"about_ca_topic_score_codex":0.0006625936,"about_ca_topic_score_gemma":0.000015251047,"teacher_disagreement_score":0.9778858,"about_ca_system_score_codex":0.0024972535,"about_ca_system_score_gemma":0.0034699992,"threshold_uncertainty_score":0.69071466},"labels":[],"label_agreement":null},{"id":"W1985662900","doi":"10.1016/j.leukres.2012.05.020","title":"Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Myeloid leukemia; Quality of life (healthcare); Chemotherapy; Young adult; Gerontology; Pediatrics; Internal medicine","score_opus":0.07527798105685493,"score_gpt":0.3864335675960221,"score_spread":0.3111555865391672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985662900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971282,0.00016342077,0.0001490079,0.0010156444,0.00009878468,0.0009886787,0.00006887987,0.000045415127,0.00034195744],"genre_scores_gemma":[0.9959642,0.000030581585,0.0000509229,0.001633576,0.00038994645,0.00013971343,0.00008094236,0.000052611955,0.0016574684],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9976687,0.00016739995,0.0002757586,0.0003738056,0.000847356,0.00066699047],"domain_scores_gemma":[0.9977775,0.0003527087,0.000069231544,0.00038350333,0.0009900272,0.0004270284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008656535,0.00020004928,0.00064752885,0.00017255383,0.00014361099,0.000032765416,0.00011185498,0.00014934727,0.00005137004],"category_scores_gemma":[0.0003474877,0.00016269358,0.000118643504,0.0005085634,0.00022381557,0.00015233908,0.00008615979,0.0004940139,0.0000074367017],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047327816,0.00069844257,0.088899344,0.0020477255,0.004198239,0.00010247379,0.16409014,0.000022825012,0.65321743,0.00033914216,0.035141155,0.0039152773],"study_design_scores_gemma":[0.013965427,0.0012487419,0.9042234,0.00048116574,0.00024681623,0.000010637554,0.012170723,0.0003162831,0.064231664,0.00009442625,0.0025144143,0.00049634767],"about_ca_topic_score_codex":0.0012014826,"about_ca_topic_score_gemma":0.00038545654,"teacher_disagreement_score":0.815324,"about_ca_system_score_codex":0.0014266968,"about_ca_system_score_gemma":0.00041828962,"threshold_uncertainty_score":0.6634452},"labels":[],"label_agreement":null},{"id":"W1986612400","doi":"10.1016/s0145-2126(99)00188-5","title":"All trans retinoic acid induces apoptosis in acute promyelocytic NB4 cells when combined with isoquinolinediol, a poly(ADP-ribose) polymerase inhibitor","year":2000,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph; Hospital for Sick Children; SickKids Foundation","funders":"Cancer Research Society","keywords":"Poly ADP ribose polymerase; Acute promyelocytic leukemia; Apoptosis; Retinoic acid; DNA fragmentation; Molecular biology; Cellular differentiation; Tretinoin; Chemistry; Acute monocytic leukemia; Biology; Cancer research; Leukemia; Polymerase; Biochemistry; Programmed cell death; Immunology; DNA","score_opus":0.018808746916901518,"score_gpt":0.2855546692322381,"score_spread":0.26674592231533656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986612400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99320936,0.0016248694,0.000080415746,0.0010850561,0.00009448761,0.0008609375,0.00004047554,0.000052400985,0.0029519976],"genre_scores_gemma":[0.9901631,0.0013917305,0.000905841,0.0003900721,0.0005996572,0.00032504255,0.0002646777,0.00011106073,0.0058488357],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99539655,0.00047857632,0.0005888808,0.0011710013,0.0009514318,0.0014135491],"domain_scores_gemma":[0.9982856,0.00006769672,0.00009270226,0.00093989127,0.0002447602,0.0003693572],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008543963,0.0004985994,0.00049521594,0.0003084784,0.00023665052,0.00016088369,0.0009669655,0.0006233223,0.00034886156],"category_scores_gemma":[0.00006653241,0.0004273634,0.00015007771,0.0007277668,0.00058929285,0.0000353608,0.00017242697,0.0011041024,0.000097656426],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029261457,0.00020296886,0.00032663372,0.00016744323,0.00016229178,0.00011012177,0.0006729113,0.000031504766,0.98590696,0.000014832723,0.0034179306,0.006060261],"study_design_scores_gemma":[0.003902693,0.0018675489,0.00011163485,0.00013501236,0.000046262463,0.000047059115,0.0002410351,0.0001208733,0.98052615,0.000100499485,0.01234654,0.0005546641],"about_ca_topic_score_codex":0.00044931605,"about_ca_topic_score_gemma":0.00008526748,"teacher_disagreement_score":0.008928609,"about_ca_system_score_codex":0.00042542967,"about_ca_system_score_gemma":0.0015893428,"threshold_uncertainty_score":0.9998178},"labels":[],"label_agreement":null},{"id":"W1989503397","doi":"10.1016/j.leukres.2005.05.014","title":"Viscum album agglutinin-I (VAA-I) induces apoptosis and degradation of cytoskeletal proteins in human leukemia PLB-985 and X-CGD cells via caspases: Lamin B1 is a novel target of VAA-I","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National de la Recherche Scientifique","funders":"Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research","keywords":"Apoptosis; Biology; Caspase; Cytoskeleton; Molecular biology; Cell culture; Cell biology; Programmed cell death; Lamin; Cell; Biochemistry; Genetics","score_opus":0.029486022539367177,"score_gpt":0.29872084006899485,"score_spread":0.2692348175296277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989503397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966002,0.0012255075,0.0003999328,0.00019251724,0.00008239486,0.00094109826,0.00013529364,0.00002421337,0.0003988373],"genre_scores_gemma":[0.9951536,0.00024919465,0.002135498,0.00005011155,0.000041471932,0.000102292084,0.0000814424,0.000041292995,0.0021450848],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997136,0.000405254,0.0007740814,0.00063460734,0.0002465736,0.00080345984],"domain_scores_gemma":[0.9987002,0.00026772692,0.00026516098,0.0004937446,0.00020596855,0.00006720728],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014515636,0.0003140595,0.00062991545,0.00066260464,0.00029105775,0.000035448535,0.00041090333,0.0005875368,0.00032309766],"category_scores_gemma":[0.00013325922,0.00029281533,0.00009264217,0.00047341353,0.0007498805,0.00029912937,0.00042192175,0.0010642192,0.00003419581],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018411032,0.00022340205,0.00042544672,0.00016885108,0.00009666141,0.0000021876078,0.0017867392,0.000014071728,0.9906316,0.0008963395,0.00037013815,0.0052004904],"study_design_scores_gemma":[0.0032063953,0.0008104562,0.003944213,0.00017043117,0.000020749536,0.000019231653,0.0009439428,0.00019354517,0.9882514,0.00028851733,0.0018730226,0.00027812502],"about_ca_topic_score_codex":0.004631777,"about_ca_topic_score_gemma":0.00040002918,"teacher_disagreement_score":0.0049223653,"about_ca_system_score_codex":0.00047731507,"about_ca_system_score_gemma":0.00049192924,"threshold_uncertainty_score":0.9999524},"labels":[],"label_agreement":null},{"id":"W1990362267","doi":"10.1016/j.leukres.2012.10.010","title":"Bone marrow dendritic cells are reduced in patients with high-risk myelodysplastic syndromes","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"","keywords":"Myelodysplastic syndromes; Immune system; Bone marrow; Flow cytometry; Medicine; Stem cell; Immunology; Dendritic cell; Bone marrow failure; Biology; Haematopoiesis; Cell biology","score_opus":0.018762837993635997,"score_gpt":0.26590736032765533,"score_spread":0.24714452233401935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990362267","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939894,0.0045268675,0.0000064749406,0.00007027448,0.0005872121,0.00051840156,0.000039725415,0.0000496586,0.00021197442],"genre_scores_gemma":[0.9937339,0.00025611158,0.000064316875,0.00003438786,0.00003515789,0.00009165228,0.00006860967,0.000052514286,0.005663342],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9960354,0.0015678536,0.00037031842,0.00037063056,0.00021241601,0.0014434132],"domain_scores_gemma":[0.9980625,0.0009945262,0.000117223724,0.0005744016,0.00019093725,0.00006041291],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012645599,0.0002593872,0.0004292127,0.0005872847,0.00039091872,0.00003703983,0.00038286243,0.0003559206,0.00079223857],"category_scores_gemma":[0.00034707805,0.00020838722,0.00006279601,0.00063035294,0.00050354196,0.00028350358,0.00014999676,0.0014181782,0.0019069259],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013338126,0.0016914948,0.45441285,0.00021705232,0.0006017373,0.000086526816,0.0022705586,0.000047891906,0.51016706,0.00046438584,0.0073946174,0.0093077235],"study_design_scores_gemma":[0.006758387,0.0008183182,0.85345244,0.00024084255,0.000025588215,0.000040148072,0.00045180993,0.0000017482569,0.13267963,0.000046602756,0.005126091,0.00035840616],"about_ca_topic_score_codex":0.0007459218,"about_ca_topic_score_gemma":0.000043096494,"teacher_disagreement_score":0.3990396,"about_ca_system_score_codex":0.0006455564,"about_ca_system_score_gemma":0.0002911069,"threshold_uncertainty_score":0.9988702},"labels":[],"label_agreement":null},{"id":"W1991554870","doi":"10.1016/j.leukres.2014.08.008","title":"Polymeric nanoparticle-mediated silencing of CD44 receptor in CD34+ acute myeloid leukemia cells","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"RNA Interference and Gene Delivery","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency; Canadian Blood Services; University of Alberta","funders":"University of Alberta; Alberta Innovates; Alberta Innovates - Health Solutions; Canadian Blood Services","keywords":"CD44; Gene silencing; Myeloid leukemia; Cancer research; Stem cell; Leukemia; Jurkat cells; Chemistry; Biology; Cell biology; Cell; Immunology; Biochemistry; Immune system; T cell","score_opus":0.020268339546957215,"score_gpt":0.2966030288540788,"score_spread":0.2763346893071216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991554870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972655,0.00042718128,0.00007531376,0.000082833736,0.00014256053,0.00019475455,0.000019272777,0.000012177065,0.0017803622],"genre_scores_gemma":[0.9971949,0.0006688815,0.00019739196,0.0001340562,0.00018415514,0.000039688915,0.00006913712,0.000030308553,0.0014814859],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9976168,0.00034982257,0.0004025717,0.0005021076,0.00043765726,0.0006910153],"domain_scores_gemma":[0.9988504,0.00011613863,0.00008341675,0.00057392876,0.00022270283,0.0001534115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009931679,0.00017472962,0.000260437,0.00022342295,0.00007890794,0.000029219756,0.0005253282,0.00020933455,0.00009922472],"category_scores_gemma":[0.0002594858,0.00017064776,0.00009167918,0.00052503706,0.00022482136,0.000011513851,0.00028748077,0.00037639585,0.00023694284],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022383436,0.000031710384,0.0015823083,0.000029983315,0.000034282046,0.0000057404645,0.00014518561,0.00013548876,0.9897524,0.000020584519,0.003562361,0.00447612],"study_design_scores_gemma":[0.0007694813,0.0005559287,0.0011775774,0.00005386928,0.0000060524612,0.000003845548,0.00020716662,0.0009382747,0.9930469,0.000032018994,0.003023441,0.00018545441],"about_ca_topic_score_codex":0.000895367,"about_ca_topic_score_gemma":0.00014067492,"teacher_disagreement_score":0.004290666,"about_ca_system_score_codex":0.00027265915,"about_ca_system_score_gemma":0.0006532709,"threshold_uncertainty_score":0.69588137},"labels":[],"label_agreement":null},{"id":"W1991958842","doi":"10.1016/j.leukres.2004.11.012","title":"Engineering 3-alkyltriazenes to block bcr-abl kinase: a novel strategy for the therapy of advanced bcr-abl expressing leukemias","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Autophosphorylation; Tyrosine kinase; K562 cells; Cancer research; ABL; Chronic myelogenous leukemia; Leukemia; breakpoint cluster region; Philadelphia chromosome; Molecular biology; Biology; Chemistry; Kinase; Cell biology; Biochemistry; Immunology; Signal transduction; Protein kinase A; Receptor","score_opus":0.10583180042391337,"score_gpt":0.3902554435472102,"score_spread":0.2844236431232968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991958842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831013,0.0067798863,0.0018581215,0.002201249,0.00020300238,0.004221733,0.00006992727,0.0001685717,0.0013962089],"genre_scores_gemma":[0.9766894,0.0010126746,0.015189906,0.00024911622,0.0010058293,0.0010120511,0.000035888857,0.00016666396,0.0046384595],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9953982,0.00010324213,0.0007680404,0.0008514437,0.0014244182,0.0014546285],"domain_scores_gemma":[0.99513394,0.0021589242,0.00014778823,0.0014242704,0.00069091463,0.00044419453],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017025121,0.00047610237,0.00074451,0.0005125951,0.0003686468,0.00010675619,0.00073470286,0.00029360465,0.00018034787],"category_scores_gemma":[0.0010748464,0.00034978616,0.0002933135,0.0011226018,0.00020282756,0.000237529,0.00024009407,0.0009432632,0.000075113356],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026649015,0.00038678816,0.00018223087,0.00035712743,0.0004527029,0.000041249245,0.0012888045,0.08656076,0.7134175,0.00053014397,0.0049536778,0.18916415],"study_design_scores_gemma":[0.030129973,0.002069684,0.0036565433,0.0012579699,0.00011732468,0.00016470057,0.0013713497,0.06347519,0.64630485,0.000068197674,0.25064346,0.00074074813],"about_ca_topic_score_codex":0.0005619948,"about_ca_topic_score_gemma":0.0000689003,"teacher_disagreement_score":0.24568978,"about_ca_system_score_codex":0.006083079,"about_ca_system_score_gemma":0.0032990903,"threshold_uncertainty_score":0.9998954},"labels":[],"label_agreement":null},{"id":"W1993701888","doi":"10.1016/j.leukres.2009.06.019","title":"CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Methylation; Myeloid leukemia; CpG site; Myelodysplastic syndromes; MEG3; DNA methylation; Internal medicine; Biology; Cancer research; Oncology; Medicine; Bone marrow; Gene; Genetics; Gene expression","score_opus":0.026018310621875942,"score_gpt":0.33296416264056117,"score_spread":0.30694585201868524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993701888","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574274,0.00289726,0.00065792375,0.0001611748,0.000026961317,0.00020242436,0.000012388399,0.000003995757,0.00029512015],"genre_scores_gemma":[0.99641013,0.0028815581,0.00031458962,0.000022180811,0.000028743016,0.000014326331,0.000038167193,0.000009869123,0.00028045903],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99846673,0.0002677966,0.00028110718,0.00037845422,0.0003232327,0.00028266304],"domain_scores_gemma":[0.9992041,0.00011000956,0.00007714498,0.00036820478,0.00016537083,0.00007516626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009199708,0.00012693026,0.00022939731,0.00036160418,0.00010871472,0.000037108184,0.00018792757,0.00018864748,0.000008584432],"category_scores_gemma":[0.00023600139,0.00009921037,0.00007149545,0.000942594,0.00017628871,0.0000073759234,0.00018077398,0.00021850997,7.221867e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073135416,0.000013897579,0.023084063,0.00001485348,0.00022289073,0.0000025874592,0.00010801812,0.0009617769,0.95957196,0.00023404894,0.000012308622,0.015700484],"study_design_scores_gemma":[0.0004670861,0.00020951117,0.57804835,0.000014931987,0.00013891427,0.0000028494353,0.00005860785,0.008500904,0.41123852,0.0008313274,0.00036947455,0.00011952168],"about_ca_topic_score_codex":0.0002223323,"about_ca_topic_score_gemma":0.00030114426,"teacher_disagreement_score":0.5549643,"about_ca_system_score_codex":0.00012683925,"about_ca_system_score_gemma":0.00021680292,"threshold_uncertainty_score":0.40456814},"labels":[],"label_agreement":null},{"id":"W1994072538","doi":"10.1016/s0145-2126(01)00181-3","title":"The kinase inhibitor STI571 reverses the Bcr–Abl induced point mutation frequencies observed in pre-leukemic P190Bcr–Abl transgenic mice","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"Medical Research Council","keywords":"ABL; Chronic myelogenous leukemia; Point mutation; Cancer research; Biology; Leukemia; Philadelphia chromosome; breakpoint cluster region; Transgene; Genetically modified mouse; Tyrosine-kinase inhibitor; Tyrosine kinase; Molecular biology; Mutation; Immunology; Chromosomal translocation; Cancer; Genetics; Signal transduction; Receptor; Gene","score_opus":0.11712964894598563,"score_gpt":0.34268559322263736,"score_spread":0.22555594427665174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994072538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98459893,0.00332363,0.000008797244,0.0058719823,0.000349485,0.0028419443,0.000023243067,0.00013354198,0.0028484392],"genre_scores_gemma":[0.98701125,0.001745378,0.00024608284,0.00035048512,0.00045151947,0.0007143405,0.00005030036,0.000103021346,0.009327611],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9931692,0.0012785507,0.0009574188,0.0009262247,0.0020353557,0.001633249],"domain_scores_gemma":[0.994744,0.0026527522,0.00017370304,0.0015862155,0.00049065525,0.00035265234],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0031010024,0.00049043895,0.00056350505,0.00041527947,0.00091223145,0.0002169081,0.0009043817,0.00041526216,0.00050404534],"category_scores_gemma":[0.002397787,0.0003099964,0.00026678471,0.0019513419,0.0007066226,0.00039138127,0.00021638897,0.0025850679,0.0005391219],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046706926,0.0015703461,0.01085658,0.0014382194,0.0011872319,0.0026376355,0.04136257,0.000762245,0.76563835,0.002295516,0.07375489,0.093825705],"study_design_scores_gemma":[0.08785182,0.007487716,0.33666107,0.0054275603,0.0010150917,0.0019356076,0.028406551,0.056437183,0.39116552,0.0062985895,0.07371587,0.003597402],"about_ca_topic_score_codex":0.009040733,"about_ca_topic_score_gemma":0.0033901015,"teacher_disagreement_score":0.37447283,"about_ca_system_score_codex":0.014200926,"about_ca_system_score_gemma":0.0025710606,"threshold_uncertainty_score":0.9999352},"labels":[],"label_agreement":null},{"id":"W1997733155","doi":"10.1016/j.leukres.2004.02.008","title":"Improved access to CD20 following B cell receptor cross-linking at Burkitt’s lymphoma cell surfaces","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Endocytosis; CD19; CD20; Lipid raft; breakpoint cluster region; B-cell receptor; Burkitt's lymphoma; B cell; Cell biology; Chemistry; Cell; Receptor; Cancer research; Antigen; Biology; Antibody; Lymphoma; Immunology; Biochemistry","score_opus":0.06860622073420451,"score_gpt":0.40398730831447704,"score_spread":0.3353810875802725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997733155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682703,0.0011251873,0.000031921332,0.0027174314,0.0003968045,0.0012960916,0.00003700927,0.00012153296,0.026003733],"genre_scores_gemma":[0.9262013,0.00034003422,0.0017342529,0.0006971536,0.0006424506,0.00012906936,0.000103496845,0.00010648667,0.070045754],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9935114,0.00021953267,0.00059682375,0.0010827674,0.002508878,0.0020805902],"domain_scores_gemma":[0.99671316,0.0005756967,0.000075977216,0.0008432615,0.0006195673,0.00117233],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020596166,0.00040583464,0.0006093535,0.00058080186,0.0010373645,0.00054780225,0.0011755922,0.00034778702,0.00066913094],"category_scores_gemma":[0.00032119706,0.0003407048,0.00038146455,0.0014365298,0.00031816735,0.00036772326,0.0018819674,0.0010228672,0.0023770414],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002916833,0.00038245722,0.060958415,0.0008286607,0.000101072575,0.0007531667,0.0011118223,0.0004984601,0.91890526,0.000055269746,0.00876471,0.0047238837],"study_design_scores_gemma":[0.0068299957,0.001058804,0.02490834,0.00044801654,0.00002479299,0.000038024875,0.00022860503,0.00047607665,0.889654,0.00022213608,0.07555683,0.0005544138],"about_ca_topic_score_codex":0.0056805015,"about_ca_topic_score_gemma":0.0003045829,"teacher_disagreement_score":0.066792116,"about_ca_system_score_codex":0.0040013525,"about_ca_system_score_gemma":0.0022853059,"threshold_uncertainty_score":0.9999045},"labels":[],"label_agreement":null},{"id":"W1999705499","doi":"10.1016/j.leukres.2012.07.006","title":"Pharmacokinetics of CPX-351; a nano-scale liposomal fixed molar ratio formulation of cytarabine:daunorubicin, in patients with advanced leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"","keywords":"Daunorubicin; Cytarabine; Pharmacokinetics; Medicine; Pharmacology; Leukemia; Liposome; Internal medicine; Drug; Chemotherapy; Gastroenterology; Chemistry","score_opus":0.023859024702157484,"score_gpt":0.3293869841911375,"score_spread":0.30552795948898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999705499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99461687,0.00037298255,0.00021285984,0.00016234936,0.00008503176,0.002387998,0.000049099468,0.000041642394,0.0020711815],"genre_scores_gemma":[0.9947579,0.00014779468,0.003672459,0.000061705396,0.0001832543,0.00014228222,0.00023053664,0.00010545446,0.0006985965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936764,0.0004569968,0.0010443161,0.00055718835,0.0027357228,0.0015293334],"domain_scores_gemma":[0.99600303,0.0005637767,0.00021551899,0.0009553961,0.0017586331,0.0005036279],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020154372,0.00037483624,0.00087092526,0.001190176,0.00012678567,0.000019761777,0.000488052,0.00034228587,0.00024921453],"category_scores_gemma":[0.0006367142,0.0003120447,0.00013899783,0.0022981248,0.0004439295,0.0006449934,0.00033401587,0.0015144084,0.000051005616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0090573905,0.00081202225,0.6098202,0.00091423787,0.00014859867,0.000018904082,0.0016666523,0.001173522,0.3666702,0.0002622687,0.0011631737,0.008292822],"study_design_scores_gemma":[0.020864286,0.0023841925,0.55394834,0.0005211706,0.000072726434,0.000013326151,0.00033632436,0.006721143,0.41369593,0.000037821123,0.0010570291,0.00034771184],"about_ca_topic_score_codex":0.0006372105,"about_ca_topic_score_gemma":0.000059097183,"teacher_disagreement_score":0.05587187,"about_ca_system_score_codex":0.004495393,"about_ca_system_score_gemma":0.002503033,"threshold_uncertainty_score":0.9999332},"labels":[],"label_agreement":null},{"id":"W1999935620","doi":"10.1016/j.leukres.2009.12.008","title":"A diphtheria toxin interleukin-3 fusion protein synergizes with tyrosine kinase inhibitors in killing leukemic progenitors from BCR/ABL positive acute leukemia","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute; Terry Fox Research Institute","keywords":"Dasatinib; Diphtheria toxin; Tyrosine kinase; Imatinib; Cancer research; Leukemia; Imatinib mesylate; Fusion protein; Progenitor cell; Biology; Immunology; Stem cell; Signal transduction; Microbiology; Cell biology; Toxin; Myeloid leukemia; Recombinant DNA; Biochemistry","score_opus":0.020862546613417465,"score_gpt":0.3207704883987825,"score_spread":0.29990794178536506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999935620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99043316,0.00033779765,0.000033115062,0.001208469,0.00031457547,0.00449097,0.000076657714,0.00021435862,0.0028909072],"genre_scores_gemma":[0.98562455,0.00016526136,0.0021945862,0.00012722198,0.0013096005,0.0010639023,0.00025508046,0.0002927141,0.008967062],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9913921,0.0007800583,0.0009678916,0.001700505,0.002974073,0.0021853733],"domain_scores_gemma":[0.9955774,0.00073701737,0.00014872287,0.0016225851,0.0010061122,0.0009081546],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027033677,0.0007549716,0.0010619198,0.0015308384,0.00043632073,0.00033181586,0.0009344258,0.000801754,0.0025087364],"category_scores_gemma":[0.00058080524,0.0006077928,0.0002649809,0.0027161883,0.0011450517,0.0004702461,0.0007188766,0.006050057,0.00028134658],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009034159,0.00029741754,0.0062978524,0.00012968037,0.00026780984,0.0022861925,0.0017069255,0.000021697233,0.95870894,0.00011593304,0.0007698201,0.020363543],"study_design_scores_gemma":[0.00942201,0.0022889357,0.007035581,0.0019517126,0.000075610806,0.00023309948,0.0011759128,0.002523261,0.9690562,0.0003400977,0.005138893,0.0007586993],"about_ca_topic_score_codex":0.014711343,"about_ca_topic_score_gemma":0.0030998976,"teacher_disagreement_score":0.019604843,"about_ca_system_score_codex":0.0077296044,"about_ca_system_score_gemma":0.0052355235,"threshold_uncertainty_score":0.99963737},"labels":[],"label_agreement":null},{"id":"W2001137834","doi":"10.1016/j.leukres.2011.07.023","title":"Promotional etiology for common childhood acute lymphoblastic leukemia: The infective lymphoid recovery hypothesis","year":2011,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Atomic Energy (Canada)","funders":"","keywords":"Lymphoblastic Leukemia; Etiology; Medicine; Immunology; Leukemia; Pathology","score_opus":0.10463915337931044,"score_gpt":0.38564800040704783,"score_spread":0.2810088470277374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001137834","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081104616,0.96601504,0.0005721051,0.00041417923,0.0009272454,0.017993541,0.0013080761,0.00037029455,0.011588443],"genre_scores_gemma":[0.00036828427,0.97779757,0.0011012066,0.00033621423,0.0023343994,0.00992919,0.0010472597,0.00062188134,0.0064639784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98625326,0.0031137906,0.0021072442,0.0025122433,0.0025261326,0.0034873397],"domain_scores_gemma":[0.97378033,0.019736055,0.0007414367,0.0030089384,0.0017753348,0.00095790677],"candidate_categories":["metaepi_narrow","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0060441,0.0016049191,0.004721019,0.0021052414,0.0014205476,0.00025172762,0.0026883318,0.0027966262,0.0006679168],"category_scores_gemma":[0.0066896784,0.0010436872,0.0023110858,0.0028025892,0.0023838843,0.00028136323,0.0016825144,0.0047238297,0.0024161912],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0011935465,0.00057989714,0.000030914383,0.013648676,0.005128638,0.0004175098,0.00037086708,0.0000071612644,0.00001216646,0.0019324344,0.045850307,0.93082786],"study_design_scores_gemma":[0.006554967,0.0035456452,0.00031147088,0.011505279,0.0039634057,0.008231829,0.000092628536,0.00031721496,0.00006775272,0.00468106,0.95951337,0.001215387],"about_ca_topic_score_codex":0.0006665139,"about_ca_topic_score_gemma":0.00006976606,"teacher_disagreement_score":0.9296125,"about_ca_system_score_codex":0.043869894,"about_ca_system_score_gemma":0.055594288,"threshold_uncertainty_score":0.9998795},"labels":[],"label_agreement":null},{"id":"W2002979416","doi":"10.1016/j.leukres.2005.04.022","title":"Acute monocytic leukemia and multiple abnormalities in a child with duplication of 1q detected by GTG-banding and SKY","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Genomic variations and chromosomal abnormalities","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"dup; Karyotype; Trisomy; Gene duplication; Acute monocytic leukemia; Trisomy 8; Biology; Chromosome; Leukemia; Pathology; Bone marrow; Cancer research; Medicine; Genetics; Gene","score_opus":0.012180110885225363,"score_gpt":0.2642647038802693,"score_spread":0.25208459299504393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002979416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99784774,0.0009808991,0.00012756755,0.00014243246,0.0000054506236,0.00023376402,0.000038688755,0.0000071649456,0.00061631773],"genre_scores_gemma":[0.99791646,0.0007508321,0.0005163341,0.000020860065,0.000053777454,0.000045078188,0.000073057745,0.000016446911,0.0006071791],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9989533,0.00008038798,0.00020981608,0.00028671205,0.00016536925,0.00030440526],"domain_scores_gemma":[0.99951,0.00004932603,0.000052533087,0.0002210649,0.00009513226,0.000071982446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031556646,0.00011745087,0.00014071968,0.0001188022,0.00013735426,0.000040241728,0.00011883933,0.00012346411,0.000007453869],"category_scores_gemma":[0.00004722211,0.00010532041,0.000017883323,0.0001538153,0.00019481113,0.00001686956,0.00012609952,0.00018962323,0.0000015698154],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001005721,0.00008572523,0.07891297,0.00025842604,0.00020620944,0.000013163407,0.0024425476,0.0010659689,0.9082427,0.00097083586,0.0006407858,0.0061549456],"study_design_scores_gemma":[0.004519051,0.00075459713,0.05529184,0.00012308273,0.0000314411,0.0002619829,0.0018563047,0.0075200666,0.924392,0.00013039514,0.004698534,0.0004207418],"about_ca_topic_score_codex":0.00078207254,"about_ca_topic_score_gemma":0.00052581023,"teacher_disagreement_score":0.023621138,"about_ca_system_score_codex":0.00021382881,"about_ca_system_score_gemma":0.00019814564,"threshold_uncertainty_score":0.42948416},"labels":[],"label_agreement":null},{"id":"W2003202645","doi":"10.1016/j.leukres.2014.02.009","title":"Polyclonal serum IgM level identifies a subgroup of multiple myeloma patients with low-risk clinicobiological features and superior survival","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Ministry of Science and Technology of the People's Republic of China","keywords":"Multiple myeloma; Polyclonal antibodies; Medicine; Monoclonal; Internal medicine; Gastroenterology; Bone marrow; Monoclonal gammopathy of undetermined significance; Clinical significance; Bortezomib; Thalidomide; Immunology; Pathology; Oncology; Antibody; Monoclonal antibody","score_opus":0.04705372373716442,"score_gpt":0.3359393037555853,"score_spread":0.28888558001842085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003202645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976003,0.00022391803,0.000033695,0.00018759756,0.00007314201,0.0009767493,0.00032361262,0.00004151751,0.0005394612],"genre_scores_gemma":[0.99700767,0.00016675553,0.00077402155,0.00003520521,0.00014765648,0.000075566175,0.00018713527,0.000042476044,0.0015635291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955307,0.00078746193,0.0004272561,0.0006964273,0.0015780191,0.0009801013],"domain_scores_gemma":[0.99618715,0.001888778,0.00009851152,0.0005969084,0.0006821499,0.0005464838],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016594019,0.00028714127,0.00064229395,0.00033907683,0.0003364527,0.00007812004,0.00027631398,0.00026536887,0.00013828918],"category_scores_gemma":[0.002774834,0.00018509374,0.00012337793,0.00043213836,0.0009910234,0.00013779195,0.00035754137,0.0010276858,0.00005294591],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004979007,0.00043497185,0.9713684,0.00021062852,0.0002226584,0.000054759286,0.00018130349,0.0000017424228,0.0020526305,0.000100777346,0.00033867938,0.020054445],"study_design_scores_gemma":[0.0113975415,0.002409095,0.9800932,0.00017214926,0.00003696012,0.000015749638,0.0001958385,0.0004244988,0.0047151037,0.00013908451,0.00022435971,0.00017643374],"about_ca_topic_score_codex":0.0017479635,"about_ca_topic_score_gemma":0.0008884887,"teacher_disagreement_score":0.01987801,"about_ca_system_score_codex":0.00026523092,"about_ca_system_score_gemma":0.000422232,"threshold_uncertainty_score":0.75479037},"labels":[],"label_agreement":null},{"id":"W2003340156","doi":"10.1016/j.leukres.2013.12.024","title":"Electromagnetic fields at extremely low frequencies and the risk for childhood leukemia: Do we have enough information to warrant this association?","year":2014,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Electromagnetic Fields and Biological Effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Medicine; Confusion; DNA damage; Ionizing radiation; Cancer; Leukemia; Cancer research; Neuroscience; Toxicology; Biology; Bioinformatics; Risk analysis (engineering); Immunology; Genetics; DNA; Psychology; Physics; Internal medicine","score_opus":0.011986858331141314,"score_gpt":0.25824767363350143,"score_spread":0.2462608153023601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003340156","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27540687,0.007131273,0.00047529436,0.7028874,0.00035034717,0.005733432,0.00025843552,0.00006803632,0.0076889205],"genre_scores_gemma":[0.5109329,0.020762792,0.0014681813,0.40832677,0.008935752,0.0033734778,0.0022437642,0.00016189036,0.043794427],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959854,0.0009186079,0.00048191237,0.00067057455,0.0007646984,0.0011788411],"domain_scores_gemma":[0.996962,0.0014804201,0.0002618807,0.00068844797,0.00048137552,0.00012585794],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0024926548,0.00041600186,0.0005070729,0.0001447061,0.000634105,0.0002592532,0.00070189097,0.0022593585,0.00008599823],"category_scores_gemma":[0.0028875084,0.0002681313,0.00027003128,0.0001847077,0.00025022434,0.000011335235,0.0003995098,0.0025003848,0.000062389794],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037174762,0.00001060781,0.000055136294,0.00018126811,0.00013375045,0.000005172162,0.0002976066,0.000010875294,0.010808076,0.00008510628,0.9811656,0.0068750884],"study_design_scores_gemma":[0.0036077867,0.006770498,0.00027588074,0.000114065944,0.00009587099,0.000037247995,0.00003045478,0.00034474995,0.013819147,0.0029400373,0.9713764,0.0005878525],"about_ca_topic_score_codex":0.0004669509,"about_ca_topic_score_gemma":0.00016250074,"teacher_disagreement_score":0.2945606,"about_ca_system_score_codex":0.0008101751,"about_ca_system_score_gemma":0.00052797695,"threshold_uncertainty_score":0.9999771},"labels":[],"label_agreement":null},{"id":"W2005428520","doi":"10.1016/j.leukres.2004.02.003","title":"Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Acute promyelocytic leukemia; Leukemia; Myeloid leukemia; Acute leukemia; Medicine; Transplantation; Stem cell; Promyelocytic leukemia protein; Bone marrow; Immunology; Cancer research; Internal medicine; Biology; Cell culture; Genetics","score_opus":0.02319983555635367,"score_gpt":0.3273943232991777,"score_spread":0.30419448774282404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005428520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792515,0.0010804024,0.01670817,0.000076721466,0.00018221726,0.001140848,0.00014406002,0.00003775753,0.0013782941],"genre_scores_gemma":[0.9898373,0.001521233,0.004171652,0.000083294464,0.00038236706,0.00054721354,0.00037171738,0.00010741496,0.0029778243],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964218,0.00016128912,0.0006640015,0.00095733,0.0007614199,0.0010341648],"domain_scores_gemma":[0.99810654,0.000099166326,0.00014773052,0.0007839386,0.00062744383,0.0002351853],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00092688267,0.00040695965,0.00045165885,0.00025745408,0.00027884624,0.00010893303,0.00073721114,0.0005883598,0.000021163527],"category_scores_gemma":[0.000038104805,0.00038547133,0.00028207613,0.0005090504,0.000399917,0.000037144357,0.00015734702,0.0006023549,0.000034467175],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002617771,0.000058317633,0.00036272372,0.0010773339,0.00030599232,0.000122016645,0.00066388526,0.0017050907,0.9880934,0.00024270623,0.00064112234,0.0041096625],"study_design_scores_gemma":[0.00393016,0.00089800253,0.00025695591,0.0001618066,0.00021458264,0.00011538566,0.00022459438,0.000201466,0.9889723,0.0006842208,0.0038902094,0.00045030416],"about_ca_topic_score_codex":0.00015436404,"about_ca_topic_score_gemma":0.000041212734,"teacher_disagreement_score":0.012536518,"about_ca_system_score_codex":0.002107037,"about_ca_system_score_gemma":0.005443965,"threshold_uncertainty_score":0.9998597},"labels":[],"label_agreement":null},{"id":"W2005871463","doi":"10.1016/s0145-2126(00)00060-6","title":"Verotoxin targets lymphoma infiltrates of patients with post-transplant lymphoproliferative disease","year":2000,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Escherichia coli research studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"H2020 European Research Council","keywords":"Lymphoma; Malignancy; Medicine; Transplantation; Pathology; Germinal center; Immunology; Cancer research; B cell; Internal medicine; Antibody","score_opus":0.010888764197983404,"score_gpt":0.276892260326297,"score_spread":0.2660034961283136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005871463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99596506,0.00063293154,0.000010340445,0.00013733696,0.000013675221,0.0007303217,0.0002512032,0.000012223289,0.0022468797],"genre_scores_gemma":[0.9970957,0.0005936251,0.00017359002,0.00009383584,0.00007862551,0.00022325084,0.00032227594,0.00003415905,0.0013849509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99744886,0.00030904406,0.00022495657,0.00047440376,0.00088217785,0.00066055154],"domain_scores_gemma":[0.99829286,0.00007894152,0.000037117687,0.000482741,0.00082760473,0.00028072653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038978897,0.00020371085,0.0002110892,0.000104120554,0.00022362931,0.00003485049,0.00039097446,0.00010443606,0.00019316253],"category_scores_gemma":[0.00021205064,0.00015714209,0.00007058645,0.00033591155,0.0005488686,0.0000127020485,0.00012675147,0.00016338396,0.000037166534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017775068,0.0010654002,0.84701425,0.00035887837,0.0005152151,0.00008729169,0.00074884156,0.00034257828,0.11704192,0.0001971683,0.0031598427,0.01169352],"study_design_scores_gemma":[0.0044405623,0.0022350468,0.8838816,0.00010798154,0.00001967737,0.0000033455608,0.00013597136,0.00014724255,0.09590279,0.00008017531,0.0126318075,0.0004137437],"about_ca_topic_score_codex":0.00019478584,"about_ca_topic_score_gemma":0.00008982305,"teacher_disagreement_score":0.03686738,"about_ca_system_score_codex":0.00016201295,"about_ca_system_score_gemma":0.0012207254,"threshold_uncertainty_score":0.64080685},"labels":[],"label_agreement":null},{"id":"W2007253664","doi":"10.1016/j.leukres.2014.11.028","title":"One day at a time: Improving the patient experience during and after intensive chemotherapy for younger and older AML patients","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Medicine; Chemotherapy; Pediatrics; Oncology; Internal medicine","score_opus":0.017615000180275193,"score_gpt":0.3000844991968336,"score_spread":0.28246949901655843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007253664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527,0.00026169792,0.000057592868,0.0018344785,0.000042723295,0.0022055872,0.000012708114,0.000034795117,0.00028038392],"genre_scores_gemma":[0.9939722,0.0001264506,0.000414881,0.0013819697,0.00019242182,0.00085260975,0.0000173192,0.000074791664,0.0029673823],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9967792,0.0002492613,0.00030745816,0.0007158456,0.0009991352,0.0009491048],"domain_scores_gemma":[0.99708307,0.0007750602,0.00006506294,0.0006566181,0.0010783923,0.0003418126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010724969,0.00022745939,0.00034642124,0.00022016517,0.00051644765,0.000115076575,0.00021490434,0.00017072281,0.00014507046],"category_scores_gemma":[0.0015521295,0.00016153797,0.00006430222,0.00028878852,0.00075145386,0.00019328929,0.00072444475,0.0007111518,0.00004674268],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014902805,0.00041098968,0.12903397,0.0018028386,0.0004171877,0.000105183935,0.065198556,0.0000029443188,0.5427344,0.00011882645,0.011896248,0.23337609],"study_design_scores_gemma":[0.01539922,0.0021653448,0.870644,0.0004872065,0.00005292562,0.00009217534,0.0021870695,0.010646027,0.088957585,0.00011023442,0.008691083,0.00056716177],"about_ca_topic_score_codex":0.00019419129,"about_ca_topic_score_gemma":0.000012929314,"teacher_disagreement_score":0.74161,"about_ca_system_score_codex":0.0015338535,"about_ca_system_score_gemma":0.00022925167,"threshold_uncertainty_score":0.6587328},"labels":[],"label_agreement":null},{"id":"W2009359182","doi":"10.1016/j.leukres.2013.04.006","title":"CD13 expression is an independent adverse prognostic factor in adults with Philadelphia chromosome negative B cell acute lymphoblastic leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Cytogenetics; Medicine; Internal medicine; Oncology; Philadelphia chromosome; Lymphoblastic Leukemia; Acute lymphocytic leukemia; Hematology; Overall survival; Leukemia; Chromosome; Biology; Chromosomal translocation; Genetics","score_opus":0.027676318770357946,"score_gpt":0.307048745033744,"score_spread":0.2793724262633861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009359182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899026,0.00010981293,0.00016638325,0.0009669468,0.000111826135,0.0056961942,0.000110102344,0.00023098175,0.0027051603],"genre_scores_gemma":[0.992531,0.0001919435,0.0017042451,0.00039221442,0.00042681635,0.0017450348,0.00017077658,0.00027021847,0.0025677704],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9878652,0.00081310084,0.0010959004,0.002194347,0.0049562613,0.0030751834],"domain_scores_gemma":[0.99259365,0.001558756,0.00019608728,0.0019277734,0.0017867144,0.001937021],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009436162,0.00091930333,0.0011359906,0.0017572748,0.00045350057,0.0002297891,0.0013059919,0.00086976157,0.0032837542],"category_scores_gemma":[0.0008330845,0.0006984424,0.00019751962,0.0027370926,0.0010119033,0.0014717923,0.0009041606,0.003194282,0.002817991],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.029559202,0.004962558,0.1517242,0.0058461986,0.0011241324,0.017943783,0.044596337,0.0014661686,0.69049877,0.00017006196,0.044974416,0.00713417],"study_design_scores_gemma":[0.09201757,0.015931888,0.3869922,0.008893229,0.00028767885,0.0015733322,0.015538051,0.11343804,0.360529,0.0007550173,0.0008349875,0.003209012],"about_ca_topic_score_codex":0.0052496637,"about_ca_topic_score_gemma":0.0002726816,"teacher_disagreement_score":0.32996976,"about_ca_system_score_codex":0.019150423,"about_ca_system_score_gemma":0.01255705,"threshold_uncertainty_score":0.99954665},"labels":[],"label_agreement":null},{"id":"W2011872467","doi":"10.1016/j.leukres.2005.05.010","title":"5-Aza-2′-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"National Cancer Institute; Canadian Institutes of Health Research; Saskatchewan Health Research Foundation","keywords":"Decitabine; Trichostatin A; Cancer research; Chromatin remodeling; Myeloid leukemia; Histone; Chromatin; Acetylation; DNA methylation; Chromatin immunoprecipitation; Epigenetics; Chemistry; Methylation; Histone deacetylase inhibitor; Biology; Histone deacetylase; Molecular biology; Promoter; Gene; Gene expression; Biochemistry","score_opus":0.03042550730184956,"score_gpt":0.36768447666998955,"score_spread":0.33725896936814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011872467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931842,0.002865988,0.0019685007,0.00036745213,0.00008646487,0.0008108776,0.00003482267,0.000033424345,0.000648249],"genre_scores_gemma":[0.9911861,0.0015678535,0.0037135957,0.00006570063,0.00031952013,0.00012314948,0.00046288106,0.00010222555,0.0024590185],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99544716,0.0006409294,0.0010011232,0.0010565742,0.00096991594,0.0008842804],"domain_scores_gemma":[0.9976649,0.00009017679,0.00034158444,0.0010828153,0.00052018766,0.00030032182],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027659934,0.00037682708,0.0004604444,0.00047440766,0.00031697188,0.00006415284,0.00053148845,0.00059157086,0.00004000975],"category_scores_gemma":[0.00071795523,0.00038704794,0.00014471823,0.0005916729,0.00022060952,0.00004538445,0.0005151049,0.00086081773,0.000011633559],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002992718,0.000097735894,0.0008320467,0.00007378658,0.000052607284,0.000013713796,0.00050300395,0.00092821795,0.9917853,0.00017411064,0.00084045826,0.004399732],"study_design_scores_gemma":[0.0021501866,0.0005445967,0.000946544,0.00018389315,0.000029517747,0.000006601513,0.00012485245,0.0052369866,0.98711485,0.0010751936,0.0021774017,0.00040935184],"about_ca_topic_score_codex":0.0014106461,"about_ca_topic_score_gemma":0.0008971101,"teacher_disagreement_score":0.0046704407,"about_ca_system_score_codex":0.0017112417,"about_ca_system_score_gemma":0.0007775049,"threshold_uncertainty_score":0.99985814},"labels":[],"label_agreement":null},{"id":"W2012049957","doi":"10.1016/j.leukres.2010.02.023","title":"Mutational analysis of K-ras codon 12 in blood samples of patients with acute myeloid leukemia","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AGE-WELL","keywords":"Myeloid leukemia; Mutation; Valine; Leukemia; Biology; Myeloid; Cancer research; Medicine; Amino acid; Gene; Immunology; Genetics","score_opus":0.030270332726815365,"score_gpt":0.3350075359139783,"score_spread":0.30473720318716296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012049957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958069,0.000039866052,0.000065129694,0.00020441417,0.000041592684,0.0010394545,0.0003107304,0.000030665655,0.0024612527],"genre_scores_gemma":[0.9938019,0.000093847906,0.004184423,0.000049179762,0.0000833636,0.00010368022,0.0008587639,0.000067670815,0.0007571754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99350935,0.00035244183,0.00095715583,0.00076828036,0.0033542265,0.0010585388],"domain_scores_gemma":[0.99463636,0.0015068286,0.0001950044,0.0011741102,0.002076384,0.0004113301],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0024013678,0.00031833127,0.0011191479,0.0036405665,0.0001238067,0.00003313195,0.0007016317,0.00040327563,0.00085707323],"category_scores_gemma":[0.0012996431,0.00025774742,0.0002648652,0.005565723,0.0011956316,0.00022564942,0.00034037075,0.002432145,0.000028397244],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033770963,0.00059383764,0.8938761,0.00026595814,0.0037461957,0.00024759083,0.00086594326,0.00037369065,0.09306081,0.0011210865,0.0005120382,0.0019596627],"study_design_scores_gemma":[0.007946258,0.00093968486,0.9386561,0.00010454942,0.0010754865,0.000019258789,0.00024252181,0.0021754552,0.04810858,0.00013812276,0.00036024637,0.00023374644],"about_ca_topic_score_codex":0.005068853,"about_ca_topic_score_gemma":0.0030948436,"teacher_disagreement_score":0.044952225,"about_ca_system_score_codex":0.0016497384,"about_ca_system_score_gemma":0.0061273472,"threshold_uncertainty_score":0.9999875},"labels":[],"label_agreement":null},{"id":"W2014246201","doi":"10.1016/j.leukres.2008.08.021","title":"Disruption of T cell suppression in chronic lymphocytic leukemia by CD200 blockade","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Therapeutics (Canada)","funders":"José Carreras Leukämie-Stiftung","keywords":"Blockade; Chronic lymphocytic leukemia; Cancer research; Leukemia; T cell; Immunology; Medicine; Internal medicine; Receptor; Immune system","score_opus":0.04986831443506784,"score_gpt":0.35710647795066497,"score_spread":0.30723816351559713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014246201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836377,0.0031960418,0.00004692714,0.00011496145,0.000112931986,0.0014097076,0.000029872817,0.00010082359,0.011351041],"genre_scores_gemma":[0.9790537,0.0033317406,0.00028148206,0.000048392736,0.00032601182,0.00018553704,0.0001439098,0.000120197976,0.016509058],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.991921,0.00058149814,0.0010671045,0.0010756762,0.0033414895,0.00201325],"domain_scores_gemma":[0.99620515,0.0009220201,0.00015812661,0.0015198281,0.00053945056,0.00065541547],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019982334,0.0004273623,0.00090227247,0.0011778083,0.0002987034,0.0000329453,0.0007771854,0.0006297109,0.00071111467],"category_scores_gemma":[0.00062364363,0.0003858259,0.00024012047,0.002376984,0.0012211619,0.00027503457,0.0005730065,0.0018030098,0.0005559556],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0023283807,0.00025301424,0.0023353372,0.0020738114,0.00006769828,0.0021169435,0.001350155,0.0025874306,0.9372962,0.00009506488,0.047246266,0.0022496767],"study_design_scores_gemma":[0.048131254,0.0015192232,0.0031112686,0.0010344272,0.00003772446,0.0010242498,0.0003577148,0.16682434,0.7643595,0.00013533635,0.012912389,0.00055259705],"about_ca_topic_score_codex":0.01178997,"about_ca_topic_score_gemma":0.0001450249,"teacher_disagreement_score":0.22010829,"about_ca_system_score_codex":0.34506285,"about_ca_system_score_gemma":0.124954574,"threshold_uncertainty_score":0.9998594},"labels":[],"label_agreement":null},{"id":"W2016677672","doi":"10.1016/j.leukres.2010.06.003","title":"Cytotoxic responses to BLV tax oncoprotein do not prevent leukemogenesis in sheep","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"T-cell and Retrovirus Studies","field":"Immunology and Microbiology","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Science Centre for Human and Animal Health; University of Saskatchewan","funders":"Canadian Institutes of Health Research; Fondation Medic; Amis de l'Institut Bordet; University of Saskatchewan","keywords":"Cytotoxic T cell; Provirus; Immunology; Leukemia; Immune system; Retrovirus; Biology; Bovine leukemia virus; Cancer; Medicine; Virology; Cancer research; Virus; Genetics; Genome","score_opus":0.040355313039611276,"score_gpt":0.3365119209058765,"score_spread":0.29615660786626524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016677672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99256796,0.0010292303,0.000007636768,0.0014641455,0.0005757481,0.0009667645,0.000050440925,0.00006578687,0.0032722766],"genre_scores_gemma":[0.9506992,0.00016202024,0.00020579662,0.00016843432,0.00013073039,0.00041150601,0.000010190473,0.00003630803,0.04817581],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9965655,0.00086477306,0.00043047403,0.00069960445,0.00023199043,0.0012076643],"domain_scores_gemma":[0.9981662,0.0007357279,0.000053861757,0.00075197057,0.00019466797,0.00009758472],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0024849102,0.00025872953,0.00042365093,0.00072190934,0.0005131386,0.000050290313,0.0007377639,0.0005249642,0.0009465765],"category_scores_gemma":[0.0011773616,0.00021052668,0.00011816393,0.0007832943,0.0005519932,0.00006129489,0.0007303665,0.0018996772,0.0044230307],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012383751,0.00012019001,0.0039557754,0.00003485891,0.000060347345,0.00006559022,0.0008444769,0.000006928089,0.9705068,0.0005974097,0.007994473,0.014574776],"study_design_scores_gemma":[0.0015392241,0.000505684,0.030136311,0.00006946443,0.0000081645785,0.000041391497,0.00050312787,0.0000031078653,0.85459584,0.0002533619,0.112026654,0.000317648],"about_ca_topic_score_codex":0.0035294949,"about_ca_topic_score_gemma":0.004495136,"teacher_disagreement_score":0.11591094,"about_ca_system_score_codex":0.00072971627,"about_ca_system_score_gemma":0.00086592045,"threshold_uncertainty_score":0.9999667},"labels":[],"label_agreement":null},{"id":"W2016908144","doi":"10.1016/j.leukres.2014.01.004","title":"Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: A systematic review and meta-analysis","year":2014,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":147,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; SickKids Foundation; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Leukapheresis; Myeloid leukemia; Meta-analysis; Chemotherapy; Leukocytosis; Oncology; Leukostasis; Leukemia; Internal medicine; Intensive care medicine; Biology","score_opus":0.13781208528964473,"score_gpt":0.4313074187190795,"score_spread":0.2934953334294348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016908144","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032234725,0.98001754,0.000009219495,0.0008108089,0.00003294455,0.014677498,0.00024346626,0.00014938325,0.00083565485],"genre_scores_gemma":[0.0015320075,0.98089325,0.00038151557,0.0011419805,0.00018235127,0.0065436466,0.00022859433,0.0004432654,0.00865336],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97725683,0.007205558,0.0044490863,0.003844279,0.0044075507,0.0028366882],"domain_scores_gemma":[0.98742586,0.0031519148,0.0012145252,0.005381615,0.0011721395,0.0016539244],"candidate_categories":["metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.018070124,0.0022154069,0.026374198,0.0041447487,0.0004660345,0.0006800392,0.0020508221,0.0019136028,0.00064371445],"category_scores_gemma":[0.002717624,0.0015691603,0.004374202,0.008973461,0.0014127073,0.00043150247,0.0014139791,0.0069417744,0.0003639003],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00016068369,0.00009910542,0.00003373264,0.82102376,0.16767223,0.00068135717,0.00020574065,8.2254115e-7,0.00002521633,0.00009980429,0.0015100533,0.0084875],"study_design_scores_gemma":[0.0029929855,0.0005141669,0.00039271763,0.107693225,0.86863554,0.00081063557,0.00011014932,0.00019600868,0.00003461337,0.0000688547,0.016725795,0.0018253003],"about_ca_topic_score_codex":0.0036597636,"about_ca_topic_score_gemma":0.00025414422,"teacher_disagreement_score":0.7133305,"about_ca_system_score_codex":0.0110997185,"about_ca_system_score_gemma":0.008152306,"threshold_uncertainty_score":0.99938214},"labels":[],"label_agreement":null},{"id":"W2017649143","doi":"10.1016/j.leukres.2012.05.016","title":"A clinical trial of supervised exercise for adult inpatients with acute myeloid leukemia (AML) undergoing induction chemotherapy","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer survivorship and care","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University Health Network; University of Toronto; Toronto Rehabilitation Institute","funders":"National Institute on Aging; Toronto Rehabilitation Institute","keywords":"Medicine; Myeloid leukemia; Induction chemotherapy; Randomized controlled trial; Physical therapy; Quality of life (healthcare); Clinical trial; Internal medicine; Physical fitness; Population; Oncology; Chemotherapy; Intensive care medicine","score_opus":0.09383302063113753,"score_gpt":0.40952396712996575,"score_spread":0.31569094649882823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017649143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994764,0.00017224687,0.00032420058,0.00048361399,0.00070222776,0.0023142814,0.000019401263,0.000046997637,0.0011730369],"genre_scores_gemma":[0.9942533,0.0010145318,0.0009905712,0.0002573809,0.0013134977,0.00044649612,0.00008259404,0.00007205216,0.0015695924],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9968887,0.00021407468,0.00059152435,0.00041400662,0.0011264409,0.0007652839],"domain_scores_gemma":[0.9972777,0.00046003563,0.00013117297,0.00060415285,0.0011459157,0.0003810199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019392463,0.00020157688,0.0005865661,0.00027893586,0.00014328038,0.000026282101,0.00021421553,0.00033590346,0.00008073824],"category_scores_gemma":[0.00041905895,0.00015842963,0.00022690091,0.0006694904,0.0002691975,0.0002374714,0.000071651186,0.0007721702,0.000017708511],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.636748,0.0013850273,0.044396646,0.0015593648,0.00086700066,0.000021888334,0.00984852,0.0000074565305,0.0069643236,0.00053742836,0.011709939,0.28595436],"study_design_scores_gemma":[0.7687505,0.037245184,0.041904666,0.0040768557,0.001112067,0.00011033132,0.015262099,0.001334185,0.101762205,0.0007805235,0.02611313,0.0015482671],"about_ca_topic_score_codex":0.0010396002,"about_ca_topic_score_gemma":0.0003963562,"teacher_disagreement_score":0.2844061,"about_ca_system_score_codex":0.001434072,"about_ca_system_score_gemma":0.0025911601,"threshold_uncertainty_score":0.6460573},"labels":[],"label_agreement":null},{"id":"W2017848739","doi":"10.1016/j.leukres.2009.06.013","title":"High incidence of chronic lymphocytic leukemia (CLL) diagnosed by immunophenotyping: A population-based Canadian cohort","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Research Manitoba; CancerCare Manitoba","funders":"Microsoft","keywords":"Cancer registry; Chronic lymphocytic leukemia; Medicine; Immunophenotyping; Incidence (geometry); Population; Epidemiology; Cohort; Relative survival; Internal medicine; Lymphoma; Leukemia; Oncology; Immunology; Flow cytometry; Environmental health","score_opus":0.02041312935278395,"score_gpt":0.32311435822261675,"score_spread":0.3027012288698328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017848739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909063,0.0025081506,0.0001088145,0.00070771854,0.0001770477,0.0023994232,0.00007348404,0.00016089632,0.00295814],"genre_scores_gemma":[0.9951968,0.00036213358,0.0004561148,0.0006165345,0.0003606332,0.00020926134,0.00059025106,0.00011110988,0.002097162],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9911073,0.00052650226,0.0011664948,0.0011980527,0.0034436942,0.002557997],"domain_scores_gemma":[0.9935229,0.001438231,0.00021230872,0.0021304819,0.0012239555,0.0014721126],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0030026427,0.00053206267,0.0010996491,0.0015088273,0.00055975287,0.00013284586,0.0011725165,0.0006529852,0.0009180915],"category_scores_gemma":[0.002576764,0.0005219788,0.00027507893,0.0027921498,0.0006142312,0.0002749511,0.00016560347,0.0015763781,0.0004011228],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.013800572,0.001645269,0.13063128,0.007965195,0.0025706147,0.015312469,0.0027606296,0.12585604,0.24753928,0.020218374,0.2769267,0.15477356],"study_design_scores_gemma":[0.0772601,0.0057474095,0.27052408,0.0034621418,0.00030242716,0.0005143275,0.00029920798,0.55294496,0.07402637,0.0025529836,0.010215472,0.0021505053],"about_ca_topic_score_codex":0.8153822,"about_ca_topic_score_gemma":0.053118553,"teacher_disagreement_score":0.7622636,"about_ca_system_score_codex":0.51725554,"about_ca_system_score_gemma":0.2707443,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W2019059796","doi":"10.1016/j.leukres.2007.06.019","title":"The morphological subcategories of acute monocytic leukemia (M5a and M5b) share similar immunophenotypic and cytogenetic features and clinical outcomes","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Immunophenotyping; Medicine; Internal medicine; Leukemia; Oncology; Immunology; Flow cytometry","score_opus":0.06637282434756417,"score_gpt":0.41099995334369255,"score_spread":0.34462712899612835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019059796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98698294,0.0080039725,0.00004529725,0.0025346053,0.00008781649,0.0011766878,0.000034967277,0.000058729456,0.0010749958],"genre_scores_gemma":[0.98366266,0.010804083,0.0014302109,0.00028857993,0.00018498105,0.00004685331,0.000031963857,0.00006919617,0.0034814775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99467456,0.00058933004,0.0009683904,0.0009421135,0.0013866719,0.0014389195],"domain_scores_gemma":[0.99167085,0.00575606,0.00014792471,0.001043982,0.0006879854,0.00069317286],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0067510577,0.00041742544,0.0009513206,0.0004042091,0.0007749722,0.00019549487,0.0005651628,0.00063180266,0.000046825706],"category_scores_gemma":[0.0027706595,0.00026154047,0.0001672416,0.0007272207,0.004127398,0.00014054237,0.0013422649,0.0027877283,0.000020945241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010860898,0.00020823673,0.82436943,0.0007366483,0.0023460484,0.0027172111,0.0014334,0.000005931824,0.019412307,0.008313847,0.010309384,0.11928667],"study_design_scores_gemma":[0.004655128,0.0014139008,0.98314166,0.00008676401,0.00020123538,0.00095803745,0.0012762087,0.00033416026,0.0031883284,0.0027870154,0.0016733004,0.00028427853],"about_ca_topic_score_codex":0.000587124,"about_ca_topic_score_gemma":0.00012989309,"teacher_disagreement_score":0.15877223,"about_ca_system_score_codex":0.0014088961,"about_ca_system_score_gemma":0.0016822485,"threshold_uncertainty_score":0.99998367},"labels":[],"label_agreement":null},{"id":"W2020921982","doi":"10.1016/j.leukres.2012.06.012","title":"Nilotinib and imatinib inhibit cytarabine cellular uptake: Implications for combination therapy","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval; Hôtel-Dieu de Québec","funders":"","keywords":"Nilotinib; Cytarabine; Imatinib; Myeloid leukemia; Medicine; Pharmacology; Tyrosine-kinase inhibitor; Nucleoside analogue; Tyrosine kinase; Oncology; Internal medicine; Nucleoside; Chemistry; Receptor","score_opus":0.13274411959298354,"score_gpt":0.4060545935447574,"score_spread":0.2733104739517739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020921982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864324,0.0024227684,0.0003988378,0.0040032887,0.00008512018,0.002588132,0.00003594868,0.000094128525,0.0039393976],"genre_scores_gemma":[0.9909422,0.0005638235,0.0028701874,0.000199913,0.0003588771,0.00082936726,0.0003072442,0.00006299715,0.003865427],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99785894,0.00011818824,0.00034659298,0.00037828297,0.00046446413,0.00083353155],"domain_scores_gemma":[0.9980321,0.00053190073,0.00007125671,0.0005806553,0.0004102468,0.0003738189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001509736,0.00019547663,0.00030178772,0.00026275322,0.00034411935,0.0000469626,0.00013657527,0.00017431841,0.00014343818],"category_scores_gemma":[0.00038331325,0.0001674581,0.000084724634,0.0004417995,0.0001996149,0.00021159853,0.000089752706,0.0004318388,0.0001116112],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018011103,0.0024948842,0.12474737,0.0008282859,0.00053689355,0.000013906746,0.0036665157,0.000006066508,0.4948748,0.066439986,0.041715417,0.26287475],"study_design_scores_gemma":[0.048433416,0.0030050003,0.56925017,0.0002976095,0.00015779458,0.00023220919,0.0005603468,0.0024141376,0.17630912,0.008111158,0.19049072,0.0007383207],"about_ca_topic_score_codex":0.00013225306,"about_ca_topic_score_gemma":0.0000052999544,"teacher_disagreement_score":0.44450277,"about_ca_system_score_codex":0.0022210074,"about_ca_system_score_gemma":0.00078188506,"threshold_uncertainty_score":0.6828743},"labels":[],"label_agreement":null},{"id":"W2022892254","doi":"10.1016/j.leukres.2012.08.001","title":"Improved survival with iron chelation therapy for red blood cell transfusion dependent lower IPSS risk MDS may be more significant in patients with a non-RARS diagnosis","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Queen's University; University of British Columbia","funders":"Celgene","keywords":"Medicine; Internal medicine; Red blood cell; Blood transfusion; Chelation therapy; Gastroenterology; Surgery; Thalassemia","score_opus":0.018809772660162583,"score_gpt":0.2856014937392905,"score_spread":0.2667917210791279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022892254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470705,0.00022626371,0.00014600846,0.0006917147,0.00009187326,0.003619101,0.00004218755,0.000031195585,0.00044457844],"genre_scores_gemma":[0.99679095,0.0014745952,0.00042941867,0.000067301546,0.000075196134,0.00057774724,0.00013789604,0.00008038546,0.00036653574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970518,0.00020165181,0.00032238293,0.00047310596,0.0010252948,0.0009257859],"domain_scores_gemma":[0.9986127,0.000259348,0.00008838102,0.00042025454,0.00030930692,0.00030999354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011876015,0.00025883762,0.00035397187,0.0002797076,0.00021165708,0.000030382622,0.00014781792,0.00033299578,0.00007430279],"category_scores_gemma":[0.0000705791,0.00016669629,0.00008265666,0.00058444584,0.0001551791,0.00017021598,0.000031146315,0.00096320926,0.0000046425253],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012853952,0.002578742,0.9685648,0.000193768,0.00010894803,0.000019869633,0.002621672,0.00016394113,0.0057904283,0.000002971749,0.00021467995,0.0068861977],"study_design_scores_gemma":[0.0573139,0.009076819,0.9015323,0.00030805133,0.00019706202,0.0000029145338,0.0023032574,0.001706174,0.02629045,0.000007368928,0.0007730422,0.0004886494],"about_ca_topic_score_codex":0.002066853,"about_ca_topic_score_gemma":0.00019258019,"teacher_disagreement_score":0.067032516,"about_ca_system_score_codex":0.00049079314,"about_ca_system_score_gemma":0.00042122745,"threshold_uncertainty_score":0.6797677},"labels":[],"label_agreement":null},{"id":"W2023637084","doi":"10.1016/j.leukres.2012.08.019","title":"Outcomes of adult patients with relapsed acute lymphoblastic leukemia following frontline treatment with a pediatric regimen","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Chemotherapy; Regimen; Lymphoblastic Leukemia; Salvage therapy; Acute lymphocytic leukemia; Internal medicine; Induction chemotherapy; Oncology; Surgery; Leukemia","score_opus":0.020238150766954708,"score_gpt":0.3091990927972103,"score_spread":0.2889609420302556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023637084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99340355,0.000267687,0.00028976784,0.00029373448,0.00015015206,0.002363916,0.000066673965,0.00014574396,0.003018743],"genre_scores_gemma":[0.9873319,0.00019829124,0.004736641,0.00011690059,0.00040353823,0.00042801184,0.00019222578,0.0002237698,0.0063687204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99102765,0.0003884173,0.00085454894,0.00094000454,0.0042764414,0.002512951],"domain_scores_gemma":[0.99390537,0.0014838353,0.00028003572,0.0015909272,0.0015020669,0.0012377399],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00096208404,0.0007164778,0.0014198124,0.0011572372,0.0003548379,0.00006057732,0.00056844956,0.00040467302,0.00013715308],"category_scores_gemma":[0.0006806863,0.00043811204,0.0003164027,0.0021364058,0.00048569895,0.0005201135,0.00031353036,0.00090823555,0.00028013322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00772197,0.0012596347,0.9825406,0.00026984347,0.0019495178,0.0004057672,0.0011965386,0.000038870392,0.0004362675,0.00013168796,0.0023486386,0.0017006501],"study_design_scores_gemma":[0.09520907,0.017053217,0.87469876,0.0005931927,0.0025490525,0.0001827371,0.00084189756,0.0018453912,0.0046394262,0.000039897983,0.0012268876,0.0011204918],"about_ca_topic_score_codex":0.001479739,"about_ca_topic_score_gemma":0.000066531094,"teacher_disagreement_score":0.10784187,"about_ca_system_score_codex":0.018217213,"about_ca_system_score_gemma":0.0078112464,"threshold_uncertainty_score":0.99980706},"labels":[],"label_agreement":null},{"id":"W2024519140","doi":"10.1016/j.leukres.2013.10.010","title":"The aryl hydrocarbon receptor nuclear translocator (ARNT) modulates the antioxidant response in AML cells","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; Scheme for Promotion of Academic and Research Collaboration","keywords":"Aryl hydrocarbon receptor nuclear translocator; Aryl hydrocarbon receptor; Apoptosis; Reactive oxygen species; Cell biology; Chemistry; Intracellular; Molecular biology; Biology; Transcription factor; Biochemistry; Gene","score_opus":0.013652361485429138,"score_gpt":0.2719087306249588,"score_spread":0.25825636913952965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024519140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936321,0.0019260267,0.000018935305,0.0023461645,0.00013692568,0.00065756787,0.0000051853162,0.000020660971,0.0012564466],"genre_scores_gemma":[0.99457693,0.0022398888,0.00009344028,0.00017673697,0.00022707047,0.00018373923,0.000012156446,0.00006011371,0.002429943],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99685943,0.0007847943,0.00036541882,0.0005503189,0.000588999,0.00085101055],"domain_scores_gemma":[0.99825555,0.00038887505,0.000062297244,0.0009454181,0.00021228584,0.0001355631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027505683,0.00022437912,0.00017125826,0.00009219267,0.0005698705,0.00023737396,0.0011500372,0.00028630818,0.00007660977],"category_scores_gemma":[0.00044900147,0.00013580099,0.00011682954,0.00047436552,0.0007058008,0.000013776782,0.00025284398,0.00078913954,0.0003366368],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072627654,0.00003320272,0.00016185391,0.000026629736,0.000025308467,0.0000066403127,0.00034047358,0.00023534324,0.9867508,0.0001092214,0.0092097875,0.0023745075],"study_design_scores_gemma":[0.0008178529,0.0004716528,0.0018864583,0.000046732624,0.0000055182486,0.000014256947,0.0015396298,0.0030031886,0.8735971,0.00077272404,0.11755658,0.00028834818],"about_ca_topic_score_codex":0.00037985368,"about_ca_topic_score_gemma":0.00004162412,"teacher_disagreement_score":0.113153696,"about_ca_system_score_codex":0.00023182333,"about_ca_system_score_gemma":0.0005896103,"threshold_uncertainty_score":0.5537804},"labels":[],"label_agreement":null},{"id":"W2026003064","doi":"10.1016/j.leukres.2009.08.007","title":"Polymorphisms in glucocorticoid receptor gene and the outcome of childhood acute lymphoblastic leukemia (ALL)","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fondation Charles-Bruneau; Canadian Institutes of Health Research; Centre de recherche du CHU Sainte-Justine; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Haplotype; Lymphoblast; Single-nucleotide polymorphism; Intron; Allele; Biology; Glucocorticoid receptor; Gene; Gene isoform; Acute lymphocytic leukemia; Genetics; Internal medicine; Molecular biology; Cancer research; Lymphoblastic Leukemia; Leukemia; Medicine; Genotype; Cell culture","score_opus":0.029972575818002556,"score_gpt":0.33503767398288353,"score_spread":0.305065098164881,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026003064","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98618275,0.0011691997,0.00012158515,0.0056416965,0.00013112549,0.0024494664,0.00003182055,0.00007080734,0.004201558],"genre_scores_gemma":[0.99322265,0.0010808244,0.0011570577,0.0011910831,0.00025144836,0.00012533071,0.000046624715,0.00008049214,0.002844502],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99264836,0.0007034636,0.0013108028,0.00096717174,0.0026474718,0.0017227037],"domain_scores_gemma":[0.99515903,0.0021568341,0.00020184938,0.0014579612,0.00047852905,0.00054578204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036861738,0.00046344477,0.0012651435,0.0010715798,0.00019546965,0.000094346295,0.00088089093,0.00044397524,0.00022972086],"category_scores_gemma":[0.0022163994,0.00031583916,0.00025733406,0.002035906,0.0015000869,0.00021510455,0.0005296228,0.0018154725,0.000310063],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.048966464,0.002481298,0.13126603,0.0012257827,0.0026780136,0.003982629,0.012781369,0.0008873646,0.6456955,0.037090596,0.017980566,0.09496437],"study_design_scores_gemma":[0.13156743,0.0055947136,0.7170432,0.0012430304,0.0006088914,0.0027868696,0.0012696482,0.039047386,0.09041862,0.0054592425,0.0034368217,0.001524097],"about_ca_topic_score_codex":0.0013341156,"about_ca_topic_score_gemma":0.000033067467,"teacher_disagreement_score":0.5857772,"about_ca_system_score_codex":0.0071864175,"about_ca_system_score_gemma":0.004714395,"threshold_uncertainty_score":0.99992937},"labels":[],"label_agreement":null},{"id":"W2026601287","doi":"10.1016/j.leukres.2005.04.020","title":"Treatment of elderly patients with acute lymphoblastic leukemia—Evidence for a benefit of imatinib in BCR-ABL positive patients","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Imatinib; Imatinib mesylate; Internal medicine; Regimen; Induction chemotherapy; Induction therapy; Chemotherapy; Oncology; Gastroenterology; Surgery; Myeloid leukemia","score_opus":0.04490805009228664,"score_gpt":0.357904061476144,"score_spread":0.31299601138385735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026601287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944593,0.0003207517,0.000051923336,0.00016395206,0.000039429924,0.003969366,0.0002898108,0.00002514594,0.00068036845],"genre_scores_gemma":[0.9931112,0.0002596642,0.004514362,0.000027041466,0.00007565653,0.0006157306,0.0003069208,0.00007784845,0.0010115637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99565464,0.0001366966,0.0009120223,0.0007522488,0.0015479944,0.0009963816],"domain_scores_gemma":[0.9956029,0.0015581611,0.00031375486,0.0008202739,0.0014174397,0.0002874543],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003463197,0.00041516218,0.0009650943,0.0006557995,0.00010817186,0.000020195928,0.00030441832,0.00022974111,0.00008289425],"category_scores_gemma":[0.0004448804,0.00031505956,0.00019957488,0.0008974112,0.0003441959,0.00030184095,0.00010804683,0.0002641179,0.000035135672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034462284,0.007109353,0.71578205,0.0013107212,0.0018101077,0.0001548692,0.005884883,0.0010762658,0.0032272434,0.00034361062,0.000606578,0.22823201],"study_design_scores_gemma":[0.101489164,0.043992795,0.7925589,0.0037359118,0.00063481036,0.000029181068,0.00025508823,0.0059676166,0.05013997,0.00016648971,0.0004544835,0.00057560176],"about_ca_topic_score_codex":0.0022973635,"about_ca_topic_score_gemma":0.00043924406,"teacher_disagreement_score":0.22765641,"about_ca_system_score_codex":0.023216365,"about_ca_system_score_gemma":0.0040257936,"threshold_uncertainty_score":0.99993014},"labels":[],"label_agreement":null},{"id":"W2027611958","doi":"10.1016/j.leukres.2014.03.022","title":"Lenalidomide and metronomic melphalan for CMML and higher risk MDS: A phase 2 clinical study with biomarkers of angiogenesis","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"Celgene","keywords":"Lenalidomide; Medicine; Melphalan; Oncology; Angiogenesis; Internal medicine; Pazopanib; Pharmacology; Multiple myeloma; Cancer; Sunitinib","score_opus":0.09011501660460082,"score_gpt":0.44628126325013334,"score_spread":0.35616624664553254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027611958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99498427,0.0006526152,0.00037957812,0.0005752798,0.00003998272,0.002574406,0.000058392696,0.000036899153,0.00069860514],"genre_scores_gemma":[0.9942503,0.00038268892,0.0038646348,0.000055252294,0.00029258654,0.00027621826,0.00002295249,0.00008178274,0.00077359483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955177,0.0012204798,0.00067271676,0.00088745303,0.0008792009,0.0008224788],"domain_scores_gemma":[0.9941165,0.0037335875,0.00016464069,0.0008118642,0.0005681165,0.00060533395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009717106,0.0002684143,0.00088191224,0.0007004053,0.00024319405,0.00006203502,0.00028454844,0.00021296764,0.000060666334],"category_scores_gemma":[0.0016615761,0.0001959848,0.00012832666,0.0007073341,0.0010854851,0.000114551774,0.000307209,0.00069441454,0.000010659166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.046351187,0.0018755877,0.73567045,0.0007684379,0.00401927,0.00012489466,0.00072326727,0.0000051681236,0.010621431,0.00037233665,0.013958001,0.18550998],"study_design_scores_gemma":[0.17432986,0.052751973,0.71249616,0.0003806984,0.001728745,0.00014917029,0.0047613266,0.014384221,0.011094948,0.00052574027,0.02644628,0.00095090066],"about_ca_topic_score_codex":0.0017731413,"about_ca_topic_score_gemma":0.00014599586,"teacher_disagreement_score":0.18455908,"about_ca_system_score_codex":0.0005973771,"about_ca_system_score_gemma":0.0010358212,"threshold_uncertainty_score":0.79920286},"labels":[],"label_agreement":null},{"id":"W2028619564","doi":"10.1016/j.leukres.2010.01.006","title":"Targeting integrin linked kinase and FMS-like tyrosine kinase-3 is cytotoxic to acute myeloid leukemia stem cells but spares normal progenitors","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Terry Fox Research Institute","funders":"Cancer Research Society; Leukemia and Lymphoma Society","keywords":"Haematopoiesis; Myeloid leukemia; Cancer research; Progenitor cell; Fms-Like Tyrosine Kinase 3; Stem cell; Leukemia; Myeloid; Cytotoxic T cell; Bone marrow; Integrin-linked kinase; CD135; Tyrosine-kinase inhibitor; Tyrosine kinase; Medicine; Biology; Immunology; Kinase; Signal transduction; Cell biology; Internal medicine; Cancer; Protein kinase A","score_opus":0.03293949577269067,"score_gpt":0.32414813245436985,"score_spread":0.2912086366816792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028619564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958665,0.0004668256,0.00010535494,0.0030758432,0.0006866825,0.0039642667,0.00021268909,0.0003683078,0.001533398],"genre_scores_gemma":[0.9653754,0.0006088153,0.00623239,0.0012120842,0.0021305378,0.0007782349,0.00013008172,0.00034992388,0.023182482],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.98902804,0.00060807826,0.001249959,0.0021511558,0.0034453312,0.0035174466],"domain_scores_gemma":[0.992208,0.0010020876,0.00019420858,0.0021039012,0.0017633872,0.002728409],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004376227,0.00095901574,0.0012522842,0.0018233852,0.0010754104,0.0005594503,0.0015027099,0.0011143005,0.00078519346],"category_scores_gemma":[0.0008491574,0.0008478653,0.00030857904,0.0026888726,0.0013025772,0.00054854905,0.0022701698,0.008065427,0.001788156],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0019512364,0.00014850554,0.005461904,0.00047839494,0.0002688041,0.0017958739,0.0014595853,0.000029497365,0.9253097,0.00012591292,0.05009706,0.0128734885],"study_design_scores_gemma":[0.0062905084,0.0019300411,0.005835672,0.0004342103,0.00014264196,0.0005412604,0.0022419456,0.006920191,0.91096133,0.000069584516,0.06344167,0.0011909204],"about_ca_topic_score_codex":0.002822992,"about_ca_topic_score_gemma":0.0002384821,"teacher_disagreement_score":0.024211181,"about_ca_system_score_codex":0.005654551,"about_ca_system_score_gemma":0.006138148,"threshold_uncertainty_score":0.9994961},"labels":[],"label_agreement":null},{"id":"W2029200519","doi":"10.1016/j.leukres.2010.04.014","title":"3-Deazauridine enhances the antileukemic action of 5-aza-2′-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Medical Research Council Canada","keywords":"Deoxycytidine kinase; Deoxycytidine; Cytarabine; Prodrug; Pharmacology; Drug; Cancer research; Leukemia; Drug resistance; In vitro; Chemistry; Chemotherapy; Medicine; Biology; Immunology; Gemcitabine; Biochemistry; Internal medicine; Genetics","score_opus":0.02942375182383521,"score_gpt":0.3517070445500963,"score_spread":0.3222832927262611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029200519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877017,0.0010581141,0.00024915344,0.0057581495,0.00025833072,0.0017693037,0.00002607181,0.00006683584,0.0031123399],"genre_scores_gemma":[0.9919896,0.00045940367,0.0021913026,0.00018306475,0.0003979705,0.00026215275,0.000022283115,0.000081544065,0.0044126557],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9938158,0.00042053265,0.0008677236,0.0010463749,0.0022916298,0.0015579425],"domain_scores_gemma":[0.99507076,0.0019398257,0.00015764222,0.0013201447,0.00089966087,0.0006119435],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0046223877,0.0004116692,0.0007917798,0.0012151478,0.0003981697,0.00008872406,0.0008613948,0.0003122449,0.00022315542],"category_scores_gemma":[0.003535622,0.00030043823,0.00012542488,0.0030510703,0.0011850971,0.0002733496,0.00062137883,0.0025738983,0.00013776921],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019943933,0.00025074926,0.0024913664,0.00065599964,0.00003772701,0.00046992875,0.0011160217,0.000032443455,0.9720151,0.0015068185,0.014823197,0.0046062977],"study_design_scores_gemma":[0.006585383,0.00062003505,0.055699296,0.0007096477,0.00005195967,0.0004271174,0.0012828641,0.004464213,0.91400415,0.0013049626,0.0142938355,0.0005565284],"about_ca_topic_score_codex":0.001691162,"about_ca_topic_score_gemma":0.0051267287,"teacher_disagreement_score":0.0580109,"about_ca_system_score_codex":0.0022740993,"about_ca_system_score_gemma":0.0035130803,"threshold_uncertainty_score":0.99994475},"labels":[],"label_agreement":null},{"id":"W2031245996","doi":"10.1016/j.leukres.2003.11.015","title":"Cytokines and retinoic acid therapy for APL: new tricks from an old combination","year":2004,"lang":"en","type":"editorial","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Retinoic acid; Combination therapy; Cancer research; Retinoic acid-inducible orphan G protein-coupled receptor; Retinoic acid receptor; Tretinoin; Medicine; Computational biology; Biology; Internal medicine; Biochemistry","score_opus":0.027928041562333774,"score_gpt":0.3558299878990524,"score_spread":0.32790194633671865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031245996","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5476568,0.046038352,0.0051034535,0.000894578,0.39147145,0.004978505,0.0012124103,0.00020176638,0.0024427301],"genre_scores_gemma":[0.0606654,0.02138958,0.0017322147,0.00015043978,0.883319,0.00050539663,0.015997665,0.00030930724,0.015931003],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961962,0.0002826223,0.00041884865,0.0013073167,0.0010808485,0.00071416027],"domain_scores_gemma":[0.9973628,0.00035732554,0.00017577791,0.0008883157,0.00092018687,0.000295626],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0011501234,0.00045233392,0.00045572783,0.00020430025,0.0003290777,0.0002911142,0.000882586,0.0021308993,0.000028851027],"category_scores_gemma":[0.0016218945,0.00042254405,0.00015174344,0.00025411064,0.00029386583,0.000017333989,0.00024964506,0.0011140129,0.000010304745],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011946701,0.00009057357,0.000060131675,0.00020096698,0.000112914444,0.000009464327,0.00015992449,0.000004901543,0.13736297,0.00010245017,0.8458056,0.014895435],"study_design_scores_gemma":[0.0042613023,0.0015543055,0.000027758457,0.00008751192,0.000022186498,0.000002188966,0.000058122456,0.000029032311,0.26562724,0.005103703,0.7228165,0.0004100964],"about_ca_topic_score_codex":0.0011544818,"about_ca_topic_score_gemma":0.00008297459,"teacher_disagreement_score":0.49184757,"about_ca_system_score_codex":0.00046088488,"about_ca_system_score_gemma":0.0046064993,"threshold_uncertainty_score":0.9998226},"labels":[],"label_agreement":null},{"id":"W2032403766","doi":"10.1016/j.leukres.2013.03.003","title":"Combined inhibition of the phosphoinosityl-3-kinase (PI3Kinase) P110δ subunit and mitogen-extracellular activated protein kinase (MEKinase) shows synergistic cytotoxicity against human acute myeloid leukemia progenitors","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Myeloid leukemia; Progenitor cell; MAPK/ERK pathway; Cancer research; Medicine; Protein kinase A; Leukemia; PI3K/AKT/mTOR pathway; Protein kinase B; Kinase; Myeloid; MEK inhibitor; Pharmacology; Chemistry; Immunology; Stem cell; Biology; Cell biology; Phosphorylation; Signal transduction; Biochemistry","score_opus":0.02154962473545705,"score_gpt":0.2819466830449602,"score_spread":0.2603970583095031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032403766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99561423,0.00076929334,0.00004587511,0.00015882181,0.00015242065,0.0027686134,0.00011377952,0.000053083342,0.0003238743],"genre_scores_gemma":[0.99592096,0.000095178424,0.00013367237,0.00009296251,0.00027681378,0.00076945144,0.00028078342,0.00011161919,0.002318542],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99528503,0.0008136028,0.00068435515,0.0010436912,0.0011030054,0.0010703218],"domain_scores_gemma":[0.9969672,0.00009833439,0.00032465122,0.0013535919,0.0009051091,0.0003511458],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001036552,0.00052210124,0.00046798636,0.00022946397,0.0007832328,0.00017303372,0.0008282426,0.0006217539,0.00010372185],"category_scores_gemma":[0.0003607642,0.00044895484,0.00023385017,0.00078539096,0.0011672585,0.000043976783,0.00085497904,0.0011131894,0.000028494698],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003988217,0.00015218124,0.0013046745,0.00020475693,0.00019241488,0.00005351378,0.00012874443,0.00008340953,0.9945237,0.00012369355,0.0018446931,0.0009893954],"study_design_scores_gemma":[0.0020800943,0.0007529741,0.0020413175,0.0002522905,0.000047401696,0.000009698849,0.00012187515,0.0003914396,0.992549,0.0002450895,0.0010135943,0.0004952048],"about_ca_topic_score_codex":0.0016793751,"about_ca_topic_score_gemma":0.00013440539,"teacher_disagreement_score":0.0019991621,"about_ca_system_score_codex":0.0011467738,"about_ca_system_score_gemma":0.0012836542,"threshold_uncertainty_score":0.9997962},"labels":[],"label_agreement":null},{"id":"W2033332996","doi":"10.1016/s0145-2126(01)00162-x","title":"Comparison of DR5 and Fas expression levels relative to the chemosensitivity of acute lymphoblastic leukemia cell lines","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; Canada Research Chairs","funders":"National Cancer Institute; Medical Research Council Canada","keywords":"Etoposide; Vincristine; Apoptosis; Cell culture; Cancer research; Dexamethasone; Methotrexate; Medicine; Immunology; Chemistry; Internal medicine; Biology; Chemotherapy; Biochemistry; Cyclophosphamide","score_opus":0.08887992542065368,"score_gpt":0.38207603295175174,"score_spread":0.29319610753109804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033332996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98756355,0.00057662284,0.0016731024,0.0018233953,0.0000845879,0.0014076077,0.00009407314,0.00004021986,0.0067368327],"genre_scores_gemma":[0.99137056,0.00019701212,0.002406016,0.00010795833,0.00020787703,0.00006706953,0.000014259215,0.00007179782,0.005557431],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9940703,0.0006613395,0.00089587324,0.00077800197,0.0025427109,0.0010518034],"domain_scores_gemma":[0.99326783,0.0034587223,0.00024403636,0.0011746462,0.0012986091,0.0005561417],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016476489,0.00036945692,0.0010395366,0.0005950488,0.00033501995,0.000043223597,0.00057341007,0.0003841118,0.00023746553],"category_scores_gemma":[0.0018508818,0.00025451172,0.0001725863,0.0016550684,0.0011628037,0.00020209492,0.0010020039,0.0012910161,0.00018474695],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013806786,0.00037499,0.0039655934,0.0007137586,0.0002455634,0.00015195463,0.0073509444,0.00030487496,0.9455978,0.00020928157,0.033269037,0.0064354953],"study_design_scores_gemma":[0.004922946,0.001529737,0.015971117,0.0007446693,0.0001587694,0.00011488183,0.0014015776,0.06101424,0.91199046,0.00016192345,0.0016994454,0.00029024435],"about_ca_topic_score_codex":0.00041921283,"about_ca_topic_score_gemma":0.000024386898,"teacher_disagreement_score":0.060709365,"about_ca_system_score_codex":0.00306011,"about_ca_system_score_gemma":0.0015706517,"threshold_uncertainty_score":0.9999907},"labels":[],"label_agreement":null},{"id":"W2033495545","doi":"10.1016/j.leukres.2009.08.030","title":"Therapeutic implications of Src independent calcium mobilization in diffuse large B-cell lymphoma","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôtel-Dieu de Montréal; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Canadian Breast Cancer Research Alliance","keywords":"Dasatinib; Proto-oncogene tyrosine-protein kinase Src; Src family kinase; Cancer research; Kinase; Phosphorylation; Imatinib; Lymphoma; Biology; Medicine; Internal medicine; Cell biology","score_opus":0.0668813852658236,"score_gpt":0.3853924470342055,"score_spread":0.3185110617683819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033495545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869745,0.0007975933,0.00008672427,0.0014266967,0.000020045723,0.0007836225,0.000013789885,0.000024759685,0.009872301],"genre_scores_gemma":[0.9984218,0.00032817316,0.000069860784,0.00038881073,0.000036593345,0.000131298,0.000054795244,0.000014179042,0.00055447826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982371,0.0001285042,0.00031775792,0.00030035566,0.0005729775,0.00044333452],"domain_scores_gemma":[0.9988905,0.00017315887,0.000048744303,0.0005242423,0.0002245309,0.00013882997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005294967,0.000115456896,0.00023947212,0.00034381993,0.00007835339,0.000019669924,0.00014533194,0.00013475597,0.000043548647],"category_scores_gemma":[0.00005042078,0.00009339001,0.00007528992,0.00069408247,0.000054226002,0.0000600054,0.00004872399,0.00014386188,0.000060469843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008154206,0.06104986,0.6643628,0.0002807905,0.00012095317,0.0002165535,0.002050093,0.000042520718,0.103391945,0.025765138,0.003236296,0.13866763],"study_design_scores_gemma":[0.01981887,0.00053757825,0.9386604,0.00006683298,0.00002395366,0.000012611909,0.000220551,0.0005758988,0.037297737,0.0012844531,0.0014144664,0.00008663564],"about_ca_topic_score_codex":0.00034805207,"about_ca_topic_score_gemma":0.00006758475,"teacher_disagreement_score":0.2742976,"about_ca_system_score_codex":0.001869948,"about_ca_system_score_gemma":0.00068776857,"threshold_uncertainty_score":0.4889849},"labels":[],"label_agreement":null},{"id":"W2034409643","doi":"10.1016/s0145-2126(03)00180-2","title":"Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia","year":2003,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Immunophenotyping; CD33; Medicine; Internal medicine; Gastroenterology; CD34; Acute promyelocytic leukemia; Myeloid leukemia; Daunorubicin; Leukemia; Oncology; Immunology; Flow cytometry; Biology; Stem cell","score_opus":0.025738497860918738,"score_gpt":0.31812977727637065,"score_spread":0.2923912794154519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034409643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828005,0.0005801026,0.00011531468,0.00020045444,0.000072502975,0.0023730607,0.000023322455,0.00006960905,0.013765141],"genre_scores_gemma":[0.9910243,0.00043293167,0.0053454936,0.00009810543,0.00006549537,0.00028295672,0.00008618139,0.0001397215,0.0025248155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929958,0.00071469904,0.00085594534,0.0009574136,0.0026266049,0.0018495135],"domain_scores_gemma":[0.99517447,0.0013535301,0.00012183535,0.0013611071,0.0015621543,0.00042691227],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0026777175,0.00041123273,0.0008557763,0.0012195555,0.0002258827,0.00005725174,0.00063972914,0.00035921848,0.0002238095],"category_scores_gemma":[0.0037584333,0.00033732475,0.00012390604,0.0034333877,0.00083458546,0.00032395349,0.0002809878,0.0028554613,0.00021682771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0102557745,0.0011216522,0.89112514,0.0017591156,0.00082124455,0.0018955016,0.0025526679,0.0005059723,0.05658234,0.006419802,0.003838889,0.023121899],"study_design_scores_gemma":[0.034049895,0.0049748113,0.8827627,0.0029759174,0.00018853086,0.000262075,0.0009112284,0.0023341475,0.054996688,0.0017878393,0.013533864,0.0012223038],"about_ca_topic_score_codex":0.0009059799,"about_ca_topic_score_gemma":0.00011123634,"teacher_disagreement_score":0.02379412,"about_ca_system_score_codex":0.008162766,"about_ca_system_score_gemma":0.008023709,"threshold_uncertainty_score":0.99990785},"labels":[],"label_agreement":null},{"id":"W2035278640","doi":"10.1016/j.leukres.2014.10.005","title":"Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors","year":2014,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Pfizer","keywords":"Bosutinib; Ponatinib; Nilotinib; Dasatinib; Medicine; Tyrosine kinase; Chronic myelogenous leukemia; Tyrosine-kinase inhibitor; Internal medicine; Imatinib; Pharmacology; Oncology; Leukemia; Myeloid leukemia","score_opus":0.08836413084802916,"score_gpt":0.4135965523823236,"score_spread":0.32523242153429444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035278640","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1323287,0.85196126,0.00003117705,0.00015576441,0.00032181334,0.013638261,0.0012891165,0.0000646295,0.0002092911],"genre_scores_gemma":[0.29758438,0.6751514,0.0011170743,0.0000901774,0.005692121,0.007360357,0.009967854,0.00050110416,0.0025355082],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9887324,0.001952921,0.0033220667,0.0018891933,0.0021919792,0.0019114156],"domain_scores_gemma":[0.9917842,0.0025801093,0.0014943784,0.0026351481,0.0010591294,0.0004470449],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0034914967,0.0015804924,0.0053696227,0.0016498887,0.00034913,0.00010437087,0.0010653405,0.001395607,0.00031466986],"category_scores_gemma":[0.00077468995,0.0011009236,0.0014525729,0.002310574,0.0010352983,0.00023034097,0.00042285744,0.0026398571,0.00011226121],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.004896398,0.0069284537,0.0001044917,0.13518871,0.004287227,0.0011881945,0.005276904,0.00037280362,0.02325279,0.0002806067,0.044180486,0.7740429],"study_design_scores_gemma":[0.07064252,0.020386403,0.00023444429,0.05183573,0.004896413,0.00039434756,0.0003128181,0.0025361145,0.042358946,0.000037157908,0.8045246,0.0018404904],"about_ca_topic_score_codex":0.0006584024,"about_ca_topic_score_gemma":0.002502901,"teacher_disagreement_score":0.77220243,"about_ca_system_score_codex":0.03627658,"about_ca_system_score_gemma":0.02130654,"threshold_uncertainty_score":0.9999008},"labels":[],"label_agreement":null},{"id":"W2035901454","doi":"10.1016/j.leukres.2013.09.025","title":"Genomic aberrations in anaplastic multiple myeloma: High frequency of 1q21(CKS1B) amplifications","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Fluorescence in situ hybridization; Multiple myeloma; Biology; Hematology; Gene duplication; Chromosome instability; Cytogenetics; Cancer research; Molecular biology; Pathology; Medicine; Internal medicine; Genetics; Gene; Chromosome","score_opus":0.06511811730914109,"score_gpt":0.3531914296015694,"score_spread":0.28807331229242833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035901454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906745,0.0002349885,0.00016198737,0.0010195287,0.00004709713,0.00180352,0.00005301762,0.000040387313,0.005964969],"genre_scores_gemma":[0.992361,0.00010811405,0.00373095,0.000024947049,0.000084906074,0.0008393015,0.00018324515,0.000036918198,0.0026306033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702746,0.00025069757,0.00052423554,0.00046405988,0.0008868413,0.0008466802],"domain_scores_gemma":[0.9970621,0.00097270194,0.00006522044,0.0007980577,0.0006891751,0.0004127419],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0005241553,0.00017587077,0.00036248864,0.0009206702,0.00020258401,0.00005080465,0.0003026287,0.0001585667,0.0012455754],"category_scores_gemma":[0.0015426308,0.00015264218,0.00008610218,0.0011928062,0.00036068907,0.00019140675,0.0001302897,0.0007355832,0.0015249554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029373955,0.0010586011,0.6854144,0.00029670942,0.00021369937,0.00015437863,0.0007125881,0.0001758173,0.2908561,0.004440027,0.0051015434,0.01128245],"study_design_scores_gemma":[0.0038232543,0.00032722403,0.98361665,0.000094510375,0.000012933609,0.000017206388,0.000302024,0.0053732637,0.004530583,0.0015785247,0.00020160196,0.00012221893],"about_ca_topic_score_codex":0.01866769,"about_ca_topic_score_gemma":0.002606355,"teacher_disagreement_score":0.2982023,"about_ca_system_score_codex":0.0014621429,"about_ca_system_score_gemma":0.0013636111,"threshold_uncertainty_score":0.9996674},"labels":[],"label_agreement":null},{"id":"W2036563645","doi":"10.1016/j.leukres.2007.09.015","title":"Up-regulation of MRP4 and down-regulation of influx transporters in human leukemic cells with acquired resistance to 6-mercaptopurine","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Efflux; Western blot; Multiple drug resistance; Transporter; Cell culture; Pharmacology; Cell biology; Biology; Chemistry; Drug resistance; Biochemistry; Gene; Genetics","score_opus":0.026076508364292508,"score_gpt":0.33030586412090385,"score_spread":0.30422935575661136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036563645","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994124,0.00010426851,0.001043363,0.00028712908,0.000031343974,0.001578401,0.000015509568,0.000029293431,0.0027867164],"genre_scores_gemma":[0.9936591,0.000025605514,0.0018346906,0.000038720293,0.000090417045,0.000043406475,0.00005858249,0.00005915906,0.0041903225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99524033,0.00016965762,0.0009753862,0.00063415733,0.0020807488,0.000899729],"domain_scores_gemma":[0.99735576,0.0005215181,0.00017495968,0.0007450064,0.00080946885,0.00039330593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030585849,0.000263183,0.0006534902,0.0015956023,0.00011025555,0.000018966453,0.00029780422,0.00026593765,0.000115812036],"category_scores_gemma":[0.00017122524,0.0002302648,0.00006876227,0.002180997,0.00076899293,0.0002096622,0.000106995125,0.00045494738,0.000008937593],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060164738,0.00010822325,0.015024028,0.0008729833,0.0000581521,0.00005968784,0.0021735777,0.00079284445,0.9707069,0.0010223694,0.0007036438,0.0024611123],"study_design_scores_gemma":[0.0077387257,0.00085479295,0.37224576,0.0008880752,0.000031246913,0.000018387776,0.00076314714,0.00086935126,0.6157927,0.00035066542,0.000240192,0.00020696469],"about_ca_topic_score_codex":0.0013570987,"about_ca_topic_score_gemma":0.0014757102,"teacher_disagreement_score":0.35722172,"about_ca_system_score_codex":0.0032425334,"about_ca_system_score_gemma":0.0014528467,"threshold_uncertainty_score":0.9389926},"labels":[],"label_agreement":null},{"id":"W2036608644","doi":"10.1016/s0145-2126(07)70460-5","title":"Improving clinical outcome in patients with myelodysplastic syndrome and iron overload using iron chelation therapy","year":2007,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Internal medicine; Chelation therapy; Overall survival; Bone marrow; Thalassemia","score_opus":0.14516294574171884,"score_gpt":0.447201765059812,"score_spread":0.3020388193180932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036608644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36261684,0.6349874,0.000013535578,0.000011563539,0.00012905066,0.0019872272,0.0000070232863,0.000026130967,0.00022120737],"genre_scores_gemma":[0.013190488,0.9858034,0.00031145578,0.00003341931,0.00010210652,0.000027762286,0.00011729054,0.00011844487,0.00029562495],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9956103,0.00047217763,0.001204166,0.00077261793,0.0010864469,0.0008542905],"domain_scores_gemma":[0.99801075,0.00074958074,0.00027120873,0.00048806734,0.00017259263,0.0003078081],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0025786704,0.0004267541,0.0016364842,0.00087260175,0.00015923311,0.000056033765,0.00017058475,0.001185085,0.000038810183],"category_scores_gemma":[0.00045742368,0.00028425007,0.00018997572,0.0009819162,0.00034512763,0.000116181756,0.00014838902,0.0034759308,0.000041734318],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003908532,0.00019280455,0.063436024,0.009585987,0.00007093886,0.00026109247,0.00004633516,0.000008300418,5.5182824e-7,0.000007743054,0.000011064964,0.9259883],"study_design_scores_gemma":[0.05108697,0.012453088,0.4591301,0.0992388,0.0018249329,0.0009652175,0.0003724323,0.0043514627,7.322237e-7,0.000030184723,0.36737785,0.0031682288],"about_ca_topic_score_codex":0.0004331806,"about_ca_topic_score_gemma":0.000015149348,"teacher_disagreement_score":0.9228201,"about_ca_system_score_codex":0.0018636361,"about_ca_system_score_gemma":0.0013877397,"threshold_uncertainty_score":0.99996096},"labels":[],"label_agreement":null},{"id":"W2038378803","doi":"10.1016/j.leukres.2007.05.004","title":"The expression of cytoplasmic CD79a correlates with surface CD3 expression in childhood T-ALL lymphoblasts","year":2007,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Lymphoblast; Expression (computer science); Cytoplasm; CD3; Biology; Cell biology; Immunology; Genetics; Cell culture; Antigen; Computer science","score_opus":0.029157580527006767,"score_gpt":0.32278567813704384,"score_spread":0.29362809761003705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038378803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.855234,0.0038100923,0.00024011763,0.11826111,0.0005952769,0.006653953,0.00014850916,0.00026767148,0.014789266],"genre_scores_gemma":[0.8466863,0.00625569,0.004905936,0.07376769,0.005843565,0.0007876836,0.001425165,0.0016683696,0.058659572],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9842291,0.0014389917,0.001569988,0.0017760257,0.007413385,0.0035724926],"domain_scores_gemma":[0.9847354,0.009992444,0.00051701,0.002846472,0.0013698767,0.00053877744],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0049437974,0.001011747,0.0015911226,0.0015267803,0.0005309189,0.00018235618,0.002055723,0.0029000875,0.00021919953],"category_scores_gemma":[0.0019642345,0.0006174389,0.00033152962,0.0023842151,0.0021875363,0.0002406559,0.0013279509,0.0123215495,0.0003564241],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0041377386,0.0002738173,0.004536425,0.0011817674,0.00018705349,0.006506381,0.0010829093,0.00030291107,0.035616647,0.000011373335,0.9449829,0.0011801025],"study_design_scores_gemma":[0.03057822,0.0046586776,0.010809579,0.029756466,0.00026754214,0.0029149982,0.0019822018,0.0036002903,0.29737088,0.00043432007,0.61517096,0.0024558494],"about_ca_topic_score_codex":0.0008818361,"about_ca_topic_score_gemma":0.0001334227,"teacher_disagreement_score":0.3298119,"about_ca_system_score_codex":0.011118919,"about_ca_system_score_gemma":0.01119071,"threshold_uncertainty_score":0.9996277},"labels":[],"label_agreement":null},{"id":"W2039249445","doi":"10.1016/j.leukres.2006.06.001","title":"CD7 expression predicts poor disease free survival and post-remission survival in patients with acute myeloid leukemia and normal karyotype","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":74,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"","keywords":"Myeloid leukemia; Internal medicine; Karyotype; Medicine; Gastroenterology; Leukemia; Multivariate analysis; CD34; Myeloid; Complete remission; Oncology; Chemotherapy; Biology; Chromosome; Stem cell","score_opus":0.015210120782076229,"score_gpt":0.2828162813017182,"score_spread":0.267606160519642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039249445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915897,0.00059920293,0.00003042362,0.001496878,0.000120062505,0.0019010687,0.00021089037,0.00012684218,0.003924912],"genre_scores_gemma":[0.9932964,0.0003748616,0.00083462585,0.00011385118,0.00042831321,0.00012534403,0.0006519158,0.00015340305,0.0040212916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919076,0.00072395377,0.0006750245,0.0013738225,0.0034956024,0.0018239913],"domain_scores_gemma":[0.9954842,0.000735097,0.00012016424,0.0012411412,0.0010057545,0.0014136417],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002089766,0.00057538954,0.000789081,0.0010207403,0.0005029987,0.00019400426,0.0006123049,0.00044725937,0.0001420312],"category_scores_gemma":[0.0010339172,0.00044198873,0.00008403106,0.0012119603,0.0008942755,0.00063301926,0.0014547698,0.0023554212,0.000042192158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028056554,0.0004772488,0.9292082,0.00067873514,0.00012684312,0.0018659905,0.0002641433,0.00004994968,0.022523206,0.0003182598,0.010115746,0.006315134],"study_design_scores_gemma":[0.01950142,0.0014002273,0.9717765,0.00062618696,0.00007666575,0.000035078338,0.00021580746,0.0016599874,0.0026998282,0.00027413206,0.0012453448,0.0004888523],"about_ca_topic_score_codex":0.003802891,"about_ca_topic_score_gemma":0.00037828783,"teacher_disagreement_score":0.04256828,"about_ca_system_score_codex":0.003221392,"about_ca_system_score_gemma":0.0039034202,"threshold_uncertainty_score":0.9999462},"labels":[],"label_agreement":null},{"id":"W2039577073","doi":"10.1016/j.leukres.2013.11.014","title":"Influence of length of time to diagnosis and treatment on the survival of children with acute lymphoblastic leukemia: A population-based study","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children; Institute for Clinical Evaluative Sciences; Pediatric Oncology Group; University of Toronto; SickKids Foundation; St. Michael's Hospital","funders":"National Cancer Institute; Pediatric Oncology Group of Ontario; McMaster University; Amgen","keywords":"Medicine; Lymphoblastic Leukemia; Pediatrics; Overall survival; Population; Internal medicine; Leukemia","score_opus":0.038217547418533296,"score_gpt":0.33992017999049995,"score_spread":0.30170263257196667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039577073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995675,0.0000341454,0.000003020983,0.0011990137,0.0000070199485,0.0028925,0.0000491513,0.000015615826,0.00012449031],"genre_scores_gemma":[0.99918,0.000022850576,0.0000865911,0.00010820079,0.00003804887,0.0003693011,0.000014123081,0.000029437637,0.00015142323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688923,0.0004898975,0.00049757,0.00037729778,0.0014162518,0.00032973752],"domain_scores_gemma":[0.996119,0.002273362,0.000162923,0.0007729085,0.00048137226,0.00019040234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010001024,0.00019944907,0.0006150049,0.00029303576,0.00008840398,0.000015418058,0.00024214343,0.000073906296,0.00013211435],"category_scores_gemma":[0.00062938925,0.00012230448,0.00006418739,0.0006789426,0.00021583431,0.00006284265,0.00009389995,0.00022341861,0.000038272035],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010382789,0.00079827814,0.9892414,0.0000926555,0.000649096,0.000005815082,0.0020730563,0.0033673781,0.0010845343,0.000039969495,0.00021805552,0.0013914837],"study_design_scores_gemma":[0.00354134,0.0074680694,0.9804032,0.0003865588,0.00012533569,0.0000028465283,0.00039639286,0.00030247864,0.0072453963,0.000018354192,0.000005259004,0.000104770945],"about_ca_topic_score_codex":0.042871725,"about_ca_topic_score_gemma":0.00097236066,"teacher_disagreement_score":0.041899364,"about_ca_system_score_codex":0.0010356448,"about_ca_system_score_gemma":0.0012114261,"threshold_uncertainty_score":0.9635019},"labels":[],"label_agreement":null},{"id":"W2041743288","doi":"10.1016/j.leukres.2010.12.009","title":"Correlation among nuclear localization of NuMA-RARα, deregulation of gene expression and leukemic phenotype of hCG-NuMA-RARα transgenic mice","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Transgene; Fusion gene; Genetically modified mouse; Biology; Phenotype; Gene; Cancer research; Gene expression; Molecular biology; Genetics","score_opus":0.02869935577656829,"score_gpt":0.2714664752402198,"score_spread":0.24276711946365148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041743288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790864,0.0010986582,0.016307397,0.0000043246373,0.00007353342,0.0003094792,0.000011407969,0.000010098116,0.0030986944],"genre_scores_gemma":[0.9975209,0.00053469895,0.0014522875,0.000006835406,0.00008623777,0.000011602995,0.00012059691,0.000041104748,0.0002257364],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99807703,0.00025305903,0.0005329808,0.00039932746,0.0004620972,0.00027551226],"domain_scores_gemma":[0.9986274,0.00005092647,0.00027629588,0.00041738347,0.00054325204,0.000084689986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062706583,0.00016560213,0.0002624897,0.00017084154,0.00010304059,0.000009725991,0.00028936975,0.0003831204,0.00008300668],"category_scores_gemma":[0.00016568834,0.00016121335,0.000084039464,0.00032757877,0.00053125207,0.000029005176,0.00010661238,0.00021259335,0.0000028500035],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079672044,0.00006364404,0.006870049,0.00042032523,0.000037526577,6.99355e-7,0.0012057606,0.0010760907,0.98786545,0.00017473707,0.00020664833,0.001282325],"study_design_scores_gemma":[0.0009545369,0.0003908148,0.008634126,0.00014218617,0.000028247672,0.000004343945,0.00041342684,0.004749573,0.98374265,0.00063770777,0.00015051772,0.0001518633],"about_ca_topic_score_codex":0.00028659406,"about_ca_topic_score_gemma":0.000014179444,"teacher_disagreement_score":0.018434491,"about_ca_system_score_codex":0.000089923386,"about_ca_system_score_gemma":0.00034223264,"threshold_uncertainty_score":0.65740895},"labels":[],"label_agreement":null},{"id":"W2041790656","doi":"10.1016/j.leukres.2005.07.008","title":"Analysis of PTEN deletions and mutations in multiple myeloma","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"PTEN; Plasma cell leukemia; Cancer research; Multiple myeloma; Biology; Tumor suppressor gene; Pathogenesis; Plasma cell; Molecular biology; Mutation; Gene; Genetics; Immunology; Carcinogenesis; Apoptosis; PI3K/AKT/mTOR pathway","score_opus":0.04689792716890501,"score_gpt":0.3650777894425504,"score_spread":0.3181798622736454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041790656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976649,0.00065635634,0.00041498386,0.00022712897,0.000010889363,0.0001058391,0.000033060554,0.00000428294,0.0008825454],"genre_scores_gemma":[0.99816144,0.00013075017,0.0010197149,0.00003776261,0.00007171083,0.000043683118,0.000095212956,0.000009808295,0.00042994152],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99900275,0.00011126978,0.00018018721,0.00025131617,0.00021839041,0.00023610216],"domain_scores_gemma":[0.99936634,0.00010358267,0.000029276962,0.00027022648,0.0001689281,0.00006164204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004968803,0.00006374603,0.00012550627,0.00036881442,0.00006892906,0.0000137431625,0.00015145505,0.00010592838,0.00004825681],"category_scores_gemma":[0.0002926032,0.0000657002,0.000054865064,0.0007781134,0.00018602789,0.0000039732777,0.00009929519,0.00015940236,0.0000061766304],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008843366,0.00006769775,0.10213774,0.000020199803,0.00031638367,0.000004351291,0.00030999005,0.018020961,0.8614881,0.0001533739,0.000903269,0.016489506],"study_design_scores_gemma":[0.0024044972,0.0003274185,0.3435938,0.000045105495,0.00018441609,0.000007816522,0.0005823854,0.10478742,0.5094533,0.00018767282,0.038016785,0.0004093571],"about_ca_topic_score_codex":0.00037399295,"about_ca_topic_score_gemma":0.0026044564,"teacher_disagreement_score":0.35203478,"about_ca_system_score_codex":0.00013818534,"about_ca_system_score_gemma":0.00022492939,"threshold_uncertainty_score":0.26791766},"labels":[],"label_agreement":null},{"id":"W2043169671","doi":"10.1016/j.leukres.2011.03.007","title":"Mouse models of myelodysplastic syndromes","year":2011,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia; Genome British Columbia","funders":"Canadian Institutes of Health Research; University of British Columbia; Michael Smith Health Research BC; European Molecular Biology Organization","keywords":"Myelodysplastic syndromes; Phenotype; Bone marrow; Haematopoiesis; Progenitor cell; Biology; Xenotransplantation; Cancer research; Disease; Leukemia; clone (Java method); Hematopoietic stem cell; Stem cell; Immunology; Computational biology; Medicine; Pathology; Genetics; Transplantation; Gene; Internal medicine","score_opus":0.2860556436850702,"score_gpt":0.4401797091625552,"score_spread":0.15412406547748503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043169671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001460958,0.96513355,0.0000908761,0.000026350473,0.00011523884,0.003223336,0.00014687276,0.00013864656,0.03097904],"genre_scores_gemma":[0.0001467572,0.96150905,0.0010750252,0.000015848813,0.00032993278,0.0006267791,0.00026373786,0.00038093547,0.03565194],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908569,0.0012576871,0.00168464,0.0014066433,0.0026880594,0.002106071],"domain_scores_gemma":[0.99236196,0.002129877,0.00038125063,0.0027714968,0.001397487,0.000957911],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0036268774,0.0008793197,0.004593305,0.003229865,0.00021036359,0.00006251206,0.0018117424,0.0015580682,0.0010430255],"category_scores_gemma":[0.0014497208,0.0006748605,0.0011629461,0.0029424685,0.0013071555,0.00023370431,0.0014055958,0.006037916,0.0022078045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00030810822,0.00028375213,0.000003894124,0.11710722,0.0013055468,0.0010550426,0.00026750052,0.0000064269298,0.000027195085,0.0064933263,0.020534731,0.85260725],"study_design_scores_gemma":[0.0013712016,0.00084883766,0.0000025183776,0.02298166,0.0008105568,0.0011515635,0.000072859046,0.0005296847,0.00007961084,0.0007523981,0.97080255,0.0005965565],"about_ca_topic_score_codex":0.00077248126,"about_ca_topic_score_gemma":0.000013082828,"teacher_disagreement_score":0.9502678,"about_ca_system_score_codex":0.006293459,"about_ca_system_score_gemma":0.017495187,"threshold_uncertainty_score":0.9998702},"labels":[],"label_agreement":null},{"id":"W2043192919","doi":"10.1016/j.leukres.2014.09.005","title":"MicroSPECT/CT imaging of primary human AML engrafted into the bone marrow and spleen of NOD/SCID mice using 111In-DTPA-NLS-CSL360 radioimmunoconjugates recognizing the CD123+/CD131− epitope expressed by leukemia stem cells","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; University Health Network; Ontario Institute for Cancer Research; University of Toronto","funders":"Canadian Institutes of Health Research; CSL Limited; University Health Network","keywords":"Radioimmunotherapy; Nod; Bone marrow; Cancer research; Leukemia; Spleen; Epitope; Monoclonal antibody; Medicine; Myeloid leukemia; Immunology; Pathology; Antigen; Antibody","score_opus":0.04371917395543981,"score_gpt":0.338180696160755,"score_spread":0.2944615222053152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043192919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911576,0.004721312,0.00010338218,0.0014619523,0.000038795366,0.0009987731,0.000033604916,0.000041799194,0.0014428103],"genre_scores_gemma":[0.9971317,0.00052547496,0.0010525675,0.00022647397,0.00019890483,0.000079323174,0.000048269092,0.00006338079,0.0006738899],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9966558,0.00048305627,0.0007738719,0.0006143541,0.0007604083,0.0007124764],"domain_scores_gemma":[0.99655193,0.0015214212,0.0002622816,0.0010338002,0.0004080023,0.00022257784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00309078,0.0003032062,0.0006297305,0.00013033109,0.00070459757,0.00010142621,0.0007014101,0.000078152996,0.000064546024],"category_scores_gemma":[0.00018136733,0.00021211029,0.0001490262,0.0006892252,0.0014940115,0.0001376715,0.00038519345,0.0013274028,0.000011911423],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018657505,0.00006262197,0.0009962268,0.0006543881,0.00008445407,0.000017909497,0.000636654,0.000015383048,0.990734,0.00010964927,0.0019194833,0.004582649],"study_design_scores_gemma":[0.001953151,0.0000661746,0.00048819018,0.0003731168,0.00012107355,0.00011806509,0.0008340495,0.0038848356,0.98373073,0.0003374494,0.007883622,0.00020955558],"about_ca_topic_score_codex":0.0011708597,"about_ca_topic_score_gemma":0.0000061122573,"teacher_disagreement_score":0.0070032896,"about_ca_system_score_codex":0.000932952,"about_ca_system_score_gemma":0.0004707282,"threshold_uncertainty_score":0.8649607},"labels":[],"label_agreement":null},{"id":"W2043263033","doi":"10.1016/j.leukres.2011.07.030","title":"Analysis of chromosome 12p deletion in plasma cell dyscrasias","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Monoclonal gammopathy of undetermined significance; Multiple myeloma; Plasma cell leukemia; Plasma cell; Immunofluorescence; Biology; Pathology; Monoclonal; Molecular biology; Medicine; Internal medicine; Monoclonal antibody; Antibody; Immunology","score_opus":0.11919883259301393,"score_gpt":0.3748475671737794,"score_spread":0.2556487345807654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043263033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96788263,0.00016842019,0.000016192027,0.00009012413,0.00001547683,0.0004902424,0.000017691982,0.00001904774,0.031300172],"genre_scores_gemma":[0.9964016,0.00022956633,0.0010961855,0.000014582532,0.000028983575,0.00008058067,0.00007837282,0.000019807527,0.0020503327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972053,0.00025045354,0.00036789972,0.00037662423,0.0011286554,0.0006710363],"domain_scores_gemma":[0.99845976,0.00021789441,0.00005030905,0.00054761936,0.00042751088,0.00029688657],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010871929,0.00012749921,0.00044478697,0.0020088812,0.00006107451,0.000011193753,0.00020915759,0.00014606248,0.0013205974],"category_scores_gemma":[0.00037906374,0.000105636835,0.00016113812,0.0029604062,0.00019508314,0.00008202316,0.00011975069,0.0005509843,0.000231444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027161806,0.001368014,0.90813464,0.00035310033,0.0013242954,0.0016312348,0.0022166034,0.00004942097,0.05255582,0.00034921966,0.00069047755,0.028611],"study_design_scores_gemma":[0.0047722775,0.00085830456,0.8561086,0.00009041677,0.00019224545,0.000010587691,0.00038755403,0.015811004,0.121127516,0.00008869742,0.00043651747,0.00011626649],"about_ca_topic_score_codex":0.0049149017,"about_ca_topic_score_gemma":0.00075420155,"teacher_disagreement_score":0.068571694,"about_ca_system_score_codex":0.0011468016,"about_ca_system_score_gemma":0.0006860674,"threshold_uncertainty_score":0.9995923},"labels":[],"label_agreement":null},{"id":"W2046150302","doi":"10.1016/j.leukres.2005.08.016","title":"Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"","keywords":"Cyclin D1; Mantle cell lymphoma; Cyclin; Cell culture; Chromosomal translocation; Biology; Molecular biology; Messenger RNA; Lymphoma; Cell; Cell cycle; Gene; Genetics; Immunology","score_opus":0.051532910390858944,"score_gpt":0.3407128781114639,"score_spread":0.28917996772060495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046150302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97453165,0.0025547391,0.000007452037,0.0010201051,0.000052922434,0.0004863308,0.000011916034,0.000045006786,0.021289904],"genre_scores_gemma":[0.9892074,0.00037971366,0.0016526636,0.00015244457,0.00042941552,0.0000740702,0.000027633518,0.000048902402,0.008027771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973747,0.0001579824,0.0004013627,0.00053362426,0.0008274893,0.0007048293],"domain_scores_gemma":[0.9983348,0.00042634265,0.000106247375,0.0005442229,0.0002821844,0.00030617378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007941396,0.00025016812,0.00048498358,0.00035767315,0.0003301463,0.00008872604,0.00019948225,0.0002145793,0.00011707689],"category_scores_gemma":[0.00009745749,0.00019833112,0.0001287476,0.000314151,0.00020625243,0.0001241492,0.00023576169,0.00027814152,0.00005387811],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001717146,0.0065196543,0.38397375,0.0029781484,0.0006001565,0.0057577244,0.007534792,0.0001219356,0.2567266,0.007079185,0.067010954,0.25998],"study_design_scores_gemma":[0.024595277,0.0020428628,0.56923485,0.00076568325,0.0002638781,0.0004114541,0.0016855969,0.0016010588,0.37557474,0.00029309452,0.0230119,0.0005195884],"about_ca_topic_score_codex":0.0020199318,"about_ca_topic_score_gemma":0.0004870135,"teacher_disagreement_score":0.2594604,"about_ca_system_score_codex":0.0011701646,"about_ca_system_score_gemma":0.00063220604,"threshold_uncertainty_score":0.8087709},"labels":[],"label_agreement":null},{"id":"W2046610014","doi":"10.1016/j.leukres.2012.01.023","title":"RBC-transfusion guidelines update","year":2012,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Myelofibrosis; Medicine; Randomized controlled trial; Erythropoiesis; Thalidomide; Disease; Clinical trial; Anemia; Intensive care medicine; Ruxolitinib; Pediatrics; Internal medicine; Bone marrow; Multiple myeloma","score_opus":0.19294292271923746,"score_gpt":0.4371403201345239,"score_spread":0.24419739741528645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046610014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011020739,0.0042919274,0.000026941862,0.96300256,0.00059082924,0.0019357317,0.00010590174,0.00013061623,0.018894764],"genre_scores_gemma":[0.0046812445,0.017096497,0.003025743,0.86193126,0.029743258,0.0014494276,0.0035066518,0.00035737874,0.07820856],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99391806,0.00045928181,0.00068209256,0.000897047,0.0025148261,0.0015286742],"domain_scores_gemma":[0.9962803,0.0005742805,0.00009445377,0.0011589713,0.001529257,0.00036270588],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity","insufficient_payload"],"category_scores_codex":[0.0014258511,0.00054309715,0.00090427406,0.00065608503,0.00034290188,0.00010446001,0.00035026527,0.0013829109,0.003798549],"category_scores_gemma":[0.00042544483,0.00039246297,0.0003355544,0.0005327436,0.000240765,0.00010811101,0.0002129087,0.0051946216,0.00463669],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012509938,0.00010068557,0.003212967,0.0003964974,0.00025535928,0.0018372757,0.00008874923,9.0845964e-7,0.00022384242,0.00010612345,0.9832413,0.010411195],"study_design_scores_gemma":[0.0017221939,0.00034079343,0.001261134,0.0006295026,0.00016975688,0.00019286196,0.000019405627,0.000048380916,0.0029630107,0.00017578316,0.99215394,0.0003232094],"about_ca_topic_score_codex":0.00091397506,"about_ca_topic_score_gemma":0.00006568889,"teacher_disagreement_score":0.101071306,"about_ca_system_score_codex":0.0020440202,"about_ca_system_score_gemma":0.0015771168,"threshold_uncertainty_score":0.9999135},"labels":[],"label_agreement":null},{"id":"W2047332763","doi":"10.1016/j.leukres.2009.03.002","title":"Correlation between trough imatinib plasma concentration and clinical response in chronic myeloid leukemia","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Reductive amination; Chemistry; Alkylation; Sodium cyanoborohydride; Iminosugar; Piperidine; Myeloid leukemia; Stereochemistry; Intramolecular force; Docking (animal); Combinatorial chemistry; Enzyme; Medicinal chemistry; Biochemistry; Cancer research; Medicine; Catalysis","score_opus":0.07239733739088638,"score_gpt":0.4088779336070712,"score_spread":0.3364805962161848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047332763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921024,0.0005171507,0.00010993367,0.0019815657,0.00009865669,0.0015366056,0.000014216082,0.00010514898,0.00353434],"genre_scores_gemma":[0.9962716,0.0006800768,0.0007203773,0.00014317314,0.0006142941,0.000049860013,0.00017009325,0.000042380656,0.001308146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99451613,0.0012905789,0.0010960591,0.00088230986,0.001167179,0.0010477568],"domain_scores_gemma":[0.9959313,0.0025420755,0.00012236515,0.0007101324,0.00023457341,0.00045951613],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0045462702,0.0003200845,0.0007075133,0.0003063413,0.00022296843,0.000087535176,0.0001889718,0.0005771299,0.0001293584],"category_scores_gemma":[0.0019995407,0.00030179246,0.00013034586,0.00090593804,0.00041826375,0.00033395446,0.00010464953,0.0020207227,0.00027507966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.037372813,0.0006252598,0.52763736,0.00044554318,0.00046602104,0.0023342345,0.0038699494,0.0014078033,0.031627875,0.0018262271,0.007917617,0.38446927],"study_design_scores_gemma":[0.020799039,0.0043822685,0.9146901,0.00047858662,0.00007780439,0.00012583725,0.00017902403,0.05317924,0.0025346766,0.00042797878,0.002827083,0.0002983923],"about_ca_topic_score_codex":0.00039732034,"about_ca_topic_score_gemma":0.000083754945,"teacher_disagreement_score":0.38705269,"about_ca_system_score_codex":0.027637744,"about_ca_system_score_gemma":0.008821594,"threshold_uncertainty_score":0.99994344},"labels":[],"label_agreement":null},{"id":"W2048159897","doi":"10.1016/j.leukres.2009.07.006","title":"Implementation of standardized international karyotype scoring practices is needed to provide uniform and systematic evaluation for patients with myelodysplastic syndrome using IPSS criteria: An International Working Group on MDS Cytogenetics Study","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"Karyotype; International Prognostic Scoring System; Cytogenetics; Myelodysplastic syndromes; Medicine; Internal medicine; Biology; Chromosome; Genetics; Bone marrow","score_opus":0.12957703736855045,"score_gpt":0.47788043306124756,"score_spread":0.3483033956926971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048159897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901661,0.000017122515,0.0010128842,0.00047101377,0.00016146663,0.007984582,0.000049436156,0.000025206478,0.00011218463],"genre_scores_gemma":[0.9921789,0.000012922887,0.00698181,0.00011446679,0.00014344393,0.00034186724,0.00014769766,0.000044473403,0.00003441444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944551,0.00045295674,0.0006932928,0.0006165051,0.003290125,0.0004920489],"domain_scores_gemma":[0.99585015,0.0006364429,0.00041608335,0.0004448891,0.0024155083,0.00023694507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004277027,0.000233098,0.000468051,0.0011049722,0.00023775124,0.00025947354,0.0003778889,0.00009319233,0.000057471112],"category_scores_gemma":[0.0017889156,0.00019446049,0.000043943313,0.000658997,0.0000683993,0.00055337633,0.00015596475,0.00038866495,0.00000295152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06582531,0.0048507284,0.76405096,0.01053453,0.0038743375,0.00026381636,0.028000088,0.002473543,0.053908415,0.00081168825,0.00046869623,0.06493789],"study_design_scores_gemma":[0.05577839,0.05136977,0.65967786,0.011160621,0.0012392817,0.00018168791,0.040949725,0.17014061,0.008039128,0.00035685164,0.00015760773,0.0009484685],"about_ca_topic_score_codex":0.00046952243,"about_ca_topic_score_gemma":0.00010868214,"teacher_disagreement_score":0.16766706,"about_ca_system_score_codex":0.003965461,"about_ca_system_score_gemma":0.0011029103,"threshold_uncertainty_score":0.99985814},"labels":[],"label_agreement":null},{"id":"W2049295282","doi":"10.1016/j.leukres.2010.07.021","title":"Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"NPM1; Internal medicine; Myeloid leukemia; Oncology; Medicine; Karyotype; Leukemia; Clinical significance; Gastroenterology; CD34; Stage (stratigraphy); Biology; Stem cell; Gene; Genetics; Chromosome","score_opus":0.03491698175438952,"score_gpt":0.34600353556413654,"score_spread":0.31108655380974704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049295282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98962766,0.0000720707,0.000009910333,0.0018774724,0.00021086,0.0022821103,0.00001901098,0.000032969234,0.0058679157],"genre_scores_gemma":[0.9976561,0.00008861716,0.00025145742,0.00017061434,0.00019977728,0.00022594609,0.000045683344,0.000056583587,0.0013052108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99364907,0.0009028569,0.00075490656,0.0006423657,0.0026950128,0.00135582],"domain_scores_gemma":[0.99530387,0.002312857,0.00013898232,0.0014601604,0.0005689486,0.0002152077],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0048675067,0.00031256877,0.0004825915,0.00086187833,0.0002682799,0.00008596438,0.0016800882,0.0004443133,0.00019118874],"category_scores_gemma":[0.003910529,0.00018334988,0.00016905685,0.0038202927,0.001127063,0.00029789036,0.0005330668,0.0059983847,0.00011490362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095613825,0.00022104649,0.80528545,0.00035681622,0.00008769045,0.00088316493,0.008143393,0.0002482883,0.17281632,0.0018646016,0.0029991362,0.006137953],"study_design_scores_gemma":[0.002609691,0.00037017406,0.9599103,0.00021332869,0.000023735933,0.00021323394,0.0026418248,0.005478963,0.02683963,0.0006062952,0.00088010466,0.00021274148],"about_ca_topic_score_codex":0.006108461,"about_ca_topic_score_gemma":0.0039452217,"teacher_disagreement_score":0.15462483,"about_ca_system_score_codex":0.003283684,"about_ca_system_score_gemma":0.007160721,"threshold_uncertainty_score":0.99846774},"labels":[],"label_agreement":null},{"id":"W2050306927","doi":"10.1016/j.leukres.2006.10.023","title":"Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes","year":2006,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame","funders":"Celgene","keywords":"Myelodysplastic syndromes; Lenalidomide; Chromosomal Abnormality; Abnormality; Medicine; Cytogenetics; Disease; Chromosome abnormality; Oncology; Internal medicine; Karyotype; Chromosome; Bone marrow; Biology; Multiple myeloma; Genetics","score_opus":0.3313275746400015,"score_gpt":0.49310803610809817,"score_spread":0.16178046146809666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050306927","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019237371,0.96893245,0.0000026064038,0.000035451107,0.00006351789,0.0048381235,0.00007019866,0.000013781683,0.006806526],"genre_scores_gemma":[0.010581754,0.9864014,0.00011438292,0.000002922059,0.00023730118,0.0013886949,0.00022327651,0.00008678798,0.0009635076],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98597884,0.0048751323,0.0015763519,0.00067311816,0.005878155,0.0010184273],"domain_scores_gemma":[0.9929319,0.0036803312,0.00034860006,0.0014329712,0.0014826054,0.00012358652],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012263076,0.00048297158,0.0023771552,0.0021025338,0.00010525528,0.000036585265,0.00077717286,0.00052254915,0.000154888],"category_scores_gemma":[0.0013330721,0.0002980154,0.0005731664,0.0025270837,0.000675604,0.00006435444,0.00013828985,0.0012201236,0.000067470435],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00008729037,0.00047115792,0.00013601665,0.02474982,0.00043741678,0.00019993349,0.0008678214,0.000082111364,0.000010450986,0.00018030299,0.0006429374,0.97213477],"study_design_scores_gemma":[0.008033969,0.0058599464,0.0015786737,0.04561968,0.005861143,0.0011592617,0.0014782524,0.0024008725,0.000285948,0.0005781491,0.9264126,0.0007315013],"about_ca_topic_score_codex":0.002505414,"about_ca_topic_score_gemma":0.00022654772,"teacher_disagreement_score":0.97140324,"about_ca_system_score_codex":0.011782357,"about_ca_system_score_gemma":0.013683636,"threshold_uncertainty_score":0.9999472},"labels":[],"label_agreement":null},{"id":"W2051711544","doi":"10.1016/j.leukres.2007.03.002","title":"Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Chronic myelogenous leukemia; Biology; Tyrosine kinase; ABL; Nilotinib; Cancer research; Imatinib mesylate; Molecular biology; Signal transduction; breakpoint cluster region; Kinase; Gene; Leukemia; Imatinib; Immunology; Cell biology; Genetics; Myeloid leukemia","score_opus":0.051629105179668136,"score_gpt":0.36487851310431596,"score_spread":0.31324940792464784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051711544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930871,0.0023729156,0.0014279794,0.00021521564,0.00009370568,0.001987642,0.00010437728,0.00006837252,0.00064269506],"genre_scores_gemma":[0.9793952,0.0001590997,0.018825479,0.00014475954,0.0003109943,0.00006302937,0.00010463667,0.000091810136,0.0009049729],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9934896,0.00056160195,0.0012183656,0.0012929128,0.0018227051,0.0016148036],"domain_scores_gemma":[0.9947463,0.0012940584,0.00024783122,0.0014513995,0.0008564865,0.0014038911],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004203483,0.0005511615,0.001496719,0.003019129,0.00043612963,0.000062155304,0.0003974492,0.00033046026,0.00012580425],"category_scores_gemma":[0.0007384588,0.0005015819,0.00027254794,0.0059709325,0.0003920705,0.00012691373,0.0006406263,0.00090808683,0.000056977173],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019370152,0.00028510508,0.001985254,0.00019927224,0.0004957174,0.0007529819,0.0038299572,0.011764839,0.9590175,0.000006961996,0.0010786962,0.0012135614],"study_design_scores_gemma":[0.0049974825,0.002819561,0.024782563,0.00062971783,0.00064650975,0.000034441367,0.0012497653,0.005786404,0.95704514,0.000010092003,0.0015695702,0.0004287502],"about_ca_topic_score_codex":0.00398681,"about_ca_topic_score_gemma":0.0010776743,"teacher_disagreement_score":0.022797307,"about_ca_system_score_codex":0.027905095,"about_ca_system_score_gemma":0.0051530064,"threshold_uncertainty_score":0.9997436},"labels":[],"label_agreement":null},{"id":"W2053491031","doi":"10.1016/j.leukres.2008.12.008","title":"Information needs of adult patients 50 or older with newly diagnosed acute myeloid leukemia","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Medicine; Leukemia; Perception; Intensive care medicine; Internal medicine; Pediatrics; Family medicine; Psychology","score_opus":0.11091300153310268,"score_gpt":0.4241619655654159,"score_spread":0.3132489640323132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053491031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980772,0.00017476677,0.00015312218,0.0045389337,0.00025199392,0.00398946,0.000114869195,0.00018580223,0.0098190205],"genre_scores_gemma":[0.9917084,0.00062192226,0.002153997,0.0026468516,0.00012406181,0.0006974288,0.00041396308,0.000040328683,0.0015930752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99396354,0.0015444796,0.0013198424,0.00020169809,0.0017384507,0.0012319969],"domain_scores_gemma":[0.9917342,0.0016683252,0.00041951903,0.0016512326,0.0041244314,0.0004022578],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00070466514,0.00027459182,0.000459269,0.0009204868,0.0011916975,0.0000374591,0.0011096109,0.00046246906,0.0002876833],"category_scores_gemma":[0.0016785274,0.00020636737,0.00006805659,0.0020230955,0.00022791288,0.0011141499,0.00037250668,0.002357162,0.00055202196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009683965,0.0005679468,0.34757406,0.0032143856,0.0002480352,0.000015514272,0.32129624,0.00036685445,0.000496435,0.011567615,0.18818197,0.11678699],"study_design_scores_gemma":[0.03711556,0.006496747,0.69561803,0.005410495,0.00008788935,0.000007568233,0.16804017,0.0027028804,0.0015260818,0.0014394219,0.08026269,0.0012924339],"about_ca_topic_score_codex":0.0048558093,"about_ca_topic_score_gemma":0.00042688136,"teacher_disagreement_score":0.348044,"about_ca_system_score_codex":0.004008747,"about_ca_system_score_gemma":0.005996772,"threshold_uncertainty_score":0.99994445},"labels":[],"label_agreement":null},{"id":"W2054701803","doi":"10.1016/j.leukres.2010.08.003","title":"Copy number alterations at polymorphic loci may be acquired somatically in patients with myelodysplastic syndromes","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Biology; Copy-number variation; Myelodysplastic syndromes; Genetics; Somatic cell; clone (Java method); Genome; Gene; Immunology","score_opus":0.03185149492784102,"score_gpt":0.3371596112225978,"score_spread":0.3053081162947568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054701803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855979,0.000015953885,0.000043466727,0.0041831913,0.00011061699,0.0017471676,0.000047142013,0.00010786518,0.008146665],"genre_scores_gemma":[0.9845287,0.00001800564,0.0030650084,0.0003650849,0.0002046586,0.00031745763,0.00035177567,0.00012962254,0.011019672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933561,0.00039955208,0.0006437388,0.0008947759,0.0029434448,0.0017623937],"domain_scores_gemma":[0.99556893,0.0012247404,0.00008165806,0.0013070969,0.0009820183,0.00083555444],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0015145467,0.00039191713,0.0006423577,0.0007901585,0.00048497695,0.00016258396,0.00062303373,0.00045204678,0.0057363305],"category_scores_gemma":[0.0015718294,0.0003087705,0.00010124693,0.0017803429,0.001156542,0.0003304775,0.0005796229,0.0023174665,0.0024154354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002668564,0.0006180483,0.95878863,0.0003121751,0.00016595988,0.0008069148,0.0006263237,0.00001778312,0.012098922,0.0016972119,0.02115698,0.0010425015],"study_design_scores_gemma":[0.019192617,0.0015219117,0.9603135,0.00039116424,0.00007216468,0.00044525616,0.0002606029,0.0043520294,0.006273256,0.00036916562,0.0060867947,0.0007215281],"about_ca_topic_score_codex":0.0006598676,"about_ca_topic_score_gemma":0.0010461244,"teacher_disagreement_score":0.016524054,"about_ca_system_score_codex":0.0036877848,"about_ca_system_score_gemma":0.003383814,"threshold_uncertainty_score":0.9999842},"labels":[],"label_agreement":null},{"id":"W2055730957","doi":"10.1016/j.leukres.2010.10.006","title":"Delineating domains and functions of NUP98 contributing to the leukemogenic activity of NUP98-HOX fusions","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"Hox gene; Biology; Cancer research; Computational biology; Evolutionary biology; Genetics; Gene; Transcription factor","score_opus":0.031152478463214565,"score_gpt":0.35880705011389596,"score_spread":0.3276545716506814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055730957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965181,0.00025887767,0.00080031855,0.00086568674,0.00007709563,0.00056478236,0.00009495114,0.00000899261,0.00081119617],"genre_scores_gemma":[0.9982782,0.00011949953,0.0003632982,0.000060551167,0.00028743976,0.0000701419,0.000026700272,0.000029746627,0.0007644442],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9975254,0.0004187348,0.0002979621,0.0004170605,0.00061151735,0.0007293187],"domain_scores_gemma":[0.9977581,0.0003876521,0.000086481785,0.00085234223,0.0007149145,0.0002005284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035552762,0.00014684201,0.00021900858,0.0001677266,0.0005564414,0.000033019383,0.00050812704,0.000206013,0.00006942765],"category_scores_gemma":[0.0014421961,0.000114457376,0.000104971354,0.0005662733,0.00044856698,0.0000068918457,0.0007691201,0.00079721445,0.000016127977],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009547789,0.00004936847,0.0018830886,0.000024929665,0.00005991144,0.0000014649614,0.00010418617,0.00016221928,0.9767468,0.00007373204,0.0006953012,0.019244244],"study_design_scores_gemma":[0.0010102002,0.0014432019,0.0040000165,0.0000221237,0.000011973592,0.0000130648305,0.00035762353,0.0012426123,0.98509353,0.0000631218,0.006601424,0.00014112235],"about_ca_topic_score_codex":0.00048795377,"about_ca_topic_score_gemma":0.003148816,"teacher_disagreement_score":0.019103123,"about_ca_system_score_codex":0.00009003049,"about_ca_system_score_gemma":0.0009268383,"threshold_uncertainty_score":0.46674362},"labels":[],"label_agreement":null},{"id":"W2055946535","doi":"10.1016/j.leukres.2013.03.012","title":"CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavourable acute myeloid leukemia","year":2013,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Lipid droplet; Biosynthesis; Biochemistry; Biogenesis; Retinoic acid; Mitochondrion; Chemistry; Organelle; Retinol binding protein; Biology; Cell biology; Retinol; Enzyme; Gene","score_opus":0.04582927067193436,"score_gpt":0.31709003017872234,"score_spread":0.27126075950678796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055946535","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87400466,0.0020407082,0.00003366279,0.110013366,0.00018171193,0.0071834615,0.00015254228,0.00038374774,0.006006142],"genre_scores_gemma":[0.7429679,0.012507619,0.020721992,0.112223156,0.010788945,0.009646655,0.006491357,0.0028968747,0.08175552],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98401326,0.0017293305,0.0014220849,0.0033037518,0.005185955,0.004345645],"domain_scores_gemma":[0.9927191,0.0015564378,0.00024970493,0.0021355893,0.0017883678,0.0015507906],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0023017803,0.0015073373,0.002134398,0.0027242757,0.0006223376,0.00069918577,0.0017712694,0.0040221065,0.0008258615],"category_scores_gemma":[0.0006768656,0.0011716015,0.00023228968,0.0023318771,0.0019357993,0.00091986835,0.0014663548,0.017901065,0.0006685138],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.004424519,0.00026960843,0.031672582,0.0017952715,0.00062733155,0.019811537,0.0006487524,0.000052216157,0.05893413,0.00003361058,0.8757512,0.0059792623],"study_design_scores_gemma":[0.0661736,0.042005274,0.13709217,0.024370205,0.0023682555,0.014351184,0.0020712558,0.07115542,0.17405888,0.0020665522,0.45380533,0.01048188],"about_ca_topic_score_codex":0.002718991,"about_ca_topic_score_gemma":0.0001712615,"teacher_disagreement_score":0.42194587,"about_ca_system_score_codex":0.008876916,"about_ca_system_score_gemma":0.011406297,"threshold_uncertainty_score":0.99976754},"labels":[],"label_agreement":null},{"id":"W2056534555","doi":"10.1016/j.leukres.2010.06.031","title":"Quantification of CD20 mRNA and protein levels in chronic lymphocytic leukemia suggests a post-transcriptional defect","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; Foothills Medical Centre; University of Calgary","funders":"Canadian Institutes of Health Research; National Institutes of Health; National Cancer Institute; National Cancer Research Institute","keywords":"CD20; Chronic lymphocytic leukemia; Flow cytometry; Leukemia; Messenger RNA; Population; Molecular biology; B cell; Biology; Real-time polymerase chain reaction; Antibody; Cancer research; Immunology; Gene; Medicine; Biochemistry","score_opus":0.057326997000381054,"score_gpt":0.36791973138580897,"score_spread":0.3105927343854279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056534555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99379754,0.0010778274,0.00004904481,0.0003837553,0.00010427701,0.0023917477,0.000044580895,0.00007575317,0.0020754884],"genre_scores_gemma":[0.9958352,0.00012369927,0.0006547621,0.000046414483,0.0002894741,0.00037937608,0.000077111894,0.00008925651,0.0025046964],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99395263,0.00044761167,0.000885993,0.0010198993,0.002314476,0.001379415],"domain_scores_gemma":[0.99620235,0.00084337575,0.00013147837,0.0012180363,0.0010846816,0.0005200812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042448337,0.00035664334,0.00068207644,0.0013031999,0.00020613628,0.00009212697,0.0005545742,0.000579153,0.00046477493],"category_scores_gemma":[0.0020798692,0.00033028072,0.00020288315,0.0016198475,0.001358177,0.0002970605,0.00026870685,0.002274739,0.00020129842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0010128318,0.00006686841,0.0011358127,0.0014573073,0.000073515395,0.00024093856,0.0005220432,0.00018808724,0.98515636,0.006234484,0.00021356961,0.0036981835],"study_design_scores_gemma":[0.061342236,0.0026572368,0.17007054,0.0021156385,0.00009886589,0.0017758178,0.00059084303,0.1351555,0.61742115,0.0023398977,0.005424797,0.0010074625],"about_ca_topic_score_codex":0.01477285,"about_ca_topic_score_gemma":0.0043664314,"teacher_disagreement_score":0.36773518,"about_ca_system_score_codex":0.11609824,"about_ca_system_score_gemma":0.12688011,"threshold_uncertainty_score":0.99991494},"labels":[],"label_agreement":null},{"id":"W2058169114","doi":"10.1016/j.leukres.2013.08.021","title":"Income and outcome in myelodysplastic syndrome: The prognostic impact of SES in a single-payer system","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research","keywords":"Quartile; Medicine; Internal medicine; Demography; Overall survival; Pediatrics; Confidence interval","score_opus":0.05507466281810802,"score_gpt":0.36357585916393176,"score_spread":0.30850119634582374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058169114","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949369,0.0004081699,0.000008067202,0.0005703497,0.000034787387,0.0028229568,0.000009224886,0.00004137744,0.0011682131],"genre_scores_gemma":[0.9985851,0.00003925836,0.00015143011,0.000016181788,0.00004778758,0.0004553492,0.0000076084048,0.00006110217,0.0006362048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950904,0.00080927234,0.0008706271,0.0005507518,0.0013910674,0.0012878488],"domain_scores_gemma":[0.9949842,0.0032944963,0.000097556265,0.0007977808,0.00047242493,0.00035351233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030510759,0.00028743708,0.0007847169,0.0014844228,0.00010566787,0.0001060083,0.0005148067,0.00026614915,0.00015007018],"category_scores_gemma":[0.003166688,0.00017605712,0.00012029651,0.0024832594,0.00070207,0.00024443868,0.00055457966,0.00204165,0.00023849601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028795854,0.00014709638,0.98928815,0.0012182975,0.000069536436,0.0010560256,0.0005425669,0.000076887176,0.0055564595,0.00016162866,0.0001404759,0.0014548994],"study_design_scores_gemma":[0.0030423207,0.0010850277,0.9815736,0.0010863909,0.000016134256,0.0011072524,0.0012587893,0.010315515,0.00021174493,0.00013450897,0.000011263036,0.00015744379],"about_ca_topic_score_codex":0.010816208,"about_ca_topic_score_gemma":0.00023905006,"teacher_disagreement_score":0.010577158,"about_ca_system_score_codex":0.0065391883,"about_ca_system_score_gemma":0.0018344839,"threshold_uncertainty_score":0.9972745},"labels":[],"label_agreement":null},{"id":"W2062483137","doi":"10.1016/j.leukres.2004.01.006","title":"Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":172,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; CD34; Pathology; Chemotherapy; Myeloid; Internal medicine; Biology","score_opus":0.11430635881337432,"score_gpt":0.41852287938176536,"score_spread":0.30421652056839105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062483137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940593,0.0008677325,0.000074830044,0.0015025558,0.000054887616,0.00097122166,0.000049525952,0.00011390126,0.0023060332],"genre_scores_gemma":[0.99452734,0.0007074814,0.0018000802,0.00030300667,0.00020997356,0.00010486579,0.00006331953,0.0000865025,0.0021974288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994211,0.00070502586,0.0011075689,0.0007033002,0.0020692006,0.0012038791],"domain_scores_gemma":[0.99456656,0.0021177984,0.00026176477,0.0009011891,0.0014276864,0.00072501344],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0045983824,0.00033943562,0.0010450113,0.0006101102,0.00028665212,0.000095650976,0.0004501177,0.00056442205,0.00017645261],"category_scores_gemma":[0.005812599,0.00024846988,0.00015447257,0.0011072945,0.00217598,0.00031176655,0.00047536634,0.0028160722,0.000052670588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014973449,0.0003345178,0.98727924,0.0005138368,0.00023062545,0.00082333764,0.00074080867,0.00004852997,0.004329997,0.0007447249,0.0022825252,0.0011744866],"study_design_scores_gemma":[0.0132781025,0.0024933373,0.9581312,0.0020428114,0.00007886984,0.0003493884,0.0039370996,0.00019261749,0.016309384,0.0012544855,0.0014883648,0.0004443325],"about_ca_topic_score_codex":0.00082402834,"about_ca_topic_score_gemma":0.00021080989,"teacher_disagreement_score":0.029148057,"about_ca_system_score_codex":0.0017525192,"about_ca_system_score_gemma":0.0037440099,"threshold_uncertainty_score":0.9999968},"labels":[],"label_agreement":null},{"id":"W2062572127","doi":"10.1016/j.leukres.2015.01.013","title":"Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":70,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of Ottawa; Atomic Energy (Canada); Ottawa Hospital","funders":"Canadian Institutes of Health Research; Canadian Nuclear Laboratories","keywords":"Mesenchymal stem cell; Haematopoiesis; CD34; Bone marrow; Myeloid leukemia; Progenitor cell; Cancer research; Stromal cell; Leukemia; Immunology; Medicine; Myeloid; Biology; Stem cell; Pathology; Cell biology","score_opus":0.07850938879730575,"score_gpt":0.3334496553550783,"score_spread":0.2549402665577726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062572127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917397,0.00007438334,0.00013658828,0.00028119062,0.00025403503,0.0036266737,0.00018649806,0.00015507994,0.0035458398],"genre_scores_gemma":[0.99124867,0.000012430108,0.001869494,0.00007828373,0.00061983714,0.00038012682,0.00030752746,0.00016020346,0.005323431],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9886896,0.0008631233,0.00076790503,0.0014854867,0.005858344,0.0023355219],"domain_scores_gemma":[0.9926477,0.0004871041,0.00013536631,0.0015909182,0.0022408143,0.00289808],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014647793,0.0006293821,0.0010240156,0.0007783262,0.00036404486,0.00029556904,0.00091225863,0.00045355418,0.0005028127],"category_scores_gemma":[0.00060782186,0.0004782312,0.0001833629,0.0013455858,0.00056056626,0.00028480802,0.00084309437,0.0021648111,0.0012620556],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02328193,0.0020899372,0.4756401,0.0007989781,0.0024659962,0.0025934062,0.013282292,0.00015986072,0.41261154,0.0001391623,0.062924035,0.0040127547],"study_design_scores_gemma":[0.029975403,0.009912577,0.23477617,0.00103346,0.00039036613,0.00011924562,0.0029479105,0.003218734,0.7107893,0.0005346427,0.0045678956,0.0017343044],"about_ca_topic_score_codex":0.0052430388,"about_ca_topic_score_gemma":0.00038658944,"teacher_disagreement_score":0.29817775,"about_ca_system_score_codex":0.005836832,"about_ca_system_score_gemma":0.003426245,"threshold_uncertainty_score":0.99976695},"labels":[],"label_agreement":null},{"id":"W2062857204","doi":"10.1016/j.leukres.2015.04.016","title":"Differential expression and function of CD27 in chronic lymphocytic leukemia cells expressing ZAP-70","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"Canadian Institutes of Health Research; Canadian Cancer Society; Canada Research Chairs; CancerCare Manitoba Foundation; Manitoba Health Research Council","keywords":"Chronic lymphocytic leukemia; Stromal cell; Cancer research; Biology; Ectopic expression; Leukemia; Immunology; Signal transduction; Cell biology; Cell culture","score_opus":0.07459560821292835,"score_gpt":0.3570972380758317,"score_spread":0.2825016298629034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062857204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99100345,0.0021574718,0.0003012881,0.00005378607,0.00025884708,0.0010277018,0.0000065743975,0.00008558193,0.00510528],"genre_scores_gemma":[0.99542284,0.00061340677,0.00024182192,0.000039611034,0.00054295326,0.00011925893,0.000033268978,0.00009690623,0.0028899563],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9923381,0.0006686983,0.00087357353,0.0009765746,0.0036873631,0.0014556893],"domain_scores_gemma":[0.99632365,0.000742527,0.00014769059,0.0011097819,0.00065983174,0.0010165361],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002540957,0.00038105604,0.00081262813,0.0011529359,0.00016806388,0.00010763562,0.00050999003,0.00062418194,0.00047510295],"category_scores_gemma":[0.0010411687,0.00033240093,0.00013129514,0.0012400044,0.0008130586,0.0003527803,0.00096092524,0.0014465455,0.00014177518],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0056722485,0.0001321302,0.0011244395,0.002187514,0.00009282028,0.00091321545,0.0016935265,0.0023781375,0.9577801,0.00031599842,0.0077033113,0.020006564],"study_design_scores_gemma":[0.062335704,0.0016982392,0.0017579948,0.0030358117,0.000055086817,0.00030012065,0.0011576152,0.29621017,0.62925524,0.00062907935,0.0030521648,0.0005127876],"about_ca_topic_score_codex":0.006210861,"about_ca_topic_score_gemma":0.00026922053,"teacher_disagreement_score":0.32852486,"about_ca_system_score_codex":0.21196486,"about_ca_system_score_gemma":0.115813576,"threshold_uncertainty_score":0.9999128},"labels":[],"label_agreement":null},{"id":"W2065022509","doi":"10.1016/s0145-2126(03)00106-1","title":"Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cells","year":2003,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"CD86; CD80; Immune system; Cytokine; Immunology; T cell; Hematopoietic stem cell transplantation; Biology; Priming (agriculture); B cell; Stem cell; Cancer research; CD40; Antibody; Cell biology; Cytotoxic T cell; In vitro; Genetics","score_opus":0.040129378897188005,"score_gpt":0.30625840562663126,"score_spread":0.2661290267294433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065022509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989075,0.00031489145,0.00012806707,0.00013118613,0.0033401093,0.00046946766,0.000009832461,0.000047183516,0.0064842864],"genre_scores_gemma":[0.91330916,0.00017617748,0.000027323176,0.0000565228,0.000040648953,0.000042986354,0.00015253833,0.000025822292,0.08616881],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99758697,0.00094553834,0.0003990343,0.00041858008,0.0001389744,0.0005108988],"domain_scores_gemma":[0.9988738,0.00015280928,0.00013406751,0.00050261477,0.0003040719,0.000032651827],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0010146963,0.00015821191,0.00022684535,0.00025575465,0.00016567712,0.000017724682,0.0002150651,0.00031791502,0.0021315604],"category_scores_gemma":[0.00021989852,0.00014756666,0.00008286647,0.00026117757,0.00009582256,0.00015472526,0.00005930707,0.0010734518,0.0008754204],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034134148,0.00019492567,0.000166273,0.000050519648,0.000051306033,7.360775e-7,0.00041205875,0.000007672384,0.9172246,0.000067729605,0.0810901,0.00039276198],"study_design_scores_gemma":[0.0011334984,0.00038921827,0.0003277247,0.00002600086,0.000009810402,0.0000144095775,0.00031444908,0.000004316871,0.81648105,0.000020415095,0.18116853,0.000110591616],"about_ca_topic_score_codex":0.0006181657,"about_ca_topic_score_gemma":0.000014355229,"teacher_disagreement_score":0.10074353,"about_ca_system_score_codex":0.00039284676,"about_ca_system_score_gemma":0.00019022424,"threshold_uncertainty_score":0.9999025},"labels":[],"label_agreement":null},{"id":"W2065183816","doi":"10.1016/j.leukres.2012.06.011","title":"FCHSD2 predicts response to chemotherapy in acute myeloid leukemia patients","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Leukemia and Lymphoma Research; Leukemia and Lymphoma Society","keywords":"Medicine; Chemotherapy; Myeloid leukemia; Induction chemotherapy; Gene knockdown; Bone marrow; Internal medicine; Oncology; Small hairpin RNA; Leukemia; Myeloid; Puma; Cytarabine; Cancer research; Clinical significance; Immunology; Gastroenterology; Biology; Apoptosis","score_opus":0.03905140989411161,"score_gpt":0.36528964764357685,"score_spread":0.32623823774946525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065183816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98244154,0.00024831115,0.000049247687,0.004995621,0.0002672256,0.003194388,0.000049165985,0.0002605383,0.008493968],"genre_scores_gemma":[0.9790559,0.00032363826,0.0020442493,0.0022127475,0.0007535959,0.0006234883,0.00010556303,0.00022398515,0.014656876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9892263,0.0014122603,0.0008862879,0.0010869224,0.0035946798,0.003793578],"domain_scores_gemma":[0.99359983,0.0013097113,0.000090323985,0.0017995957,0.001002013,0.0021985054],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008735695,0.0005489193,0.0008717827,0.0024830587,0.00032860538,0.000120443634,0.0010492818,0.0006527275,0.0005761348],"category_scores_gemma":[0.0033844751,0.0004978792,0.00020899557,0.004128211,0.00044577377,0.0005907433,0.0008642318,0.0032780918,0.0036378521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.062918864,0.0013679377,0.46929634,0.00035379047,0.00044337657,0.00075563893,0.009241462,0.000056432105,0.1319093,0.0003320151,0.28261253,0.04071235],"study_design_scores_gemma":[0.015261381,0.0021338,0.824531,0.00034790626,0.00003475905,0.00010081582,0.0004964435,0.0008417945,0.027401865,0.0000745331,0.12815967,0.00061602454],"about_ca_topic_score_codex":0.0008181328,"about_ca_topic_score_gemma":0.00004566605,"teacher_disagreement_score":0.35523468,"about_ca_system_score_codex":0.023512589,"about_ca_system_score_gemma":0.0054528215,"threshold_uncertainty_score":0.9997473},"labels":[],"label_agreement":null},{"id":"W2066443904","doi":"10.1016/j.leukres.2009.02.010","title":"Estimating the prevalence of myelodysplastic syndromes in patients with unexplained cytopenias: A retrospective study of 322 bone marrows","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Western University; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Internal medicine; Anemia; Pediatrics; Bone marrow","score_opus":0.027599261148578996,"score_gpt":0.32929654646346235,"score_spread":0.3016972853148834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066443904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994954,0.000086697015,0.00002881459,0.00035973688,0.000024951909,0.0034682679,0.000018149469,0.000026884883,0.0010324903],"genre_scores_gemma":[0.9976841,0.000014036518,0.00113028,0.000025206564,0.000045312972,0.0001262287,0.000008372312,0.000039221133,0.000927195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99399126,0.0006901686,0.00078315905,0.0006579634,0.0030058718,0.0008715641],"domain_scores_gemma":[0.9963698,0.00079020346,0.00022929178,0.001143464,0.0012830971,0.00018417947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029855382,0.0002661796,0.00078593486,0.0007977774,0.00018191956,0.00003030975,0.00069103745,0.00013308458,0.00011583259],"category_scores_gemma":[0.002836894,0.00016986049,0.0000658979,0.0026634445,0.00051536626,0.00019827938,0.0002982665,0.0016607451,0.000016419637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069388165,0.0021637045,0.97691864,0.0010926978,0.00016146139,0.00035264803,0.006217782,0.0008115885,0.002173038,0.00015964569,0.00037176264,0.0026382343],"study_design_scores_gemma":[0.010621051,0.010772887,0.97001684,0.00081889983,0.00006044416,0.000027927637,0.001443451,0.0053939996,0.00054429006,0.0001451443,0.0000041822254,0.00015087289],"about_ca_topic_score_codex":0.0006451103,"about_ca_topic_score_gemma":0.00010310652,"teacher_disagreement_score":0.008609182,"about_ca_system_score_codex":0.0023982327,"about_ca_system_score_gemma":0.0014353903,"threshold_uncertainty_score":0.72152036},"labels":[],"label_agreement":null},{"id":"W2068835878","doi":"10.1016/j.leukres.2006.09.010","title":"Nucleoside transporter expression and activity is regulated during granulocytic differentiation of NB4 cells in response to all-trans-retinoic acid","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Guanosine; Retinoic acid; Intracellular; Nucleoside transporter; Nucleoside; Transporter; Cell biology; Cellular differentiation; Biochemistry; Chemistry; Biology; Gene","score_opus":0.013672177237651472,"score_gpt":0.28047803128854365,"score_spread":0.2668058540508922,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068835878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985223,0.00026708542,0.00048114572,0.00015989294,0.0000318095,0.00036810242,0.000018690376,0.000011883819,0.00013909346],"genre_scores_gemma":[0.99889565,0.00013426189,0.00021264171,0.000026023308,0.000073400646,0.000040549083,0.000033869655,0.0000336268,0.00054997194],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978362,0.00037174867,0.00032297935,0.0005510717,0.00044813164,0.00046988123],"domain_scores_gemma":[0.9992277,0.000054635148,0.00006392475,0.00041314392,0.00013278851,0.000107827065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007468823,0.00018571448,0.00022554652,0.00024035061,0.00009723897,0.000032672473,0.0002383801,0.00028939397,0.000026240481],"category_scores_gemma":[0.000056590492,0.00017820865,0.000068848385,0.0003133914,0.00015035881,0.000013758231,0.00009221943,0.00030151109,0.0000037507639],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031985966,0.000065658714,0.002252158,0.0001868971,0.000011038768,0.000016473557,0.00039303064,0.00012247042,0.993287,0.0000023540606,0.00022266853,0.00024162668],"study_design_scores_gemma":[0.0015143896,0.00018942686,0.05539048,0.00011009323,0.000008319043,0.0000054641077,0.000071026305,0.00014633105,0.94199884,0.0000931331,0.00029603494,0.00017645242],"about_ca_topic_score_codex":0.00026838342,"about_ca_topic_score_gemma":0.00007583525,"teacher_disagreement_score":0.053138323,"about_ca_system_score_codex":0.00017075929,"about_ca_system_score_gemma":0.0001878659,"threshold_uncertainty_score":0.7267138},"labels":[],"label_agreement":null},{"id":"W2069327083","doi":"10.1016/j.leukres.2013.04.014","title":"Ectodomain shedding of CD200 from the B-CLL cell surface is regulated by ADAM28 expression","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Ectodomain; Disintegrin; Transfection; Molecular biology; Biology; ADAM10; Metalloproteinase; Cell culture; Glycoprotein; Cell biology; Enzyme; Receptor; Genetics; Biochemistry","score_opus":0.033153868947830935,"score_gpt":0.3298452281077127,"score_spread":0.29669135915988176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069327083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98218715,0.0028237577,0.00007565561,0.0017948044,0.00008111419,0.0016795499,0.00007196293,0.00007947157,0.011206536],"genre_scores_gemma":[0.975659,0.0004518774,0.001303634,0.0002948118,0.00022073119,0.00008274085,0.0001109614,0.000102397855,0.02177381],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99313796,0.0008131232,0.0006884456,0.00084786257,0.003096025,0.0014165979],"domain_scores_gemma":[0.9933986,0.0031413385,0.00013948945,0.0019381902,0.0008635866,0.0005187767],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0022402895,0.00032457832,0.0005926608,0.00017538623,0.0003655858,0.00013089036,0.0010651137,0.00043778363,0.0062770983],"category_scores_gemma":[0.00078539294,0.00021676024,0.00019562946,0.0012458258,0.00076147245,0.00024165884,0.00078738714,0.0015977637,0.0011693124],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0002978637,0.00009903067,0.00061709696,0.00012275988,0.000049746403,0.000037714035,0.0008598148,0.000042300442,0.5960437,0.000016111066,0.40092486,0.00088900136],"study_design_scores_gemma":[0.012552104,0.00039754747,0.0010848274,0.00057657616,0.000030180243,0.000027272219,0.0013350284,0.0306483,0.94062775,0.00072466594,0.011731985,0.00026378664],"about_ca_topic_score_codex":0.03695968,"about_ca_topic_score_gemma":0.000042321393,"teacher_disagreement_score":0.38919288,"about_ca_system_score_codex":0.014690992,"about_ca_system_score_gemma":0.007750461,"threshold_uncertainty_score":0.9996084},"labels":[],"label_agreement":null},{"id":"W2069409895","doi":"10.1016/j.leukres.2005.01.002","title":"Immune evasion strategies of pediatric precursor-B acute lymphoblastic leukemia after allogeneic bone marrow transplantation—a case study","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Transplantation; Immunology; Immune system; Leukemia; Lymphoblastic Leukemia; Bone marrow; Acute lymphocytic leukemia; Co-stimulation; T cell; Internal medicine; CD28","score_opus":0.036769347658729606,"score_gpt":0.3442511086549102,"score_spread":0.30748176099618063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069409895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943665,0.0011346692,0.00046944962,0.000114909875,0.000105370775,0.001985772,0.000044658565,0.00008731571,0.0016913395],"genre_scores_gemma":[0.99549097,0.001244838,0.0012340061,0.000019646855,0.00032952538,0.00034737668,0.00007247726,0.00007640456,0.0011847386],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9953567,0.0005025652,0.0010054375,0.00065859716,0.0016834898,0.0007932513],"domain_scores_gemma":[0.9976342,0.0006538954,0.00014313491,0.000715006,0.0005487991,0.00030502022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016153394,0.00034279135,0.0006257605,0.00081155205,0.00018860643,0.00006744988,0.00023319876,0.00027326253,0.00037708238],"category_scores_gemma":[0.00006308699,0.00030601223,0.00017739613,0.0010714614,0.0001956525,0.00033685574,0.000052380576,0.0006599714,0.00021673317],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023136163,0.0052870796,0.15820393,0.016177975,0.0024523214,0.18199512,0.08090523,0.0052921665,0.505936,0.00065454753,0.0012409994,0.018718457],"study_design_scores_gemma":[0.08759757,0.015479938,0.41669846,0.0024793302,0.010365462,0.10800718,0.06756285,0.012477334,0.27513853,0.00046688458,0.000630758,0.0030957116],"about_ca_topic_score_codex":0.00066575536,"about_ca_topic_score_gemma":0.00044928037,"teacher_disagreement_score":0.25849456,"about_ca_system_score_codex":0.0014149406,"about_ca_system_score_gemma":0.002619602,"threshold_uncertainty_score":0.9999392},"labels":[],"label_agreement":null},{"id":"W2072432392","doi":"10.1016/j.leukres.2004.11.011","title":"Cytokinetics and mechanism of action of AKO4: a novel nitrogen mustard targeted to bcr-abl","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Royal Victoria Hospital; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"","keywords":"Chlorambucil; Nitrogen mustard; breakpoint cluster region; ABL; K562 cells; Cancer research; Apoptosis; Philadelphia chromosome; Biology; Tyrosine kinase; DNA damage; Flow cytometry; Chemistry; Molecular biology; Cell biology; DNA; Biochemistry; Receptor; Signal transduction; Chemotherapy; Chromosomal translocation; Genetics","score_opus":0.08074433413515884,"score_gpt":0.37642908915909085,"score_spread":0.295684755023932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072432392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955267,0.00027005217,0.0005605427,0.00081009715,0.000039488783,0.00090352236,0.000045644218,0.000027522692,0.0018164715],"genre_scores_gemma":[0.9840185,0.00016203163,0.014025769,0.000098105884,0.0001674512,0.000051556228,0.000028063818,0.000041520416,0.0014069877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99756175,0.0000833676,0.0004194651,0.00038380473,0.0010182597,0.0005333502],"domain_scores_gemma":[0.99833,0.00020556124,0.000087897344,0.00054964883,0.00051189587,0.00031502306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006759661,0.00017635632,0.0004333032,0.0004972129,0.000068667745,0.000011027183,0.00016463242,0.00019125518,0.0002736624],"category_scores_gemma":[0.00040423629,0.00016039291,0.00007882128,0.0006579153,0.00015367658,0.00007460222,0.00020776736,0.00045583266,0.00006609295],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008670233,0.00027938507,0.0014311468,0.00036691647,0.00019482421,0.000023704471,0.00085486384,0.00008944498,0.97760147,0.0014398771,0.0012188513,0.015632497],"study_design_scores_gemma":[0.006813999,0.0013023972,0.0031255584,0.00021819113,0.00009009381,0.000084529485,0.0004815359,0.0041970927,0.9768625,0.0005757333,0.0060925614,0.00015581699],"about_ca_topic_score_codex":0.00068286824,"about_ca_topic_score_gemma":0.00012214344,"teacher_disagreement_score":0.01547668,"about_ca_system_score_codex":0.002826412,"about_ca_system_score_gemma":0.0013348307,"threshold_uncertainty_score":0.73909694},"labels":[],"label_agreement":null},{"id":"W2072804684","doi":"10.1016/j.leukres.2013.10.021","title":"The role of hematopoietic cell transplantation in adult ALL: Clinical equipoise persists","year":2013,"lang":"es","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Manitoba Health; University of Manitoba","funders":"","keywords":"Medicine; Transplantation; Hematopoietic cell; Clinical equipoise; Hematopoietic stem cell transplantation; Sibling; Clinical trial; Blinatumomab; Induction chemotherapy; Chemotherapy; Oncology; Internal medicine; Intensive care medicine; Surgery; Leukemia; Haematopoiesis; Stem cell; Lymphoblastic Leukemia; Psychology","score_opus":0.03696496635478481,"score_gpt":0.3732737135994941,"score_spread":0.33630874724470927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072804684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9648676,0.003742994,0.000033708773,0.0036324728,0.00021300603,0.0027362304,0.000033625496,0.000038262355,0.024702083],"genre_scores_gemma":[0.97831345,0.017791547,0.00022629715,0.0001542711,0.00042855248,0.00034696155,0.00004778791,0.0001094419,0.0025816783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98853815,0.0026611097,0.0019026771,0.0009831201,0.0036182243,0.002296741],"domain_scores_gemma":[0.98638076,0.009178467,0.00025918183,0.0014721806,0.0019087235,0.00080071593],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00694319,0.00043174243,0.0008959413,0.0006796624,0.0003324784,0.00026256402,0.0014767945,0.000796412,0.00056494575],"category_scores_gemma":[0.0025237615,0.00031385207,0.00038352972,0.0015208762,0.0021363073,0.00028776936,0.0004471995,0.0032856048,0.002865663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01591946,0.0052785752,0.43780896,0.017093096,0.0015664466,0.0028000074,0.029738115,0.00021217164,0.15018502,0.02927025,0.062827036,0.24730086],"study_design_scores_gemma":[0.07202469,0.010386521,0.44163862,0.010450438,0.00097284856,0.00067339,0.067078635,0.18780476,0.15175922,0.01806989,0.03634301,0.0027979836],"about_ca_topic_score_codex":0.008361472,"about_ca_topic_score_gemma":0.00024081863,"teacher_disagreement_score":0.24450287,"about_ca_system_score_codex":0.0036784469,"about_ca_system_score_gemma":0.0060253288,"threshold_uncertainty_score":0.99993134},"labels":[],"label_agreement":null},{"id":"W2073489459","doi":"10.1016/j.leukres.2013.09.018","title":"Quality of life following completion of treatment for adult acute lymphoblastic leukemia with a pediatric-based protocol","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); Regimen; Pediatrics; Vincristine; Lymphoblastic Leukemia; Normative; Population; Protocol (science); Physical therapy; Internal medicine; Leukemia; Chemotherapy; Alternative medicine; Pathology","score_opus":0.09730389761392953,"score_gpt":0.42129860007737513,"score_spread":0.3239947024634456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073489459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.924985,0.000020503592,0.0021005336,0.0009676862,0.000040552597,0.07126779,0.00007161578,0.00006204317,0.00048428215],"genre_scores_gemma":[0.910674,0.000005433807,0.005397732,0.00027763535,0.00027610612,0.08294585,0.00007107146,0.00006349473,0.00028868267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99541074,0.0005311806,0.0010994324,0.00055715913,0.00171851,0.00068300456],"domain_scores_gemma":[0.99440056,0.0019110057,0.00040563827,0.0008351153,0.0020333459,0.00041434393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017975532,0.0002906465,0.0010569488,0.00039020338,0.00014805855,0.000030609193,0.0002700633,0.00018272336,0.00010116656],"category_scores_gemma":[0.0017175551,0.00022072796,0.00036675486,0.00073929835,0.00023443042,0.00013260962,0.00006488158,0.00028018322,0.000027796174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071863964,0.0056205145,0.7370352,0.041785903,0.0049092174,0.000069634065,0.009541779,0.0022882961,0.0829703,0.0029635835,0.03176652,0.0091850525],"study_design_scores_gemma":[0.22754903,0.05687627,0.58529675,0.0036650186,0.0012876836,0.000027111915,0.00478005,0.034502197,0.07957529,0.0013575393,0.0030747326,0.0020083108],"about_ca_topic_score_codex":0.014266223,"about_ca_topic_score_gemma":0.00046865395,"teacher_disagreement_score":0.15568507,"about_ca_system_score_codex":0.0037684385,"about_ca_system_score_gemma":0.00912442,"threshold_uncertainty_score":0.9964929},"labels":[],"label_agreement":null},{"id":"W2074908346","doi":"10.1016/j.leukres.2012.12.007","title":"Abducted by the illness: A qualitative study of traumatic stress in individuals with acute leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; University Health Network","keywords":"Traumatic stress; Qualitative research; Psychological intervention; Grounded theory; Medicine; Clinical psychology; Preference; Population; Psychiatry; Leukemia; Acute leukemia; Psychology; Internal medicine","score_opus":0.07244435580026112,"score_gpt":0.4215284975666684,"score_spread":0.34908414176640723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074908346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198866,0.00022299385,0.000011162811,0.0024115078,0.00003480503,0.00411076,0.00007055883,0.000046636065,0.0011029107],"genre_scores_gemma":[0.9976051,0.000031633004,0.00013666744,0.0001794556,0.000084142266,0.0009779,0.000046834633,0.00005916149,0.00087909854],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9921704,0.0027745592,0.0008072253,0.0005990581,0.0028455441,0.00080320047],"domain_scores_gemma":[0.9953008,0.0025157635,0.00017494771,0.001115878,0.00064684474,0.00024576046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042364183,0.00029962245,0.000847633,0.00047866523,0.0002044308,0.000086299995,0.0007041437,0.0001358304,0.00021028772],"category_scores_gemma":[0.00067071425,0.00018760438,0.000073711235,0.0019571374,0.0006458668,0.00026124154,0.00022140754,0.0015180374,0.000073211086],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040895963,0.0015345168,0.017766956,0.00047897318,0.00087009615,0.00004827028,0.9635823,0.0000388555,0.0013991784,0.000135429,0.011886549,0.0018499494],"study_design_scores_gemma":[0.009606932,0.0032513326,0.067428894,0.00074194756,0.00011683979,0.000030314115,0.9137115,0.00030185413,0.0037376701,0.0005959729,0.00015246283,0.00032427083],"about_ca_topic_score_codex":0.05744027,"about_ca_topic_score_gemma":0.005302107,"teacher_disagreement_score":0.05213816,"about_ca_system_score_codex":0.0014415755,"about_ca_system_score_gemma":0.0017040994,"threshold_uncertainty_score":0.9488363},"labels":[],"label_agreement":null},{"id":"W2075549873","doi":"10.1016/j.leukres.2004.09.006","title":"Coexpression and regulation of the FGF-2 and FGF antisense genes in leukemic cells","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Nova Scotia Health Research Foundation; University of Manitoba; Cancer Research Society; Philipps-Universität Marburg","keywords":"Fibroblast growth factor; Antisense RNA; Sense (electronics); Haematopoiesis; Biology; Cell biology; Messenger RNA; Gene expression; K562 cells; RNA; Molecular biology; Gene; Stem cell; Chemistry; Genetics","score_opus":0.02260809386565673,"score_gpt":0.30874492795088265,"score_spread":0.28613683408522594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075549873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983074,0.0008877164,0.000024649278,0.00016269225,0.000028330336,0.0003300003,0.00000885765,0.000003674702,0.00024668334],"genre_scores_gemma":[0.9983922,0.0006836883,0.0002125361,0.00001329364,0.00004962572,0.000012844239,0.000009786433,0.00001877458,0.00060719927],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9984088,0.00027027907,0.0001907775,0.00035275915,0.0004273691,0.00035004417],"domain_scores_gemma":[0.9992919,0.000065763605,0.000041445757,0.00039299377,0.00012579456,0.000082076185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006805987,0.00010470916,0.00012438964,0.00013320793,0.00011493783,0.000028884375,0.00020878518,0.00018498687,0.0000068247855],"category_scores_gemma":[0.00016541542,0.000079530204,0.000030096217,0.00027542232,0.00047150222,0.000008711647,0.00051600905,0.00030957695,0.0000034809984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000125653,0.000016043465,0.008285485,0.00007981287,0.0000058517703,0.0000027183785,0.00009977374,0.00027234125,0.98968285,0.000104177656,0.00022621281,0.0010990982],"study_design_scores_gemma":[0.0009810191,0.00013664442,0.09857754,0.00010551759,0.0000014524785,0.000012585932,0.00007727019,0.00019149063,0.89876693,0.0003710042,0.00070019264,0.00007836248],"about_ca_topic_score_codex":0.0005168533,"about_ca_topic_score_gemma":0.0001209629,"teacher_disagreement_score":0.09091591,"about_ca_system_score_codex":0.00013545375,"about_ca_system_score_gemma":0.000440814,"threshold_uncertainty_score":0.32431474},"labels":[],"label_agreement":null},{"id":"W2076061288","doi":"10.1016/s0145-2126(01)00052-2","title":"Regression of engineered myeloma cells secreting interferon-γ-inducing factor is mediated by both CD4+/CD8+ T and natural killer cells","year":2001,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Saskatchewan Cancer Agency; University of Saskatchewan","funders":"Medical Research Council","keywords":"CD8; Immune system; Cytotoxic T cell; Interleukin 21; Cytokine; Biology; Interleukin 12; Interferon gamma; In vivo; Immunology; In vitro; T cell; Molecular biology; Cancer research; Biochemistry","score_opus":0.022898225258847826,"score_gpt":0.2891107219130749,"score_spread":0.2662124966542271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076061288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992521,0.0026516838,0.00005206151,0.00018545029,0.0031643636,0.00024764208,0.0000089742825,0.00005887966,0.0011099387],"genre_scores_gemma":[0.94911027,0.0007862581,0.000030071003,0.00009482108,0.00004517912,0.0000104841665,0.00012410792,0.000030482246,0.04976835],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980199,0.00041568096,0.00041082507,0.0004144529,0.0001530818,0.0005860913],"domain_scores_gemma":[0.998677,0.00060401135,0.00012688263,0.0003133264,0.00022617537,0.00005260902],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005146435,0.00022408194,0.0003194153,0.00032822648,0.00024390062,0.000036756668,0.0002329847,0.00039531157,0.0030179145],"category_scores_gemma":[0.0001814929,0.00017765375,0.000080245,0.0003145928,0.00020719848,0.00019555136,0.00019097405,0.0013750729,0.00037747464],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004664647,0.00003224632,0.0002099797,0.000037832728,0.00006853596,0.000004580731,0.0012113871,0.0000016400038,0.90328574,0.0000045156553,0.09148629,0.0031907798],"study_design_scores_gemma":[0.0011529953,0.00025598065,0.0005757425,0.00017769873,0.0000071913905,0.000023282713,0.0011217194,0.00030423564,0.9034782,0.0000032064534,0.092730105,0.00016964645],"about_ca_topic_score_codex":0.0005521632,"about_ca_topic_score_gemma":0.000009873808,"teacher_disagreement_score":0.048658412,"about_ca_system_score_codex":0.00033560698,"about_ca_system_score_gemma":0.00010429755,"threshold_uncertainty_score":0.99789345},"labels":[],"label_agreement":null},{"id":"W2077489715","doi":"10.1016/j.leukres.2012.02.013","title":"Notch-mediated repression of miR-223 contributes to IGF1R regulation in T-ALL","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Canadian Cancer Society Research Institute; Cancer Research Institute","keywords":"Notch signaling pathway; Insulin-like growth factor 1 receptor; microRNA; Biology; Cell biology; Signal transduction; Context (archaeology); Cancer research; Receptor; Growth factor; Gene; Genetics","score_opus":0.05331835162137881,"score_gpt":0.374634736131901,"score_spread":0.3213163845105222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077489715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709255,0.00093430985,0.0004304549,0.00029579783,0.00006648953,0.000449267,0.000017919721,0.000008336778,0.0007048931],"genre_scores_gemma":[0.9986645,0.000035196044,0.00029585627,0.000063866064,0.00013648436,0.000052043964,0.00030793407,0.00001900429,0.00042510955],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983622,0.00028070004,0.0002809044,0.00027289853,0.00034568275,0.0004576439],"domain_scores_gemma":[0.99897534,0.00008816419,0.0000592854,0.00046185582,0.0002641028,0.00015126205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013482863,0.00009598251,0.00014139168,0.00022103569,0.000041616553,0.00001287674,0.00019450978,0.00022720727,0.000039615108],"category_scores_gemma":[0.001066431,0.00009318957,0.000045004792,0.00040527096,0.00008197679,0.000009661384,0.00021746628,0.00015503864,0.00004022803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028913864,0.000080731705,0.014621633,0.00003484052,0.000015410036,7.453214e-7,0.00008742562,0.00017512312,0.9765274,0.00012926725,0.0072986376,0.00073965953],"study_design_scores_gemma":[0.0009159308,0.000066466804,0.23229171,0.000067587884,0.000004218463,0.000001237844,0.000042754597,0.00033879883,0.746235,0.00020026421,0.019733675,0.00010234755],"about_ca_topic_score_codex":0.00017767586,"about_ca_topic_score_gemma":0.000055960805,"teacher_disagreement_score":0.23029238,"about_ca_system_score_codex":0.00027395107,"about_ca_system_score_gemma":0.00018985599,"threshold_uncertainty_score":0.38001606},"labels":[],"label_agreement":null},{"id":"W2078892073","doi":"10.1016/j.leukres.2013.04.019","title":"Epigenetic action of decitabine (5-aza-2′-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C)","year":2013,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Canadian Cancer Society","keywords":"Decitabine; Cytarabine; Myeloid leukemia; Deoxycytidine; Medicine; Azacitidine; Oncology; Chemotherapy; Leukopenia; Leukemia; Clinical trial; Pharmacology; Acute leukemia; Internal medicine; DNA methylation; Gemcitabine; Biology","score_opus":0.06026619633971207,"score_gpt":0.370613817139751,"score_spread":0.3103476208000389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078892073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9029075,0.0012533581,0.00032628875,0.08052336,0.00071716594,0.010285205,0.0006698185,0.00021745669,0.0030998678],"genre_scores_gemma":[0.81330097,0.023986356,0.0037791028,0.05374666,0.01659376,0.006319298,0.007826078,0.0022684494,0.07217931],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9812813,0.0021179935,0.002638643,0.002860925,0.00748212,0.0036190113],"domain_scores_gemma":[0.98545706,0.003106224,0.0013527864,0.004209878,0.0049562785,0.0009177499],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.0035692342,0.0018014002,0.0038248547,0.004903789,0.00051191123,0.00015632703,0.0022257254,0.004729554,0.0015188382],"category_scores_gemma":[0.0018162153,0.0016312718,0.0014190322,0.0044184905,0.0025816618,0.00066603004,0.0012936301,0.016253548,0.001344814],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0023438123,0.00018808027,0.0006144395,0.0046615223,0.0021951501,0.0010585001,0.00072112697,0.00008270279,0.4626879,0.000009063897,0.50216436,0.023273332],"study_design_scores_gemma":[0.011189642,0.004515673,0.01510978,0.0034869614,0.0010683142,0.0005812543,0.0007710962,0.005341544,0.85702664,0.00032770727,0.09881941,0.0017619688],"about_ca_topic_score_codex":0.005725552,"about_ca_topic_score_gemma":0.00008433413,"teacher_disagreement_score":0.40334496,"about_ca_system_score_codex":0.026079267,"about_ca_system_score_gemma":0.01084742,"threshold_uncertainty_score":0.9994731},"labels":[],"label_agreement":null},{"id":"W2080820574","doi":"10.1016/j.leukres.2005.08.013","title":"HLA-DM expression is elevated in ETV6–AML1 translocation-positive pediatric acute lymphoblastic leukemia","year":2005,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"ETV6; Chromosomal translocation; Human leukocyte antigen; CD19; Immunology; Leukemia; Major histocompatibility complex; MHC class I; Cancer research; Medicine; Biology; Antigen; Gene; Genetics","score_opus":0.02856127762690191,"score_gpt":0.34426415436863905,"score_spread":0.31570287674173714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080820574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825701,0.0011201715,0.0010120113,0.0040009404,0.00015782686,0.002414812,0.00009847087,0.00026804444,0.008357621],"genre_scores_gemma":[0.9853406,0.0023220407,0.0019675836,0.0011139693,0.0013607369,0.0004954846,0.00021774041,0.00021235525,0.0069694663],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9892885,0.00081649754,0.0013424738,0.0017132014,0.0040744017,0.0027649172],"domain_scores_gemma":[0.99385655,0.0019870615,0.00013130611,0.0015270002,0.0013595289,0.001138567],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.002759995,0.0007003413,0.0010265631,0.0025643497,0.0005085541,0.00018607047,0.00108246,0.0009143618,0.0014698692],"category_scores_gemma":[0.0011439396,0.0006347203,0.00029330453,0.004892758,0.0005750854,0.0006673751,0.00047986445,0.0028802655,0.0030339563],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.014559638,0.002217322,0.024986682,0.0016153351,0.0008376143,0.005558599,0.014969711,0.004397934,0.69394803,0.00086330203,0.1936783,0.042367537],"study_design_scores_gemma":[0.05053327,0.0025381192,0.05244438,0.0020229009,0.0004282913,0.0012877148,0.0015330784,0.21011245,0.662124,0.0006086519,0.014126033,0.0022411589],"about_ca_topic_score_codex":0.0010883424,"about_ca_topic_score_gemma":0.00012343204,"teacher_disagreement_score":0.20571452,"about_ca_system_score_codex":0.027041448,"about_ca_system_score_gemma":0.014157051,"threshold_uncertainty_score":0.9996104},"labels":[],"label_agreement":null},{"id":"W2081434852","doi":"10.1016/j.leukres.2013.06.020","title":"t(11;14) multiple myeloma: A subtype associated with distinct immunological features, immunophenotypic characteristics but divergent outcome","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Multiple myeloma; Bortezomib; Cohort; Internal medicine; CD20; Incidence (geometry); Medicine; Plasma cell leukemia; Population; Oncology; Immunology; Gastroenterology; Lymphoma","score_opus":0.06183816214560683,"score_gpt":0.32980931248744055,"score_spread":0.2679711503418337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081434852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942372,0.0005322257,0.000027126309,0.00083387655,0.00013470468,0.0022158797,0.00012751862,0.00020472435,0.001686741],"genre_scores_gemma":[0.98011434,0.000118245196,0.00040168522,0.000082223225,0.00016174778,0.0006042485,0.0008567703,0.000085739375,0.017575005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99404514,0.00058173167,0.00058934564,0.0008159764,0.002082169,0.0018856092],"domain_scores_gemma":[0.99548644,0.0012016182,0.00014934958,0.0010512647,0.0013718781,0.0007394642],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0009645765,0.00046520372,0.0008138101,0.00038254962,0.00069509115,0.00022323933,0.0005571492,0.00042025468,0.0016040222],"category_scores_gemma":[0.0051768934,0.000306892,0.00018998233,0.00087712175,0.00067084323,0.00024283417,0.0005661593,0.0019608098,0.0018458209],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022241878,0.00095097173,0.9696213,0.00011543957,0.00065281754,0.0013802191,0.0001472294,0.0000010335145,0.0098989485,0.00013659529,0.0021518252,0.012719436],"study_design_scores_gemma":[0.0072980872,0.001289684,0.9876652,0.00016241093,0.000058521757,0.00008514186,0.00016409352,0.0005480827,0.0010742552,0.00007769779,0.001259256,0.0003175636],"about_ca_topic_score_codex":0.0055322414,"about_ca_topic_score_gemma":0.00045768562,"teacher_disagreement_score":0.01804391,"about_ca_system_score_codex":0.0027566864,"about_ca_system_score_gemma":0.0008473005,"threshold_uncertainty_score":0.9999383},"labels":[],"label_agreement":null},{"id":"W2082440968","doi":"10.1016/j.leukres.2010.01.015","title":"Leukemia-selective uptake and cytotoxicity of CPX-351, a synergistic fixed-ratio cytarabine:daunorubicin formulation, in bone marrow xenografts","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"Celator Pharmaceuticals","keywords":"Daunorubicin; Cytarabine; Leukemia; Bone marrow; Pharmacology; Medicine; Cancer research; Immunology","score_opus":0.031563724515059406,"score_gpt":0.33557359054153746,"score_spread":0.30400986602647806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082440968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98949695,0.0003780947,0.00032538828,0.0010041358,0.00012513236,0.0022522972,0.000045868364,0.000097202625,0.0062749563],"genre_scores_gemma":[0.99281174,0.00023203544,0.0027287714,0.00014093582,0.00045847814,0.00031400737,0.000106197724,0.00011548892,0.0030923611],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9931644,0.0005089282,0.0012206237,0.0011514544,0.002214433,0.001740163],"domain_scores_gemma":[0.9946932,0.0015252391,0.00021353907,0.0012651982,0.001590415,0.00071238726],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0048072836,0.00049371086,0.0010879632,0.0019871683,0.00036889737,0.000105742634,0.00055230747,0.0007479229,0.0002845616],"category_scores_gemma":[0.005038418,0.00045515885,0.00017605026,0.0031187818,0.0010592552,0.00042999286,0.00052183995,0.0046422128,0.00008698744],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0022654855,0.00026981058,0.039836276,0.00065849745,0.00012968738,0.00048568877,0.0014358835,0.00016808696,0.93807125,0.0050929273,0.0066263033,0.00496011],"study_design_scores_gemma":[0.016940597,0.0023934136,0.49595237,0.0006905761,0.000112413174,0.000563626,0.0010564725,0.06406439,0.40994194,0.0037325341,0.0034919516,0.0010597348],"about_ca_topic_score_codex":0.004972399,"about_ca_topic_score_gemma":0.0037962687,"teacher_disagreement_score":0.52812934,"about_ca_system_score_codex":0.0043645217,"about_ca_system_score_gemma":0.0058493335,"threshold_uncertainty_score":0.99979},"labels":[],"label_agreement":null},{"id":"W2083042132","doi":"10.1016/j.leukres.2011.01.004","title":"Dual inhibition of the homologous recombinational repair and the nonhomologous end-joining repair pathways in chronic lymphocytic leukemia therapy","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research; Jewish General Hospital; Leukemia and Lymphoma Society","keywords":"Chlorambucil; RAD51; Chronic lymphocytic leukemia; DNA repair; Homologous recombination; Non-homologous end joining; Cancer research; DNA; DNA damage; Biology; Leukemia; Homologous chromosome; Genetics; Chemotherapy; Gene","score_opus":0.07937477045542254,"score_gpt":0.3175927071213793,"score_spread":0.23821793666595678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083042132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810503,0.0031121525,0.00000752175,0.00032153723,0.00017530307,0.0022236297,0.000013377682,0.00018279155,0.012913373],"genre_scores_gemma":[0.99535614,0.0017273364,0.00035075017,0.00027458929,0.00023863555,0.000453954,0.000021707634,0.000078385776,0.0014984921],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99276954,0.0018498204,0.0010306692,0.0009170666,0.0021305284,0.0013023483],"domain_scores_gemma":[0.99506736,0.002246917,0.00023128196,0.0015687827,0.0006518423,0.00023383318],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.008343819,0.00037408064,0.00074680604,0.00064145244,0.0005013284,0.000038750983,0.000522284,0.00047442102,0.00037988153],"category_scores_gemma":[0.0020228003,0.00022881856,0.00042166252,0.0017500733,0.0036656505,0.00019886938,0.0008546499,0.0019002468,0.000055487923],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.09507595,0.0028577803,0.04197103,0.009371941,0.0050040297,0.023070704,0.13596088,0.0036590153,0.115199156,0.38154575,0.051825162,0.1344586],"study_design_scores_gemma":[0.3020367,0.0073732506,0.15024002,0.0034408935,0.00023777019,0.011826785,0.0053951624,0.34253865,0.12920189,0.04229821,0.0037404008,0.0016702795],"about_ca_topic_score_codex":0.014167521,"about_ca_topic_score_gemma":0.00069080945,"teacher_disagreement_score":0.33924752,"about_ca_system_score_codex":0.12438079,"about_ca_system_score_gemma":0.075414546,"threshold_uncertainty_score":0.9990458},"labels":[],"label_agreement":null},{"id":"W2084532520","doi":"10.1016/s0145-2126(11)70040-6","title":"38 Uncoupling of GTP hydrolysis from eIF6 release on the ribosome causes Shwachman-Diamond syndrome","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Blood disorders and treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Medical Research Council; Institut National de la Santé et de la Recherche Médicale; Canadian Institutes of Health Research; Institut de Veille Sanitaire; Leukemia and Lymphoma Society; National Institute for Health and Care Research; University College Dublin; National Institutes of Health; Cancer Research UK; Leukemia and Lymphoma Research","keywords":"Chemistry; GTP'; Hydrolysis; Pharmacology; Food science; Biochemistry; Biology; Enzyme","score_opus":0.06756490857831893,"score_gpt":0.30104212818858905,"score_spread":0.23347721961027013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084532520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934185,0.0012324173,0.000009880985,0.000109858345,0.00004413346,0.00024288212,0.00006458092,0.0000095232035,0.004868184],"genre_scores_gemma":[0.99839276,0.00036741063,0.00009859533,0.000080435835,0.000056857178,0.00006685673,0.00009280098,0.000031310108,0.0008130018],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983688,0.00014946221,0.00021204415,0.00043748206,0.0004204512,0.00041176856],"domain_scores_gemma":[0.9987733,0.00011142885,0.00006416744,0.00081747666,0.00012014026,0.00011352905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035272873,0.00016618446,0.00019304751,0.0000912258,0.00018450346,0.000021996037,0.00043588137,0.0001788253,0.00023356928],"category_scores_gemma":[0.00016023875,0.00011693579,0.00012572516,0.00023873037,0.00023323845,0.000005085776,0.00021833913,0.00027833373,0.00010512436],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035277228,0.004263526,0.15553498,0.00022989705,0.0051525603,0.0011890598,0.0030436402,0.00056400645,0.791743,0.0045571616,0.019035004,0.011159463],"study_design_scores_gemma":[0.0024026383,0.0016584455,0.024940528,0.000097938086,0.00010605844,0.000015248481,0.0008168338,0.00035569255,0.9620224,0.0044416185,0.00273444,0.0004081285],"about_ca_topic_score_codex":0.0026748707,"about_ca_topic_score_gemma":0.00024501592,"teacher_disagreement_score":0.17027946,"about_ca_system_score_codex":0.00006527427,"about_ca_system_score_gemma":0.00021300335,"threshold_uncertainty_score":0.4768503},"labels":[],"label_agreement":null},{"id":"W2086512786","doi":"10.1016/j.leukres.2004.02.006","title":"Growth and apoptosis of human natural killer cell neoplasms: role of interleukin-2/15 signaling","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Immune Cell Function and Interaction","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"Shionogi; Cell Science Research Foundation; World Health Organization","keywords":"Interleukin 15; STAT5; Apoptosis; Lymphokine-activated killer cell; Natural killer cell; Cell biology; Cancer research; Biology; Cell culture; Cell; Cell growth; Interleukin; Interleukin 21; Immunology; Signal transduction; In vitro; Cytokine; Cytotoxicity; T cell; Immune system; Biochemistry","score_opus":0.017384462507242075,"score_gpt":0.2822947841443441,"score_spread":0.26491032163710204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086512786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99156076,0.0015158415,0.000014620907,0.000063181935,0.0006332465,0.00014225613,0.0000013187873,0.000019120467,0.006049646],"genre_scores_gemma":[0.99528825,0.000084133324,0.000050221195,0.000025016072,0.000020737327,0.000009829043,0.00003596858,0.000014421158,0.0044714264],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9988506,0.00019731844,0.0003266661,0.00022516554,0.00009355574,0.00030670196],"domain_scores_gemma":[0.9992927,0.00018210789,0.00010171853,0.00019128784,0.00021169144,0.000020516945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003693826,0.000113570655,0.00022845459,0.00032507753,0.00016880999,0.000012930069,0.00018604638,0.00018940581,0.0004580462],"category_scores_gemma":[0.00007825745,0.000101076446,0.00007835373,0.00021721718,0.00033519085,0.00012290227,0.00013851309,0.00074368034,0.00009281315],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024459275,0.00007494824,0.0003655887,0.000071815666,0.00005489841,4.569081e-7,0.001437212,0.000011254417,0.99505144,0.001411296,0.00090708677,0.0003694051],"study_design_scores_gemma":[0.0014977437,0.00045185053,0.00040312193,0.00008864873,0.00001069328,0.0000109610455,0.0025715807,0.0000056377435,0.9927437,0.0005058045,0.0016209049,0.000089396046],"about_ca_topic_score_codex":0.001987472,"about_ca_topic_score_gemma":0.000022397098,"teacher_disagreement_score":0.0037274794,"about_ca_system_score_codex":0.00017943875,"about_ca_system_score_gemma":0.00013717424,"threshold_uncertainty_score":0.5015285},"labels":[],"label_agreement":null},{"id":"W2087111933","doi":"10.1016/j.leukres.2009.09.012","title":"Genetic inactivation of Ikaros is a rare event in human T-ALL","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; Ligue Contre le Cancer; Institut National Du Cancer; Association pour la Recherche sur le Cancer","keywords":"Biology; Genetics; Allele; Gene; Molecular biology","score_opus":0.05855812171636873,"score_gpt":0.4050134406573147,"score_spread":0.34645531894094594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087111933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839575,0.00018075899,0.00017035205,0.0022787685,0.000022328719,0.0010527737,0.0000071141408,0.000034797038,0.00785735],"genre_scores_gemma":[0.9957432,0.00009690047,0.0007296594,0.00045603618,0.00016234447,0.000062461935,0.000025375979,0.000034068216,0.002689913],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9955791,0.0002898126,0.0006165892,0.00053375034,0.0020499923,0.000930751],"domain_scores_gemma":[0.9979523,0.00030821664,0.000084031155,0.0007882996,0.0005769598,0.00029022223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00130287,0.00019380901,0.0004493558,0.0011004121,0.000100299796,0.00002950282,0.0004011,0.0002744271,0.00040464083],"category_scores_gemma":[0.0006372839,0.00017583724,0.000109899665,0.0015293448,0.00023783736,0.00012202775,0.00016340512,0.0010997523,0.00010201547],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020428179,0.0011520035,0.02497643,0.00070923404,0.00012390788,0.0012178668,0.004445777,0.00021401384,0.8715,0.002048062,0.036697127,0.05487272],"study_design_scores_gemma":[0.015668683,0.0042512757,0.60914695,0.001106123,0.000041452797,0.00021539131,0.000991398,0.014707045,0.34071285,0.007164322,0.0055199387,0.00047457917],"about_ca_topic_score_codex":0.0013551931,"about_ca_topic_score_gemma":0.0000418205,"teacher_disagreement_score":0.5841705,"about_ca_system_score_codex":0.0065402756,"about_ca_system_score_gemma":0.0023616857,"threshold_uncertainty_score":0.99727345},"labels":[],"label_agreement":null},{"id":"W2089243465","doi":"10.1016/j.leukres.2011.07.033","title":"Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review","year":2011,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital; Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"Medical Center, University of Rochester; University of Toronto; European Hematology Association","keywords":"Presentation (obstetrics); Context (archaeology); Lineage (genetic); Neoplasm; Expression (computer science); Pathology; Medicine; Biology; Gene; Computer science; Genetics; Radiology","score_opus":0.07700582834842269,"score_gpt":0.3829620155647267,"score_spread":0.305956187216304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089243465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010756651,0.9877615,0.000010198714,0.00010214987,0.000078651006,0.006921344,0.00016171891,0.00012455758,0.0037641877],"genre_scores_gemma":[0.00026605983,0.9809079,0.0004551083,0.00014721026,0.0002726223,0.0008619901,0.0006673172,0.0003397491,0.016082011],"study_design_codex":"systematic_review","study_design_gemma":"case_report","domain_scores_codex":[0.99163425,0.0015376356,0.0012490281,0.0017914765,0.0019755992,0.0018120228],"domain_scores_gemma":[0.99384934,0.0016131246,0.00032416894,0.001465677,0.0018308684,0.00091682316],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0012267712,0.0011546718,0.0029982405,0.001406105,0.0007429142,0.0004495162,0.0006064596,0.0007389367,0.00036513084],"category_scores_gemma":[0.0010677867,0.00086349575,0.0003779046,0.002725529,0.0011299696,0.00034591084,0.00067082624,0.004147772,0.0003374143],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006816425,0.00024250206,0.00010762403,0.5926275,0.0006925677,0.2255358,0.0016015397,0.000001667895,0.000017318844,0.00019665304,0.0077456622,0.17054951],"study_design_scores_gemma":[0.0011411238,0.0011456625,4.444242e-7,0.14888076,0.0008902202,0.45308912,0.00037703163,0.00004292243,0.000030179603,0.0000547099,0.3937563,0.00059151836],"about_ca_topic_score_codex":0.0003794269,"about_ca_topic_score_gemma":0.0004773219,"teacher_disagreement_score":0.44374675,"about_ca_system_score_codex":0.003070486,"about_ca_system_score_gemma":0.007348052,"threshold_uncertainty_score":0.9993816},"labels":[],"label_agreement":null},{"id":"W2089483976","doi":"10.1016/j.leukres.2011.09.020","title":"Identification of a novel non-immunoglobulin/MYC translocation t(8;12)(q24;p12) involving the LRMP gene in a primary B-cell lymphoma. A case report","year":2011,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Vascular Malformations and Hemangiomas","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Vascular endothelial growth factor A; Flow cytometry; Cell growth; Angiogenesis; Apoptosis; Biology; Molecular biology; MALAT1; Cancer research; microRNA; Cell; Chemistry; Downregulation and upregulation; Vascular endothelial growth factor; Gene; Genetics; VEGF receptors","score_opus":0.06736260677681681,"score_gpt":0.3178418013336248,"score_spread":0.25047919455680795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089483976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9154517,0.0057515907,0.0036790827,0.05980769,0.0004092019,0.006476374,0.00010904176,0.000105788924,0.008209524],"genre_scores_gemma":[0.95261884,0.0019298687,0.003005728,0.021520732,0.002144181,0.0017394625,0.0034424155,0.00031594283,0.0132828215],"study_design_codex":"not_applicable","study_design_gemma":"case_report","domain_scores_codex":[0.99498934,0.0002851868,0.0016449795,0.0006878395,0.0016412681,0.0007514124],"domain_scores_gemma":[0.9960029,0.00027222803,0.000539926,0.0021237524,0.0009654967,0.00009570569],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0048092455,0.00035474024,0.00070938567,0.0012212828,0.0002948643,0.000086895285,0.0005640705,0.00094543665,0.000051461742],"category_scores_gemma":[0.0002607635,0.00028498727,0.0003832463,0.0012237893,0.00033791314,0.00024373774,0.00018259214,0.0020595891,0.00007037275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012449728,0.003980369,0.0016871769,0.02014367,0.0014089099,0.16720527,0.028927898,0.00012994763,0.25016004,0.00020228379,0.50926095,0.015648501],"study_design_scores_gemma":[0.06529608,0.0017737382,0.051258236,0.010183691,0.0024277247,0.3511834,0.0065510157,0.05149198,0.15792973,0.0008428321,0.296778,0.0042835646],"about_ca_topic_score_codex":0.005905895,"about_ca_topic_score_gemma":0.0003032244,"teacher_disagreement_score":0.21248296,"about_ca_system_score_codex":0.0023488894,"about_ca_system_score_gemma":0.0034228882,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W2090923510","doi":"10.1016/j.leukres.2014.08.017","title":"Socioeconomic status and event free survival in pediatric acute lymphoblastic leukemia: A population-based cohort study","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group; Institute for Clinical Evaluative Sciences; University of Toronto; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; Hospital for Sick Children; Ontario Ministry of Health and Long-Term Care; Canadian Child Health Clinician Scientist Program","keywords":"Lymphoblastic Leukemia; Medicine; Cohort; Socioeconomic status; Cohort study; Event (particle physics); Oncology; Population; Pediatrics; Demography; Internal medicine; Leukemia; Environmental health","score_opus":0.0198843650246531,"score_gpt":0.3273311305163556,"score_spread":0.30744676549170247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090923510","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940228,0.00013777753,0.00027362767,0.00052173325,0.00021391685,0.003081771,0.000033462242,0.0001280725,0.0015868363],"genre_scores_gemma":[0.9969368,0.00021956276,0.0003560203,0.0001605057,0.00059837743,0.00056414626,0.0001208818,0.000143193,0.0009004867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99120206,0.0013777192,0.0010692881,0.0014866478,0.0026879534,0.0021763444],"domain_scores_gemma":[0.9929711,0.0037711482,0.00016166875,0.0016415269,0.00047624818,0.0009783017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0063294987,0.000512651,0.0011102656,0.0017531127,0.0003940822,0.00017874356,0.0007011139,0.00045091574,0.00025699876],"category_scores_gemma":[0.0028418498,0.0004812026,0.00015443948,0.0012654566,0.00033344136,0.00022885377,0.00076489913,0.001765839,0.00037021498],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0009728608,0.00034961654,0.9941552,0.00025260542,0.00015392149,0.00023738127,0.00029584332,0.00088832487,0.000104855855,0.00020663341,0.001250791,0.0011319136],"study_design_scores_gemma":[0.01762618,0.0013413841,0.9147481,0.00006010537,0.00017690836,0.000028722678,0.00033920666,0.0645364,0.000045679724,0.0005646048,0.00014414583,0.00038857138],"about_ca_topic_score_codex":0.012483305,"about_ca_topic_score_gemma":0.0021395283,"teacher_disagreement_score":0.07940716,"about_ca_system_score_codex":0.02490672,"about_ca_system_score_gemma":0.008656983,"threshold_uncertainty_score":0.99976397},"labels":[],"label_agreement":null},{"id":"W2091231814","doi":"10.1016/j.leukres.2012.02.022","title":"Assessing signaling pathways associated with in vitro resistance to cytotoxic agents in AML","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Clofarabine; Gemtuzumab ozogamicin; Decitabine; Cytarabine; Myeloid leukemia; Daunorubicin; Azacitidine; In vitro; Leukemia; Cancer research; Medicine; Pharmacology; Biology; Immunology; Stem cell; CD33; Biochemistry; DNA methylation; Cell biology; CD34","score_opus":0.1375267582072328,"score_gpt":0.40075598130245965,"score_spread":0.26322922309522684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091231814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9877797,0.00029631058,0.000074229094,0.0008567909,0.00004306367,0.0010161239,0.00000951533,0.00006550089,0.009858761],"genre_scores_gemma":[0.99506235,0.000021897757,0.002100398,0.0003887137,0.00020399147,0.00029513813,0.00005545533,0.00010083087,0.0017712504],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.993154,0.00093269866,0.0005268009,0.0006265693,0.0023781997,0.0023817667],"domain_scores_gemma":[0.99699426,0.001165074,0.00007410031,0.00066081574,0.0003714572,0.0007342998],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.007826089,0.00026302316,0.00052333635,0.0015163505,0.0002276952,0.00018062675,0.0004850792,0.0003118773,0.00013260584],"category_scores_gemma":[0.0033610372,0.00023968909,0.00006593697,0.0040364657,0.00019874577,0.00058514037,0.00034895257,0.0025212453,0.00021968648],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004165427,0.00071080093,0.12820075,0.0003457277,0.000103161176,0.002751826,0.004883008,0.00016905737,0.84901863,0.0003198719,0.0047613406,0.0045703733],"study_design_scores_gemma":[0.01101301,0.0004758827,0.48908123,0.0032964388,0.000025254969,0.000055124696,0.0043649534,0.0030339474,0.48547307,0.00020634894,0.0022076964,0.0007670261],"about_ca_topic_score_codex":0.0005744304,"about_ca_topic_score_gemma":0.000522305,"teacher_disagreement_score":0.36354557,"about_ca_system_score_codex":0.011941011,"about_ca_system_score_gemma":0.0026321686,"threshold_uncertainty_score":0.99978},"labels":[],"label_agreement":null},{"id":"W2092340195","doi":"10.1016/j.leukres.2012.03.001","title":"Synergistic antileukemic action of a combination of inhibitors of DNA methylation and histone methylation","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"National Institutes of Health","keywords":"EZH2; PRC2; Biology; DNA methylation; Epigenetics; Histone methyltransferase; Cancer research; Histone methylation; Cancer epigenetics; Gene silencing; Molecular biology; Methylation; Carcinogenesis; Histone H3; Epigenetic therapy; Histone; Gene expression; Gene; Genetics","score_opus":0.05787510951991737,"score_gpt":0.3848753231151511,"score_spread":0.32700021359523374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092340195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931223,0.0032776368,0.002674602,0.00001796008,0.00010955996,0.00022731694,0.000009470257,0.0000036676684,0.00055749627],"genre_scores_gemma":[0.9984732,0.000627284,0.00055751816,0.0000015551251,0.000093489936,0.000011056312,0.00010029082,0.000016203521,0.00011939293],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99844444,0.00031382797,0.00042184614,0.00018615456,0.00042603226,0.00020767876],"domain_scores_gemma":[0.9987677,0.00013849487,0.0002761786,0.00024828152,0.00050284615,0.00006654902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017865045,0.00009576061,0.00019230974,0.00028055217,0.000053125517,0.0000048384854,0.00008575687,0.00020169931,0.000008479366],"category_scores_gemma":[0.0005585025,0.000098029,0.00005430283,0.0003253674,0.00021780201,0.00001870062,0.000078472156,0.00012607152,9.061743e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009688039,0.00007067955,0.0067875255,0.00015419944,0.000028406856,6.210638e-8,0.0002223494,0.00009880582,0.9814157,0.0006718459,0.00003786266,0.010415715],"study_design_scores_gemma":[0.0004976164,0.00030175102,0.0368768,0.000029540577,0.000021317986,4.2553782e-7,0.00011391735,0.0006088965,0.9605732,0.0005480797,0.00035091522,0.000077562334],"about_ca_topic_score_codex":0.00022568434,"about_ca_topic_score_gemma":0.00001591669,"teacher_disagreement_score":0.030089276,"about_ca_system_score_codex":0.00012667665,"about_ca_system_score_gemma":0.0001586444,"threshold_uncertainty_score":0.39975065},"labels":[],"label_agreement":null},{"id":"W2092925479","doi":"10.1016/j.leukres.2004.03.015","title":"The efficacy of diphtheria-growth factor fusion proteins is enhanced by co-administration of cytosine arabinoside in an immunodeficient mouse model of human acute myeloid leukemia","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Toxin Mechanisms and Immunotoxins","field":"Immunology and Microbiology","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"Diphtheria toxin; Cytarabine; Cytosine; Myeloid leukemia; Bone marrow; Granulocyte macrophage colony-stimulating factor; Leukemia; Immunology; Cancer research; Molecular biology; Biology; Virology; Medicine; Toxin; Cytokine; Microbiology; Gene; Biochemistry","score_opus":0.033625179882540567,"score_gpt":0.3283182852802339,"score_spread":0.29469310539769333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092925479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971361,0.00035822645,0.0006878237,0.00007696031,0.000050276183,0.0011378387,0.00033979092,0.000021797994,0.0001911531],"genre_scores_gemma":[0.9983109,0.00035904357,0.00017200061,0.00001317327,0.0000081318185,0.00009208048,0.00016670879,0.000036004447,0.00084195664],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99729365,0.00040101763,0.00091355405,0.00043999794,0.00031682494,0.0006349436],"domain_scores_gemma":[0.9982845,0.00017084592,0.00028514062,0.00082717976,0.00039493034,0.000037372298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096301717,0.0002497459,0.0004972649,0.00025032792,0.00036626842,0.000026131249,0.00081329944,0.00040562436,0.00008275687],"category_scores_gemma":[0.00013226573,0.00019230478,0.00013332984,0.00038480316,0.00073614507,0.00017062071,0.00018411949,0.00079709647,0.000017828701],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017948814,0.0005256756,0.00003105323,0.00005472992,0.00007336542,8.716389e-7,0.002538322,0.00022888502,0.9920741,0.0019741144,0.000045287965,0.0006587168],"study_design_scores_gemma":[0.0039724945,0.0022321618,0.0010506669,0.00010607432,0.000012650153,0.0000021985477,0.00051145616,0.00009912296,0.9912435,0.0005715361,0.000027135915,0.0001710146],"about_ca_topic_score_codex":0.001529481,"about_ca_topic_score_gemma":0.0001547072,"teacher_disagreement_score":0.0021776133,"about_ca_system_score_codex":0.0008349484,"about_ca_system_score_gemma":0.0011843235,"threshold_uncertainty_score":0.78419614},"labels":[],"label_agreement":null},{"id":"W2093592416","doi":"10.1016/j.leukres.2005.06.011","title":"Progression of myelodysplasia to acute lymphoblastic leukaemia: Implications for disease biology","year":2005,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University Health Network; University of Toronto; Princess Margaret Cancer Centre","funders":"Canadian Institutes of Health Research; World Health Organization","keywords":"Myelodysplastic syndromes; Haematopoiesis; Leukemia; Bone marrow; Stem cell; Preleukemia; Disease; Immunology; Hematology; Pathogenesis; Cancer research; Acute leukemia; Medicine; Biology; Pathology; Genetics","score_opus":0.14402969213854586,"score_gpt":0.5130137743359242,"score_spread":0.3689840821973783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093592416","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014773649,0.97965485,0.001240875,0.0023760535,0.00015020675,0.013255836,0.0016981583,0.00015244984,0.001323819],"genre_scores_gemma":[0.00021816223,0.97543657,0.0072600627,0.00011933107,0.0012539182,0.00912183,0.0020268436,0.00032118082,0.0042421073],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99244654,0.00072214764,0.0016360891,0.0017898072,0.0011883847,0.0022170027],"domain_scores_gemma":[0.98995924,0.0032827042,0.0003839506,0.0025606223,0.001862705,0.0019507861],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00251843,0.0008299164,0.003177748,0.0026564552,0.00042215837,0.00007350096,0.0016738684,0.001208802,0.00014491743],"category_scores_gemma":[0.0029506246,0.0006375325,0.0010970801,0.0031746486,0.0008163146,0.00011274658,0.001208144,0.0022432744,0.00066241785],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0007601683,0.00020932862,0.000046604426,0.019737098,0.0005889239,0.000053003772,0.000040224233,0.0000021371836,0.00022954009,0.0024349939,0.026516292,0.9493817],"study_design_scores_gemma":[0.0018224475,0.0012491983,0.0001348734,0.012678287,0.001367427,0.00017700222,0.000013509177,0.0001390257,0.00004641433,0.00038770417,0.98148584,0.0004982399],"about_ca_topic_score_codex":0.000045728862,"about_ca_topic_score_gemma":0.000009565991,"teacher_disagreement_score":0.9549696,"about_ca_system_score_codex":0.010666325,"about_ca_system_score_gemma":0.0255802,"threshold_uncertainty_score":0.9996076},"labels":[],"label_agreement":null},{"id":"W2094949617","doi":"10.1016/j.leukres.2013.07.020","title":"Pregnancies in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitor","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Medicine; Myeloid leukemia; Abortion; Tyrosine-kinase inhibitor; Tyrosine kinase; Pregnancy; Leukemia; Myeloid; Obstetrics; Internal medicine; Cancer","score_opus":0.02018674346074954,"score_gpt":0.2786858571405371,"score_spread":0.25849911367978756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094949617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906537,0.0007278764,0.000005918721,0.00034645485,0.000040509254,0.004010222,0.000019558676,0.00017411787,0.0040216562],"genre_scores_gemma":[0.9891498,0.00011716719,0.0005964893,0.00009124843,0.0002295617,0.0011071337,0.00029522204,0.000163533,0.008249809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941769,0.00024360229,0.00057153596,0.001105571,0.0020796596,0.0018227027],"domain_scores_gemma":[0.9967153,0.0002577323,0.00012713298,0.001320175,0.0009770342,0.0006026002],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00042686405,0.0005894083,0.0007819001,0.0008149325,0.00025018022,0.00014157851,0.00037772744,0.0003330254,0.00085524446],"category_scores_gemma":[0.00018124383,0.00039577147,0.00008602538,0.0020679638,0.0006905717,0.0005372079,0.00022363337,0.001498059,0.0009677429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0035213116,0.00086464453,0.9621237,0.00068217196,0.00028880354,0.0006725784,0.0004565271,0.00020768907,0.0048531094,0.00009087411,0.0068723843,0.019366222],"study_design_scores_gemma":[0.038858823,0.0066216392,0.93059826,0.0025723767,0.0000781036,0.00004752195,0.00014587671,0.00082457607,0.01746648,0.000028577855,0.002184274,0.0005734856],"about_ca_topic_score_codex":0.00814112,"about_ca_topic_score_gemma":0.0011575739,"teacher_disagreement_score":0.03533751,"about_ca_system_score_codex":0.033597402,"about_ca_system_score_gemma":0.0070321443,"threshold_uncertainty_score":0.99984944},"labels":[],"label_agreement":null},{"id":"W2095086994","doi":"10.1016/s0145-2126(02)00002-4","title":"Engineered fusion hybrid vaccine of IL-4 gene-modified myeloma and relative mature dendritic cells enhances antitumor immunity","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; Saskatchewan Cancer Agency","funders":"","keywords":"CTL*; Dendritic cell; CD86; Immune system; Priming (agriculture); CD40; Biology; Cell fusion; Immunology; CD80; Immunotherapy; Immunity; Cytotoxic T cell; T cell; In vitro; Cell culture; CD8","score_opus":0.02628098346899559,"score_gpt":0.2836075055417486,"score_spread":0.257326522072753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095086994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9609913,0.037044793,0.00009786881,0.00019946552,0.00027906615,0.00038287576,0.00006280041,0.000047858095,0.00089392933],"genre_scores_gemma":[0.98141176,0.007254533,0.00014637904,0.000034498906,0.000026803387,0.000027785798,0.000045110348,0.000029598767,0.011023523],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973524,0.0010617606,0.00042743358,0.0003582281,0.00014505241,0.0006550816],"domain_scores_gemma":[0.9980382,0.0009994517,0.000104210965,0.0005586793,0.00026363676,0.000035862187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009418784,0.00023828901,0.00045163007,0.00040355147,0.00047104238,0.000030003192,0.00042728122,0.0002952363,0.0008652161],"category_scores_gemma":[0.00028747894,0.00020622436,0.000099788296,0.00040789277,0.00044011447,0.00023991503,0.00022305788,0.001260677,0.00030286773],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097400235,0.000112346745,0.00003686066,0.0000780274,0.00016738992,0.000028513034,0.0009801739,0.0000073552733,0.9915829,0.0004063006,0.0019080257,0.0037181368],"study_design_scores_gemma":[0.0022486441,0.0005263955,0.004754837,0.00012990818,0.000019030376,0.00015845861,0.0003028009,0.00011752782,0.98492455,0.00017266259,0.0064339666,0.00021121383],"about_ca_topic_score_codex":0.00022814501,"about_ca_topic_score_gemma":0.00000858358,"teacher_disagreement_score":0.029790262,"about_ca_system_score_codex":0.0001554131,"about_ca_system_score_gemma":0.00011153413,"threshold_uncertainty_score":0.9473509},"labels":[],"label_agreement":null},{"id":"W2096848137","doi":"10.1016/j.leukres.2014.04.008","title":"Telomerase, hTERT and splice variants in patients with myelodysplastic syndromes","year":2014,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Science and Technology Facilities Council; Natural Sciences and Engineering Research Council of Canada; Science and Technology Development Fund","keywords":"Telomerase; Telomerase reverse transcriptase; Telomere; Telomerase RNA component; Biology; Cancer research; Reverse transcriptase; Molecular biology; Genetics; DNA; RNA; Gene","score_opus":0.023649398371706636,"score_gpt":0.2954190187352776,"score_spread":0.27176962036357094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096848137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958255,0.00011993659,0.000043811157,0.00033904327,0.00006267246,0.0005709753,0.0000067013734,0.000049187947,0.002982157],"genre_scores_gemma":[0.9977151,0.00009833933,0.000597589,0.00022484097,0.000090730566,0.000040813604,0.000028680997,0.000044699333,0.0011592079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697673,0.00022755805,0.00030122572,0.0006108977,0.0010612375,0.0008223241],"domain_scores_gemma":[0.9981746,0.00058024,0.000044197357,0.0005373537,0.00027674367,0.00038686188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000885395,0.00022406137,0.0004316583,0.0005976855,0.00016097503,0.000048971386,0.00019897851,0.00014996727,0.000114018265],"category_scores_gemma":[0.0006145625,0.00017113943,0.0000273782,0.0009183213,0.0003266623,0.00017345494,0.0001348452,0.0007804643,0.00014523618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013832392,0.0002941667,0.9683736,0.00040982215,0.000049302394,0.00021344042,0.00054366817,0.000008242515,0.0008998397,0.00035714952,0.0010631437,0.026404383],"study_design_scores_gemma":[0.005178829,0.0010321938,0.9896456,0.00041926882,0.000017173064,0.000054645312,0.00010645814,0.0008002842,0.00027879712,0.00009758582,0.002154514,0.00021465399],"about_ca_topic_score_codex":0.00057427236,"about_ca_topic_score_gemma":0.00012988913,"teacher_disagreement_score":0.02618973,"about_ca_system_score_codex":0.0004024405,"about_ca_system_score_gemma":0.00037612268,"threshold_uncertainty_score":0.69788635},"labels":[],"label_agreement":null},{"id":"W2099334882","doi":"10.1016/j.leukres.2006.08.002","title":"Bortezomib therapy response is independent of cytogenetic abnormalities in relapsed/refractory multiple myeloma","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Cancer Research Society","keywords":"Bortezomib; Multiple myeloma; Internal medicine; Fluorescence in situ hybridization; Refractory (planetary science); Medicine; Gastroenterology; Salvage therapy; Oncology; Cytogenetics; Chemotherapy; Biology; Chromosome","score_opus":0.06428577554715627,"score_gpt":0.36019112052934144,"score_spread":0.2959053449821852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099334882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99178934,0.0022817717,0.0000057561065,0.00048423198,0.000042000815,0.0012295416,0.000060523238,0.000040428713,0.0040664086],"genre_scores_gemma":[0.990617,0.0006061671,0.00037700348,0.00007348635,0.00012478308,0.00021591606,0.00005311101,0.000059745646,0.007872807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945251,0.0009883229,0.0006654078,0.0005739541,0.0021028644,0.0011443802],"domain_scores_gemma":[0.99681735,0.0013968475,0.00009207986,0.0008988556,0.0004936719,0.0003011829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026663635,0.00026697776,0.0005220728,0.0011852003,0.00015060727,0.000040770836,0.00034385905,0.0002878496,0.0005232289],"category_scores_gemma":[0.000661671,0.00022402698,0.00017164218,0.00092126685,0.00044976463,0.00010416753,0.00017685935,0.0010127582,0.00017408765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035828017,0.0013688544,0.78715104,0.00019905159,0.00016425058,0.0017622577,0.0012883116,0.00006219505,0.15331197,0.00014345495,0.0030587842,0.015661791],"study_design_scores_gemma":[0.014813233,0.0014852013,0.84627765,0.00016002305,0.0000069097764,0.000052299347,0.00052882114,0.0007380101,0.13097072,0.00031878735,0.0044756737,0.00017265082],"about_ca_topic_score_codex":0.010889919,"about_ca_topic_score_gemma":0.00080788817,"teacher_disagreement_score":0.05912662,"about_ca_system_score_codex":0.0017471809,"about_ca_system_score_gemma":0.0019161128,"threshold_uncertainty_score":0.99569666},"labels":[],"label_agreement":null},{"id":"W2102107035","doi":"10.1016/j.leukres.2006.10.001","title":"Inhibition of HuR and MMP-9 expression in macrophage-differentiated HL-60 myeloid leukemia cells by green tea polyphenol EGCg","year":2006,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Tea Polyphenols and Effects","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université du Québec à Montréal","funders":"","keywords":"Myeloid leukemia; Cancer research; Matrix metalloproteinase; Angiogenesis; Leukemia; Catechin; Secretion; Myeloid; Epicatechin gallate; Epigallocatechin gallate; Chemistry; Biology; Molecular biology; Immunology; Biochemistry; Polyphenol","score_opus":0.01868978015668817,"score_gpt":0.29305602553917054,"score_spread":0.2743662453824824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102107035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943662,0.0015959627,0.000052216503,0.00022670951,0.000065585446,0.00086906884,0.000047998183,0.00007006467,0.0027061366],"genre_scores_gemma":[0.9950532,0.00014913385,0.0003128822,0.000068821726,0.00018882079,0.000065496875,0.0001558786,0.00006575905,0.003940053],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99654055,0.0003886121,0.00056171656,0.0006030194,0.0010209808,0.00088511634],"domain_scores_gemma":[0.99868065,0.00026215578,0.00011475177,0.00050349423,0.00017560464,0.000263338],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00083715166,0.00028564097,0.00053820846,0.00053921534,0.00014985619,0.000048104223,0.0001662315,0.00039074567,0.00019985392],"category_scores_gemma":[0.00009144742,0.00024576922,0.00008356934,0.0007458369,0.00032265738,0.0001562814,0.00024898365,0.0010609287,0.000065434324],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053865154,0.00017263158,0.00742137,0.0005316735,0.000014642686,0.00018983819,0.0003405297,0.000015766895,0.97307605,0.000046083147,0.013880076,0.0037726886],"study_design_scores_gemma":[0.005665748,0.00051571,0.08302626,0.0007331618,0.000022131964,0.00002394076,0.00022673262,0.0013385147,0.90705025,0.0005158035,0.00063677883,0.00024498804],"about_ca_topic_score_codex":0.016140461,"about_ca_topic_score_gemma":0.0002928429,"teacher_disagreement_score":0.07560489,"about_ca_system_score_codex":0.0011512229,"about_ca_system_score_gemma":0.00043190742,"threshold_uncertainty_score":0.99999946},"labels":[],"label_agreement":null},{"id":"W2102640163","doi":"10.1016/s0145-2126(01)00010-8","title":"CD8+ T cells in large granular lymphocyte leukemia are not defective in activation- and replication-related apoptosis","year":2001,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Terry Fox Research Institute","funders":"National Institute of Allergy and Infectious Diseases; National Institute of General Medical Sciences; National Institutes of Health","keywords":"Apoptosis; Programmed cell death; CD28; CD8; Cell biology; Fas ligand; Biology; CD3; Lymphocyte; Cytotoxic T cell; Chemistry; Molecular biology; Immunology; In vitro; Antigen; Biochemistry","score_opus":0.043982405355010995,"score_gpt":0.3521894276525018,"score_spread":0.30820702229749075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102640163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895131,0.00046550375,0.000071573566,0.0010030315,0.000064693566,0.0021455365,0.000018653831,0.00010362562,0.006614275],"genre_scores_gemma":[0.99338704,0.0023345293,0.00017388069,0.0002922612,0.0001230709,0.0005257341,0.00007951465,0.00010740378,0.002976576],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9929173,0.0007367147,0.00092612475,0.0016194028,0.0019295223,0.0018709503],"domain_scores_gemma":[0.9950399,0.0019282761,0.00015941783,0.0017473688,0.00060052477,0.00052454],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004608166,0.00041051363,0.00079306733,0.0019130993,0.00033762347,0.00011482842,0.00050169276,0.0006583735,0.0002615159],"category_scores_gemma":[0.0029150832,0.00040409004,0.00013809217,0.0042147906,0.00048067298,0.00039534725,0.00049911335,0.0020155732,0.000336032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.019787198,0.0031272622,0.3946479,0.0037591963,0.00066806894,0.0059460048,0.016940778,0.0036382254,0.49139425,0.009549476,0.0098092975,0.040732328],"study_design_scores_gemma":[0.120734155,0.00082703034,0.30606788,0.0030462316,0.00007091506,0.00066886126,0.0048943474,0.14917655,0.39725858,0.002154424,0.013665054,0.0014359469],"about_ca_topic_score_codex":0.011437198,"about_ca_topic_score_gemma":0.0015261677,"teacher_disagreement_score":0.14553833,"about_ca_system_score_codex":0.10262516,"about_ca_system_score_gemma":0.0147420745,"threshold_uncertainty_score":0.9998411},"labels":[],"label_agreement":null},{"id":"W2103243005","doi":"10.1016/j.leukres.2007.10.003","title":"The GNAS1 T393C polymorphism and lack of clinical prognostic value in chronic lymphocytic leukemia","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cancerfonden; Swedish Cancer Foundation; Cancer Research Society","keywords":"IGHV@; Chronic lymphocytic leukemia; GNAS complex locus; Single-nucleotide polymorphism; SNP; Oncology; Internal medicine; Genotype; CD38; Cohort; Medicine; Leukemia; Immunology; Biology; Genetics; Gene","score_opus":0.16642233714392834,"score_gpt":0.4781560145288114,"score_spread":0.31173367738488306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103243005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792177,0.0072772657,0.000052656225,0.00058825134,0.00022956163,0.0020255444,0.000005877039,0.00007314084,0.010529998],"genre_scores_gemma":[0.9910445,0.0032685655,0.00029758437,0.00014442738,0.0008192913,0.00009446069,0.000013904228,0.000102520615,0.004214728],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9901699,0.0009999009,0.0021105304,0.0011044344,0.0030619833,0.0025532695],"domain_scores_gemma":[0.9851757,0.011496354,0.00017858436,0.0016114345,0.00067036704,0.0008675028],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.021523882,0.00039383364,0.0010494253,0.00080476253,0.00039535662,0.000101819765,0.00089632336,0.00065814133,0.000086050764],"category_scores_gemma":[0.008208905,0.0002846423,0.0002616217,0.0021608137,0.0032467674,0.00016337998,0.0008967599,0.002580501,0.00021994668],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.042652078,0.0011934825,0.17714751,0.011724218,0.0023991924,0.02266429,0.006482002,0.004302572,0.061142705,0.08314406,0.04568003,0.54146785],"study_design_scores_gemma":[0.13928333,0.0070407754,0.30161816,0.004143397,0.00025723534,0.0028820196,0.002445523,0.45326433,0.032978754,0.0053221937,0.049287062,0.0014772298],"about_ca_topic_score_codex":0.011586555,"about_ca_topic_score_gemma":0.0012812373,"teacher_disagreement_score":0.53999066,"about_ca_system_score_codex":0.17540267,"about_ca_system_score_gemma":0.14405733,"threshold_uncertainty_score":0.9999606},"labels":[],"label_agreement":null},{"id":"W2103291845","doi":"10.1016/s0145-2126(02)00040-1","title":"The novel helicase homologue DDX32 is down-regulated in acute lymphoblastic leukemia","year":2002,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Helicase; Gene; Biology; Genetics; RNA Helicase A; Exon; Homology (biology); Coding region; Conserved sequence; Peptide sequence","score_opus":0.05516609748878513,"score_gpt":0.3378502918039867,"score_spread":0.28268419431520153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103291845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96700233,0.0018839176,0.0002935618,0.01244277,0.00031137592,0.0025626211,0.00011010682,0.00028507604,0.015108268],"genre_scores_gemma":[0.9552533,0.0016779006,0.0006310299,0.0012289914,0.00048481073,0.0005166662,0.000060028517,0.00019434417,0.03995291],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9894956,0.0005980328,0.0011944906,0.0015068445,0.0037366601,0.00346839],"domain_scores_gemma":[0.99162143,0.003615451,0.0001117911,0.0024979478,0.0010810846,0.0010722663],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0032814962,0.0006551033,0.0009135432,0.0012755,0.0010781339,0.0003413982,0.0016286961,0.0008101737,0.0013391847],"category_scores_gemma":[0.0025738874,0.000468435,0.0003249166,0.004433117,0.0020211749,0.00029571305,0.0010361515,0.003133718,0.004424664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067920415,0.0017461651,0.0039167674,0.00073791936,0.001781315,0.022677856,0.005400856,0.00062980526,0.19334674,0.004329908,0.69963986,0.05900076],"study_design_scores_gemma":[0.055545427,0.0035702332,0.032487817,0.0015059332,0.0003736026,0.010503495,0.0019111417,0.6561932,0.05001327,0.0015667595,0.18411472,0.002214401],"about_ca_topic_score_codex":0.002398182,"about_ca_topic_score_gemma":0.00027838687,"teacher_disagreement_score":0.6555634,"about_ca_system_score_codex":0.022502147,"about_ca_system_score_gemma":0.004847133,"threshold_uncertainty_score":0.9997767},"labels":[],"label_agreement":null},{"id":"W2106234158","doi":"10.1016/s0145-2126(03)00076-6","title":"Prognostic significance of trisomy 4 as the sole cytogenetic abnormality in acute myeloid leukemia","year":2003,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Abnormality; Trisomy; Cytogenetics; Chromosomal Abnormality; Clinical significance; Myeloid leukemia; Acute myeloblastic leukemia; Trisomy 8; Chromosome abnormality; Internal medicine; Medicine; Aneuploidy; Leukemia; Oncology; Karyotype; Pathology; Biology; Chromosome; Genetics","score_opus":0.10789559779961926,"score_gpt":0.42323121666036095,"score_spread":0.3153356188607417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106234158","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003701816,0.9665767,0.000023190241,0.00030652588,0.00018792415,0.012077601,0.00013960464,0.000086130545,0.016900485],"genre_scores_gemma":[0.0014402298,0.9786591,0.00047546253,0.0001495705,0.00039097437,0.0034012094,0.0002483739,0.00033726022,0.014897846],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98194695,0.00538715,0.0028594371,0.0020654798,0.004501011,0.003239985],"domain_scores_gemma":[0.988234,0.005384135,0.0005242619,0.0037432488,0.00127717,0.0008372085],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.010944568,0.0012344242,0.0045957738,0.0021229193,0.00043105468,0.00016731021,0.0029342552,0.0016712685,0.0005332954],"category_scores_gemma":[0.0034054886,0.00084230735,0.0012215088,0.0071823266,0.0022880994,0.00018703254,0.0011444592,0.00978998,0.0012910002],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0013109071,0.00068684155,0.0011517758,0.07871395,0.0024690963,0.0062209647,0.00091684796,0.000042673506,0.00040324224,0.0012806102,0.027839785,0.8789633],"study_design_scores_gemma":[0.0029889098,0.0010229162,0.000312868,0.012572924,0.0010925039,0.0015257209,0.00025118867,0.00013158271,0.00050829625,0.00032778375,0.9784392,0.0008261091],"about_ca_topic_score_codex":0.0023831474,"about_ca_topic_score_gemma":0.00012466912,"teacher_disagreement_score":0.95059943,"about_ca_system_score_codex":0.018489644,"about_ca_system_score_gemma":0.052900095,"threshold_uncertainty_score":0.9996248},"labels":[],"label_agreement":null},{"id":"W2108145697","doi":"10.1016/j.leukres.2010.05.029","title":"p53 and autophagy contribute to dasatinib resistance in primary CLL lymphocytes","year":2010,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":51,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; CancerCare Manitoba; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Dasatinib; Autophagy; Chronic lymphocytic leukemia; Cancer research; Endoplasmic reticulum; Medicine; Leukemia; Cytotoxic T cell; Immunology; In vitro; Apoptosis; Biology; Imatinib; Cell biology; Myeloid leukemia","score_opus":0.030326447120379046,"score_gpt":0.36152442372722693,"score_spread":0.3311979766068479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108145697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624088,0.0011424522,0.000023630519,0.002576883,0.00015970616,0.0016622867,0.000026214826,0.00010244507,0.031897597],"genre_scores_gemma":[0.97481555,0.0002921954,0.0049962862,0.000877124,0.00043860477,0.0003267925,0.000041985913,0.00008480513,0.018126644],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942998,0.00030963437,0.0006044115,0.0010211482,0.0020299652,0.0017350275],"domain_scores_gemma":[0.9953255,0.0017572155,0.000053937314,0.0012725162,0.0006182204,0.00097262324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004340548,0.000297641,0.0006628303,0.00090710114,0.0002413495,0.00015073878,0.0005542445,0.00041486754,0.00027056754],"category_scores_gemma":[0.0038758542,0.00027093824,0.00007996389,0.0016743534,0.0006958524,0.00018524831,0.0007347406,0.002079384,0.000456282],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.021502016,0.0011495703,0.029320013,0.005258465,0.00036704715,0.013905933,0.007943391,0.00005004029,0.67007893,0.039897807,0.12841444,0.08211233],"study_design_scores_gemma":[0.113014996,0.0014728919,0.3080873,0.0016571648,0.000054512453,0.0011898865,0.0006116852,0.0066421805,0.0926212,0.004427186,0.46876156,0.0014594564],"about_ca_topic_score_codex":0.002078445,"about_ca_topic_score_gemma":0.0027624425,"teacher_disagreement_score":0.5774577,"about_ca_system_score_codex":0.031385675,"about_ca_system_score_gemma":0.024580656,"threshold_uncertainty_score":0.9999743},"labels":[],"label_agreement":null},{"id":"W2116177153","doi":"10.1016/j.leukres.2009.05.020","title":"Susceptibility of mantle cell lymphomas to reovirus oncolysis","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Mantle cell lymphoma; Cytopathic effect; Lymphoma; Cancer research; Cell culture; In vivo; Virology; In vitro; Oncolytic virus; Cell; Biology; Medicine; Virus; Immunology; Tumor cells; Biochemistry; Genetics","score_opus":0.038046361106444916,"score_gpt":0.370724057029703,"score_spread":0.3326776959232581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116177153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98207706,0.00050566014,0.00006560574,0.0004401304,0.000031692063,0.0004988328,0.000023359187,0.000014580267,0.01634309],"genre_scores_gemma":[0.9933525,0.00021468208,0.0005214716,0.00026288966,0.00019915635,0.00003339735,0.000036161262,0.000028154089,0.0053515993],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9968369,0.00047840725,0.0003205169,0.0006563773,0.00092239515,0.0007853935],"domain_scores_gemma":[0.9977756,0.00006880608,0.000045516514,0.0012849023,0.00050974765,0.00031543826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022463086,0.00017032321,0.0002443345,0.00026785288,0.00015097043,0.00003535108,0.00079044694,0.00021995507,0.00023910838],"category_scores_gemma":[0.000289705,0.00016515722,0.00014616975,0.0007881481,0.00019041241,0.00000498592,0.00027524857,0.0003020419,0.000229638],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029071546,0.00018107939,0.00083437626,0.000027283431,0.000020416426,0.000011068407,0.000090312795,0.00015350585,0.96572566,0.000029137966,0.0075261467,0.022493886],"study_design_scores_gemma":[0.0009162145,0.006056083,0.0026193247,0.000011404302,0.0000041560747,0.0000027639105,0.000110061206,0.00006203188,0.976227,0.00026547624,0.013553589,0.00017193287],"about_ca_topic_score_codex":0.0002522531,"about_ca_topic_score_gemma":0.00077740406,"teacher_disagreement_score":0.022321953,"about_ca_system_score_codex":0.0004397527,"about_ca_system_score_gemma":0.0011094881,"threshold_uncertainty_score":0.67349166},"labels":[],"label_agreement":null},{"id":"W2116251489","doi":"10.1016/j.leukres.2007.03.011","title":"Therapeutic efficacy of NSC606985, a novel camptothecin analog, in a mouse model of acute promyelocytic leukemia","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Changjiang Scholar Program of Chinese Ministry of Education; Institute of Genetics; National Natural Science Foundation of China","keywords":"Camptothecin; Acute promyelocytic leukemia; Medicine; Apoptosis; Myeloid leukemia; Pharmacology; In vitro; Cytarabine; Cancer research; Leukemia; Myeloid; Immunology; Biology; Cell culture; Retinoic acid","score_opus":0.04523862598922479,"score_gpt":0.34851472211330575,"score_spread":0.30327609612408096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116251489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98632973,0.0006171466,0.010005224,0.000024006637,0.000029998437,0.0005297398,0.000036371803,0.000011997986,0.0024157867],"genre_scores_gemma":[0.99520695,0.0003876422,0.001860748,0.000043672408,0.000084669424,0.000037244223,0.000052652078,0.000057114106,0.0022693337],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969521,0.00013273314,0.0007204184,0.00061066187,0.0007564064,0.0008276634],"domain_scores_gemma":[0.99826384,0.00016152048,0.00013784716,0.0008408938,0.00044858115,0.0001473232],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023477275,0.00025910733,0.00041931434,0.0004207322,0.00007307171,0.000018541274,0.0008024871,0.00043376102,0.000015490363],"category_scores_gemma":[0.00028193372,0.00023638911,0.00016949234,0.00072764495,0.000558174,0.000011265957,0.00028806977,0.0006080461,0.0000060529555],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008993968,0.00017427574,0.001739088,0.00019702925,0.00013175541,0.000009496078,0.00035276043,0.003076862,0.99110985,0.00053813914,0.00007706719,0.0016943075],"study_design_scores_gemma":[0.0027259695,0.00044187246,0.0009105379,0.00007076642,0.00002590253,0.000013138018,0.00021672431,0.0071950178,0.98766726,0.0002856831,0.00020704289,0.0002400665],"about_ca_topic_score_codex":0.00029577137,"about_ca_topic_score_gemma":0.00010735295,"teacher_disagreement_score":0.008877195,"about_ca_system_score_codex":0.0006502424,"about_ca_system_score_gemma":0.0026061733,"threshold_uncertainty_score":0.9639668},"labels":[],"label_agreement":null},{"id":"W2117111164","doi":"10.1016/j.leukres.2014.01.003","title":"Standardizing dysgranulopoiesis in MDS and AML: Refining diagnostics and laying the foundation for novel morphological-genetic correlations","year":2014,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Medical Research Council; European Hematology Association","keywords":"Myeloid leukemia; Imatinib mesylate; Medicine; Mutation; Oncology; Internal medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Point mutation; Drug resistance; Imatinib; Protein kinase domain; Cancer research; Genetics; Biology; Cancer; Gene","score_opus":0.11842634867562067,"score_gpt":0.3782195400815864,"score_spread":0.25979319140596574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117111164","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46485943,0.005323936,0.008979703,0.5102309,0.00045919837,0.0059445235,0.0002867226,0.00018168219,0.003733891],"genre_scores_gemma":[0.7197979,0.011840756,0.041637246,0.19661377,0.008001773,0.005184528,0.0040116766,0.00073470554,0.012177641],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99664354,0.00030025793,0.0005281401,0.0007734327,0.00090842356,0.0008461748],"domain_scores_gemma":[0.9907203,0.008076111,0.00014800618,0.0006186747,0.00032060812,0.00011632264],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0018460194,0.00034096232,0.00060441054,0.0004700062,0.00059894414,0.00019459253,0.00020906617,0.0007905968,0.000039764145],"category_scores_gemma":[0.0037986885,0.00025172447,0.00008289144,0.000445278,0.0005726286,0.00006926472,0.0002494418,0.0028821854,0.000016052642],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007905099,0.00014634029,0.10802877,0.0035296439,0.00065286097,0.0018098742,0.0024778824,0.00039781176,0.0013478628,0.0006036593,0.81260896,0.06760581],"study_design_scores_gemma":[0.012689275,0.0010476087,0.059141,0.0022100878,0.0004893939,0.00084581703,0.0005249801,0.011467508,0.00006252232,0.0011341204,0.90971154,0.0006761386],"about_ca_topic_score_codex":0.0008397266,"about_ca_topic_score_gemma":0.00010817325,"teacher_disagreement_score":0.31361714,"about_ca_system_score_codex":0.0036816904,"about_ca_system_score_gemma":0.0011565646,"threshold_uncertainty_score":0.9999935},"labels":[],"label_agreement":null},{"id":"W2119733997","doi":"10.1016/j.leukres.2013.03.001","title":"All-trans retinoic acid and late relapses in acute promyelocytic leukemia: Very long-term follow-up of the North American Intergroup Study I0129","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Acute promyelocytic leukemia; Medicine; Chemotherapy; Retinoic acid; Randomized controlled trial; Induction chemotherapy; Internal medicine; Surgery; Pediatrics; Gastroenterology","score_opus":0.019261250513052133,"score_gpt":0.299783781594682,"score_spread":0.2805225310816299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119733997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974359,0.00057708577,0.000028385497,0.00016621899,0.0001271954,0.0012325638,0.000009038805,0.000016441341,0.00040714387],"genre_scores_gemma":[0.99643606,0.0010804626,0.00006381685,0.00009208522,0.00009453819,0.00029125693,0.00004176296,0.00005571172,0.0018442909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99667346,0.000571756,0.0005389692,0.0007676031,0.00065995386,0.0007882593],"domain_scores_gemma":[0.9983273,0.00008651211,0.00016326504,0.0009592132,0.00029927673,0.00016439904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074171013,0.00031834602,0.00041329383,0.00017633516,0.00017118889,0.000095150426,0.0009962098,0.00019530402,0.000023541344],"category_scores_gemma":[0.00025799067,0.00023854504,0.0001319165,0.00077666907,0.0009311165,0.00002876079,0.00076310337,0.00092611666,0.000015873717],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038341124,0.00013034057,0.6537257,0.00021493513,0.00024454488,0.000053278116,0.0011169726,0.00002991935,0.33877045,0.0000055046708,0.0005584887,0.0047664405],"study_design_scores_gemma":[0.003127564,0.0014811028,0.7459474,0.00012704138,0.00007903205,0.000042836633,0.00087440753,0.00012769274,0.24744374,0.000060156694,0.0002680397,0.0004209912],"about_ca_topic_score_codex":0.0010809058,"about_ca_topic_score_gemma":0.0017524752,"teacher_disagreement_score":0.09222168,"about_ca_system_score_codex":0.00045367988,"about_ca_system_score_gemma":0.00088283746,"threshold_uncertainty_score":0.9727584},"labels":[],"label_agreement":null},{"id":"W2121112512","doi":"10.1016/j.leukres.2007.06.013","title":"Bone marrow mononuclear cells of MDS patients are characterized by in vitro proliferation and increased apoptosis independently of stromal interactions","year":2007,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Sciences Centre Foundation; Amgen","keywords":"Apoptosis; Bone marrow; Stromal cell; Progenitor cell; Biology; In vitro; Myeloid leukemia; In vivo; Myeloid; Cell growth; Cancer research; Peripheral blood mononuclear cell; Immunology; Leukemia; Cell biology; Stem cell; Genetics","score_opus":0.022879054072160572,"score_gpt":0.3158942908060971,"score_spread":0.29301523673393653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121112512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733263,0.0000600289,0.000052900832,0.00018593237,0.000046873658,0.001581807,0.00010957448,0.000020625539,0.0006096141],"genre_scores_gemma":[0.99808645,0.000101456615,0.0007397274,0.00005039947,0.00007946066,0.000083349114,0.00020437589,0.000051131166,0.000603654],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99613875,0.00038010173,0.00081298477,0.0004681536,0.0014677542,0.0007322541],"domain_scores_gemma":[0.9976039,0.00051188434,0.00024316463,0.00044940927,0.0008452571,0.00034641757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024560995,0.00020588803,0.0006102769,0.0011961255,0.000097084674,0.00003374991,0.0002173796,0.00025311715,0.00011208848],"category_scores_gemma":[0.0005118562,0.00019887045,0.00008504224,0.0009479164,0.0003221361,0.00028629322,0.00026676783,0.0013599396,0.000018419074],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007888838,0.0005433136,0.05305865,0.00041546268,0.000057483692,0.000025523754,0.00033185506,7.269012e-7,0.93051994,0.000007649139,0.00086371537,0.0062868386],"study_design_scores_gemma":[0.007412644,0.00058527116,0.12139044,0.00020058501,0.000021043654,0.000009686303,0.0006497156,0.0005107502,0.8685725,0.000016516644,0.0004898326,0.00014103935],"about_ca_topic_score_codex":0.0015385587,"about_ca_topic_score_gemma":0.00006701494,"teacher_disagreement_score":0.06833179,"about_ca_system_score_codex":0.0017847804,"about_ca_system_score_gemma":0.0006425406,"threshold_uncertainty_score":0.8109701},"labels":[],"label_agreement":null},{"id":"W2125735390","doi":"10.1016/j.leukres.2009.07.043","title":"Synergistic effect of inhibiting translation initiation in combination with cytotoxic agents in acute myelogenous leukemia cells","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; McGill University","funders":"National Institute of General Medical Sciences; Canadian Institutes of Health Research","keywords":"Daunorubicin; Etoposide; Leukemia; Cytotoxic T cell; Cytarabine; Cancer research; Chemistry; Pharmacology; Biology; In vitro; Biochemistry; Immunology; Chemotherapy","score_opus":0.03392273483800691,"score_gpt":0.34130229196626527,"score_spread":0.3073795571282584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125735390","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977355,0.0001784846,0.00056708924,0.000040919116,0.00003550505,0.0005984051,0.0000093760855,0.000009548028,0.0008251603],"genre_scores_gemma":[0.9993116,0.00009053858,0.00023014245,0.000034721394,0.00005670884,0.000059015594,0.00014817128,0.000023086242,0.00004597601],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978617,0.00048443707,0.00035012592,0.000387714,0.00049323984,0.00042278843],"domain_scores_gemma":[0.99930775,0.0001496128,0.000100167286,0.00024591543,0.0001407383,0.00005583856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001436749,0.0001589147,0.00022255076,0.0003498397,0.000060465256,0.000024150248,0.00020282486,0.00023670032,0.0000081062035],"category_scores_gemma":[0.00012961631,0.000152497,0.000042350548,0.0006296251,0.00009272336,0.000015541353,0.00003147624,0.00037872142,0.0000050921803],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068902,0.000045238354,0.0027900473,0.00007619149,0.000016266244,0.00004081906,0.00020541807,0.006015356,0.98336834,0.00002358485,0.00004509843,0.006684642],"study_design_scores_gemma":[0.0031456333,0.0020786696,0.009269828,0.00019505486,0.000011029214,0.000004826902,0.000024472052,0.0039006048,0.98105925,0.00011664003,0.000035041623,0.00015895319],"about_ca_topic_score_codex":0.00019635345,"about_ca_topic_score_gemma":0.00017421073,"teacher_disagreement_score":0.006525689,"about_ca_system_score_codex":0.000937901,"about_ca_system_score_gemma":0.00051997707,"threshold_uncertainty_score":0.62186474},"labels":[],"label_agreement":null},{"id":"W2127147516","doi":"10.1016/j.leukres.2008.02.021","title":"Iron overload in myelodysplastic syndromes: A Canadian consensus guideline","year":2008,"lang":"en","type":"editorial","venue":"Leukemia Research","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; BC Cancer Agency; University of Alberta; Université de Montréal; Queen Elizabeth II Health Sciences Centre; McMaster University; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Diamond Blackfan Anemia Foundation","keywords":"Guideline; Medicine; Myelodysplastic syndromes; Clinical Practice; Intensive care medicine; Expert opinion; Mandate; Family medicine; Internal medicine; Pathology","score_opus":0.039923936664683496,"score_gpt":0.36495552449591284,"score_spread":0.3250315878312293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127147516","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044064157,0.012144867,0.000004292195,0.0027838766,0.86170304,0.0030006496,0.0010576486,0.00015703934,0.07508445],"genre_scores_gemma":[0.014628196,0.009616118,0.00079844345,0.000481446,0.9084174,0.00027069898,0.0042052446,0.00038615198,0.061196323],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924401,0.0004255146,0.00094947807,0.0010147374,0.0031606646,0.002009478],"domain_scores_gemma":[0.9949163,0.0017089283,0.00010374246,0.0010802852,0.0010319328,0.0011588109],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0019804123,0.0005131118,0.001099539,0.002585054,0.0002605813,0.000061874765,0.0005274631,0.001961198,0.00071593357],"category_scores_gemma":[0.01074496,0.0004899003,0.00017278834,0.0012818536,0.00059753243,0.00004637343,0.00016128545,0.0051386473,0.0012112787],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00041783732,0.00005561968,0.00018006016,0.00059523806,0.000020370377,0.0058626854,0.00020723233,0.000037125395,0.000037043745,0.00003310696,0.9916157,0.0009379493],"study_design_scores_gemma":[0.005033422,0.00027996267,0.00063195004,0.00048749582,0.0000529474,0.00013303879,0.00033162214,0.00015017933,0.00000622017,0.000063801774,0.99241096,0.00041841876],"about_ca_topic_score_codex":0.5492942,"about_ca_topic_score_gemma":0.24920824,"teacher_disagreement_score":0.3000859,"about_ca_system_score_codex":0.005670062,"about_ca_system_score_gemma":0.042684317,"threshold_uncertainty_score":0.99975526},"labels":[],"label_agreement":null},{"id":"W2131671733","doi":"10.1016/j.leukres.2008.01.008","title":"Prognostic significance of EBV-LMP1 and VEGF-A expressions in non-Hodgkin's lymphomas","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Terry Fox Foundation","keywords":"Lymphoma; Angiogenesis; Medicine; Immunohistochemistry; Carcinogenesis; Epstein–Barr virus; Pathology; Immunology; Virus; Cancer research; Internal medicine; Cancer","score_opus":0.05021236526045336,"score_gpt":0.3500590489006126,"score_spread":0.29984668364015926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131671733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837724,0.0012138302,0.000015521164,0.00048790008,0.000034213976,0.0006427883,0.000007336998,0.00002107266,0.0138049275],"genre_scores_gemma":[0.99668473,0.0011759335,0.00024023822,0.00007936938,0.00005099556,0.00013916852,0.000008463063,0.000023856195,0.0015972262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808407,0.00012672972,0.0002652195,0.00032703733,0.00067179464,0.0005251363],"domain_scores_gemma":[0.9989713,0.00031308585,0.000052767806,0.000289859,0.00018509217,0.00018791574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051404955,0.00011829034,0.0003177802,0.0002876816,0.00014209171,0.000009516008,0.000132921,0.00015728755,0.00007988633],"category_scores_gemma":[0.0006120477,0.00010313511,0.000049378086,0.00074484496,0.00045317906,0.000074750766,0.00009356412,0.00046723048,0.000018258632],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015227429,0.00063719414,0.80340147,0.0007432276,0.00008632416,0.0009290005,0.0063255355,0.00010739476,0.14836507,0.00035297673,0.024700565,0.012828484],"study_design_scores_gemma":[0.013470795,0.0013272614,0.9540514,0.0011395193,0.000031181517,0.00006708129,0.0031277875,0.0018489375,0.019849265,0.0011334677,0.0036109914,0.00034234257],"about_ca_topic_score_codex":0.0017871377,"about_ca_topic_score_gemma":0.000098319644,"teacher_disagreement_score":0.15064988,"about_ca_system_score_codex":0.0006339365,"about_ca_system_score_gemma":0.0014069589,"threshold_uncertainty_score":0.42057276},"labels":[],"label_agreement":null},{"id":"W2134390751","doi":"10.1016/j.leukres.2014.07.008","title":"CLL—Clear sailing ahead for many, while rough waters remain for some","year":2014,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Leukemia & Lymphoma Society of Canada; University of British Columbia","funders":"","keywords":"Environmental science","score_opus":0.1405077939171797,"score_gpt":0.4000109766601689,"score_spread":0.25950318274298917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134390751","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.014637855,0.0019211575,0.002980692,0.9428279,0.0018600062,0.0238497,0.00066524924,0.00074930204,0.010508166],"genre_scores_gemma":[0.014562856,0.0010881462,0.013634627,0.51975924,0.07332631,0.011354332,0.009364318,0.0025162057,0.354394],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98581034,0.00078564446,0.0014003599,0.0025811933,0.004264443,0.005158009],"domain_scores_gemma":[0.9872551,0.0068156985,0.0002630052,0.0031712092,0.0017753829,0.0007196179],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.008195929,0.0010133651,0.0020600192,0.0015787627,0.0008968329,0.00042514765,0.0019002482,0.0028241547,0.00029052963],"category_scores_gemma":[0.00341542,0.0008953518,0.0011141995,0.00080152135,0.001022757,0.000287804,0.0007898997,0.0075299866,0.0012538236],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0025447274,0.000060860395,0.000005686923,0.0095712,0.00041524947,0.0010352896,0.00023474557,0.000054887016,0.0007069139,0.0006834888,0.98109967,0.00358729],"study_design_scores_gemma":[0.023756161,0.002045016,0.0000040089494,0.001489274,0.00018808196,0.0004477844,0.00011126883,0.033720136,0.003494435,0.0032510725,0.93065625,0.0008365348],"about_ca_topic_score_codex":0.0013384299,"about_ca_topic_score_gemma":0.00002388899,"teacher_disagreement_score":0.42306864,"about_ca_system_score_codex":0.0849542,"about_ca_system_score_gemma":0.02944412,"threshold_uncertainty_score":0.9995238},"labels":[],"label_agreement":null},{"id":"W2135893584","doi":"10.1016/j.leukres.2011.07.016","title":"Expression, adverse prognostic significance and therapeutic small molecule inhibition of Polo-like kinase 1 in multiple myeloma","year":2011,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saint John Regional Hospital","funders":"Alberta Heritage Foundation for Medical Research; Alberta Cancer Foundation","keywords":"Multiple myeloma; PLK1; Cancer research; Bone marrow; Centrosome; Medicine; Plasma Cell Myeloma; Internal medicine; Cell cycle; Cancer","score_opus":0.10407348632317467,"score_gpt":0.3334838629593509,"score_spread":0.22941037663617622,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135893584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960263,0.00060313503,0.000051827265,0.000079519436,0.00001962207,0.0015162589,0.000015612324,0.000030395213,0.0016573594],"genre_scores_gemma":[0.99746656,0.00013824634,0.0015300765,0.000040636834,0.00002673858,0.00032727153,0.000030198842,0.00003294453,0.00040735086],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9974567,0.00037711725,0.00033381145,0.0004707433,0.00067250273,0.00068911695],"domain_scores_gemma":[0.9984234,0.00043566455,0.00005954449,0.00043467927,0.00031001563,0.000336721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007188212,0.00017598047,0.00030202552,0.000509268,0.00010828634,0.000010460588,0.00012691076,0.00014821933,0.00014365549],"category_scores_gemma":[0.0006540067,0.00014285836,0.000058564045,0.0005818365,0.0004517014,0.0000753686,0.00015883779,0.00055161177,0.000045177338],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003174597,0.00081898004,0.45715916,0.00046243702,0.000058706453,0.0012833001,0.0016633434,0.0000026050375,0.5249281,0.00011565171,0.00009363003,0.010239517],"study_design_scores_gemma":[0.006014746,0.00093716395,0.5621909,0.00046139956,0.000015114027,0.000023823084,0.0006787368,0.001128879,0.4280486,0.0003014454,0.00006833154,0.00013085859],"about_ca_topic_score_codex":0.0020267658,"about_ca_topic_score_gemma":0.00031421386,"teacher_disagreement_score":0.10503175,"about_ca_system_score_codex":0.00038811442,"about_ca_system_score_gemma":0.00055672217,"threshold_uncertainty_score":0.5825595},"labels":[],"label_agreement":null},{"id":"W2136112505","doi":"10.1016/j.leukres.2008.06.028","title":"In vivo maintenance of synergistic cytarabine:daunorubicin ratios greatly enhances therapeutic efficacy","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Nanoparticle-Based Drug Delivery","field":"Materials Science","cited_by":354,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Celator Pharmaceuticals (Canada)","funders":"Celator Pharmaceuticals","keywords":"Daunorubicin; Cytarabine; In vivo; Pharmacology; Drug; Therapeutic index; Medicine; Chemistry; Leukemia; Immunology; Biology","score_opus":0.052816271630835215,"score_gpt":0.32778969499979,"score_spread":0.2749734233689548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136112505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99674845,0.00034330858,0.00022217917,0.00037603022,0.00017902735,0.00048638156,0.000014669412,0.000048391343,0.0015815451],"genre_scores_gemma":[0.996109,0.00015472305,0.00035719,0.00012280505,0.000107510125,0.00008386537,0.0000016336197,0.000029280814,0.0030339789],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9961292,0.00065636716,0.0005851375,0.0005557728,0.0011348228,0.0009386781],"domain_scores_gemma":[0.9974779,0.0012301891,0.00010961147,0.00068646367,0.0003532883,0.00014253131],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019198788,0.00019595747,0.00039362482,0.00035941007,0.00020217134,0.000040070656,0.0007159449,0.00010781171,0.0011017311],"category_scores_gemma":[0.000641061,0.00016724953,0.0000704524,0.0011128405,0.00090534444,0.00032750805,0.00015554613,0.0004017654,0.0006256951],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036969403,0.00016443623,0.000718674,0.000055363034,0.0000062614786,0.00023920354,0.00064994214,0.0011875082,0.99261576,0.0011241226,0.002678027,0.00019101957],"study_design_scores_gemma":[0.0014329243,0.00024727924,0.0020025105,0.00010991015,0.0000049387327,0.000019761479,0.00012876661,0.0014488377,0.9932966,0.0005093275,0.00061959884,0.00017951654],"about_ca_topic_score_codex":0.0015844455,"about_ca_topic_score_gemma":0.00017607721,"teacher_disagreement_score":0.002058428,"about_ca_system_score_codex":0.0007778662,"about_ca_system_score_gemma":0.0010070342,"threshold_uncertainty_score":0.9998114},"labels":[],"label_agreement":null},{"id":"W2136752052","doi":"10.1016/j.leukres.2012.08.022","title":"Corrigendum to ‘Older age is associated with similar quality of life and physical function compared to younger age during intensive chemotherapy for acute myeloid leukemia’ [Leuk. Res. 36 (10) (2012) 1241–1248]","year":2012,"lang":"en","type":"erratum","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Myeloid leukemia; Medicine; Gerontology; Oncology; Quality of life (healthcare); Chemotherapy; Internal medicine","score_opus":0.09005882696424405,"score_gpt":0.3805983479039067,"score_spread":0.2905395209396626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136752052","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961756,0.0016191474,0.00052821,0.007725404,0.0041547245,0.014666343,0.0023539779,0.00045227094,0.0067439135],"genre_scores_gemma":[0.244798,0.001004893,0.0010759938,0.00767604,0.0068625403,0.002356235,0.004980747,0.001173049,0.7300725],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9855697,0.0011166934,0.0017043275,0.0026559099,0.0051622316,0.0037911104],"domain_scores_gemma":[0.9851488,0.0012853169,0.0007043055,0.0026597746,0.0069443434,0.0032574497],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0042958055,0.0015283986,0.0041917576,0.0021062975,0.0007511217,0.00027719728,0.0013106253,0.0020121913,0.0008053467],"category_scores_gemma":[0.005758584,0.0013194997,0.00065211306,0.0028199889,0.0011945326,0.0005285919,0.0012531995,0.006436932,0.00025837027],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.029662468,0.0003531612,0.00037520085,0.0016866856,0.0036107162,0.00035483713,0.006833539,0.000010882559,0.034713972,0.000028008526,0.92148125,0.00088928966],"study_design_scores_gemma":[0.058798507,0.01186198,0.21593317,0.007878135,0.0026121028,0.00019442983,0.008140687,0.0023899593,0.019770568,0.00029933557,0.6663264,0.005794714],"about_ca_topic_score_codex":0.0019947507,"about_ca_topic_score_gemma":0.00048890867,"teacher_disagreement_score":0.7233286,"about_ca_system_score_codex":0.016159398,"about_ca_system_score_gemma":0.009772882,"threshold_uncertainty_score":0.99974644},"labels":[],"label_agreement":null},{"id":"W2137302850","doi":"10.1016/j.leukres.2012.05.022","title":"An emerging role for retinoid X receptor α in malignant hematopoiesis","year":2012,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Retinoid X receptor; Haematopoiesis; Retinoid X receptor alpha; Nuclear receptor; Receptor; Biology; Acute promyelocytic leukemia; Retinoid; Extramedullary hematopoiesis; Cancer research; Cell biology; Immunology; Genetics; Stem cell; Retinoic acid; Transcription factor; Gene","score_opus":0.0974717512306307,"score_gpt":0.4227176889337155,"score_spread":0.32524593770308474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137302850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012061697,0.99467844,0.00011187215,0.000016746391,0.00021580796,0.0014469811,0.00005999761,0.000025670803,0.0022383088],"genre_scores_gemma":[0.0013909315,0.99032545,0.0013793625,0.000019906889,0.0014883822,0.0015842273,0.001423822,0.00020422683,0.0021837123],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952182,0.0008099649,0.0008116472,0.0011531913,0.0005725234,0.001434429],"domain_scores_gemma":[0.9977354,0.0001739633,0.0002227015,0.0012580403,0.00030905125,0.0003008452],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003308873,0.00054584147,0.0011069763,0.00042392238,0.00024495056,0.00011480748,0.0012800916,0.0011932682,0.00012739918],"category_scores_gemma":[0.00040466446,0.00047864302,0.00044143572,0.00062624214,0.00021729607,0.000015487987,0.00038275972,0.00092890236,0.000109746354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012096292,0.00018128469,0.000038203918,0.023652337,0.00014490343,0.000014109145,0.00019381201,0.000005737255,0.029660793,0.0005305871,0.0045390925,0.94091815],"study_design_scores_gemma":[0.0003255899,0.00023542478,4.733997e-7,0.00203216,0.000076778546,0.0000301643,0.00018766397,0.000017027445,0.023347441,0.00013680411,0.97305346,0.00055699423],"about_ca_topic_score_codex":0.00005160495,"about_ca_topic_score_gemma":0.00002478821,"teacher_disagreement_score":0.9685144,"about_ca_system_score_codex":0.00064391526,"about_ca_system_score_gemma":0.0020546955,"threshold_uncertainty_score":0.9997665},"labels":[],"label_agreement":null},{"id":"W2142535539","doi":"10.1016/j.leukres.2008.10.013","title":"Mutation or polymorphism of the CD20 gene is not associated with the response to R-CHOP in diffuse large B cell lymphoma patients","year":2008,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Calgary Laboratory Services","funders":"","keywords":"CHOP; Lymphoma; CD20; Rituximab; Diffuse large B-cell lymphoma; Oncology; Cancer research; Internal medicine; Immunology; Medicine; Mutation; Biology; Gene; Gastroenterology; Genetics","score_opus":0.04413447653465624,"score_gpt":0.3095650200788036,"score_spread":0.26543054354414736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142535539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423766,0.000057799,0.000001053371,0.004106561,0.000029854158,0.0011027311,0.00007527826,0.000012237285,0.00037684568],"genre_scores_gemma":[0.9943556,0.000040553798,0.00003769865,0.0013780546,0.000023977937,0.00018697132,0.00001852626,0.000027776403,0.003930848],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970828,0.0005854525,0.00025538474,0.0002966284,0.0012843795,0.0004953248],"domain_scores_gemma":[0.9978484,0.001011642,0.00008373726,0.0005744502,0.00034438996,0.0001373829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008698949,0.00014640282,0.00024691503,0.00020691604,0.00026703216,0.000015737023,0.00023944858,0.00010602377,0.000047788235],"category_scores_gemma":[0.00079108565,0.000068150606,0.000072440605,0.0011465506,0.00015144228,0.000045379373,0.00014916711,0.00017460035,0.000050347026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045133963,0.023157282,0.8506388,0.000081066006,0.00034142344,0.0025232914,0.028556513,0.000020360007,0.013046308,0.00004503423,0.03233825,0.0041177305],"study_design_scores_gemma":[0.030909846,0.001021476,0.90975505,0.000111035835,0.000025089494,0.000021481826,0.00022836034,0.00011880375,0.05682728,0.000004762888,0.0008961984,0.00008058886],"about_ca_topic_score_codex":0.0012518534,"about_ca_topic_score_gemma":0.00037994428,"teacher_disagreement_score":0.059116296,"about_ca_system_score_codex":0.0023760484,"about_ca_system_score_gemma":0.0013847327,"threshold_uncertainty_score":0.62132835},"labels":[],"label_agreement":null},{"id":"W2144153160","doi":"10.1016/j.leukres.2009.05.014","title":"Valproic acid exerts differential effects on CXCR4 expression in leukemic cells","year":2009,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Histone Deacetylase Inhibitors Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; University of Alberta","funders":"Canadian Institutes of Health Research; Canadian Blood Services","keywords":"CD34; CXCR4; Haematopoiesis; Progenitor cell; Cancer research; Stem cell; Histone deacetylase inhibitor; Cell culture; Chemistry; Biology; Histone deacetylase; Molecular biology; Receptor; Cell biology; Histone; Biochemistry; Chemokine; Genetics","score_opus":0.01772282883425628,"score_gpt":0.3261410201651962,"score_spread":0.3084181913309399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144153160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946241,0.00039124276,0.00009522107,0.00019859738,0.00019515093,0.0007370276,0.0000067586875,0.000029646852,0.0037223028],"genre_scores_gemma":[0.99384236,0.000211536,0.00014813627,0.0001292024,0.0006602242,0.00011426203,0.00008107856,0.00005028277,0.0047629033],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.995597,0.0007490607,0.0003342354,0.00094133953,0.0011900438,0.0011882873],"domain_scores_gemma":[0.99839014,0.00013013359,0.000046928613,0.0009641764,0.00016031397,0.0003082823],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007963106,0.00029416266,0.00029245391,0.0005098074,0.0002254322,0.000079956095,0.00067749625,0.00046375033,0.00006380403],"category_scores_gemma":[0.00040080425,0.00027116117,0.00013549817,0.00050791795,0.00016336146,0.000010532584,0.00029007334,0.0011766532,0.0003492848],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006071214,0.00015313324,0.00005548397,0.00005477338,0.00000664948,0.000121351564,0.00009619145,0.000057195604,0.96419656,0.000018881537,0.02414258,0.010490065],"study_design_scores_gemma":[0.0018532287,0.0012397921,0.0014437833,0.00019741154,0.0000021340863,0.000008528653,0.00002410751,0.0001660021,0.98957324,0.00012547294,0.0050939876,0.0002723183],"about_ca_topic_score_codex":0.000056986388,"about_ca_topic_score_gemma":0.00003088221,"teacher_disagreement_score":0.02537666,"about_ca_system_score_codex":0.0010583892,"about_ca_system_score_gemma":0.0006162829,"threshold_uncertainty_score":0.9999741},"labels":[],"label_agreement":null},{"id":"W2150386152","doi":"10.1016/j.leukres.2004.03.019","title":"Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia","year":2004,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Saskatchewan","funders":"National Cancer Institute; Canadian Institutes of Health Research; University of Texas MD Anderson Cancer Center; University of Saskatchewan","keywords":"Methylation; Molecular biology; Biology; DNA methylation; Cancer research; Epigenetics; Gene silencing; CpG site; Gene expression; Gene; Genetics","score_opus":0.02305254884950352,"score_gpt":0.2981897047031424,"score_spread":0.27513715585363885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150386152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597573,0.0017691844,0.00082127494,0.0000658621,0.00014514875,0.0006933296,0.000050074963,0.000015722411,0.00046364972],"genre_scores_gemma":[0.9987413,0.00036929193,0.0001376101,0.000015601618,0.0002561436,0.000079650345,0.0001490382,0.00005523637,0.00019612287],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9969778,0.00031737666,0.0006218309,0.00056488306,0.0008129004,0.0007052305],"domain_scores_gemma":[0.9987869,0.00008992002,0.00013264087,0.0005255211,0.00030269477,0.00016226797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092725427,0.00024618706,0.00024759994,0.00028928468,0.00023319855,0.00004780668,0.0003672186,0.0003803939,0.000012810954],"category_scores_gemma":[0.0001390939,0.0002079191,0.00012759578,0.0005438334,0.00026041843,0.000021611131,0.00014254042,0.0003071071,0.000008804746],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022839902,0.00007553504,0.00078142225,0.00009370931,0.000030764862,0.000007870993,0.0006608239,0.018880894,0.97301394,0.0003355081,0.000014724509,0.0058763847],"study_design_scores_gemma":[0.0035542469,0.00035757583,0.003946089,0.00007666621,0.000011163058,0.0000064041888,0.00033913678,0.00048943335,0.99004036,0.00055982225,0.00039469666,0.0002243936],"about_ca_topic_score_codex":0.0035000534,"about_ca_topic_score_gemma":0.0022485126,"teacher_disagreement_score":0.01839146,"about_ca_system_score_codex":0.0027316234,"about_ca_system_score_gemma":0.0028965115,"threshold_uncertainty_score":0.84786946},"labels":[],"label_agreement":null},{"id":"W2156134411","doi":"10.1016/s0145-2126(02)00222-9","title":"Preclinical evaluation of antineoplastic activity of inhibitors of DNA methylation (5-aza-2′-deoxycytidine) and histone deacetylation (trichostatin A, depsipeptide) in combination against myeloid leukemic cells","year":2003,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":103,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Trichostatin A; Histone deacetylase; DNA methylation; Cancer research; Azacitidine; Acetylation; Histone deacetylase inhibitor; Histone; Decitabine; Myeloid leukemia; Epigenetics; CpG site; Deoxycytidine; Chromatin; Biology; Chemistry; DNA; Biochemistry; Gene expression; Chemotherapy; Genetics; Gene","score_opus":0.06027886334873608,"score_gpt":0.3861331952723275,"score_spread":0.3258543319235914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156134411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592245,0.0011059826,0.0017573674,0.000016471246,0.000079226054,0.0006371953,0.000011466961,0.0000032085475,0.00046666036],"genre_scores_gemma":[0.99807006,0.0007400989,0.0009992899,0.0000019859638,0.000025681245,0.00002514063,0.000078328114,0.000019689474,0.000039745257],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9964519,0.0013602,0.0007106712,0.00038168082,0.0008602814,0.00023525329],"domain_scores_gemma":[0.9977325,0.00048523475,0.00041837108,0.00029649373,0.0010046224,0.00006273014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061755455,0.00013888422,0.00028276857,0.0003971881,0.00004948827,0.000008220848,0.00010346649,0.00028059122,0.0000072602384],"category_scores_gemma":[0.0030499506,0.00014984023,0.00006340658,0.0005588879,0.00020470023,0.00002048961,0.000066746674,0.00024247816,7.462243e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016611657,0.00014579186,0.010916669,0.00011512013,0.000019648238,1.9166389e-7,0.00016292915,0.0056816996,0.96541727,0.000089408786,0.000015094579,0.017270036],"study_design_scores_gemma":[0.0020594832,0.00041201626,0.066216566,0.0000617914,0.000024120121,3.1995594e-7,0.00007088638,0.015252048,0.91521245,0.0005427608,0.000037461858,0.0001101094],"about_ca_topic_score_codex":0.0001706512,"about_ca_topic_score_gemma":0.00012179519,"teacher_disagreement_score":0.055299893,"about_ca_system_score_codex":0.00029341545,"about_ca_system_score_gemma":0.00078402384,"threshold_uncertainty_score":0.6110307},"labels":[],"label_agreement":null},{"id":"W2157051030","doi":"10.1016/j.leukres.2013.10.025","title":"Predictors of outcome in adults with BCR-ABL negative acute lymphoblastic leukemia treated with a pediatric-based regimen","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Dana-Farber Cancer Institute","keywords":"Medicine; Lymphoblastic Leukemia; Internal medicine; Regimen; Philadelphia chromosome; Overall survival; Acute lymphocytic leukemia; Oncology; Leukemia; Gastroenterology; Chromosomal translocation; Biology","score_opus":0.02066863335111047,"score_gpt":0.2998187167356622,"score_spread":0.2791500833845517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157051030","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893972,0.000084404826,0.00023972994,0.0005613976,0.000038719532,0.0042358274,0.000060230675,0.0001753422,0.005207091],"genre_scores_gemma":[0.99157846,0.00009536673,0.002715112,0.0001395383,0.00025021663,0.0012028018,0.00010458974,0.00020998367,0.003703945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9904538,0.00065151043,0.0012170993,0.0013945464,0.0039890353,0.0022940387],"domain_scores_gemma":[0.99208415,0.002644886,0.00033619942,0.00159422,0.0022885683,0.0010519638],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013765108,0.00072867115,0.0014060837,0.0022588766,0.00021053056,0.00010368473,0.0008938996,0.0005478546,0.000503277],"category_scores_gemma":[0.0012744209,0.000491512,0.0001664697,0.0051573957,0.0013596436,0.00047581727,0.0003159477,0.001913892,0.00038671648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.022196282,0.0006166463,0.95975614,0.0017890673,0.00068553776,0.0025261817,0.0015820591,0.0013300021,0.0019948673,0.00008657454,0.0066710007,0.00076562795],"study_design_scores_gemma":[0.108220816,0.019745246,0.750443,0.0036527903,0.0007822778,0.0005930643,0.0029335674,0.08742517,0.024206461,0.0001322034,0.00022272959,0.0016427183],"about_ca_topic_score_codex":0.014322933,"about_ca_topic_score_gemma":0.0004139673,"teacher_disagreement_score":0.2093132,"about_ca_system_score_codex":0.0147722,"about_ca_system_score_gemma":0.0133403875,"threshold_uncertainty_score":0.99975365},"labels":[],"label_agreement":null},{"id":"W2158429148","doi":"10.1016/j.leukres.2015.03.017","title":"Whole genome and transcriptome analysis of a novel AML cell line with a normal karyotype","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"Louisiana State University","keywords":"Biology; Karyotype; Cancer research; Transcriptome; Cell culture; Myeloid leukemia; Myeloid; Progenitor cell; Haematopoiesis; Gene; Cell growth; CD34; Genetics; Stem cell; Gene expression; Chromosome","score_opus":0.081088432951783,"score_gpt":0.3520627893634922,"score_spread":0.2709743564117092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158429148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98591703,0.0008744854,0.0011713963,0.001290811,0.000017947717,0.0007371191,0.00012337697,0.000048953334,0.009818893],"genre_scores_gemma":[0.9861513,0.00012401026,0.004095949,0.00013873496,0.00013829212,0.000060162845,0.00020089332,0.000062332765,0.009028339],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99559635,0.00019313597,0.0004541893,0.0006404009,0.0021157416,0.0010002088],"domain_scores_gemma":[0.99638873,0.00027644567,0.00007725282,0.0008574289,0.0014545929,0.00094556884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025563806,0.00025404815,0.00082333136,0.002033363,0.000117338685,0.00005674782,0.00039729886,0.00023288513,0.00013273791],"category_scores_gemma":[0.00025215326,0.00019491879,0.00014334246,0.0049713682,0.0007480596,0.00019226232,0.00024084153,0.0013481692,0.00006017267],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009931038,0.0010967662,0.030435005,0.00090396666,0.002832063,0.0007625848,0.006718096,0.002340884,0.9399479,0.00029969605,0.0031181418,0.0016138569],"study_design_scores_gemma":[0.103489526,0.028140312,0.32987374,0.0006151096,0.0069312896,0.0008681807,0.014236765,0.3420038,0.08022602,0.00016966213,0.09097557,0.002470017],"about_ca_topic_score_codex":0.001798834,"about_ca_topic_score_gemma":0.00024804613,"teacher_disagreement_score":0.8597219,"about_ca_system_score_codex":0.0014011298,"about_ca_system_score_gemma":0.003383893,"threshold_uncertainty_score":0.7948557},"labels":[],"label_agreement":null},{"id":"W2158505514","doi":"10.1016/j.leukres.2013.05.001","title":"Differential survival improvement for patients 20–29 years of age with acute lymphoblastic leukemia","year":2013,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Hospital for Sick Children; Public Health Ontario; University of Toronto; University Health Network; Pediatric Oncology Group","funders":"Canadian Institutes of Health Research; Pediatric Oncology Group of Ontario","keywords":"Medicine; Lymphoblastic Leukemia; Epidemiology; Surveillance, Epidemiology, and End Results; Cancer registry; Overall survival; Survival analysis; Pediatrics; Leukemia; Internal medicine; Oncology","score_opus":0.02425534564726084,"score_gpt":0.30988027109674005,"score_spread":0.2856249254494792,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158505514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908687,0.000021341064,0.0015871512,0.00019959263,0.00023834853,0.0044588153,0.00014755028,0.000084987936,0.002393531],"genre_scores_gemma":[0.9886963,0.00006589207,0.0020049876,0.00008336214,0.00038929773,0.0011962157,0.00038990047,0.00017404399,0.007000026],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99263775,0.0002069561,0.00082007935,0.0009905255,0.0034222302,0.0019224625],"domain_scores_gemma":[0.9943103,0.001475759,0.00014490711,0.0011933197,0.0020901416,0.0007855394],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071175373,0.00044796453,0.0009449925,0.00074094767,0.0002350874,0.00014141189,0.0007894122,0.00037523653,0.00072132814],"category_scores_gemma":[0.0007576849,0.00036020073,0.00025873783,0.0010076207,0.0009120785,0.000262327,0.00059677375,0.0008852918,0.00033266886],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.031542324,0.004328758,0.0415626,0.005324722,0.006331521,0.0017275302,0.002781766,0.00024073734,0.63420916,0.002757061,0.13163823,0.13755558],"study_design_scores_gemma":[0.19394821,0.05914831,0.4815301,0.0026782579,0.0017174858,0.00025443736,0.0022610424,0.063543275,0.17184696,0.0030494432,0.01641544,0.003607039],"about_ca_topic_score_codex":0.001987542,"about_ca_topic_score_gemma":0.00007995274,"teacher_disagreement_score":0.4623622,"about_ca_system_score_codex":0.008361855,"about_ca_system_score_gemma":0.005775236,"threshold_uncertainty_score":0.999885},"labels":[],"label_agreement":null},{"id":"W2158751744","doi":"10.1016/j.leukres.2007.11.012","title":"Common features of myeloproliferative disorders with t(8;9)(p12;q33) and CEP110–FGFR1 fusion: Report of a new case and review of the literature","year":2007,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institut National Du Cancer; Institute of Cancer Research; Institut National de la Santé et de la Recherche Médicale","keywords":"Fibroblast growth factor receptor 1; Myeloproliferative Disorders; Cancer research; Fibroblast growth factor receptor; Chronic myelomonocytic leukemia; Medicine; Acute leukemia; Chromosomal translocation; Fusion gene; Haematopoiesis; Leukemia; Myelofibrosis; Tyrosine kinase; Bone marrow; Internal medicine; Stem cell; Fibroblast growth factor; Biology; Gene; Myelodysplastic syndromes; Receptor; Genetics","score_opus":0.06378112172896884,"score_gpt":0.41930828561375,"score_spread":0.35552716388478117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158751744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031682232,0.9896023,0.0000012239444,0.0006658424,0.00003277304,0.00268726,0.00005422582,0.000007339483,0.0037808088],"genre_scores_gemma":[0.0009884087,0.99415016,0.00025027993,0.000072870636,0.000064913,0.000040967167,0.00007822333,0.000049234826,0.0043049394],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963554,0.00046707073,0.0010650096,0.0005508631,0.0011806643,0.00038099237],"domain_scores_gemma":[0.99692196,0.00054808264,0.00063521,0.0010902518,0.0005731528,0.00023133542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019695696,0.00041194906,0.0026903981,0.0003811917,0.00017239645,0.000018947645,0.0002562781,0.0004330726,0.00003919394],"category_scores_gemma":[0.0006261694,0.00021192343,0.00030546868,0.0016258124,0.0009642342,0.00006111068,0.00043662012,0.0015980637,3.2964883e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013573223,0.00009662876,0.0004543077,0.32329977,0.00033278772,0.0024174475,0.0014605236,4.3026528e-8,0.0000021361575,0.00028001328,0.0057614837,0.66575915],"study_design_scores_gemma":[0.001050582,0.0008986766,0.0005985683,0.39043403,0.00074346334,0.03614908,0.00035563996,6.3051226e-7,0.000013225879,0.00016431938,0.56934446,0.00024734242],"about_ca_topic_score_codex":0.000854024,"about_ca_topic_score_gemma":0.00039930185,"teacher_disagreement_score":0.6655118,"about_ca_system_score_codex":0.00013820575,"about_ca_system_score_gemma":0.0028330388,"threshold_uncertainty_score":0.8641987},"labels":[],"label_agreement":null},{"id":"W2165275170","doi":"10.1016/j.leukres.2012.03.013","title":"Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"North York General Hospital","funders":"","keywords":"Bone marrow; Fluorescence in situ hybridization; Concomitant; Myelodysplastic syndromes; Peripheral blood; clone (Java method); Fish <Actinopterygii>; Pathology; Abnormality; Karyotype; Biology; Cytogenetics; Medicine; Chromosome; Internal medicine; DNA; Genetics","score_opus":0.08444588771323226,"score_gpt":0.3568744699875528,"score_spread":0.27242858227432054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165275170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965235,0.009737414,0.000053974636,0.019137423,0.00013896057,0.0036011315,0.0001336968,0.000066794615,0.0018956306],"genre_scores_gemma":[0.99174935,0.0027333647,0.00064127747,0.0012494047,0.0009713614,0.00064374914,0.00013574267,0.0001177607,0.0017579842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923608,0.0013067317,0.00069323066,0.0009687658,0.0022109253,0.0024595752],"domain_scores_gemma":[0.9714015,0.024210185,0.00010735256,0.0031191322,0.00035805992,0.0008037313],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00747922,0.00044181425,0.0006441069,0.00037565074,0.00068011787,0.0002722187,0.0017250517,0.00034275485,0.00063393405],"category_scores_gemma":[0.035584375,0.00026125487,0.00009341769,0.00153878,0.0017692152,0.00053796015,0.0025212297,0.0034783296,0.00024133241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026002834,0.0012937429,0.86370885,0.0010471131,0.0008341046,0.0026553017,0.011375312,0.00004265479,0.044128608,0.005108775,0.042040102,0.025165146],"study_design_scores_gemma":[0.023079978,0.0048206067,0.7625981,0.002541407,0.0011115198,0.010424908,0.015648521,0.01583648,0.010523698,0.004407916,0.1468891,0.0021177784],"about_ca_topic_score_codex":0.006270033,"about_ca_topic_score_gemma":0.0013779878,"teacher_disagreement_score":0.10484901,"about_ca_system_score_codex":0.0013833412,"about_ca_system_score_gemma":0.0028116293,"threshold_uncertainty_score":0.99998397},"labels":[],"label_agreement":null},{"id":"W2185835112","doi":"10.1016/j.leukres.2015.11.011","title":"Deletion of the putative tumor suppressor gene, G0s2, does not affect progression of Eμ-Myc driven lymphomas in mice","year":2015,"lang":"en","type":"article","venue":"Leukemia Research","topic":"RNA Research and Splicing","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Cancer Research Society","keywords":"Suppressor; Cancer research; Leukemia; Lymphoma; Gene; Latency (audio); Affect (linguistics); Tumor suppressor gene; Biology; Cancer; Carcinogenesis; Immunology; Genetics; Psychology","score_opus":0.03688109432518323,"score_gpt":0.36289647678563736,"score_spread":0.32601538246045414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185835112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981763,0.0002581801,0.000036729478,0.00023909098,0.0000459529,0.0005750212,0.000033018197,0.000003923147,0.00063179794],"genre_scores_gemma":[0.99845773,0.000052955973,0.00046007463,0.000021036247,0.000075314914,0.00007705541,0.000031135296,0.00001950108,0.0008052078],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.997299,0.0007745592,0.00027341288,0.00033573442,0.00084310176,0.00047417585],"domain_scores_gemma":[0.9987229,0.00011980729,0.00010277058,0.0004062501,0.0005138677,0.00013440724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016623527,0.00011910052,0.00019793582,0.00014459861,0.000072269766,0.000019295952,0.00053389516,0.0001328373,0.000006187291],"category_scores_gemma":[0.0010941781,0.00007268397,0.00008598975,0.0003777959,0.0003795015,0.00000973757,0.00039038569,0.0002848686,0.0000044789717],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007216105,0.000073917974,0.008747808,0.000081362894,0.000020916345,0.000011538453,0.0002094073,0.00023472882,0.98819256,0.00006928792,0.0005393744,0.0010974638],"study_design_scores_gemma":[0.0013506414,0.00049617037,0.008389847,0.00009063019,0.0000032277958,0.000008328391,0.00035216514,0.0015696279,0.9872463,0.00014694795,0.0002623234,0.00008381037],"about_ca_topic_score_codex":0.0007330869,"about_ca_topic_score_gemma":0.0002506145,"teacher_disagreement_score":0.0014238813,"about_ca_system_score_codex":0.0002445925,"about_ca_system_score_gemma":0.001048849,"threshold_uncertainty_score":0.29639664},"labels":[],"label_agreement":null},{"id":"W2314043688","doi":"10.1016/j.leukres.2016.03.013","title":"Zfp521 promotes B-cell viability and cyclin D1 gene expression in a B cell culture system","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Genomics and Chromatin Dynamics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University of Toronto; University of Westminster; University of Manchester; Lunds Universitet; Biotechnology and Biological Sciences Research Council; Thomas Jefferson University","keywords":"Cyclin D1; Biology; Progenitor cell; Cell growth; B cell; Haematopoiesis; Cancer research; Cyclin D2; Leukemia; Cell culture; Cell biology; Gene knockdown; Cyclin B; Cell; Molecular biology; Stem cell; Cell cycle; Immunology; Genetics; Antibody","score_opus":0.012790216540334071,"score_gpt":0.2725568820615396,"score_spread":0.25976666552120553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314043688","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99676365,0.0006207174,0.00027559392,0.00007277668,0.00004527252,0.00036765065,0.000028912797,0.000010269446,0.0018151634],"genre_scores_gemma":[0.99482614,0.00029280945,0.001791308,0.000009028229,0.000099538236,0.000055787248,0.000025048614,0.00002288691,0.0028774398],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983699,0.00023850541,0.00022746793,0.0005185932,0.00023150616,0.00041403266],"domain_scores_gemma":[0.9991743,0.000043293687,0.000047270627,0.0004894156,0.00012004789,0.0001256867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083768164,0.00014015166,0.00014990571,0.00005968374,0.000099210694,0.000038085105,0.00025968207,0.00027770607,0.0000080878],"category_scores_gemma":[0.00008591348,0.00009494896,0.00004380319,0.000105885134,0.0001255923,0.0000046513665,0.00037680176,0.0002031364,0.0000192097],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055854944,0.000057797304,0.005391974,0.00018819519,0.0000029973894,0.00000866346,0.0001057645,0.000008208916,0.99308056,0.00001348765,0.00055947807,0.00052702735],"study_design_scores_gemma":[0.0013041276,0.00021565804,0.0019280982,0.00007952057,0.0000023112457,0.000010007306,0.00021885853,0.0004772336,0.99300003,0.0001465725,0.002452109,0.00016549492],"about_ca_topic_score_codex":0.000052083153,"about_ca_topic_score_gemma":0.00004704432,"teacher_disagreement_score":0.003463876,"about_ca_system_score_codex":0.00025224156,"about_ca_system_score_gemma":0.00021207171,"threshold_uncertainty_score":0.38719064},"labels":[],"label_agreement":null},{"id":"W2326073198","doi":"10.1016/j.leukres.2016.04.005","title":"Incremental value of the bone marrow trephine biopsy in detecting residual leukemia following treatment for Acute Myeloid Leukemia","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Hematological disorders and diagnostics","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Myeloid leukemia; Concordance; Minimal residual disease; Leukemia; Internal medicine; Bone marrow; Biopsy; Oncology; Pathology","score_opus":0.057582608312993236,"score_gpt":0.37202350533225254,"score_spread":0.3144408970192593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2326073198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940654,0.00041234278,0.000109734494,0.002145949,0.00012802942,0.0016604541,0.000058323465,0.00004658159,0.0013731807],"genre_scores_gemma":[0.99639875,0.00021778593,0.0014217293,0.00011327382,0.0001460494,0.00031584164,0.000016099819,0.0000532587,0.0013172069],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9963772,0.00028419474,0.00073380856,0.0006070273,0.0009767495,0.001020964],"domain_scores_gemma":[0.99641246,0.0023708558,0.000101459445,0.00070580177,0.00017468868,0.0002347503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015750964,0.00029913223,0.0007201778,0.0003246491,0.00027611732,0.000029747383,0.0003357475,0.00030840095,0.00007003226],"category_scores_gemma":[0.0034910438,0.00015967024,0.0003710792,0.0007820134,0.00031589394,0.000107987675,0.00028913998,0.00043713782,0.00002571157],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037472302,0.0004397497,0.117513046,0.00032064196,0.00057312555,0.0010147041,0.00085765717,0.000055993467,0.83511674,0.0025096044,0.0031966788,0.03465482],"study_design_scores_gemma":[0.040924117,0.0052629774,0.13259101,0.0027564962,0.0005147372,0.00041428785,0.0020789127,0.0023327866,0.80431557,0.005389548,0.002603047,0.0008165209],"about_ca_topic_score_codex":0.001742342,"about_ca_topic_score_gemma":0.0003143182,"teacher_disagreement_score":0.03717689,"about_ca_system_score_codex":0.006477963,"about_ca_system_score_gemma":0.0021424645,"threshold_uncertainty_score":0.997336},"labels":[],"label_agreement":null},{"id":"W2411195875","doi":"10.1016/j.leukres.2016.06.001","title":"Do quality of life, physical function, or the Wheatley index at diagnosis predict 1-year mortality with intensive chemotherapy in older acute myeloid leukemia patients?","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Public Health Ontario; Toronto Rehabilitation Institute; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Internal medicine; Odds ratio; Quality of life (healthcare); Confidence interval; Myeloid leukemia; Prospective cohort study; Logistic regression; Univariate analysis; Intensive care medicine; Multivariate analysis","score_opus":0.056334667987655206,"score_gpt":0.37537310767456816,"score_spread":0.319038439686913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411195875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507606,0.00003335491,0.00005149914,0.0022604358,0.00009329243,0.001246617,0.00006274344,0.00003884044,0.0011371567],"genre_scores_gemma":[0.995916,0.00050604105,0.000007717111,0.0005988471,0.00027110588,0.0006104783,0.00001533749,0.000043776603,0.0020306942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99676245,0.0004166654,0.00044640043,0.0005383018,0.0012835418,0.00055265933],"domain_scores_gemma":[0.9965581,0.0008051236,0.00013166833,0.00087485154,0.001389873,0.00024032641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084136456,0.00021953817,0.0005283303,0.00018790596,0.00018492698,0.00002739542,0.0002523971,0.00014493137,0.0007385318],"category_scores_gemma":[0.00054874335,0.00009431223,0.00013058318,0.0009527123,0.0007474782,0.00017492434,0.00017226528,0.00067958754,0.00006268757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007697629,0.0002876449,0.9699069,0.00009176871,0.0003363754,0.000009969196,0.00067876774,0.0000066847606,0.0019391474,0.00014338586,0.014706528,0.004195171],"study_design_scores_gemma":[0.009477081,0.001236799,0.9805475,0.00027509299,0.000061926345,0.000004576762,0.00045633074,0.000015742844,0.004918156,0.00015144967,0.0027108493,0.00014452687],"about_ca_topic_score_codex":0.0021879352,"about_ca_topic_score_gemma":0.0011974168,"teacher_disagreement_score":0.011995679,"about_ca_system_score_codex":0.0025851917,"about_ca_system_score_gemma":0.0017404787,"threshold_uncertainty_score":0.80864054},"labels":[],"label_agreement":null},{"id":"W2488647697","doi":"10.1016/j.leukres.2016.07.004","title":"A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML)","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Merck","keywords":"Medicine; Regimen; Tolerability; Internal medicine; Refractory (planetary science); Gastroenterology; Phases of clinical research; Adverse effect; Surgery; Clinical trial; Biology","score_opus":0.05038255470315886,"score_gpt":0.36697083761968635,"score_spread":0.3165882829165275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2488647697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904112,0.000097904835,0.000012582315,0.0010896815,0.00030077627,0.005224436,0.00012595723,0.00006606423,0.00267135],"genre_scores_gemma":[0.99158746,0.00010587554,0.00015900127,0.00007976078,0.0005936485,0.00051061943,0.000075318865,0.00013976598,0.0067485776],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9909375,0.0008097442,0.0011587758,0.0011452839,0.0040039276,0.0019447729],"domain_scores_gemma":[0.99479586,0.00063581706,0.0003271788,0.0022401058,0.0013894624,0.00061160664],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027660462,0.0005311484,0.0010250525,0.0010800288,0.00042677083,0.00007120229,0.0013463052,0.00050316134,0.0003038565],"category_scores_gemma":[0.0005891103,0.0002834749,0.00029682138,0.0022209615,0.0014020718,0.00035276506,0.0009120905,0.0024065955,0.0001712015],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.60112685,0.009443798,0.039823767,0.00067874294,0.0010953172,0.00076189847,0.002548934,0.00000615702,0.22248814,0.0008219584,0.035786826,0.085417636],"study_design_scores_gemma":[0.8265563,0.027739124,0.02620374,0.0018419854,0.00020243063,0.00004238317,0.00024328651,0.00006114173,0.093693316,0.0002563181,0.022357767,0.00080216967],"about_ca_topic_score_codex":0.001059742,"about_ca_topic_score_gemma":0.00033075578,"teacher_disagreement_score":0.2254295,"about_ca_system_score_codex":0.013741477,"about_ca_system_score_gemma":0.007502311,"threshold_uncertainty_score":0.99996173},"labels":[],"label_agreement":null},{"id":"W2505615084","doi":"10.1016/j.leukres.2016.07.012","title":"Palliative care for patients with hematological malignancies: Time for a new model","year":2016,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hematologic Neoplasms; Palliative care; Oncology; Intensive care medicine; Internal medicine; Nursing; Cancer","score_opus":0.21951116096228762,"score_gpt":0.4541278630218535,"score_spread":0.23461670205956586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2505615084","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051666897,0.012378048,0.064272255,0.7989322,0.00055615406,0.040738165,0.013437198,0.0005351026,0.01748401],"genre_scores_gemma":[0.012144237,0.0024261102,0.24293981,0.33585992,0.022310136,0.011737073,0.018716257,0.0015216809,0.35234475],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99639344,0.00008948138,0.00041599272,0.00075401284,0.0012695998,0.0010775005],"domain_scores_gemma":[0.9939684,0.0022012321,0.00017643272,0.0005872751,0.0028592169,0.0002074035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027155972,0.00039606178,0.0011079576,0.0002992721,0.00013616205,0.000024736493,0.00039486916,0.0009729416,0.00008175668],"category_scores_gemma":[0.0011944544,0.0002373441,0.00030769323,0.0002202116,0.0003206716,0.00006264265,0.000114801995,0.0010394529,0.000065960565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016617932,0.000030199306,0.0017350507,0.0028861254,0.0002375303,0.00004633765,0.0011961757,0.00000459715,0.000060683353,0.00009328797,0.9909854,0.0010628002],"study_design_scores_gemma":[0.008308056,0.0027890508,0.00008131091,0.00641087,0.00016179608,0.0000010909032,0.00019502196,0.0006777157,0.0012846221,0.0014604636,0.97821414,0.00041587697],"about_ca_topic_score_codex":0.000053586256,"about_ca_topic_score_gemma":0.000005832146,"teacher_disagreement_score":0.46307224,"about_ca_system_score_codex":0.0014317589,"about_ca_system_score_gemma":0.002851083,"threshold_uncertainty_score":0.9678611},"labels":[],"label_agreement":null},{"id":"W2523424222","doi":"10.1016/j.leukres.2016.09.016","title":"Cross-resistance and synergy with bendamustine in chronic lymphocytic leukemia","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Manitoba Beekeepers' Association; University of Winnipeg; George & Fay Yee Centre for Healthcare Innovation; University of Manitoba; Research Institute in Oncology and Hematology","funders":"Canadian Institutes of Health Research","keywords":"Bendamustine; Chronic lymphocytic leukemia; Chlorambucil; Pentostatin; Fludarabine; Cladribine; Nucleoside analogue; Nucleoside; Deoxyadenosine; Cytotoxicity; Cytotoxic T cell; Medicine; Cancer research; Leukemia; Cross-resistance; Pharmacology; Biology; In vitro; Immunology; Chemotherapy; Virology; Lymphoma; Biochemistry; Internal medicine; Adenosine","score_opus":0.035868452944270934,"score_gpt":0.3611571789687671,"score_spread":0.32528872602449616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2523424222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97962886,0.002722051,0.000092525486,0.0006534883,0.00005614809,0.001065085,0.00001920332,0.00014915205,0.015613509],"genre_scores_gemma":[0.9505287,0.001368712,0.00040608723,0.000103847735,0.00040838393,0.00028513957,0.000013759326,0.0001327923,0.046752594],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.992892,0.00032726573,0.00067749096,0.0013916324,0.0023952606,0.002316324],"domain_scores_gemma":[0.9953606,0.0016609299,0.000068354566,0.0014355207,0.0006746706,0.00079993694],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023950876,0.00045639588,0.000750615,0.00097483204,0.00029838955,0.00016160308,0.0005761269,0.00039894014,0.0005710091],"category_scores_gemma":[0.0012202018,0.00028945427,0.00009143044,0.0018470632,0.00221858,0.00039104687,0.0005480298,0.0010008763,0.00036262788],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0644445,0.0005305767,0.06904437,0.016845684,0.0016769397,0.05662152,0.0035283205,0.0052226274,0.5019556,0.04849196,0.03239796,0.1992399],"study_design_scores_gemma":[0.41635332,0.0071446723,0.11967232,0.018485732,0.00018992512,0.006425192,0.0007020025,0.06461906,0.15793484,0.0025361937,0.20229957,0.0036371672],"about_ca_topic_score_codex":0.0050399997,"about_ca_topic_score_gemma":0.0037735675,"teacher_disagreement_score":0.35190883,"about_ca_system_score_codex":0.4057129,"about_ca_system_score_gemma":0.12351725,"threshold_uncertainty_score":0.9999558},"labels":[],"label_agreement":null},{"id":"W2552329590","doi":"10.1016/j.leukres.2016.11.007","title":"Conserved hierarchical gain of chromosome 4 is an independent prognostic factor in high hyperdiploid pediatric acute lymphoblastic leukemia","year":2016,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pediatric Oncology Group","funders":"","keywords":"Trisomy; Fluorescence in situ hybridization; Lymphoblastic Leukemia; Chromosome; Biology; Aneuploidy; Internal medicine; Oncology; Leukemia; Genetics; Medicine; Gene","score_opus":0.04352849427960141,"score_gpt":0.3317221267253496,"score_spread":0.2881936324457482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2552329590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462855,0.00019927576,0.00031649592,0.0013819252,0.00018277233,0.0022577427,0.0003347346,0.0001630491,0.00053547695],"genre_scores_gemma":[0.9947305,0.0006684926,0.00085139234,0.00024095332,0.0006884371,0.0003967776,0.00006943896,0.0002080025,0.0021460052],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9878125,0.0013035428,0.0015731811,0.0017866457,0.004744772,0.0027793443],"domain_scores_gemma":[0.9905393,0.0045161024,0.00019092456,0.0019425168,0.0012665103,0.0015446113],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0025116813,0.00070093566,0.0014527037,0.002494894,0.00023924251,0.00009940484,0.0014457329,0.00092790235,0.0015350651],"category_scores_gemma":[0.00381115,0.0005007235,0.00029601477,0.0029729214,0.0013201346,0.00053035887,0.0010478774,0.001983755,0.0008487592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0066330493,0.0014837616,0.540116,0.0014840217,0.0005750511,0.0055409824,0.0015737239,0.000040541676,0.42812538,0.0010342214,0.0047016116,0.0086916555],"study_design_scores_gemma":[0.047266964,0.0074875765,0.8308578,0.0014900655,0.000352776,0.0013569243,0.00040675615,0.007462361,0.09874655,0.0025346484,0.0005365867,0.0015009883],"about_ca_topic_score_codex":0.0013873243,"about_ca_topic_score_gemma":0.00016815838,"teacher_disagreement_score":0.32937884,"about_ca_system_score_codex":0.016397221,"about_ca_system_score_gemma":0.019249376,"threshold_uncertainty_score":0.9999292},"labels":[],"label_agreement":null},{"id":"W2574014792","doi":"10.1016/j.leukres.2017.01.023","title":"Characterization of treatment and outcomes in a population-based cohort of patients with chronic lymphocytic leukemia referred for cytogenetic testing in British Columbia, Canada","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada); St. Paul's Hospital; Canada's Michael Smith Genome Sciences Centre; Royal Columbian Hospital; University of British Columbia; Vancouver General Hospital; BC Cancer Agency","funders":"","keywords":"Fludarabine; Medicine; Rituximab; Hazard ratio; Internal medicine; Chemoimmunotherapy; Population; Chronic lymphocytic leukemia; Confidence interval; Regimen; Proportional hazards model; Oncology; Cohort; Alemtuzumab; Vincristine; Surgery; Cyclophosphamide; Chemotherapy; Leukemia; Transplantation; Lymphoma","score_opus":0.03724798008251208,"score_gpt":0.3164581650059118,"score_spread":0.2792101849233997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574014792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99657255,0.0000489026,0.0000049603204,0.00002365946,0.00002922985,0.0030758583,0.00015902884,0.000008987301,0.000076841],"genre_scores_gemma":[0.9984131,0.000033178036,0.00021806757,0.000011764068,0.000027669515,0.00043365674,0.00032834045,0.00004874279,0.0004854868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971138,0.00012806508,0.0006617606,0.00052712794,0.0008892518,0.00067996926],"domain_scores_gemma":[0.9974177,0.00074573566,0.0002702263,0.0007577767,0.0006320801,0.00017652268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007000712,0.00016517712,0.00074108964,0.00026294042,0.00020001446,0.00010305462,0.00025998987,0.00014828987,0.000021363749],"category_scores_gemma":[0.0015095455,0.00019300485,0.000043600365,0.00038830363,0.00026979824,0.00011330083,0.00010059172,0.00020018328,3.73858e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0003944539,0.000067791596,0.9922909,0.0007481569,0.000053498068,0.00004865258,0.000037585378,0.0004274167,0.0014070965,0.0000015297325,0.000008048756,0.0045148395],"study_design_scores_gemma":[0.033794623,0.0010893611,0.92300403,0.000850087,0.000029431227,0.0000073300025,0.000018757064,0.040162418,0.00086676615,0.000010417162,0.000022705917,0.00014407178],"about_ca_topic_score_codex":0.98710227,"about_ca_topic_score_gemma":0.9849136,"teacher_disagreement_score":0.1057535,"about_ca_system_score_codex":0.21971735,"about_ca_system_score_gemma":0.11396385,"threshold_uncertainty_score":0.89105916},"labels":[],"label_agreement":null},{"id":"W2576905928","doi":"10.1016/j.leukres.2017.01.005","title":"Current approach to the treatment of chronic myeloid leukaemia","year":2017,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Bosutinib; Nilotinib; Dasatinib; Medicine; Ponatinib; Hematologist; Imatinib; Intensive care medicine; Imatinib mesylate; Chronic myeloid leukaemia; Oncology; Myeloid leukemia; Immunology; Internal medicine; Disease","score_opus":0.31006381007860545,"score_gpt":0.4895030462241493,"score_spread":0.17943923614554386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2576905928","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008228351,0.97484845,0.000017891587,0.00011677427,0.00050469243,0.0087014735,0.00015845735,0.00006831779,0.015501654],"genre_scores_gemma":[0.00009183008,0.9798663,0.00021202743,0.000008686356,0.0024987548,0.0036431458,0.0006028092,0.00022038705,0.012856021],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922735,0.00080406124,0.0013003543,0.0015758852,0.0023138758,0.0017322951],"domain_scores_gemma":[0.9919732,0.000800959,0.00054545305,0.0054827924,0.00047309676,0.0007244522],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016379405,0.0010530262,0.0039951988,0.0009668755,0.0006612171,0.00014396447,0.0019218464,0.00068848365,0.00015258067],"category_scores_gemma":[0.00043556144,0.0005875024,0.0015372359,0.0010793629,0.0006772351,0.00007932051,0.0005459889,0.0020122465,0.0019656864],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00007333628,0.0009233738,0.0000084994335,0.020352293,0.00083875976,0.00007051055,0.000305281,0.0000059941303,0.0000011338011,0.0001682239,0.011377404,0.9658752],"study_design_scores_gemma":[0.0025488543,0.0020485667,0.00003126239,0.014731954,0.0013612406,0.00023686618,0.000027301125,0.000100448655,0.000021847092,0.000013041462,0.97848034,0.00039829698],"about_ca_topic_score_codex":0.0008714272,"about_ca_topic_score_gemma":0.00008285061,"teacher_disagreement_score":0.96710294,"about_ca_system_score_codex":0.057639662,"about_ca_system_score_gemma":0.027922524,"threshold_uncertainty_score":0.99965763},"labels":[],"label_agreement":null},{"id":"W2610988607","doi":"10.1016/j.leukres.2017.11.005","title":"Iron chelation therapy in lower IPSS risk myelodysplastic syndromes; which subtypes benefit?","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Myelodysplastic syndromes; Chelation therapy; Medicine; Internal medicine; Chelation; International Prognostic Scoring System; Oncology; Chemistry","score_opus":0.06300820510607573,"score_gpt":0.3745029270335802,"score_spread":0.31149472192750444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2610988607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744105,0.000525663,0.00003293176,0.0027698944,0.00024687036,0.0013956256,0.000022045793,0.00009005013,0.020506442],"genre_scores_gemma":[0.9848802,0.0028069383,0.00038718074,0.0000691418,0.00049794954,0.000199412,0.000055158802,0.00011817383,0.010985835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99407953,0.00044119265,0.000569091,0.0010304989,0.0022139302,0.0016657391],"domain_scores_gemma":[0.9948354,0.0009972191,0.00019755318,0.002437914,0.0010138554,0.0005181086],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003967852,0.00037477043,0.0006366109,0.0010299959,0.0011123095,0.00038571356,0.0011845184,0.0005862019,0.0008076551],"category_scores_gemma":[0.004644149,0.00032155024,0.0001394158,0.0009966107,0.00060524564,0.00055738847,0.0005732626,0.0036618763,0.0015993667],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010072498,0.0008749369,0.80128396,0.0005598941,0.00033696188,0.0024938097,0.0021328328,0.00074631145,0.03472257,0.0023621356,0.0069325226,0.13748156],"study_design_scores_gemma":[0.0087461155,0.0013841597,0.9655079,0.00036922065,0.000024112182,0.00012472863,0.000179438,0.011983172,0.0039134184,0.0014761267,0.005891585,0.0004000277],"about_ca_topic_score_codex":0.0048836973,"about_ca_topic_score_gemma":0.0014356351,"teacher_disagreement_score":0.16422392,"about_ca_system_score_codex":0.0054679676,"about_ca_system_score_gemma":0.002786416,"threshold_uncertainty_score":0.99992365},"labels":[],"label_agreement":null},{"id":"W2619736384","doi":"10.1016/j.leukres.2017.05.017","title":"A novel spliced variant of the TIN2 shelterin is present in chronic lymphocytic leukemia","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Chronic lymphocytic leukemia; Biology; Shelterin; Exon; RNA splicing; Alternative splicing; Molecular biology; Leukemia; Promyelocytic leukemia protein; Telomere; Gene; Cancer research; RNA; Genetics; Nuclear protein; DNA-binding protein","score_opus":0.09683330156801429,"score_gpt":0.40200515823104815,"score_spread":0.30517185666303387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2619736384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96697855,0.00059150707,0.00006837057,0.001936159,0.0003084048,0.0025620349,0.000040613042,0.000054473338,0.027459905],"genre_scores_gemma":[0.9827406,0.00035466804,0.00032336373,0.0001647126,0.0006464813,0.0002832647,0.000008744983,0.00011040867,0.015367782],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9921068,0.00034365978,0.0009839709,0.0011326562,0.0034204868,0.0020124414],"domain_scores_gemma":[0.99264354,0.00073671143,0.0002405765,0.0052237646,0.00066566875,0.0004897302],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036473267,0.00042869285,0.00088293076,0.000594846,0.0007348551,0.0002453103,0.0029647462,0.00048708194,0.00064758887],"category_scores_gemma":[0.002164491,0.0003119496,0.00036162054,0.0010080242,0.0018679723,0.00029235723,0.0029836409,0.0018849277,0.00033286234],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0066298754,0.00065529894,0.005108784,0.008054723,0.0010112438,0.003994712,0.0061773392,0.005836753,0.8799383,0.006738299,0.048062578,0.027792104],"study_design_scores_gemma":[0.08273048,0.0010981074,0.0656768,0.0036562372,0.00011550766,0.0017834249,0.00046932456,0.5868808,0.22794606,0.0007897508,0.028018843,0.00083464134],"about_ca_topic_score_codex":0.062131148,"about_ca_topic_score_gemma":0.0014927429,"teacher_disagreement_score":0.65199226,"about_ca_system_score_codex":0.30985606,"about_ca_system_score_gemma":0.16364725,"threshold_uncertainty_score":0.99993324},"labels":[],"label_agreement":null},{"id":"W2620862566","doi":"10.1016/j.leukres.2017.05.023","title":"Sharing post-AML consolidation supportive therapy with local centers reduces patient travel burden without compromising outcomes","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Consolidation (business); Myeloid leukemia; Chemotherapy; Internal medicine; Business","score_opus":0.07686276982342112,"score_gpt":0.38999897339934586,"score_spread":0.31313620357592475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620862566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817255,0.0000899548,0.0003080197,0.0062665893,0.00010357013,0.002139249,0.000032363452,0.00008937779,0.009245358],"genre_scores_gemma":[0.9949157,0.00014290013,0.000943125,0.00028942397,0.00023033797,0.00016471045,0.00012533486,0.00011783325,0.0030705957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942765,0.0002777691,0.0005643095,0.001053906,0.0023465704,0.0014809187],"domain_scores_gemma":[0.9955432,0.0003251451,0.00027491784,0.0017039839,0.0015165603,0.0006362293],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0016413789,0.00041383487,0.0007550739,0.00056479394,0.0014094933,0.0005819218,0.0010351561,0.0002583073,0.00027152328],"category_scores_gemma":[0.00069383555,0.00029872122,0.00015685582,0.00027637382,0.0018009685,0.00055098307,0.0005998237,0.0018935521,0.00017401953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.023773674,0.0008416635,0.41009766,0.00054935354,0.0020203867,0.00317963,0.01947423,0.00020466217,0.27000856,0.0007804097,0.0045707603,0.264499],"study_design_scores_gemma":[0.022819102,0.005516667,0.68886316,0.0012247087,0.00008705847,0.00049684325,0.017387854,0.013840727,0.2462262,0.00020558262,0.0023362008,0.0009959185],"about_ca_topic_score_codex":0.0070511745,"about_ca_topic_score_gemma":0.00014712187,"teacher_disagreement_score":0.27876547,"about_ca_system_score_codex":0.0034202635,"about_ca_system_score_gemma":0.002793829,"threshold_uncertainty_score":0.9999465},"labels":[],"label_agreement":null},{"id":"W2625541339","doi":"10.1016/j.leukres.2017.06.009","title":"Exome sequencing reveals DNMT3A and ASXL1 variants associate with progression of chronic myeloid leukemia after tyrosine kinase inhibitor therapy","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; University of Toronto","funders":"Ministry of Education, Science and Technology; National Research Foundation of Korea; Ministry of Education","keywords":"Myeloid leukemia; Tyrosine-kinase inhibitor; Exome sequencing; Tyrosine kinase; Cancer research; Exome; CD135; Medicine; Mutation; Biology; Receptor; Genetics; Internal medicine; Gene; Cancer","score_opus":0.054807777901119875,"score_gpt":0.36418839409618997,"score_spread":0.30938061619507007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625541339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904232,0.004257726,0.000010986169,0.0006306408,0.00012183706,0.001903613,0.000044110104,0.000079809055,0.0025280833],"genre_scores_gemma":[0.9909784,0.0018054481,0.0011164156,0.00007773585,0.00062069757,0.00037498632,0.00004182144,0.00013141692,0.004853072],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99468184,0.00035903932,0.0006468543,0.0010296555,0.0019365438,0.0013460951],"domain_scores_gemma":[0.996028,0.0003108218,0.00046550838,0.0019486091,0.0007111307,0.0005359056],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022407058,0.0004981908,0.00094423816,0.0004017085,0.0007516364,0.00023511724,0.0005156218,0.000449164,0.00027226834],"category_scores_gemma":[0.0006658356,0.00036114786,0.000132682,0.00039730564,0.0010397481,0.0005143644,0.000514573,0.001308083,0.00008202128],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011443733,0.0006532623,0.22850575,0.0024478796,0.0011908525,0.005602951,0.002454499,0.000022057024,0.57639897,0.00021510622,0.0029553548,0.16810957],"study_design_scores_gemma":[0.040881086,0.007919514,0.69652873,0.0088875,0.00021983344,0.00054626644,0.00029361225,0.0016955226,0.23865621,0.0004581187,0.0029404592,0.0009731663],"about_ca_topic_score_codex":0.0014476022,"about_ca_topic_score_gemma":0.00015788528,"teacher_disagreement_score":0.46802297,"about_ca_system_score_codex":0.01842767,"about_ca_system_score_gemma":0.0076399148,"threshold_uncertainty_score":0.99988407},"labels":[],"label_agreement":null},{"id":"W2747596230","doi":"10.1016/j.leukres.2017.08.011","title":"Re-evaluation of acute erythroid leukemia according to the 2016 WHO classification","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Medical Research Council; World Health Organization","keywords":"Myeloid leukemia; Medicine; Myeloid; Myelodysplastic syndromes; Leukemia; Internal medicine; Oncology; Immunology; Bone marrow; Cancer research","score_opus":0.19457947418994617,"score_gpt":0.4626872585099872,"score_spread":0.268107784320041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2747596230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89143074,0.0002719814,0.00039103974,0.031094482,0.00032336876,0.0035914946,0.00004547519,0.00007251842,0.07277892],"genre_scores_gemma":[0.98466384,0.0005542747,0.0006872055,0.00030094213,0.00089139666,0.0005325102,0.000055627537,0.00008899275,0.012225223],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9911188,0.0009966606,0.00070504233,0.000913984,0.005015888,0.0012496567],"domain_scores_gemma":[0.99050844,0.0006544408,0.0003220163,0.004209548,0.003805018,0.00050056237],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016406981,0.00030187736,0.0005978957,0.00072948524,0.0017171949,0.00036625325,0.002127833,0.0003635693,0.00032877037],"category_scores_gemma":[0.006537031,0.0002140427,0.00021715593,0.000910744,0.00089023315,0.0005058273,0.0011941195,0.0019096634,0.0011316069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.002948192,0.00015679546,0.021366665,0.00036729936,0.0009666786,0.00012040555,0.0031219085,0.00022672996,0.21733703,0.0034461005,0.48606208,0.26388013],"study_design_scores_gemma":[0.01606139,0.0020827195,0.5483915,0.0020899065,0.0011056849,0.00016800496,0.012402637,0.18165298,0.14063051,0.0031253602,0.091177836,0.001111467],"about_ca_topic_score_codex":0.0019831918,"about_ca_topic_score_gemma":0.00022795262,"teacher_disagreement_score":0.5270248,"about_ca_system_score_codex":0.010570867,"about_ca_system_score_gemma":0.0102022905,"threshold_uncertainty_score":0.9996461},"labels":[],"label_agreement":null},{"id":"W2766904819","doi":"10.1016/j.leukres.2017.10.016","title":"JAK2V617F detection and allele burden measurement in saliva vs. peripheral blood in patients with myelofibrosis","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"DNA Genotek","keywords":"Saliva; Myelofibrosis; Medicine; Concordance; Internal medicine; Gastroenterology; Peripheral blood; Allele; Bone marrow; Biology; Genetics","score_opus":0.04390164215939978,"score_gpt":0.3152982846775243,"score_spread":0.2713966425181245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766904819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963982,0.00011707955,0.0000021982266,0.0008351355,0.0000280865,0.0010312718,0.000002818924,0.000009833096,0.0015753581],"genre_scores_gemma":[0.99908286,0.0001415717,0.00018563418,0.000030037167,0.00008998344,0.000230166,0.000008870668,0.000025025249,0.00020582696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975474,0.00015736671,0.0002226171,0.00044866712,0.001107483,0.00051646767],"domain_scores_gemma":[0.9988344,0.000059913735,0.00005566451,0.00046822504,0.00040296308,0.00017887482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084739295,0.00017214128,0.00031742064,0.0002395829,0.00032696791,0.00011966141,0.00012328246,0.00011160681,0.00006398342],"category_scores_gemma":[0.00034655494,0.00012883368,0.00002673137,0.00017787356,0.00016681703,0.0001510884,0.00011755923,0.00043641796,0.00001652243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018326472,0.00037742517,0.9817563,0.00008104426,0.0000698661,0.000075392694,0.0008012899,0.00001301324,0.0012174286,0.000019644174,0.000060020302,0.013695892],"study_design_scores_gemma":[0.011351948,0.0025037276,0.9773206,0.00033696878,0.000023577662,0.0000052233386,0.000118712866,0.00019330978,0.0075792274,0.000025688387,0.00041824192,0.00012274581],"about_ca_topic_score_codex":0.0068980795,"about_ca_topic_score_gemma":0.009519321,"teacher_disagreement_score":0.013573146,"about_ca_system_score_codex":0.0020655869,"about_ca_system_score_gemma":0.00047458094,"threshold_uncertainty_score":0.9997151},"labels":[],"label_agreement":null},{"id":"W2775090033","doi":"10.1016/j.leukres.2017.12.003","title":"Overexpression of Arginase 1 is linked to DNMT3A and TET2 mutations in lower-grade myelodysplastic syndromes and chronic myelomonocytic leukemia","year":2017,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Queen's University","funders":"European Hematology Association","keywords":"Chronic myelomonocytic leukemia; Arginase; Cancer research; Myelodysplastic syndromes; Bone marrow; Myeloid; Biology; Immune dysregulation; Immune system; Epigenetics; Immunology; Innate immune system; Inflammation; Genetics; Arginine; Gene","score_opus":0.06930819219866653,"score_gpt":0.39275013868571823,"score_spread":0.3234419464870517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2775090033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921639,0.0007102195,0.000034761375,0.0031112912,0.0000726721,0.00164881,0.000050130024,0.000043395958,0.0021648365],"genre_scores_gemma":[0.9945017,0.0009917992,0.0009898558,0.000094427895,0.00018617055,0.00020159257,0.000023454026,0.00008590578,0.0029250672],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.995258,0.00028444867,0.00065684086,0.0010482512,0.0014422934,0.0013102164],"domain_scores_gemma":[0.9956624,0.0012340066,0.00013000457,0.0016519672,0.0004402618,0.00088136137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016694856,0.0003847773,0.0008219462,0.0013669695,0.00069608126,0.00024266765,0.00070087553,0.00041514012,0.00021310744],"category_scores_gemma":[0.0031792535,0.00034783038,0.00009428878,0.0007091636,0.0013895002,0.00042246908,0.0012651469,0.001884528,0.00012474137],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034638701,0.00040045733,0.04927358,0.0043288693,0.0003254957,0.0027815786,0.0048026294,0.0002481264,0.88800895,0.0011447939,0.0070099565,0.038211685],"study_design_scores_gemma":[0.020895377,0.00429358,0.81737876,0.0067924545,0.00013627233,0.0008113928,0.0014108493,0.048010405,0.090610206,0.0025731896,0.0060381447,0.0010493646],"about_ca_topic_score_codex":0.0021678805,"about_ca_topic_score_gemma":0.0002468175,"teacher_disagreement_score":0.79739875,"about_ca_system_score_codex":0.0059386296,"about_ca_system_score_gemma":0.0046894467,"threshold_uncertainty_score":0.99989736},"labels":[],"label_agreement":null},{"id":"W2782967915","doi":"10.1016/j.leukres.2018.01.006","title":"Targeting the IL-17/IL-6 axis can alter growth of Chronic Lymphocytic Leukemia in vivo/in vitro","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Chronic lymphocytic leukemia; Fludarabine; Cancer research; Bone marrow; In vivo; Immunology; In vitro; Leukemia; Mesenchymal stem cell; Interleukin 4; Interleukin; Cytokine; Medicine; Biology; Chemotherapy; Pathology; Internal medicine; Cyclophosphamide","score_opus":0.033310886801141915,"score_gpt":0.33809158004007767,"score_spread":0.30478069323893575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782967915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832833,0.0010212363,0.000036470756,0.0009633262,0.00022777413,0.002144351,0.000070348964,0.00008365694,0.012169548],"genre_scores_gemma":[0.9919413,0.0005438838,0.0002792955,0.0003329365,0.00131346,0.00032581654,0.00003969123,0.00014881838,0.005074837],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9900104,0.0010512938,0.0013843874,0.001283437,0.0032436952,0.0030267825],"domain_scores_gemma":[0.99429065,0.00206738,0.000190381,0.0018259598,0.00110289,0.00052272715],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006912706,0.0005274754,0.0010553278,0.0015473498,0.00034830745,0.0001017714,0.0015418318,0.0005174319,0.0009065104],"category_scores_gemma":[0.0028664062,0.00040006544,0.00024746175,0.004062708,0.0025424936,0.00022823823,0.0010573814,0.0023141936,0.000324406],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008124581,0.00030195335,0.0024955475,0.0030286158,0.00034877594,0.0029844053,0.008989825,0.0018936895,0.9026353,0.0014205327,0.059557103,0.008219669],"study_design_scores_gemma":[0.03313135,0.001484121,0.001075391,0.0011127589,0.00004213548,0.00036445804,0.0013856319,0.35677278,0.59469277,0.00093914603,0.008378187,0.0006212651],"about_ca_topic_score_codex":0.069113664,"about_ca_topic_score_gemma":0.0044787615,"teacher_disagreement_score":0.35487908,"about_ca_system_score_codex":0.38093126,"about_ca_system_score_gemma":0.1315387,"threshold_uncertainty_score":0.9999875},"labels":[],"label_agreement":null},{"id":"W2789431138","doi":"10.1016/j.leukres.2018.02.005","title":"Iron overload in lower international prognostic scoring system risk patients with myelodysplastic syndrome receiving red blood cell transfusions: Relation to infections and possible benefit of iron chelation therapy","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Incidence (geometry); Internal medicine; Hazard ratio; International Prognostic Scoring System; Deferasirox; Blood transfusion; Anemia; Surgery; Thalassemia; Confidence interval; Bone marrow","score_opus":0.014959519650715038,"score_gpt":0.28039519484022407,"score_spread":0.26543567518950906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789431138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949996,0.00007582526,0.00022758529,0.00016537536,0.00014478959,0.0021776436,0.000024578301,0.000055118857,0.0021294795],"genre_scores_gemma":[0.99791425,0.00023442271,0.0009931964,0.000009232954,0.00011610374,0.00018253918,0.000046181416,0.0000578196,0.00044622386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660605,0.00025935363,0.0005380167,0.00062989106,0.001378073,0.00058859214],"domain_scores_gemma":[0.9975373,0.0006901809,0.00013638691,0.00043626584,0.00094475626,0.00025511984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001364884,0.00022384482,0.00034089517,0.001362594,0.00030630885,0.00006706192,0.00020273656,0.00023037958,0.000095664764],"category_scores_gemma":[0.0007805858,0.00019280605,0.00004701541,0.0015852089,0.00021268934,0.00035577183,0.00013378082,0.0010159911,0.000043507618],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019461911,0.00047324464,0.9787111,0.0003363206,0.000067436195,0.000045705478,0.0011921177,0.0007419165,0.013345259,0.00007217348,0.000029305242,0.0030392231],"study_design_scores_gemma":[0.0074566863,0.003779884,0.97946537,0.0016634222,0.000048558217,0.00005104607,0.00022871114,0.0054344167,0.0016270145,0.000033080916,0.000032544944,0.00017927786],"about_ca_topic_score_codex":0.0013878187,"about_ca_topic_score_gemma":0.00032721637,"teacher_disagreement_score":0.011718245,"about_ca_system_score_codex":0.0021961057,"about_ca_system_score_gemma":0.0005853918,"threshold_uncertainty_score":0.7862403},"labels":[],"label_agreement":null},{"id":"W2789525108","doi":"10.1016/j.leukres.2018.03.002","title":"An autologous tumor vaccine for CLL","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Sunnybrook Hospital; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Cytotoxic T cell; Immunology; Chronic lymphocytic leukemia; Antigen; Cancer research; CD8; Ionomycin; Antigen-presenting cell; Biology; CD40; Medicine; Leukemia; T cell; Immune system; In vitro; Stimulation; Endocrinology","score_opus":0.08414939493496212,"score_gpt":0.4536357256324654,"score_spread":0.36948633069750325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789525108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97270316,0.00026763554,0.00073055114,0.0014999068,0.00023003995,0.0025081781,0.000027536045,0.00031054288,0.021722464],"genre_scores_gemma":[0.98308873,0.000033600685,0.0045785327,0.0006592465,0.0022538481,0.00043584165,0.00007650081,0.00012316392,0.008750554],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946701,0.0003035829,0.00048619448,0.0009842406,0.0016173563,0.0019385525],"domain_scores_gemma":[0.99457705,0.0008968021,0.00005925801,0.0016972226,0.0019035452,0.0008661348],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0034822442,0.00027178432,0.0005394592,0.000654601,0.00057044195,0.00012077376,0.0007639554,0.00027350147,0.0009825323],"category_scores_gemma":[0.00189262,0.00022719268,0.0001600944,0.0011385004,0.0006858856,0.00020866735,0.00027920588,0.0009285125,0.001483071],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.031734526,0.0020780377,0.0047803274,0.0030753885,0.00077729236,0.0039608595,0.0033740161,0.0000580343,0.23638503,0.030474164,0.5673479,0.11595441],"study_design_scores_gemma":[0.07704054,0.019800775,0.008674337,0.00043180058,0.00012349851,0.00302984,0.0011060316,0.27356786,0.17397106,0.0062594083,0.43503234,0.0009625298],"about_ca_topic_score_codex":0.0013182517,"about_ca_topic_score_gemma":0.00025163442,"teacher_disagreement_score":0.27350983,"about_ca_system_score_codex":0.027326444,"about_ca_system_score_gemma":0.023113966,"threshold_uncertainty_score":0.9999307},"labels":[],"label_agreement":null},{"id":"W2790326841","doi":"10.1016/j.leukres.2018.02.009","title":"The importance of meaningful activity in people living with acute myeloid leukemia","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Deconditioning; Quality of life (healthcare); Psychology; Psychological intervention; Qualitative research; Gerontology; Population; Observational study; Medicine; Disease; Incentive; Physical therapy; Psychiatry; Environmental health; Psychotherapist; Pathology","score_opus":0.03365902177792159,"score_gpt":0.3485649236618035,"score_spread":0.31490590188388196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790326841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97107595,0.00020161475,0.000085018495,0.0017549626,0.00007000672,0.0011817042,0.000009108313,0.00007482083,0.025546815],"genre_scores_gemma":[0.9923827,0.00057835196,0.0007032278,0.00012230095,0.00042307985,0.00019772924,0.000006398399,0.000105486644,0.0054807095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934457,0.00053475855,0.00060370576,0.0008832813,0.0026378059,0.0018947498],"domain_scores_gemma":[0.9934514,0.0027671414,0.00014378442,0.0017708943,0.0014409226,0.00042582027],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0062334393,0.00035306628,0.00070457096,0.0006609926,0.00066138373,0.00011398118,0.0010496557,0.00030636048,0.00027215207],"category_scores_gemma":[0.002130524,0.00023217352,0.0001345375,0.0034544151,0.0019835748,0.00033272224,0.000824518,0.002775234,0.00019014638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009221893,0.00032746224,0.7403465,0.00064937887,0.0007672756,0.0010691758,0.006835178,0.000029335559,0.19611222,0.0029504283,0.01790087,0.02379029],"study_design_scores_gemma":[0.0052690785,0.0028275491,0.8969863,0.0010804035,0.00007012286,0.00043419184,0.0027379312,0.007106706,0.07736403,0.00040585504,0.00517835,0.0005394725],"about_ca_topic_score_codex":0.0030836123,"about_ca_topic_score_gemma":0.009392556,"teacher_disagreement_score":0.15663981,"about_ca_system_score_codex":0.008143968,"about_ca_system_score_gemma":0.009646833,"threshold_uncertainty_score":0.9995254},"labels":[],"label_agreement":null},{"id":"W2791883352","doi":"10.1016/j.leukres.2018.02.012","title":"AML refractory to primary induction with Ida-FLAG has a poor clinical outcome","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care; Princess Margaret Cancer Foundation","keywords":"Flag (linear algebra); Refractory (planetary science); Medicine; Complete remission; Internal medicine; Induction chemotherapy; Oncology; Chemotherapy; Salvage therapy; Transplantation; Surgery; Biology","score_opus":0.2133251517237102,"score_gpt":0.46321697722524635,"score_spread":0.24989182550153616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2791883352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9498978,0.000092007824,0.0003127399,0.015505525,0.00033396974,0.0019970287,0.000012535666,0.00023958634,0.031608783],"genre_scores_gemma":[0.9545179,0.00008779158,0.0068147024,0.0037903287,0.0041913176,0.0002426457,0.00006006391,0.00017314359,0.03012208],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9917058,0.0009241771,0.0009915087,0.0013483453,0.003199762,0.001830457],"domain_scores_gemma":[0.9934766,0.00094931887,0.00011828229,0.0017777997,0.0021826073,0.0014953364],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0073606414,0.0003826235,0.00086238474,0.0011827584,0.0006624739,0.00020733738,0.00081093877,0.0006228591,0.0008540507],"category_scores_gemma":[0.0031313866,0.00028829914,0.00019005233,0.0024409504,0.00220995,0.00033756727,0.0008064801,0.0043469043,0.0064272378],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.023808016,0.0011932919,0.15594831,0.0007035428,0.00064807135,0.0022251208,0.0018144037,0.0000071689083,0.06361833,0.00063086406,0.58474606,0.1646568],"study_design_scores_gemma":[0.010046024,0.014310667,0.34387186,0.00044059928,0.000090722846,0.0005855665,0.0008502709,0.0004916556,0.006971584,0.00018610894,0.62144893,0.0007059809],"about_ca_topic_score_codex":0.001072455,"about_ca_topic_score_gemma":0.00023829135,"teacher_disagreement_score":0.18792355,"about_ca_system_score_codex":0.007095864,"about_ca_system_score_gemma":0.007826228,"threshold_uncertainty_score":0.9999569},"labels":[],"label_agreement":null},{"id":"W2793996297","doi":"10.1016/j.leukres.2018.02.016","title":"RETRACTED: Arsenic Trioxide Inhibits Proliferation and Induced apoptosis of Leukemia Stem Cells with Drug Resistance","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":true,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Science and Technology Department of Gansu Province; Lanzhou University; Ryerson University","keywords":"Arsenic trioxide; Apoptosis; Cancer research; Drug resistance; Leukemia; Stem cell; Drug; Pharmacology; Arsenic; Medicine; Chemistry; Biology; Cell biology; Immunology; Microbiology; Biochemistry","score_opus":0.024333322470176194,"score_gpt":0.28935695904442615,"score_spread":0.26502363657425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793996297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99471414,0.0005984095,0.00014403023,0.00010447856,0.00006811119,0.0004936499,0.000008917711,0.000020638769,0.0038476386],"genre_scores_gemma":[0.99084234,0.00041529984,0.0007552137,0.000053945147,0.0003653081,0.00006800959,0.00002711064,0.000050252114,0.0074225],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99726623,0.00031846104,0.0004063432,0.0007137358,0.0007417522,0.0005534919],"domain_scores_gemma":[0.99802935,0.000086019136,0.00016934662,0.00064189243,0.00090629834,0.00016709337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012604133,0.00024048326,0.00027720194,0.0001729819,0.00026450172,0.00007965002,0.00035619145,0.00039078586,0.0000118054295],"category_scores_gemma":[0.00013353325,0.00020500775,0.000052323066,0.00057800865,0.0006094372,0.00002278723,0.00019742275,0.0006033254,0.000014323984],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007930132,0.000027548444,0.0006621036,0.00023279327,0.00004557561,0.0000036724643,0.00029686917,0.000010160873,0.9927439,0.00011572107,0.0037566964,0.0013119421],"study_design_scores_gemma":[0.0010894665,0.0005402075,0.00025619284,0.00014996722,0.000015968808,0.000011182151,0.00032124275,0.00009328397,0.992263,0.000086527434,0.0049309796,0.00024198575],"about_ca_topic_score_codex":0.00006308652,"about_ca_topic_score_gemma":0.00016233923,"teacher_disagreement_score":0.0038717648,"about_ca_system_score_codex":0.00031380655,"about_ca_system_score_gemma":0.0016617611,"threshold_uncertainty_score":0.83599734},"labels":[],"label_agreement":null},{"id":"W2799981331","doi":"10.1016/j.leukres.2018.04.007","title":"Cell membrane-bound CD200 signals both via an extracellular domain and following nuclear translocation of a cytoplasmic fragment","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Neuroinflammation and Neurodegeneration Mechanisms","field":"Neuroscience","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute; University of Toronto; University Health Network; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Transfection; Cell biology; Biology; Chromatin immunoprecipitation; Transcription factor; Nuclear localization sequence; Cytoplasm; Immunoprecipitation; Molecular biology; Intracellular; HEK 293 cells; Cell; Cell culture; Gene; Gene expression; Genetics","score_opus":0.05781588580220475,"score_gpt":0.32169662980595093,"score_spread":0.26388074400374617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2799981331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938687,0.000047541915,0.0041573304,0.00019362176,0.0001413859,0.0005430873,0.000005553452,0.00007394602,0.0009688515],"genre_scores_gemma":[0.9978628,0.0000791302,0.0009271174,0.00022163897,0.00010557552,0.000020584112,0.000003222204,0.00004702194,0.00073289016],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99661356,0.000876642,0.00040554174,0.00063354766,0.0010284579,0.00044225063],"domain_scores_gemma":[0.9988903,0.0002524236,0.000093134004,0.00045068547,0.0000993687,0.0002141128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013394343,0.00016642966,0.0002016861,0.00031267354,0.0005597171,0.00016233674,0.00034498758,0.000107242195,0.0002665726],"category_scores_gemma":[0.00008708707,0.00016714478,0.00006511555,0.00051879487,0.0002791916,0.00040423492,0.00006605507,0.0003372798,0.00012010511],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009692375,0.00006533271,0.000005270683,0.00004015583,0.000002161664,0.00003481109,0.001260282,0.00008220158,0.9925244,0.0049072644,0.00007568085,0.0009055243],"study_design_scores_gemma":[0.000926824,0.0005058982,0.000014477423,0.000021348524,0.0000046476193,0.000019117027,0.00013752701,0.024136472,0.97169024,0.0013571398,0.0010396936,0.00014664256],"about_ca_topic_score_codex":0.000032433523,"about_ca_topic_score_gemma":0.000016563044,"teacher_disagreement_score":0.024054272,"about_ca_system_score_codex":0.000120940334,"about_ca_system_score_gemma":0.00019724375,"threshold_uncertainty_score":0.68159664},"labels":[],"label_agreement":null},{"id":"W2806323598","doi":"10.1016/j.leukres.2018.06.001","title":"The real-world outcomes of treating Polycythemia Vera: Physician adherence to treatment guidelines","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Population Health Research Institute; McMaster University","funders":"Heart and Stroke Foundation of Canada; American Society of Hematology","keywords":"Medicine; Polycythemia vera; Internal medicine; Myeloproliferative neoplasm; Cohort; Retrospective cohort study; White blood cell; Myelofibrosis; Bone marrow","score_opus":0.1747975853204603,"score_gpt":0.477876164278517,"score_spread":0.3030785789580567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806323598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509193,0.00020022843,0.000008373357,0.006468077,0.000112461814,0.0011500848,0.00002074529,0.000042009287,0.041078765],"genre_scores_gemma":[0.97284,0.00049247715,0.001567307,0.00038638886,0.00059018703,0.00048389146,0.000012546317,0.000035852958,0.023591325],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9973655,0.00016469887,0.0005132994,0.0004445239,0.0008625853,0.0006494392],"domain_scores_gemma":[0.9967082,0.0011135575,0.000093953364,0.000777037,0.0010509016,0.00025634322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006488496,0.0002491251,0.00051321497,0.00021410051,0.0005398537,0.00005475414,0.00022493913,0.00006175214,0.00010009578],"category_scores_gemma":[0.000545473,0.00013334648,0.00016017602,0.00076037925,0.00032593953,0.00004870129,0.00012379585,0.00019357621,0.00031102815],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014142554,0.0006686418,0.52682453,0.000057423655,0.00085775746,0.000084298335,0.0024859484,0.000011206768,0.011353894,0.0068604383,0.021943506,0.4274381],"study_design_scores_gemma":[0.006517706,0.013911857,0.4474523,0.0007062742,0.00019237657,0.000010382964,0.0015676072,0.00081654085,0.44918582,0.0007775458,0.078451686,0.00040988217],"about_ca_topic_score_codex":0.00674667,"about_ca_topic_score_gemma":0.0047925147,"teacher_disagreement_score":0.43783194,"about_ca_system_score_codex":0.0015748895,"about_ca_system_score_gemma":0.0008398905,"threshold_uncertainty_score":0.9998675},"labels":[],"label_agreement":null},{"id":"W2806968913","doi":"10.1016/j.leukres.2018.06.005","title":"Antimalarial drugs trigger lysosome-mediated cell death in chronic lymphocytic leukemia (CLL) cells","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Research Institute in Oncology and Hematology","funders":"Canadian Cancer Society Research Institute; CancerCare Manitoba Foundation; Research Manitoba","keywords":"Mefloquine; Lysosome; Programmed cell death; Chronic lymphocytic leukemia; Pharmacology; Leukemia; Primaquine; Myeloid leukemia; Apoptosis; Cancer research; Chemistry; Immunology; Medicine; Chloroquine; Biochemistry","score_opus":0.04492586500004525,"score_gpt":0.35592609796185143,"score_spread":0.3110002329618062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806968913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.955675,0.0006508188,0.000027586175,0.00020588924,0.00056700205,0.0038790605,0.000030507395,0.00031001645,0.0386541],"genre_scores_gemma":[0.97291774,0.000500041,0.00033164365,0.00023999029,0.0028812033,0.00039183797,0.000103537524,0.00027645676,0.022357564],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98587865,0.0013358135,0.0015448203,0.0022226565,0.0048216325,0.004196428],"domain_scores_gemma":[0.99232763,0.0020604474,0.00020013748,0.0027229511,0.0013537476,0.0013350939],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.006198033,0.00083400914,0.001460497,0.0026537906,0.00059361756,0.00029878545,0.0015844037,0.0009940221,0.0023242263],"category_scores_gemma":[0.0012078916,0.00075867004,0.00036795274,0.0050652046,0.0015824148,0.00045067057,0.001205156,0.0030883728,0.010114562],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.03271628,0.0028365892,0.009228146,0.0056696045,0.0012279442,0.026418494,0.018483395,0.002940017,0.7366446,0.0011618856,0.15067758,0.011995423],"study_design_scores_gemma":[0.20304312,0.009288613,0.0052276724,0.0010870135,0.00020724302,0.0004883069,0.0019271602,0.45046192,0.28234723,0.00039190424,0.043626197,0.0019036086],"about_ca_topic_score_codex":0.022078114,"about_ca_topic_score_gemma":0.00085309974,"teacher_disagreement_score":0.4542974,"about_ca_system_score_codex":0.4844968,"about_ca_system_score_gemma":0.23061347,"threshold_uncertainty_score":0.99948645},"labels":[],"label_agreement":null},{"id":"W2807946057","doi":"10.1016/j.leukres.2018.06.008","title":"Hodgkin lymphoma of the gastrointestinal tract in patients with inflammatory bowel disease: Portrait of a rare clinical entity","year":2018,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Immunosuppression; Internal medicine; Lymphoma; Gastroenterology; Inflammatory bowel disease; Ulcerative colitis; Chemotherapy; Gastrointestinal tract; Disease","score_opus":0.07467158238057321,"score_gpt":0.39730007063406203,"score_spread":0.32262848825348883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807946057","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4696671,0.52599376,5.191908e-7,0.000036143025,0.000085175474,0.003385347,0.00026301426,0.000014694149,0.00055424444],"genre_scores_gemma":[0.14286895,0.85523325,0.00025026433,0.000022502196,0.00029355576,0.0004438329,0.00030542605,0.00011596286,0.00046627317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949069,0.00090565823,0.0013558166,0.0005985873,0.0016880312,0.00054501084],"domain_scores_gemma":[0.9964166,0.00081822753,0.0005988872,0.0011997531,0.0006218548,0.00034467594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016273861,0.00035910355,0.001570018,0.00034482873,0.00006475559,0.000017238111,0.0005079497,0.00021342002,0.000099765246],"category_scores_gemma":[0.0011446654,0.00019436113,0.00071431865,0.0006368336,0.00091260305,0.000059869846,0.00029607382,0.00058460236,0.00003005301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005718844,0.002252979,0.8574106,0.012491233,0.00011397228,0.00028369456,0.00001761027,1.7275136e-7,3.19313e-8,0.000038241462,0.0010543171,0.12576523],"study_design_scores_gemma":[0.0048022363,0.0011345607,0.9059635,0.046437163,0.00042982676,0.00003975087,0.000008794319,0.0000033830847,0.0000014763376,0.000010748819,0.041038185,0.00013042393],"about_ca_topic_score_codex":0.00015857302,"about_ca_topic_score_gemma":0.00006063315,"teacher_disagreement_score":0.3292395,"about_ca_system_score_codex":0.0017953753,"about_ca_system_score_gemma":0.009958773,"threshold_uncertainty_score":0.99565387},"labels":[],"label_agreement":null},{"id":"W2888861919","doi":"10.1016/j.leukres.2018.08.004","title":"Acute promyelocytic leukemia in the intensive care unit: A retrospective analysis","year":2018,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Flow cytometry; Medicine; Acute promyelocytic leukemia; Acute leukemia; Leukemia; Immunophenotyping; Chronic myelomonocytic leukemia; Internal medicine; Immunology; Pathology; Bone marrow; Myelodysplastic syndromes; Biology","score_opus":0.037696488725430174,"score_gpt":0.3518346856172466,"score_spread":0.31413819689181643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2888861919","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89836186,0.005569299,0.00027468384,0.06390911,0.0006198716,0.0034774428,0.00044771424,0.000084587155,0.027255401],"genre_scores_gemma":[0.8033927,0.0016439823,0.00021845309,0.15793529,0.009518112,0.0011131135,0.0071836887,0.00026602639,0.018728642],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927449,0.0014475946,0.00062499545,0.0017658812,0.0018577633,0.0015588531],"domain_scores_gemma":[0.99297994,0.00017220793,0.00023731765,0.0023489175,0.0041530416,0.00010854453],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0015548544,0.0006784613,0.00082405517,0.0009853797,0.00044879864,0.0003141853,0.0027116812,0.0022623506,0.000097499775],"category_scores_gemma":[0.0011503571,0.0005088367,0.0005552249,0.0032310085,0.0012747097,0.000012127342,0.00080623396,0.005828482,0.00015196565],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022098407,0.000011195124,0.0037138513,0.0004358878,0.0020040604,0.0017882888,0.0032020644,0.000055834313,0.0076172478,0.000028865577,0.98062456,0.0002971924],"study_design_scores_gemma":[0.0019690646,0.0016824806,0.0028194683,0.00027092712,0.0014322889,0.0002219146,0.010182183,0.0003555598,0.03842921,0.00073434616,0.9403579,0.0015446094],"about_ca_topic_score_codex":0.00056490523,"about_ca_topic_score_gemma":0.0003861679,"teacher_disagreement_score":0.09496918,"about_ca_system_score_codex":0.003889199,"about_ca_system_score_gemma":0.0056148395,"threshold_uncertainty_score":0.9999347},"labels":[],"label_agreement":null},{"id":"W2889965434","doi":"10.1016/j.leukres.2018.09.005","title":"Iron overload in myelodysplastic syndromes: Evidence based guidelines from the Canadian consortium on MDS","year":2018,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Foothills Medical Centre; Université Laval; CancerCare Manitoba; Health Sciences Centre; University of Alberta Hospital; University Health Network; Employment and Social Development Canada; Princess Margaret Cancer Centre; University of Saskatchewan; Leukemia & Lymphoma Society of Canada; Queen Elizabeth II Health Sciences Centre; University of Alberta; Jewish General Hospital; Sunnybrook Health Science Centre; McMaster University; St. Paul's Hospital","funders":"","keywords":"Myelodysplastic syndromes; Medicine; Guideline; Intensive care medicine; Grading (engineering); Myeloid leukemia; Internal medicine; Pathology; Bone marrow","score_opus":0.3079888152962133,"score_gpt":0.4594524009597839,"score_spread":0.1514635856635706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2889965434","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006497645,0.9895039,0.0000013931533,0.0037195305,0.00044498968,0.0021095162,0.00012035569,0.000038245154,0.0034122998],"genre_scores_gemma":[0.0007808836,0.99407524,0.000062752755,0.0011868777,0.0005380251,0.00023561288,0.00020919666,0.00010327456,0.0028081592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938848,0.0011211756,0.0010820815,0.0009823705,0.0016074256,0.0013221587],"domain_scores_gemma":[0.9924763,0.0045955554,0.00016453941,0.0014971545,0.00059650117,0.000669945],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0031452656,0.00054243737,0.0014804441,0.0009330368,0.00044064052,0.00014405703,0.00090782397,0.0012314637,0.0008016906],"category_scores_gemma":[0.009504544,0.0003193324,0.00037310045,0.0017362554,0.0007591824,0.000071437265,0.00014934977,0.0037362245,0.0023689086],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00033856175,0.00013308504,0.0005076777,0.0180522,0.00035604296,0.0038259726,0.00025380906,0.00007284756,0.0000029269102,0.00024342476,0.33475405,0.6414594],"study_design_scores_gemma":[0.00069555547,0.0003745523,0.0001835529,0.113145255,0.00024810783,0.000059560527,0.000102878956,0.00063371676,8.732999e-7,0.000037794573,0.88421553,0.00030260824],"about_ca_topic_score_codex":0.34200245,"about_ca_topic_score_gemma":0.14560352,"teacher_disagreement_score":0.6411568,"about_ca_system_score_codex":0.0065084365,"about_ca_system_score_gemma":0.027079096,"threshold_uncertainty_score":0.99992585},"labels":[],"label_agreement":null},{"id":"W2890730652","doi":"10.1016/j.leukres.2018.08.021","title":"Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Toronto; Ottawa Hospital; University Health Network; Université Laval; University of Ottawa; Vancouver General Hospital; Princess Margaret Cancer Centre; University of Calgary; Alberta Health Services; BC Cancer Agency; McMaster University","funders":"","keywords":"Medicine; Internal medicine; Myeloid leukemia; Transplantation; Gastroenterology; Tyrosine-kinase inhibitor; Population; Oncology; Cancer","score_opus":0.03327361829229448,"score_gpt":0.3345510187944684,"score_spread":0.30127740050217394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2890730652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97150207,0.00095750584,0.000003508072,0.011583379,0.00033012702,0.0018858281,0.000119577875,0.00008653534,0.013531462],"genre_scores_gemma":[0.99008685,0.00027425488,0.00018083306,0.0021233335,0.0013371471,0.0002871832,0.00026511386,0.00009951533,0.0053457934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99376017,0.0005188348,0.00065774075,0.000927335,0.0018368722,0.002299036],"domain_scores_gemma":[0.9962357,0.0006427803,0.000069334375,0.001644407,0.00058211904,0.0008256012],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0022733114,0.0004929256,0.00064060243,0.0011326079,0.00063944637,0.00015632174,0.0009096492,0.0004365677,0.0011718925],"category_scores_gemma":[0.0005314685,0.00033836125,0.00020929278,0.0016849734,0.0007485354,0.00021645382,0.00014734258,0.0023449548,0.0022097535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.004289383,0.0012226229,0.6204537,0.0018065439,0.0011907625,0.025878694,0.025857069,0.00009333378,0.09178857,0.006363954,0.13876522,0.08229013],"study_design_scores_gemma":[0.021798348,0.0043995995,0.82553715,0.0013515741,0.00018623633,0.0011158959,0.0016985709,0.0016530938,0.023043197,0.00034842998,0.11778947,0.0010784193],"about_ca_topic_score_codex":0.44594324,"about_ca_topic_score_gemma":0.5875566,"teacher_disagreement_score":0.20508344,"about_ca_system_score_codex":0.054228526,"about_ca_system_score_gemma":0.029065477,"threshold_uncertainty_score":0.99995667},"labels":[],"label_agreement":null},{"id":"W2903979174","doi":"10.1016/j.leukres.2018.12.002","title":"The management and outcomes of patients with myelodysplastic syndrome with persistent severe thrombocytopenia: An observational single centre registry study","year":2018,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto","funders":"Celgene","keywords":"Medicine; Observational study; Myelodysplastic syndromes; Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.06938188478336435,"score_gpt":0.33238649535146897,"score_spread":0.26300461056810465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2903979174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947288,0.000036577458,0.000011015998,0.0008367034,0.000031461394,0.002298401,0.000022604729,0.000031852982,0.0020025964],"genre_scores_gemma":[0.9914973,0.000012716685,0.0011891426,0.000057923855,0.000047935962,0.00007614985,0.000052881307,0.000053344873,0.007012636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99528974,0.00030356008,0.00034998584,0.0006506229,0.0026171631,0.0007889442],"domain_scores_gemma":[0.99665505,0.00047591337,0.00010695809,0.001063088,0.0013738613,0.0003251161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010564146,0.00025719547,0.00045976456,0.00021997026,0.0006782555,0.00012732706,0.0005062742,0.0000926672,0.000090189664],"category_scores_gemma":[0.0001553418,0.00014134817,0.000048352053,0.00076709344,0.0013018693,0.00022203947,0.00046143762,0.0006661636,0.000029531184],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035211244,0.0009906328,0.9899962,0.00021978721,0.0011405394,0.00035799146,0.0012042867,0.000014106233,0.000044320608,0.00027777074,0.00096314837,0.0012701051],"study_design_scores_gemma":[0.0072697224,0.008353578,0.97505814,0.000160385,0.00015930552,0.00007742952,0.00773226,0.00026544498,0.00004741933,0.000029347982,0.00067154196,0.00017544751],"about_ca_topic_score_codex":0.00019000498,"about_ca_topic_score_gemma":0.000400412,"teacher_disagreement_score":0.014938069,"about_ca_system_score_codex":0.0015023937,"about_ca_system_score_gemma":0.0007419762,"threshold_uncertainty_score":0.5764011},"labels":[],"label_agreement":null},{"id":"W2907456071","doi":"10.1016/j.leukres.2019.01.002","title":"Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease","year":2019,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"Université de Montréal; Hoechst Marion Roussel","keywords":"Medicine; Hematopoietic stem cell transplantation; Transplantation; Internal medicine; Population; Context (archaeology); Lymphoma; Hematopoietic cell; Oncology; Surgery; Stem cell; Haematopoiesis","score_opus":0.018073278266295643,"score_gpt":0.2787530836565074,"score_spread":0.2606798053902118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907456071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996922,0.00024121879,0.000007543923,0.0001575083,0.000021116146,0.002224104,0.00009034526,0.000017246952,0.00031891261],"genre_scores_gemma":[0.99858993,0.000024169023,0.00012796686,0.00004547839,0.00000915905,0.00018218269,0.00010012797,0.000031061794,0.000889923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982372,0.00008814247,0.00028253844,0.00041432198,0.00051677966,0.0004610501],"domain_scores_gemma":[0.99863255,0.0004281358,0.00005721048,0.00030163684,0.000356324,0.00022416415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002098475,0.00017758223,0.00045936013,0.00018492996,0.000046006928,0.000014978154,0.00007774239,0.000098622055,0.000021879756],"category_scores_gemma":[0.000013492623,0.0001250059,0.000053085663,0.00026753577,0.000101146456,0.00005006152,0.0000366607,0.00010902421,0.0000146130915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024107771,0.0015116162,0.9900572,0.0018225978,0.00004255805,0.0001665459,0.0019042592,0.000006322384,0.00040520186,0.000035009587,0.00012180685,0.0015161503],"study_design_scores_gemma":[0.028434247,0.000872749,0.94269824,0.0003606724,0.000079543635,0.000007900358,0.00027867302,0.0005768316,0.026489142,0.000024478837,0.000034572215,0.00014294012],"about_ca_topic_score_codex":0.00023808907,"about_ca_topic_score_gemma":0.000027508848,"teacher_disagreement_score":0.047358904,"about_ca_system_score_codex":0.0006983461,"about_ca_system_score_gemma":0.00057675893,"threshold_uncertainty_score":0.50975925},"labels":[],"label_agreement":null},{"id":"W2949586010","doi":"10.1016/j.leukres.2019.106170","title":"Delayed time from RBC transfusion dependence to first cardiac event in lower IPSS risk MDS patients receiving iron chelation therapy","year":2019,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Celgene","keywords":"Chelation therapy; Medicine; Internal medicine; Cardiovascular event; Cardiology; Thalassemia","score_opus":0.01229884529623126,"score_gpt":0.2871517802211221,"score_spread":0.2748529349248908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949586010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940637,0.0005427021,0.000041727304,0.00060593785,0.00027642833,0.001712175,0.000025956493,0.0000381015,0.0026932892],"genre_scores_gemma":[0.9944862,0.0035542413,0.00011917883,0.000086706474,0.00007398752,0.000051765048,0.00010112689,0.000042121163,0.0014846391],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970939,0.0003312038,0.0003546125,0.00054383,0.0010883481,0.0005881064],"domain_scores_gemma":[0.9987092,0.0003176625,0.000047097892,0.0004905805,0.0002041402,0.00023132697],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011269773,0.00017944157,0.00032129706,0.0002905915,0.00015870402,0.00003217377,0.0001873226,0.00035725482,0.0007424509],"category_scores_gemma":[0.0002264108,0.00014893051,0.000118286815,0.00071622094,0.000041965264,0.00012864693,0.000077475015,0.0011196192,0.0014227841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005068705,0.00057325873,0.787762,0.00007094714,0.0001193714,0.000042819196,0.0068183304,0.0038368693,0.023825722,0.0000061592964,0.0027389594,0.16913688],"study_design_scores_gemma":[0.00821128,0.0017879241,0.9627296,0.00070689386,0.000027838232,0.0000011268802,0.00052162475,0.010579819,0.0028513302,0.00010534841,0.012107394,0.0003698215],"about_ca_topic_score_codex":0.008755556,"about_ca_topic_score_gemma":0.00040063998,"teacher_disagreement_score":0.17496762,"about_ca_system_score_codex":0.0013013135,"about_ca_system_score_gemma":0.0003017008,"threshold_uncertainty_score":0.9993547},"labels":[],"label_agreement":null},{"id":"W2956956185","doi":"10.1016/j.leukres.2019.106193","title":"Chronic lymphocytic leukemia patients with HLA-B27 referred for allogeneic hematopoietic stem cell transplantation do not have worse outcomes: Results of a population-based case series analysis in British Columbia, Canada","year":2019,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; Vancouver General Hospital; University of British Columbia","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Transplantation; Immunology; Human leukocyte antigen; Stem cell; Leukemia; Chronic lymphocytic leukemia; Population; Internal medicine; Biology; Antigen; Genetics","score_opus":0.020211706848198577,"score_gpt":0.28614271253281076,"score_spread":0.2659310056846122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956956185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943653,0.0001710504,0.000033593868,0.0000658878,0.0000762753,0.0040848735,0.00092875806,0.000043305026,0.0002309952],"genre_scores_gemma":[0.99123645,0.00004500836,0.000301685,0.000067020126,0.00004674642,0.00044078592,0.0017771578,0.000112551366,0.0059725707],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924879,0.0004764712,0.0014371296,0.0012607345,0.0028630043,0.001474739],"domain_scores_gemma":[0.99468654,0.00185609,0.00033982142,0.00141395,0.0012316975,0.0004718676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017547559,0.00037462657,0.0013734524,0.0008634165,0.00025064094,0.00020937633,0.00046329206,0.0003754786,0.00016784229],"category_scores_gemma":[0.00025936248,0.00044052894,0.00028668495,0.0025160355,0.00023518101,0.00024145049,0.000093027236,0.00066860387,0.000011787621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008021245,0.00019792102,0.9109753,0.0071847886,0.00086096313,0.006125907,0.0009892783,0.06273793,0.0002489365,0.000007230696,0.0007190938,0.0019314334],"study_design_scores_gemma":[0.21663478,0.003497704,0.6461836,0.0024613233,0.0013917562,0.0012277121,0.0032553102,0.12004156,0.003406724,0.000030225663,0.00040956985,0.0014597306],"about_ca_topic_score_codex":0.965695,"about_ca_topic_score_gemma":0.99020916,"teacher_disagreement_score":0.26479167,"about_ca_system_score_codex":0.20201474,"about_ca_system_score_gemma":0.10152296,"threshold_uncertainty_score":0.9998047},"labels":[],"label_agreement":null},{"id":"W2970918745","doi":"10.1016/j.leukres.2019.106220","title":"Buccal cell telomere length is not a useful marker for comorbidities in chronic lymphocytic leukemia","year":2019,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"Research Manitoba","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Outbreak; Cluster (spacecraft); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Family medicine; Virology; Disease; Internal medicine; Infectious disease (medical specialty)","score_opus":0.09863748031594236,"score_gpt":0.37400464742956685,"score_spread":0.2753671671136245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2970918745","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.55874956,0.0126430895,0.00009466348,0.31867042,0.0034824386,0.034311857,0.0028156003,0.0010441683,0.06818821],"genre_scores_gemma":[0.21666832,0.0046468577,0.00079110195,0.3125759,0.022464635,0.005615667,0.0034754886,0.002125116,0.4316369],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9799222,0.001217906,0.0020807083,0.0035488198,0.006814321,0.006416041],"domain_scores_gemma":[0.9847846,0.008123373,0.00030611147,0.0045060506,0.0016204949,0.0006593455],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.004893776,0.001722935,0.0031903898,0.0035446414,0.0004933236,0.0005002274,0.0027191348,0.0051399325,0.0024679354],"category_scores_gemma":[0.0014886687,0.0016258574,0.001194768,0.0023409722,0.0017242164,0.00040177032,0.001636991,0.014107101,0.0050745658],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0023680103,0.00005108635,0.0001261574,0.015985927,0.00037097628,0.0051475917,0.0005727478,0.0002141148,0.0012183586,0.000051263192,0.9728342,0.0010595145],"study_design_scores_gemma":[0.048227523,0.001614147,0.00018349354,0.0026074168,0.00019079878,0.0006780121,0.0002673357,0.07469732,0.009893242,0.00020823907,0.8599563,0.0014761344],"about_ca_topic_score_codex":0.014041717,"about_ca_topic_score_gemma":0.0003920064,"teacher_disagreement_score":0.36344868,"about_ca_system_score_codex":0.67038715,"about_ca_system_score_gemma":0.3737177,"threshold_uncertainty_score":0.9995517},"labels":[],"label_agreement":null},{"id":"W2971612352","doi":"10.1016/j.leukres.2019.106222","title":"Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literature","year":2019,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Toxicity; Oncology; Internal medicine; Clinical trial; Leukemia; Cancer; Myeloid leukemia; Chemotherapy; Pharmacology","score_opus":0.08932005962414828,"score_gpt":0.40803120393072545,"score_spread":0.31871114430657715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971612352","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010858629,0.9802254,5.146265e-7,0.000022956185,0.000062231586,0.008562692,0.00004133929,0.000012010535,0.00021421626],"genre_scores_gemma":[0.0040220497,0.99516636,0.0001142408,0.000046308363,0.000029556884,0.00033927223,0.00005820746,0.00008081614,0.00014317811],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99386233,0.0015891202,0.0016210077,0.0005241475,0.0018952647,0.0005081236],"domain_scores_gemma":[0.99582446,0.00085654884,0.0010537397,0.0011268083,0.0010516426,0.00008681445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034141617,0.0004040789,0.0037130052,0.00051849603,0.0000688643,0.00003061767,0.00040124732,0.00043305752,0.000013039127],"category_scores_gemma":[0.0047861678,0.00021596905,0.00032022333,0.0022096673,0.00028748155,0.00005841943,0.00039145723,0.0016984987,0.0000054490415],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027165937,0.0000386387,0.000100363526,0.99529463,0.00015259183,0.000020028056,0.0004865403,9.0826853e-7,0.000029669654,0.000041001607,0.000055069853,0.003753393],"study_design_scores_gemma":[0.0010021211,0.00050552515,0.000023284123,0.9967779,0.00077521626,0.00010493973,0.00017525034,0.000011757236,0.00012882621,0.000008999004,0.00030749087,0.00017868052],"about_ca_topic_score_codex":0.000025087777,"about_ca_topic_score_gemma":0.000005853589,"teacher_disagreement_score":0.01494096,"about_ca_system_score_codex":0.0012892386,"about_ca_system_score_gemma":0.0029886663,"threshold_uncertainty_score":0.8806962},"labels":[],"label_agreement":null},{"id":"W2976783757","doi":"10.1016/j.leukres.2019.106228","title":"Impact of DARC, GSDMA and CXCL2 polymorphisms on induction toxicity in children with acute lymphoblastic leukemia: A complementary study","year":2019,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Lymphoblastic Leukemia; Medicine; Leukemia; Oncology; Internal medicine","score_opus":0.040023689254644314,"score_gpt":0.35315997224226175,"score_spread":0.3131362829876174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976783757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.977525,0.00011702561,0.000017597842,0.013292117,0.00010980767,0.0073633916,0.0005165188,0.00007952721,0.0009790203],"genre_scores_gemma":[0.98230445,0.00016088245,0.00018126499,0.011576857,0.0016426791,0.00039806994,0.0012897325,0.00035857514,0.0020874823],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.98676074,0.0014477946,0.0013056196,0.0022852477,0.005610084,0.0025905427],"domain_scores_gemma":[0.9941662,0.0017851276,0.00042073522,0.0023827755,0.00078206055,0.0004631188],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0022666596,0.0011945292,0.0023290373,0.0038613165,0.00027277396,0.00015191661,0.0011333995,0.0015187018,0.00044027742],"category_scores_gemma":[0.00041140063,0.0008938618,0.00033321086,0.0025263105,0.0012721961,0.0002933133,0.0011097634,0.00939726,0.00018602138],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.01244674,0.0016601719,0.48020056,0.00080907944,0.007159054,0.0076252087,0.0014611008,0.0002549632,0.0038583518,0.00001637165,0.4816277,0.0028807088],"study_design_scores_gemma":[0.04313436,0.03899804,0.904984,0.0020214478,0.00086751685,0.003981637,0.0005738573,0.0018745379,0.0010260548,0.00008301589,0.0010324225,0.0014230829],"about_ca_topic_score_codex":0.024303539,"about_ca_topic_score_gemma":0.00028837463,"teacher_disagreement_score":0.4805953,"about_ca_system_score_codex":0.035369426,"about_ca_system_score_gemma":0.017188821,"threshold_uncertainty_score":0.99977756},"labels":[],"label_agreement":null},{"id":"W2991655819","doi":"10.1016/j.leukres.2019.106285","title":"The predictive value of intracellular imatinib levels in newly diagnosed chronic myeloid leukemia","year":2019,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University Health Network; Dalhousie University; Windsor Regional Hospital; Université de Montréal; Ottawa Hospital; Alberta Health Services; McMaster University","funders":"Novartis Pharmaceuticals Canada; Princess Margaret Cancer Foundation","keywords":"Imatinib; Myeloid leukemia; Medicine; Predictive value; Value (mathematics); Internal medicine; Oncology; Leukemia; Cancer research; Statistics; Mathematics","score_opus":0.04394516131639886,"score_gpt":0.33581562774929136,"score_spread":0.2918704664328925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991655819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5636449,0.029698964,0.0001641746,0.34344688,0.002890379,0.024131378,0.0011533173,0.00045636646,0.034413658],"genre_scores_gemma":[0.6715921,0.019689655,0.0019881001,0.10156922,0.029800842,0.006819266,0.005450592,0.0025419223,0.16054831],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9865328,0.001867377,0.0019472955,0.0018619745,0.004681004,0.0031095527],"domain_scores_gemma":[0.9860572,0.008530118,0.0004974964,0.003693635,0.0009369583,0.00028454533],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.004124639,0.001099593,0.002112015,0.0012502184,0.0003814382,0.00015578364,0.0019879998,0.0027223283,0.0005518518],"category_scores_gemma":[0.0026410525,0.0008223193,0.0006251132,0.0018462989,0.0015723954,0.00023318833,0.00095541886,0.014199078,0.0010970151],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00086094067,0.00015249458,0.0019275188,0.003778301,0.0011667566,0.0060813692,0.0011473532,0.0009797318,0.0050038323,0.00021277566,0.9666646,0.012024304],"study_design_scores_gemma":[0.031560678,0.0039398223,0.018045101,0.0072338753,0.00050593266,0.0003839271,0.0005511923,0.022454424,0.01818047,0.00093613117,0.8947745,0.0014339694],"about_ca_topic_score_codex":0.0050980602,"about_ca_topic_score_gemma":0.00027328008,"teacher_disagreement_score":0.24187768,"about_ca_system_score_codex":0.07086175,"about_ca_system_score_gemma":0.03863958,"threshold_uncertainty_score":0.99968076},"labels":[],"label_agreement":null},{"id":"W3007551495","doi":"10.1016/j.leukres.2020.106335","title":"Comparison of real-world treatment patterns in chronic lymphocytic leukemia management before and after availability of ibrutinib in the province of British Columbia, Canada","year":2020,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Richmond Hospital; St. Paul's Hospital; BC Cancer Agency; University of British Columbia, Okanagan Campus; Kelowna General Hospital; Abbotsford Veterinary Clinic; Kwantlen Polytechnic University; Surrey Memorial Hospital; University of British Columbia; Royal Columbian Hospital; Vernon Jubilee Hospital; University of British Columbia Hospital; Vancouver General Hospital; Columbia Bible College","funders":"","keywords":"Ibrutinib; Chemoimmunotherapy; Medicine; Chronic lymphocytic leukemia; Internal medicine; Population; Oncology; Leukemia","score_opus":0.03979922661886139,"score_gpt":0.34434966859959676,"score_spread":0.3045504419807354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007551495","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944282,0.0005308037,0.0000020928958,0.00020841564,0.00002024553,0.002609852,0.00014802162,0.000010117506,0.0020422544],"genre_scores_gemma":[0.99748755,0.0005064945,0.00006977277,0.00006032683,0.000055384953,0.00027075104,0.000034914337,0.000034663684,0.0014801348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99468136,0.0005514489,0.0012287669,0.0007114959,0.0019519972,0.00087494665],"domain_scores_gemma":[0.9977657,0.0006549118,0.00018951923,0.00089826423,0.00024156168,0.00025004585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015159925,0.00020580638,0.0010080265,0.00022729737,0.000048046782,0.00003874016,0.0005334887,0.00013388612,0.000198855],"category_scores_gemma":[0.00019155639,0.00021561894,0.00009905354,0.0013950923,0.00070360117,0.000076924145,0.0004237885,0.0005892478,0.000002848604],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0014983807,0.00027290624,0.95814353,0.0104414215,0.000168332,0.0024128438,0.0026094443,0.00054967013,0.00024823967,0.00004180676,0.0033985162,0.020214926],"study_design_scores_gemma":[0.02216545,0.0021784646,0.93272334,0.0016232016,0.00006409889,0.000037143625,0.0026722986,0.035335895,0.0018508089,0.000042864078,0.0010999717,0.00020644683],"about_ca_topic_score_codex":0.98613226,"about_ca_topic_score_gemma":0.9970845,"teacher_disagreement_score":0.09813287,"about_ca_system_score_codex":0.18249181,"about_ca_system_score_gemma":0.08435894,"threshold_uncertainty_score":0.9208319},"labels":[],"label_agreement":null},{"id":"W3028535930","doi":"10.1016/j.leukres.2020.106370","title":"Anabolic steroids in myelodysplastic syndromes: A systematic review","year":2020,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Danazol; Medicine; Randomized controlled trial; Anabolism; Myelodysplastic syndromes; Systematic review; Internal medicine; MEDLINE; Chemistry","score_opus":0.153479901526021,"score_gpt":0.4567358407268689,"score_spread":0.3032559392008479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028535930","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006756172,0.97761065,0.000008560428,0.0006818112,0.000118747485,0.017948745,0.00007304346,0.00018492859,0.0033667467],"genre_scores_gemma":[0.000013984012,0.9865637,0.00014418288,0.0004904828,0.00040616147,0.00548209,0.00034450844,0.00043312975,0.0061217933],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9824098,0.005069665,0.0034213176,0.0021252234,0.0042681075,0.002705915],"domain_scores_gemma":[0.99037105,0.0038467937,0.0005160263,0.003081629,0.00072775665,0.0014567376],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0075060343,0.0013118077,0.012335593,0.0032660451,0.00020418197,0.00019978808,0.0023642823,0.001203993,0.00049509644],"category_scores_gemma":[0.012377574,0.00097130984,0.0013298008,0.009717608,0.0005466811,0.00019799614,0.0014819712,0.010053378,0.010070288],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000035863904,0.000076261706,0.0000021600515,0.9135944,0.0005159419,0.008739787,0.000078746685,1.3852409e-7,8.3864063e-7,0.00010782571,0.010171418,0.06667662],"study_design_scores_gemma":[0.00085882243,0.00033889752,0.0000019642994,0.60967356,0.0015115621,0.0023925588,0.000058403173,0.00007717511,2.6958335e-7,0.000014980338,0.38461867,0.00045316806],"about_ca_topic_score_codex":0.00022451521,"about_ca_topic_score_gemma":0.000026498154,"teacher_disagreement_score":0.37444726,"about_ca_system_score_codex":0.018888513,"about_ca_system_score_gemma":0.020222964,"threshold_uncertainty_score":0.99996334},"labels":[],"label_agreement":null},{"id":"W3043664983","doi":"10.1016/j.leukres.2020.106423","title":"Antihistamines are synergistic with Bruton’s tyrosine kinase inhibiter ibrutinib mediated by lysosome disruption in chronic lymphocytic leukemia (CLL) cells","year":2020,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; Research Institute in Oncology and Hematology","funders":"Cancer Research Society","keywords":"Ibrutinib; Bruton's tyrosine kinase; Chronic lymphocytic leukemia; Programmed cell death; Tyrosine kinase; Pharmacology; Cancer research; Apoptosis; Leukemia; Medicine; Immunology; Chemistry; Receptor; Biochemistry; Internal medicine","score_opus":0.04239485212341118,"score_gpt":0.3200529764841595,"score_spread":0.2776581243607483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043664983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990217,0.0030937358,0.00014673735,0.0017597507,0.00011721102,0.0023329135,0.00017600069,0.00035739393,0.001799305],"genre_scores_gemma":[0.9919513,0.0008909666,0.00016382718,0.00082267495,0.00078549056,0.00033977567,0.0006577018,0.00028149015,0.0041068047],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9893784,0.0007180933,0.0012601354,0.0020138966,0.003792132,0.0028373252],"domain_scores_gemma":[0.9944615,0.0013482345,0.0002763465,0.0014474579,0.0008608349,0.0016056531],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016805276,0.00084228115,0.0014098377,0.0010344164,0.0003441675,0.0002599289,0.00092042447,0.00067429757,0.0006645793],"category_scores_gemma":[0.0017119022,0.00070565374,0.00021659926,0.0046805823,0.0014085486,0.00046542665,0.0006840892,0.0023608143,0.0014781056],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009749843,0.00033174874,0.0043845037,0.006507422,0.00035847095,0.015976105,0.0019849062,0.0053298413,0.88957715,0.00023613287,0.06339551,0.0021683483],"study_design_scores_gemma":[0.109061785,0.004988736,0.0042680777,0.004194449,0.0002270837,0.00057309837,0.001437959,0.516702,0.32578352,0.000064421765,0.030587472,0.0021114373],"about_ca_topic_score_codex":0.0069121607,"about_ca_topic_score_gemma":0.00068934396,"teacher_disagreement_score":0.56379366,"about_ca_system_score_codex":0.28951484,"about_ca_system_score_gemma":0.072920166,"threshold_uncertainty_score":0.99994075},"labels":[],"label_agreement":null},{"id":"W3081594107","doi":"10.1016/j.leukres.2020.106442","title":"Plerixafor in combination with chemotherapy and/or hematopoietic cell transplantation to treat acute leukemia: A systematic review and metanalysis of preclinical and clinical studies","year":2020,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"University of Ottawa","keywords":"Plerixafor; Medicine; Leukemia; CXCR4; CXCR4 antagonist; Oncology; Transplantation; Acute leukemia; Bone marrow; Context (archaeology); Internal medicine; Hematopoietic stem cell transplantation; Immunology; Biology","score_opus":0.15597014319122254,"score_gpt":0.48267794293402844,"score_spread":0.3267077997428059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081594107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002903109,0.98769486,0.00011330791,0.00063820655,0.0000143169855,0.008489994,0.000045612444,0.000025433985,0.000075184784],"genre_scores_gemma":[0.000986405,0.9962294,0.0013307647,0.00015624013,0.000023344926,0.00080579676,0.000083282044,0.000074869844,0.0003098927],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99368906,0.0015615064,0.0024993299,0.0009491894,0.0009123356,0.0003885674],"domain_scores_gemma":[0.9936574,0.0046559973,0.00048712696,0.0004942204,0.00033744986,0.00036777594],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039876206,0.00050415145,0.0066027795,0.0005814077,0.0000689669,0.000037258473,0.00018289791,0.00042042992,0.000014820084],"category_scores_gemma":[0.0006603706,0.0003107461,0.00025942796,0.0014380276,0.00036882862,0.00009030354,0.000060092836,0.0009872379,0.000009095067],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004960077,0.00009864393,0.00011573582,0.9825608,0.0012304713,0.00030472127,0.0011173432,1.13663006e-7,0.000004117101,0.00002765704,0.00004612152,0.013998241],"study_design_scores_gemma":[0.0077191093,0.003936721,0.00016946945,0.93046373,0.05335068,0.0016524476,0.0007469345,0.00010136158,0.00007369235,0.00003330695,0.001165869,0.00058666256],"about_ca_topic_score_codex":0.000041242918,"about_ca_topic_score_gemma":0.00005195714,"teacher_disagreement_score":0.05212021,"about_ca_system_score_codex":0.0006084987,"about_ca_system_score_gemma":0.0011674702,"threshold_uncertainty_score":0.99993443},"labels":[],"label_agreement":null},{"id":"W3106887103","doi":"10.1016/j.leukres.2020.106489","title":"Murine double minute 2 inhibition alone or with cytarabine in acute myeloid leukemia: Results from an idasanutlin phase 1/1b study⋆","year":2020,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; Princess Margaret Cancer Centre","funders":"F. Hoffmann-La Roche","keywords":"Cytarabine; Medicine; Myeloid leukemia; Adverse effect; Internal medicine; Gastroenterology; Refractory (planetary science); Myeloid; Leukemia; Acute leukemia; Pharmacology; Biology","score_opus":0.10250909267722716,"score_gpt":0.3992120490464178,"score_spread":0.29670295636919064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106887103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779532,0.0001527698,0.00012549483,0.01341799,0.00006669975,0.0055728005,0.00044341825,0.000381008,0.0018866173],"genre_scores_gemma":[0.98665076,0.00038442545,0.0029565422,0.001414028,0.001387603,0.00071495876,0.0022981751,0.00027298223,0.0039205384],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9876144,0.0012296779,0.0017601934,0.0027497946,0.0042227725,0.0024231805],"domain_scores_gemma":[0.9933717,0.0010355068,0.00026388915,0.0021587543,0.001138106,0.0020320448],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.004084319,0.00085756625,0.001669645,0.0013315158,0.00045256945,0.00030834452,0.0010552031,0.0006120129,0.00065436924],"category_scores_gemma":[0.0011782364,0.0006555492,0.00016360648,0.005329879,0.0007335471,0.0010129387,0.0009441306,0.005478249,0.00077116553],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.588893,0.010308887,0.0067526307,0.0005623139,0.001532575,0.084836416,0.022485135,0.0006919282,0.21285966,0.000071544375,0.05551552,0.01549038],"study_design_scores_gemma":[0.6302657,0.06485773,0.018642465,0.0013640019,0.00061003544,0.000770523,0.015548421,0.045219075,0.2047341,0.00018363964,0.015384707,0.0024195781],"about_ca_topic_score_codex":0.01655885,"about_ca_topic_score_gemma":0.0051917015,"teacher_disagreement_score":0.0840659,"about_ca_system_score_codex":0.008976076,"about_ca_system_score_gemma":0.0083359275,"threshold_uncertainty_score":0.99958956},"labels":[],"label_agreement":null},{"id":"W3130191480","doi":"10.1016/j.leukres.2021.106538","title":"Impact of age and treatment institution type on outcomes of patients treated for chronic lymphocytic leukemia in British Columbia, Canada","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vernon Jubilee Hospital; Richmond Hospital; St. Paul's Hospital; BC Cancer Agency; University of British Columbia, Okanagan Campus; Abbotsford Veterinary Clinic; Kwantlen Polytechnic University; Surrey Memorial Hospital; University of British Columbia; Royal Columbian Hospital; Kelowna General Hospital; Vancouver General Hospital; Columbia Bible College","funders":"","keywords":"Medicine; Fludarabine; Rituximab; Ibrutinib; Chronic lymphocytic leukemia; Internal medicine; Population; Stage (stratigraphy); Leukemia; Chemotherapy; Surgery; Pediatrics; Lymphoma; Cyclophosphamide","score_opus":0.042227606311361854,"score_gpt":0.3518739953660461,"score_spread":0.3096463890546842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130191480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709755,0.00045740185,8.581908e-7,0.000014763194,0.00006542528,0.0014498403,0.00020892378,0.000013457833,0.00069178897],"genre_scores_gemma":[0.9954704,0.0005926402,0.00004746116,0.000017682934,0.000045329245,0.00011533759,0.00031310573,0.000041221265,0.0033568318],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99671745,0.0001985307,0.00059565454,0.00056045345,0.001117368,0.00081052503],"domain_scores_gemma":[0.99727637,0.00077137153,0.00009899182,0.0005984845,0.00096455717,0.00029021726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043479088,0.00019010747,0.0008268535,0.00023828138,0.00011106976,0.000059077345,0.00016085918,0.0002089672,0.00014031505],"category_scores_gemma":[0.001353066,0.00021546351,0.00015789535,0.0010419464,0.00035399076,0.00007371502,0.00012140562,0.00028204484,0.0000032375383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0030703053,0.00058411085,0.94465125,0.0015403463,0.0009137461,0.0033676608,0.00032451868,0.0019832673,0.0026956762,0.000049652455,0.004418503,0.036400948],"study_design_scores_gemma":[0.05057255,0.005794735,0.93008524,0.0005953001,0.000059794533,0.00006075147,0.00009072229,0.008824671,0.003027332,0.000033185697,0.0006508737,0.00020485616],"about_ca_topic_score_codex":0.98082995,"about_ca_topic_score_gemma":0.9699494,"teacher_disagreement_score":0.19413552,"about_ca_system_score_codex":0.45867994,"about_ca_system_score_gemma":0.26454443,"threshold_uncertainty_score":0.87863475},"labels":[],"label_agreement":null},{"id":"W3131490660","doi":"10.1016/j.leukres.2021.106542","title":"Association of insurance disparities and survival in adults with multiple myeloma: A non-concurrent cohort study","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health","funders":"","keywords":"Medicine; Hazard ratio; Medicaid; Marital status; Socioeconomic status; Residence; Confidence interval; Demography; Epidemiology; Cohort; Internal medicine; Environmental health; Population; Health care","score_opus":0.027287999753992848,"score_gpt":0.33705095681831604,"score_spread":0.3097629570643232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131490660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963507,0.0003439708,0.000004713922,0.0003136014,0.000034924466,0.0014993419,0.000042627456,0.000012871739,0.0013972382],"genre_scores_gemma":[0.99758005,0.00036915534,0.000087849374,0.0000064473475,0.000043237495,0.00029849712,0.000062840685,0.00002021811,0.0015317161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662554,0.00044101605,0.00029793792,0.00045324973,0.0016109606,0.00057129853],"domain_scores_gemma":[0.9977601,0.00084577175,0.000060991246,0.0003311,0.0007999632,0.00020203847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013630881,0.00014199421,0.00047056784,0.0002378561,0.00009573716,0.00003613162,0.00008993181,0.000089754816,0.000026151256],"category_scores_gemma":[0.0013881164,0.00011290169,0.000035745034,0.00072144956,0.00013087873,0.0001027364,0.00015323132,0.0006140097,0.000010192443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013621633,0.0009454933,0.9909431,0.000371909,0.00024592623,0.00063845527,0.00079412194,0.0000033591762,0.00036264225,0.000013128181,0.00016830658,0.004151445],"study_design_scores_gemma":[0.015845312,0.0008165664,0.9781571,0.00039038365,0.000017868506,0.000010974738,0.0015304934,0.0010809727,0.0020113944,0.000008246565,0.000040285096,0.00009040388],"about_ca_topic_score_codex":0.005111469,"about_ca_topic_score_gemma":0.012030039,"teacher_disagreement_score":0.014483149,"about_ca_system_score_codex":0.0011105167,"about_ca_system_score_gemma":0.0008572183,"threshold_uncertainty_score":0.7727046},"labels":[],"label_agreement":null},{"id":"W3141356097","doi":"10.1016/j.leukres.2021.106576","title":"Isatuximab plus pomalidomide and dexamethasone in patients with relapsed/refractory multiple myeloma according to prior lines of treatment and refractory status: ICARIA-MM subgroup analysis","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"Sanofi","keywords":"Pomalidomide; Dexamethasone; Lenalidomide; Refractory (planetary science); Medicine; Internal medicine; Multiple myeloma; Oncology; Materials science","score_opus":0.04205705449643045,"score_gpt":0.34249226574410163,"score_spread":0.3004352112476712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3141356097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99666727,0.0013507901,0.00003525655,0.00019582456,0.000024033367,0.0013648196,0.00010298051,0.000027461645,0.00023158638],"genre_scores_gemma":[0.993113,0.00091213017,0.004741771,0.000035133293,0.000052470252,0.0001672144,0.00024666416,0.000056994162,0.0006746384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570745,0.00058185676,0.0005524186,0.0009815231,0.0010941754,0.0010825932],"domain_scores_gemma":[0.99593544,0.0014952874,0.00011324107,0.0008167066,0.00079438457,0.00084496354],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00075756066,0.00035322923,0.001072006,0.0014122338,0.00019095349,0.000085270665,0.00013112037,0.00020913655,0.000058103953],"category_scores_gemma":[0.0020828529,0.00026774663,0.00012108367,0.0023037214,0.0002908281,0.00022806077,0.00032658712,0.00061377126,0.000009863313],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00919365,0.00088867475,0.9371414,0.00017883499,0.0012845995,0.0003809171,0.0011540727,0.000039733623,0.007850556,0.000009160494,0.000024571062,0.04185381],"study_design_scores_gemma":[0.029601384,0.0036312663,0.9577522,0.00024515743,0.00031641455,0.0000090945,0.0016292507,0.0013382244,0.00472013,0.000009364609,0.0005168607,0.00023062994],"about_ca_topic_score_codex":0.0065315203,"about_ca_topic_score_gemma":0.0032091453,"teacher_disagreement_score":0.041623183,"about_ca_system_score_codex":0.0034956532,"about_ca_system_score_gemma":0.001787447,"threshold_uncertainty_score":0.99997747},"labels":[],"label_agreement":null},{"id":"W3169270290","doi":"10.1016/j.leukres.2021.106628","title":"Rapid improvement in symptoms and physical function following ibrutinib initiation in chronic lymphocytic leukemia and the associated changes in plasma cytokines","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Institute in Oncology and Hematology; University of Manitoba; CancerCare Manitoba","funders":"Janssen Canada","keywords":"Ibrutinib; Medicine; Chronic lymphocytic leukemia; Internal medicine; Gastroenterology; Immunology; Oncology; Leukemia","score_opus":0.034291604812851754,"score_gpt":0.32793218762742576,"score_spread":0.293640582814574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169270290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941309,0.0022946573,0.000002951163,0.00088876864,0.000105922576,0.0014259049,0.000005378728,0.000040811392,0.0011047189],"genre_scores_gemma":[0.9965849,0.0018549191,0.000012970839,0.00019046679,0.00025962136,0.00049114134,0.00007027833,0.0000542892,0.0004814235],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99483234,0.0009826926,0.00057542644,0.00088654476,0.0014597271,0.0012632712],"domain_scores_gemma":[0.99663925,0.0023374401,0.00008887643,0.00052333204,0.00021150755,0.00019957095],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042456496,0.00030939374,0.0007587728,0.0008396276,0.00017850628,0.00015288514,0.00020102753,0.0003266029,0.00003982576],"category_scores_gemma":[0.0022994669,0.00024858763,0.00009619926,0.0023429666,0.0004916953,0.0002329177,0.00053969474,0.0013846823,0.000017479184],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.03001528,0.0013142738,0.073344074,0.007016115,0.0017631281,0.015652072,0.043968257,0.0063760164,0.3459501,0.008101219,0.0013866624,0.4651128],"study_design_scores_gemma":[0.16845936,0.0013685864,0.06262269,0.0019105473,0.000084394174,0.00015710208,0.003020058,0.7402619,0.019746872,0.0014233881,0.0004636901,0.00048142616],"about_ca_topic_score_codex":0.0067693116,"about_ca_topic_score_gemma":0.011859112,"teacher_disagreement_score":0.7338859,"about_ca_system_score_codex":0.18298931,"about_ca_system_score_gemma":0.033626378,"threshold_uncertainty_score":0.99999666},"labels":[],"label_agreement":null},{"id":"W3174295420","doi":"10.1016/j.leukres.2021.106650","title":"Human Leucocyte Antigen alleles associated with asparaginase hypersensitivity in childhood Acute Lymphoblastic Leukemia patients treated with Pegylated asparaginase within Dana Farber Cancer Institute treatment protocols","year":2021,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"Fondation Charles-Bruneau; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Asparaginase; Medicine; Lymphoblastic Leukemia; Immunology; Leukemia; PEGylation; Allele; Human leukocyte antigen; Antigen; PEG ratio; Biology; Gene; Genetics","score_opus":0.051924648371481766,"score_gpt":0.34520293444192146,"score_spread":0.2932782860704397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3174295420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9484246,0.00019947077,0.000013639749,0.012783943,0.00012472922,0.0345414,0.0009546992,0.00045081426,0.0025067138],"genre_scores_gemma":[0.8679746,0.000464368,0.00050625816,0.024638232,0.0024005917,0.052488517,0.023607913,0.0017963211,0.026123242],"study_design_codex":"case_report","study_design_gemma":"observational","domain_scores_codex":[0.97957444,0.0026338825,0.0018825647,0.004257854,0.006795181,0.0048560672],"domain_scores_gemma":[0.98992264,0.0009962716,0.00094340433,0.0031644495,0.003732546,0.0012406606],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["metaepi_narrow","research_integrity"],"category_scores_codex":[0.0015680427,0.0026919015,0.004136576,0.002872507,0.0011064605,0.0006618111,0.0012522785,0.0030330892,0.00024641294],"category_scores_gemma":[0.0008242264,0.0020054963,0.0004889827,0.005413563,0.002497086,0.0007481135,0.0007064122,0.008944427,0.00015826385],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.017003823,0.008379415,0.19434136,0.003006318,0.02192356,0.46446252,0.0048335493,0.005181315,0.0045028497,0.000037557038,0.27235383,0.0039738924],"study_design_scores_gemma":[0.2483754,0.03568243,0.5285123,0.045258608,0.005781842,0.00433372,0.0008435854,0.013836462,0.024106007,0.000056225246,0.08252985,0.010683581],"about_ca_topic_score_codex":0.029008586,"about_ca_topic_score_gemma":0.012190545,"teacher_disagreement_score":0.4601288,"about_ca_system_score_codex":0.08473389,"about_ca_system_score_gemma":0.0457436,"threshold_uncertainty_score":0.99858147},"labels":[],"label_agreement":null},{"id":"W3185598664","doi":"10.1016/j.leukres.2021.106674","title":"Clinical outcome of chronic myeloid leukemia patients who switch from first-line therapy with a second generation tyrosine kinase inhibitor to an alternative TKI","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; Alberta Children's Hospital","funders":"Alberta Health Services","keywords":"Medicine; Tyrosine-kinase inhibitor; Myeloid leukemia; Internal medicine; Tyrosine kinase; Nilotinib; Oncology; First line; Dasatinib; Cancer; Imatinib; Receptor","score_opus":0.10737315984632013,"score_gpt":0.40013615825058946,"score_spread":0.29276299840426934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185598664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518585,0.0008655479,0.00018433777,0.0006227174,0.00036741188,0.0018277577,0.0002796413,0.00006304417,0.0006036774],"genre_scores_gemma":[0.98892236,0.0006957546,0.0022588957,0.00059220195,0.0023281602,0.00024423611,0.0014098906,0.00014402266,0.0034044522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993415,0.00065414177,0.001354505,0.0015000018,0.0020769534,0.0009993932],"domain_scores_gemma":[0.99450666,0.00064272055,0.0002784869,0.001718788,0.0020029256,0.00085040694],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0011863598,0.0005174638,0.0011837196,0.0003838461,0.0002675202,0.000100902966,0.00045334874,0.00040628677,0.0015391844],"category_scores_gemma":[0.000713217,0.00041541338,0.0002292042,0.0011539276,0.00032744298,0.00033596376,0.00035143827,0.0014067403,0.00018403935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009298584,0.004974024,0.7539639,0.00055008644,0.0017020755,0.0017491849,0.003177714,0.0012350774,0.07800254,0.0002089051,0.011126344,0.13401157],"study_design_scores_gemma":[0.06525271,0.019688858,0.4587885,0.0012376864,0.00018802927,0.000046164205,0.0002899306,0.015932573,0.4165491,0.00018834347,0.020820266,0.0010178566],"about_ca_topic_score_codex":0.0029083136,"about_ca_topic_score_gemma":0.0068140742,"teacher_disagreement_score":0.33854654,"about_ca_system_score_codex":0.012936516,"about_ca_system_score_gemma":0.006728684,"threshold_uncertainty_score":0.99982977},"labels":[],"label_agreement":null},{"id":"W3195599002","doi":"10.1016/j.leukres.2021.106690","title":"Efficacy and safety following bosutinib dose reduction in patients with Philadelphia chromosome‒positive leukemias","year":2021,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Bosutinib; Medicine; Oncology; Reduction (mathematics); Internal medicine; Imatinib; Dasatinib","score_opus":0.030280875152699713,"score_gpt":0.33020283225029673,"score_spread":0.299921957097597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195599002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99263775,0.00069749565,0.000005563599,0.0012846612,0.00015627366,0.0014423659,0.000018820714,0.0000695104,0.003687554],"genre_scores_gemma":[0.99704397,0.00023174567,0.00061046204,0.00008250803,0.00025567747,0.00008464663,0.00040811067,0.00008049366,0.0012024082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99560046,0.00039422582,0.0004980687,0.0010355542,0.0014557029,0.0010159697],"domain_scores_gemma":[0.9979258,0.00039795414,0.00007858313,0.0007565068,0.00043777603,0.0004033455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00078583864,0.00034154704,0.00060412794,0.00043171184,0.00031678067,0.0000809812,0.00014889466,0.00028062618,0.00016577906],"category_scores_gemma":[0.00050163205,0.00029727435,0.00010188381,0.0015526257,0.00028698388,0.00028449655,0.00027485596,0.0013784388,0.00007723317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059267204,0.007903131,0.72599787,0.0017855063,0.0041142763,0.01446446,0.014433373,0.0007873764,0.042226452,0.0014565208,0.009444245,0.11811961],"study_design_scores_gemma":[0.06474379,0.0015177875,0.921023,0.0015396015,0.00014673709,0.00027148813,0.00065973523,0.00024828746,0.0076472345,0.00007763365,0.0016892083,0.00043551667],"about_ca_topic_score_codex":0.0004511278,"about_ca_topic_score_gemma":0.00006764072,"teacher_disagreement_score":0.19502515,"about_ca_system_score_codex":0.011399845,"about_ca_system_score_gemma":0.003970958,"threshold_uncertainty_score":0.99994797},"labels":[],"label_agreement":null},{"id":"W3200673876","doi":"10.1016/j.leukres.2021.106712","title":"Improved resolution of phenotypic subsets in human T-ALL by incorporation of RNA-seq based developmental profiling","year":2021,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; BC Cancer Agency","funders":"Canadian Institutes of Health Research; University of British Columbia; Terry Fox Research Institute","keywords":"Profiling (computer programming); Phenotype; Computational biology; Leukemia; Biology; Genetics; Gene; Computer science","score_opus":0.06967804416424138,"score_gpt":0.34728749848442525,"score_spread":0.27760945432018386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200673876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85735,0.0021981127,0.0014773626,0.11994889,0.0003923534,0.0086888885,0.0006923133,0.00016804287,0.009084073],"genre_scores_gemma":[0.88777727,0.0003850995,0.022024205,0.041892856,0.0024833423,0.0012744569,0.031099983,0.0007068493,0.012355945],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.991122,0.0010737178,0.0016344909,0.0011431046,0.0036055017,0.001421173],"domain_scores_gemma":[0.99553126,0.0010043539,0.0005103488,0.0009857904,0.0017505253,0.00021772512],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0032847065,0.0005045151,0.0012822575,0.0018732406,0.00013885132,0.000050842194,0.0007315075,0.0018033326,0.00026960057],"category_scores_gemma":[0.0015147959,0.0005031024,0.00022203315,0.002036594,0.0007756298,0.000161337,0.0005048582,0.0055109244,0.000023415867],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00082286657,0.00023964592,0.0012709835,0.00410676,0.00017727673,0.0008356713,0.00028024203,0.000024043087,0.5888764,0.000036333488,0.40257847,0.0007512561],"study_design_scores_gemma":[0.018653614,0.0015945764,0.0013364217,0.00434294,0.00015981503,0.000103884006,0.0005318011,0.034918565,0.8963665,0.0003126448,0.040598422,0.0010808299],"about_ca_topic_score_codex":0.0041608736,"about_ca_topic_score_gemma":0.00018194426,"teacher_disagreement_score":0.36198005,"about_ca_system_score_codex":0.015554829,"about_ca_system_score_gemma":0.018537998,"threshold_uncertainty_score":0.99974203},"labels":[],"label_agreement":null},{"id":"W3209503376","doi":"10.1016/j.leukres.2021.106735","title":"RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia","year":2021,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto; Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Venetoclax; Myeloid leukemia; Medicine; Refractory (planetary science); Myeloid; Oncology; Leukemia; Cancer research; Internal medicine; Biology; Chronic lymphocytic leukemia","score_opus":0.04014037466090893,"score_gpt":0.3415210087808559,"score_spread":0.301380634119947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209503376","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6057605,0.0011489707,0.00007992688,0.38276762,0.00040117468,0.00490616,0.00018926941,0.00028362338,0.0044627176],"genre_scores_gemma":[0.295983,0.0031593735,0.005878705,0.35762104,0.005907565,0.007773433,0.010049772,0.002352475,0.31127468],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9829174,0.004281534,0.0013822429,0.0024888753,0.005661562,0.0032683716],"domain_scores_gemma":[0.9881785,0.0049592974,0.00023799129,0.0030270228,0.0027851677,0.00081200653],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.005903747,0.0011626732,0.0018704393,0.005211424,0.00067982916,0.00046360507,0.0015223104,0.0030079102,0.0007914444],"category_scores_gemma":[0.0025281701,0.001051922,0.0003781363,0.00611896,0.0011460553,0.0003441814,0.00088860915,0.021884497,0.0016263278],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.014673069,0.00017589735,0.00070867373,0.00072026806,0.0011044987,0.045855694,0.0042573507,0.00055314077,0.019789776,0.00007754599,0.90857667,0.0035074013],"study_design_scores_gemma":[0.01687756,0.005647009,0.021929218,0.0037413014,0.00032985388,0.0016262176,0.0017840718,0.0021601284,0.0026794905,0.00039584973,0.94105,0.0017792969],"about_ca_topic_score_codex":0.0021948968,"about_ca_topic_score_gemma":0.00034129084,"teacher_disagreement_score":0.30977756,"about_ca_system_score_codex":0.06091841,"about_ca_system_score_gemma":0.042216472,"threshold_uncertainty_score":0.99919313},"labels":[],"label_agreement":null},{"id":"W4206049855","doi":"10.1016/j.leukres.2022.106788","title":"Characterizing Frailty In Myeloproliferative Neoplasms: results from the ORCHID study","year":2022,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute; University of Ottawa; Queen's University","funders":"","keywords":"Medicine; Grip strength; Internal medicine; Gerontology; Physical therapy","score_opus":0.1357372759358897,"score_gpt":0.38400832411243013,"score_spread":0.24827104817654044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206049855","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46454546,0.00047225863,4.967621e-7,0.52171135,0.0004151475,0.00589494,0.0012996261,0.00008188186,0.005578862],"genre_scores_gemma":[0.42524424,0.0015391636,0.00026450047,0.51486254,0.013250914,0.012085353,0.012914459,0.00048485142,0.019353949],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9871048,0.0038514875,0.0013272443,0.0021504627,0.0039086672,0.001657392],"domain_scores_gemma":[0.9885152,0.008231792,0.00031726537,0.0022323504,0.00047216855,0.00023125081],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003333991,0.0008537315,0.0015112638,0.0007395694,0.0010177494,0.00033011462,0.0010508773,0.0007687737,0.0021286458],"category_scores_gemma":[0.002068776,0.00057248375,0.00030149962,0.0015241657,0.00035042883,0.00015118853,0.0011023483,0.01500738,0.00050994055],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033699558,0.00093478383,0.031742174,0.000083805455,0.0009425458,0.01594847,0.01757714,0.00001135008,0.00010661132,0.000034406374,0.926897,0.0023517667],"study_design_scores_gemma":[0.011564992,0.0032703718,0.102082506,0.00056530454,0.00017853477,0.00006951599,0.0044888915,0.00017600626,0.000511138,0.00020396442,0.876251,0.00063780526],"about_ca_topic_score_codex":0.010766029,"about_ca_topic_score_gemma":0.0020286515,"teacher_disagreement_score":0.070340335,"about_ca_system_score_codex":0.005467833,"about_ca_system_score_gemma":0.0034392998,"threshold_uncertainty_score":0.99967265},"labels":[],"label_agreement":null},{"id":"W4251910573","doi":"10.1016/j.leukres.2012.09.019","title":"CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavorable acute myeloid leukemia","year":2012,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Medical Research Council; Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"Myeloid leukemia; Karyotype; Myeloid; Medicine; Oncology; Leukemia; Biology; Internal medicine; Cancer research; Immunology; Genetics; Chromosome; Gene","score_opus":0.049620682203062864,"score_gpt":0.33658012484074346,"score_spread":0.2869594426376806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251910573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98869514,0.002017558,0.000078444835,0.0008660383,0.00008917045,0.0024529572,0.0000292343,0.00020352562,0.0055679525],"genre_scores_gemma":[0.9879446,0.0012526151,0.0065499875,0.00019839493,0.000514979,0.0005787016,0.00014175996,0.00020453335,0.0026144506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99154854,0.00086226914,0.00073977775,0.0012895607,0.0025523927,0.0030074469],"domain_scores_gemma":[0.9954907,0.00071220624,0.00009056625,0.001014853,0.0007124689,0.001979207],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.003025255,0.00060903054,0.00087070424,0.0011785051,0.0004736021,0.00020884721,0.00068841013,0.00073600543,0.0002917609],"category_scores_gemma":[0.00054756325,0.0004722226,0.00009472016,0.0019680029,0.0010144892,0.0011060196,0.00079635094,0.0032028884,0.00023992223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077478075,0.0006506918,0.650997,0.00040498277,0.00022330818,0.0011986656,0.0017421779,0.00007306101,0.32155824,0.00041937226,0.005417717,0.009566994],"study_design_scores_gemma":[0.017668566,0.007946791,0.62486994,0.0017840413,0.00027486184,0.0020560822,0.0019310627,0.019887427,0.31748492,0.00034210042,0.0043669324,0.0013872716],"about_ca_topic_score_codex":0.00086091075,"about_ca_topic_score_gemma":0.00013871434,"teacher_disagreement_score":0.026127052,"about_ca_system_score_codex":0.004328498,"about_ca_system_score_gemma":0.0041342415,"threshold_uncertainty_score":0.99977297},"labels":[],"label_agreement":null},{"id":"W4280581414","doi":"10.1016/j.leukres.2022.106858","title":"Genetic changes during leukemic transformation to secondary acute myeloid leukemia from myeloproliferative neoplasms","year":2022,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Research Foundation of Korea; Ministry of Health and Welfare; Ministry of Science, ICT and Future Planning; National Natural Science Foundation of China; Natural Sciences and Engineering Research Council of Canada; Princess Margaret Cancer Foundation","keywords":"Myeloid leukemia; Cancer research; Myeloid; Biology; Allele; Mutation; Myeloproliferative Disorders; Gene; Spliceosome; Malignant transformation; Internal medicine; Genetics; Oncology; Immunology; Medicine; RNA splicing","score_opus":0.03371642877177031,"score_gpt":0.32196012770747157,"score_spread":0.28824369893570123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280581414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985166,0.0008289377,0.00006948295,0.0056862948,0.00028683495,0.003019279,0.0005716137,0.00018379923,0.004187767],"genre_scores_gemma":[0.9865021,0.00091301964,0.0015783128,0.0015142513,0.00058314775,0.004390759,0.00055424985,0.00012357034,0.003840589],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99393564,0.00063680334,0.00066321925,0.0011674194,0.0022444883,0.0013524219],"domain_scores_gemma":[0.9974187,0.00045843463,0.00011487016,0.0008434219,0.00041858578,0.0007459943],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00078072195,0.00053060043,0.0008014223,0.00096055435,0.0016565868,0.00015998643,0.00048708674,0.0001984869,0.0034625735],"category_scores_gemma":[0.00011148795,0.00049862213,0.00020495607,0.0014136716,0.00016156642,0.00022511811,0.0005174529,0.002078163,0.0006349076],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019733401,0.0015399689,0.051128153,0.0010865649,0.005263323,0.007545834,0.09586547,0.008894278,0.62384343,0.003030107,0.043749783,0.13831967],"study_design_scores_gemma":[0.02079792,0.0069884663,0.47272903,0.00040035284,0.00048065902,0.0012297049,0.007937194,0.005371836,0.42710462,0.0011710544,0.054189134,0.0016000137],"about_ca_topic_score_codex":0.0015681874,"about_ca_topic_score_gemma":0.0006637296,"teacher_disagreement_score":0.42160088,"about_ca_system_score_codex":0.011740739,"about_ca_system_score_gemma":0.003378478,"threshold_uncertainty_score":0.99974656},"labels":[],"label_agreement":null},{"id":"W4281259838","doi":"10.1016/j.leukres.2022.106869","title":"NPM1-mutated AML-MRC diagnosed on the basis of history of MDS or MDS/MPN frequently harbours secondary-type mutations and confers inferior outcome compared to AML with mutated NPM1","year":2022,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"Leukemia and Lymphoma Society of Canada; Cancer Research Society","keywords":"NPM1; Internal medicine; Oncology; Medicine; Myeloid leukemia; Proportional hazards model; Exact test; Survival analysis; Biology; Genetics; Karyotype; Gene","score_opus":0.10397729320274199,"score_gpt":0.3633612639273743,"score_spread":0.25938397072463226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281259838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845874,0.00024260308,0.00002248282,0.005346136,0.00015952981,0.0029934954,0.00028411203,0.000094296935,0.0062699914],"genre_scores_gemma":[0.9898507,0.000072570474,0.00042677572,0.0010206876,0.000052688512,0.0006218336,0.0002470933,0.00013297393,0.0075746817],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9927821,0.0013702039,0.0009940637,0.00085049355,0.0028381967,0.0011649398],"domain_scores_gemma":[0.9927572,0.0033206416,0.00028220034,0.001275819,0.0016966896,0.00066745473],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.003040796,0.00042948997,0.0010860795,0.0015173397,0.00047569067,0.00005229253,0.0008875436,0.00017705002,0.0043318565],"category_scores_gemma":[0.0027312138,0.00030548626,0.0001449272,0.0027750111,0.0016906599,0.00014989969,0.0006342341,0.002831943,0.00006914862],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.077997334,0.0030758262,0.18719657,0.0040339082,0.004406573,0.008140177,0.051193677,0.0050942027,0.38057652,0.005407035,0.25949457,0.013383618],"study_design_scores_gemma":[0.06518623,0.034755364,0.62066007,0.0016096705,0.00095303304,0.0008596312,0.061397433,0.022006026,0.109636515,0.00039427783,0.079866506,0.0026752437],"about_ca_topic_score_codex":0.00819763,"about_ca_topic_score_gemma":0.00091668894,"teacher_disagreement_score":0.43346348,"about_ca_system_score_codex":0.009462457,"about_ca_system_score_gemma":0.012580798,"threshold_uncertainty_score":0.99993974},"labels":[],"label_agreement":null},{"id":"W4285736749","doi":"10.1016/j.leukres.2022.106919","title":"Patient-driven research: Initial results from a prospective health–related quality of life study performed at the request of patients living with hairy cell leukemia","year":2022,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; CancerCare Manitoba","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Quality of life (healthcare); Hairy cell leukemia; Prospective cohort study; Activities of daily living; Disease; Leukemia; Cancer; Physical therapy; Longitudinal study; Internal medicine; Pediatrics; Pathology","score_opus":0.12194974847105526,"score_gpt":0.4023675352351923,"score_spread":0.28041778676413703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285736749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98379636,0.00046847723,0.0000013488954,0.00045196142,0.0001338671,0.007470083,0.0007379358,0.00006812171,0.006871871],"genre_scores_gemma":[0.99653435,0.00006989381,0.00010503958,0.00007186839,0.00013472619,0.0009956609,0.0003892345,0.00013767302,0.0015615566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.971641,0.010626098,0.002698494,0.0016367285,0.011288777,0.0021088768],"domain_scores_gemma":[0.98203826,0.010120041,0.0007662328,0.0027849402,0.0034870468,0.00080348895],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.018090611,0.0004497436,0.0014063857,0.0010354293,0.0020131087,0.00006294916,0.001291846,0.00023937733,0.0008145106],"category_scores_gemma":[0.0095812585,0.0003274734,0.00023380501,0.0039302683,0.0022392757,0.000225714,0.0042477287,0.0049986755,0.00007118647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.134529,0.01395414,0.5223975,0.0028169032,0.0022258726,0.00074307324,0.27688092,0.004790977,0.0044291858,0.00025227005,0.031207796,0.0057723746],"study_design_scores_gemma":[0.14235245,0.053540286,0.63727844,0.0013638781,0.00012693531,0.000051648385,0.142448,0.0118745295,0.008628135,0.00024882157,0.0010778527,0.0010090338],"about_ca_topic_score_codex":0.10002618,"about_ca_topic_score_gemma":0.004399579,"teacher_disagreement_score":0.13443293,"about_ca_system_score_codex":0.10543928,"about_ca_system_score_gemma":0.06942238,"threshold_uncertainty_score":0.99991775},"labels":[],"label_agreement":null},{"id":"W4294287236","doi":"10.1016/j.leukres.2022.106943","title":"Corrigendum to “Patient-driven research: Initial results from a prospective health–related quality of life study performed at the request of patients living with hairy cell leukemia” [Leuk. Res. 120 (2022) 106919]","year":2022,"lang":"en","type":"erratum","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba","funders":"","keywords":"Quality of life (healthcare); Medicine; Hairy cell leukemia; Leukemia; Oncology; Gerontology; Internal medicine; Nursing","score_opus":0.13778950801035084,"score_gpt":0.4023719804040977,"score_spread":0.2645824723937469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294287236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9327337,0.0021746813,0.0000018837554,0.0007557537,0.0043885405,0.018683692,0.0040758112,0.00015527189,0.03703068],"genre_scores_gemma":[0.86590326,0.0008053809,0.00013013816,0.00018407223,0.001078957,0.0024199442,0.004109305,0.0005451897,0.12482378],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9482011,0.01534381,0.0056613986,0.004184913,0.022136135,0.004472613],"domain_scores_gemma":[0.9700675,0.009884581,0.0025139176,0.006836484,0.0084310165,0.0022665064],"candidate_categories":["metaresearch","metaepi_narrow","sts","open_science","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","sts","research_integrity"],"category_scores_codex":[0.024870303,0.001371402,0.0040303716,0.0032142093,0.0025532022,0.00018858198,0.0036593238,0.0014369265,0.0025660018],"category_scores_gemma":[0.029649945,0.0010444649,0.00061332603,0.007829632,0.003300514,0.00032620007,0.009162911,0.017396497,0.00027436877],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.044589322,0.003679885,0.013167066,0.0031033186,0.0015088009,0.00060630566,0.060071804,0.00029017538,0.00020372773,0.000030426421,0.87137824,0.0013709461],"study_design_scores_gemma":[0.21503554,0.14908898,0.28074527,0.017937034,0.0008719667,0.00013548392,0.1704541,0.009323492,0.0035501227,0.00028776564,0.14706537,0.005504891],"about_ca_topic_score_codex":0.20369308,"about_ca_topic_score_gemma":0.025200654,"teacher_disagreement_score":0.72431284,"about_ca_system_score_codex":0.2198843,"about_ca_system_score_gemma":0.20432702,"threshold_uncertainty_score":0.9999037},"labels":[],"label_agreement":null},{"id":"W4303648477","doi":"10.1016/j.leukres.2022.106968","title":"A 5-microRNA signature derived from core binding factor-AML is predictive in adult and childhood AML","year":2022,"lang":"en","type":"letter","venue":"Leukemia Research","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; University of Toronto","funders":"Canadian Cancer Society; Canadian Institutes of Health Research; Leukemia and Lymphoma Society of Canada","keywords":"Signature (topology); microRNA; Medicine; Oncology; Cancer research; Internal medicine; Biology; Genetics; Gene; Mathematics","score_opus":0.023764915289874976,"score_gpt":0.29264816136749333,"score_spread":0.2688832460776184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4303648477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755919,0.0032171342,0.0000136087765,0.016395384,0.00015920903,0.0010387547,0.0033130911,0.000024759562,0.00024615612],"genre_scores_gemma":[0.9312308,0.0017758213,0.00025340324,0.044101212,0.0034223017,0.0004365793,0.016508672,0.00027235196,0.0019988613],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.996164,0.000473128,0.0003624547,0.0013216073,0.0008568437,0.0008219163],"domain_scores_gemma":[0.9985141,0.00014557617,0.00015989879,0.00078535336,0.0002539979,0.0001410499],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.00026106997,0.0004287674,0.00038708272,0.00041075534,0.0002501947,0.000110207955,0.0006648215,0.0016004592,0.00051239086],"category_scores_gemma":[0.00027688686,0.0004519216,0.00015069259,0.0003771196,0.00025339104,0.000010131854,0.00096080283,0.003940501,0.000021870861],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023388103,0.00003660591,0.0019228522,0.00014009338,0.0002185165,0.00024571555,0.00063632516,0.000012001041,0.49072775,0.0000010688669,0.5052888,0.00053639745],"study_design_scores_gemma":[0.006138205,0.0011030001,0.08087802,0.0008558679,0.00012540317,0.00007269208,0.0008224512,0.0005571668,0.26161677,0.00053277233,0.6451779,0.0021197428],"about_ca_topic_score_codex":0.0004569121,"about_ca_topic_score_gemma":0.00005382833,"teacher_disagreement_score":0.22911099,"about_ca_system_score_codex":0.00095060555,"about_ca_system_score_gemma":0.0011944319,"threshold_uncertainty_score":0.99979323},"labels":[],"label_agreement":null},{"id":"W4312129123","doi":"10.1016/j.leukres.2022.107002","title":"Molecular genetic characterization of Philadelphia chromosome-positive acute myeloid leukemia","year":2022,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Myeloid leukemia; Internal medicine; Medicine; Trisomy 8; Myeloid; Gastroenterology; Philadelphia chromosome; Oncology; Cytogenetics; Chromosome; Chromosomal translocation; Gene; Biology; Genetics","score_opus":0.027602650302154672,"score_gpt":0.3254544267275147,"score_spread":0.29785177642536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312129123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98975325,0.00035898414,0.0004159619,0.0032092007,0.0001552327,0.0020911659,0.0003231389,0.00012322492,0.0035698486],"genre_scores_gemma":[0.99376184,0.00053217995,0.0006093163,0.00057558634,0.00031506552,0.0007079887,0.0009344521,0.00017802801,0.0023855455],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99153286,0.0011431781,0.00085805857,0.0010773925,0.0038562277,0.001532299],"domain_scores_gemma":[0.99640894,0.00032033876,0.00016537684,0.0014212256,0.0011154686,0.0005686291],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001966189,0.00040743963,0.00081006606,0.0014408831,0.00072346895,0.00006706845,0.0010523121,0.00026580886,0.0019154346],"category_scores_gemma":[0.00029156526,0.00042375806,0.00030316098,0.0033825138,0.00071206695,0.00020832988,0.0016419132,0.0030911916,0.00021176123],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0013615162,0.00017644274,0.0009455298,0.0002070537,0.0004263979,0.0020288732,0.00071016117,0.00035397825,0.9871878,0.0005981682,0.0023038571,0.0037002186],"study_design_scores_gemma":[0.008567113,0.00419983,0.066936046,0.00022495101,0.00029618546,0.0019114417,0.0008802834,0.018688153,0.87975204,0.00046734157,0.017207729,0.00086890336],"about_ca_topic_score_codex":0.00045882768,"about_ca_topic_score_gemma":0.0000037201726,"teacher_disagreement_score":0.10743578,"about_ca_system_score_codex":0.011780618,"about_ca_system_score_gemma":0.0071135843,"threshold_uncertainty_score":0.9998214},"labels":[],"label_agreement":null},{"id":"W4313575102","doi":"10.1016/j.leukres.2023.107016","title":"Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update","year":2023,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; Princess Margaret Cancer Centre; Foothills Medical Centre; Ottawa Hospital; Spinal Cord Injury BC; Jewish General Hospital; CancerCare Manitoba","funders":"","keywords":"Guideline; Chronic lymphocytic leukemia; Front line; Medicine; First line treatment; Leukemia; Family medicine; Intensive care medicine; Internal medicine; Political science; Pathology; Chemotherapy","score_opus":0.2859934808552033,"score_gpt":0.48700136605915856,"score_spread":0.20100788520395524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313575102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007981833,0.98439115,0.000111233414,0.0006061869,0.00055570266,0.0123116495,0.0012819775,0.00024408483,0.0004181796],"genre_scores_gemma":[0.00007418006,0.96540236,0.00093671714,0.00013375517,0.0026926592,0.0054853484,0.003959048,0.0007121803,0.02060373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98474294,0.0011608233,0.0036417164,0.0024978213,0.003718109,0.004238612],"domain_scores_gemma":[0.98410684,0.006522445,0.0006881708,0.0040523037,0.0023179816,0.002312256],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","insufficient_payload"],"category_scores_codex":[0.0067109982,0.0014815951,0.005951722,0.004944183,0.0005771618,0.00016223216,0.0019228868,0.0019789184,0.0011467758],"category_scores_gemma":[0.0045383926,0.0011828981,0.0023424549,0.00482098,0.00089788437,0.00020135404,0.00044861043,0.0017228174,0.0023014792],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0007154834,0.00012129208,0.0000015878927,0.08067631,0.0015689528,0.0019201852,0.000055493376,0.00068439083,0.0000144399455,0.00016890981,0.12432925,0.7897437],"study_design_scores_gemma":[0.016537605,0.003182134,4.7547152e-7,0.03765446,0.001568539,0.00024590554,0.00003613438,0.07593054,0.00015933569,0.00007159312,0.8638846,0.00072867237],"about_ca_topic_score_codex":0.4278539,"about_ca_topic_score_gemma":0.11078773,"teacher_disagreement_score":0.78901505,"about_ca_system_score_codex":0.8356285,"about_ca_system_score_gemma":0.7746173,"threshold_uncertainty_score":0.99979335},"labels":[],"label_agreement":null},{"id":"W4362575420","doi":"10.1016/j.leukres.2023.107073","title":"Corrigendum to “Canadian evidence-based guideline for frontline treatment of chronic lymphocytic leukemia: 2022 update” [Leukemia Research 125 (2023) 107016]","year":2023,"lang":"en","type":"erratum","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Toronto; Princess Margaret Cancer Centre; Foothills Medical Centre; Ottawa Hospital; Spinal Cord Injury BC; Jewish General Hospital; CancerCare Manitoba","funders":"","keywords":"Guideline; Chronic lymphocytic leukemia; Leukemia; Medicine; Internal medicine; Oncology; Cancer research; Pathology","score_opus":0.2076538861783778,"score_gpt":0.4403279693230669,"score_spread":0.2326740831446891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362575420","genre_codex":"review","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.029635988,0.36621848,0.0032117951,0.083959475,0.17856495,0.19071774,0.034805585,0.0054374924,0.10744849],"genre_scores_gemma":[0.008174346,0.034642715,0.002282207,0.001412012,0.020148698,0.011686106,0.01534999,0.002001543,0.90430236],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9621335,0.0027539534,0.004905211,0.0057957047,0.01346245,0.0109491395],"domain_scores_gemma":[0.96241874,0.0062859366,0.00075808546,0.008489779,0.015640471,0.0064070197],"candidate_categories":["metaresearch","metaepi_narrow","bibliometrics","sts","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.020830883,0.0025117754,0.0051837247,0.013789257,0.0020465925,0.0005963889,0.0051137023,0.005115484,0.0046355044],"category_scores_gemma":[0.023079159,0.0023302906,0.001783506,0.014855375,0.002712226,0.0004611523,0.0018545804,0.007814585,0.009239926],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.005564105,0.0002395965,0.000016415355,0.0057359138,0.0011305737,0.0035824676,0.00033351852,0.0029875648,0.0014009799,0.00025540864,0.9590737,0.019679708],"study_design_scores_gemma":[0.025183616,0.009910059,0.00004141275,0.0069627897,0.00042407957,0.00015700176,0.0004252333,0.20946187,0.004479275,0.0002941258,0.7412986,0.0013619117],"about_ca_topic_score_codex":0.59973526,"about_ca_topic_score_gemma":0.2675135,"teacher_disagreement_score":0.7968539,"about_ca_system_score_codex":0.8636296,"about_ca_system_score_gemma":0.8133142,"threshold_uncertainty_score":0.999331},"labels":[],"label_agreement":null},{"id":"W4367601325","doi":"10.1016/j.leukres.2023.107162","title":"Topic: AS02-Epidemiology: TET2 CLONAL HEMATOPOIESIS MUTATIONS ARE ENRICHED AMONG RECIPIENTS OF SOLID-ORGAN TRANSPLANTS","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Internal medicine; Medicine; Hazard ratio; Cardiology; Ventricle; Regurgitation (circulation); Pulmonary hypertension; Confidence interval","score_opus":0.1719432447663443,"score_gpt":0.44451773000139005,"score_spread":0.2725744852350458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367601325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444836,0.00026373775,0.000017425398,0.0025334547,0.000094754345,0.0006719581,0.00015382528,0.00011055775,0.001705949],"genre_scores_gemma":[0.98869324,0.00062691676,0.00030496006,0.00010825121,0.00010298154,0.00015423373,0.00037562268,0.000037192156,0.009596616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960487,0.00061671005,0.00055200484,0.0005357456,0.0011710144,0.0010758485],"domain_scores_gemma":[0.9962422,0.001916612,0.0000972921,0.0006027584,0.0005792647,0.0005618742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019312483,0.00019856151,0.00068708067,0.000819704,0.00029883927,0.000009704065,0.00029882442,0.00025335982,0.0005238256],"category_scores_gemma":[0.0026948627,0.00015699882,0.00019484307,0.001621771,0.00054433604,0.00011091245,0.00015495326,0.0007591388,0.000628668],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006610437,0.0004675414,0.9548299,0.00038116792,0.0004208502,0.0044129095,0.00032186476,0.000028653052,0.016986243,0.00016194068,0.019450651,0.0018772873],"study_design_scores_gemma":[0.0024020507,0.00037713308,0.9857775,0.0002837779,0.000042338717,0.00012769634,0.00061992963,0.0013867758,0.0061348057,0.0019936631,0.00072307733,0.00013126081],"about_ca_topic_score_codex":0.0005218025,"about_ca_topic_score_gemma":0.00007781693,"teacher_disagreement_score":0.030947644,"about_ca_system_score_codex":0.00043207165,"about_ca_system_score_gemma":0.00060072175,"threshold_uncertainty_score":0.80804646},"labels":[],"label_agreement":null},{"id":"W4367601443","doi":"10.1016/j.leukres.2023.107136","title":"Topic: AS01-Diagnosis/AS01a-Cytomorphology: AUTOMATED DIGITAL TOOL FOR MDS AND MDS/MPN CLASSIFICATION USING WHO AND ICC: INTERNATIONAL GUIDELINES WORKING GROUP ON MDS DIAGNOSIS, PROGNOSIS, AND GERMLINE PREDISPOSITION","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Electric Motor Design and Analysis","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Rotor (electric); Constant (computer programming); Squirrel-cage rotor; Copper loss; Thermal; Variable (mathematics); Core (optical fiber); Computer science; Applied mathematics; Mathematics; Physics; Mathematical analysis; Thermodynamics; Mechanical engineering; Electrical engineering; Engineering; Telecommunications; Induction motor","score_opus":0.12145867541619708,"score_gpt":0.37773132607085985,"score_spread":0.25627265065466276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367601443","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946549,0.00086795626,0.0017947787,0.0011190323,0.00012951979,0.0007367732,0.00006890396,0.0005328519,0.000095297946],"genre_scores_gemma":[0.9927547,0.0038423594,0.0015371464,0.00006930641,0.00043702847,0.00080090255,0.0003252106,0.000053991345,0.0001793341],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980509,0.00008302877,0.00042943316,0.0005001245,0.00045027453,0.00048620946],"domain_scores_gemma":[0.9986535,0.00073643454,0.00005861194,0.00018607365,0.00024267421,0.00012272358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086543855,0.00021741253,0.00027531126,0.0006331931,0.0002623355,0.00044558462,0.00016845738,0.000214122,0.000011261922],"category_scores_gemma":[0.00044187138,0.0002137726,0.000056623157,0.0007561378,0.0001165,0.0003150842,0.00010574107,0.00031894483,0.0000050004173],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027449132,0.00016995492,0.29162222,0.0006763939,0.00064760295,0.000105713516,0.00049628044,0.0028254974,0.035117537,0.0017719474,0.053058565,0.6132338],"study_design_scores_gemma":[0.000858237,0.00016417817,0.052570842,0.0003044555,0.00004140227,0.00001925568,0.000038615068,0.939337,0.0015880954,0.00028369713,0.004549588,0.00024464002],"about_ca_topic_score_codex":0.000056204586,"about_ca_topic_score_gemma":0.000018663282,"teacher_disagreement_score":0.9365115,"about_ca_system_score_codex":0.00039659967,"about_ca_system_score_gemma":0.000050344817,"threshold_uncertainty_score":0.8717394},"labels":[],"label_agreement":null},{"id":"W4367601728","doi":"10.1016/j.leukres.2023.107271","title":"Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: EFFICACY AND SAFETY OF ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN THE CMML SUBPOPULATION FROM PHASE 2 AND ASCERTAIN PHASE 3 STUDIES","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta Hospital; Queen Elizabeth II Health Sciences Centre; Princess Margaret Cancer Centre; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Decitabine; Phase (matter); Medicine; Biology; Chemistry","score_opus":0.6696574450061488,"score_gpt":0.6687300280735872,"score_spread":0.0009274169325615977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367601728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9802624,0.0058364086,0.000009904664,0.011673836,0.00013478886,0.0015705304,0.00013480983,0.000031582895,0.00034577004],"genre_scores_gemma":[0.97396845,0.024607958,0.00010654154,0.0001823211,0.00041821584,0.0001018704,0.0001845661,0.000018024364,0.00041205614],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9948487,0.0022605082,0.001114248,0.0005245878,0.00072459877,0.0005273534],"domain_scores_gemma":[0.981025,0.017913476,0.0001934266,0.0003749385,0.0002557076,0.00023749823],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011950488,0.00023412767,0.0011112769,0.00022209813,0.00041287727,0.000047481968,0.00015162025,0.00014267201,0.0001835958],"category_scores_gemma":[0.014444783,0.0001393329,0.00011716741,0.00095050427,0.00051193335,0.00015818601,0.0002739045,0.00066023576,0.000010933799],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039203227,0.004673486,0.009016008,0.00016481103,0.0013494772,0.0005280176,0.005259116,0.0000072840794,0.0069027278,0.00030384937,0.010060992,0.922531],"study_design_scores_gemma":[0.45659125,0.028150555,0.04479567,0.00065498234,0.0016178684,0.000049067352,0.013804062,0.01484615,0.0061870366,0.0024263675,0.43022135,0.00065562944],"about_ca_topic_score_codex":0.0017122625,"about_ca_topic_score_gemma":0.0003735886,"teacher_disagreement_score":0.92187536,"about_ca_system_score_codex":0.00026266454,"about_ca_system_score_gemma":0.00023120575,"threshold_uncertainty_score":0.99385697},"labels":[],"label_agreement":null},{"id":"W4367601910","doi":"10.1016/j.leukres.2023.107277","title":"Topic: AS08-Treatment/AS08j-Supportive care, transfusion medicine and MDS, iron overload: MDS CLEARPATH: A WEB-BASED EDUCATIONAL ALGORITHM FOR THE DIAGNOSIS AND MANAGEMENT OF PATIENTS WITH MYELODYSPLASTIC SYNDROMES FROM THE CANADIAN CONSORTIUM ON MDS (CCMDS); 2023 UPDATE","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Elbow and Forearm Trauma Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Juravinski Cancer Centre; St. Paul's Hospital; McGill University; Centre Hospitalier de l’Université de Montréal; University of British Columbia","funders":"","keywords":"Medicine; Intraclass correlation; Kappa; Orthopedic surgery; Surgery","score_opus":0.05455240344001887,"score_gpt":0.3387365405749015,"score_spread":0.2841841371348826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367601910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984698,0.0010064837,0.000014951492,0.009410812,0.00012365053,0.0030281087,0.0010558503,0.000021441612,0.0006407194],"genre_scores_gemma":[0.99072397,0.0050804466,0.00031204318,0.00023475068,0.00011257995,0.0012651822,0.0012845321,0.000039003713,0.00094751676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978481,0.00011102167,0.0002650177,0.0004721955,0.00080120104,0.0005024768],"domain_scores_gemma":[0.9973453,0.0016587311,0.00006024714,0.00039986015,0.00025080732,0.0002850332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032859546,0.00023810442,0.0003181751,0.0002544524,0.00054520764,0.000036527166,0.00013591086,0.000102079975,0.00021492223],"category_scores_gemma":[0.000053455435,0.00012383863,0.000059048205,0.00043182404,0.00053121924,0.000042809454,0.00003799984,0.00023921867,0.000017401906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023168942,0.0006749977,0.567434,0.0007847812,0.0017273546,0.00030780365,0.005086653,0.0000656786,0.000023606895,0.0014924373,0.016837724,0.40324807],"study_design_scores_gemma":[0.010149642,0.003953985,0.97199297,0.0006938182,0.0005231222,0.0000040336336,0.0024769148,0.0016081531,0.00012657938,0.00013920537,0.0081787,0.00015290012],"about_ca_topic_score_codex":0.08583359,"about_ca_topic_score_gemma":0.059892923,"teacher_disagreement_score":0.40455893,"about_ca_system_score_codex":0.0009655743,"about_ca_system_score_gemma":0.00084723067,"threshold_uncertainty_score":0.95726156},"labels":[],"label_agreement":null},{"id":"W4367602086","doi":"10.1016/j.leukres.2023.107274","title":"Topic: AS08-Treatment/AS08h-Allogeneic hematopoietic cell transplantation – Post-transplantation treatment: IN VIVO DUAL T CELL DEPLETION (TCD) IMPROVES TRANSPLANT OUTCOMES IN MYELODYSPLASTIC SYNDROME (MDS) PATIENTS WHO UNDERGO MATCHED UNRELATED ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT)","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Transplantation; Hematopoietic cell; Medicine; Hematopoietic stem cell transplantation; Haematopoiesis; Intensive care medicine; Stem cell; Internal medicine; Biology","score_opus":0.024924774068694554,"score_gpt":0.3027709996817769,"score_spread":0.27784622561308236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367602086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175596,0.00027929802,0.00013516599,0.0004562585,0.00026153185,0.0050909333,0.00051102915,0.00028368726,0.0012261204],"genre_scores_gemma":[0.9720798,0.014084098,0.0001306594,0.00007136258,0.00006362593,0.0010678993,0.0040727234,0.00024973913,0.00818006],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99059904,0.0012863514,0.0017162205,0.0017460185,0.0023349896,0.0023174055],"domain_scores_gemma":[0.9960631,0.0018224588,0.00023826395,0.00089164596,0.00037363463,0.0006109025],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012154699,0.0010782965,0.0015281992,0.00293067,0.0003866594,0.00017635252,0.00046472825,0.0009479677,0.0007368377],"category_scores_gemma":[0.000041229974,0.0009740668,0.00047767206,0.0027810605,0.0002811232,0.00047530327,0.000039150116,0.0011869286,0.0004976477],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0077308165,0.003260264,0.3282761,0.006943822,0.00031839364,0.010618381,0.025243035,0.002286358,0.6135923,0.000049413702,0.000036395068,0.0016447004],"study_design_scores_gemma":[0.04044231,0.0062970743,0.63455325,0.0010806442,0.00069917104,0.00075209356,0.0022607436,0.001297944,0.31095812,0.00024497666,0.00011252208,0.00130113],"about_ca_topic_score_codex":0.0063278903,"about_ca_topic_score_gemma":0.005714619,"teacher_disagreement_score":0.3062772,"about_ca_system_score_codex":0.004227055,"about_ca_system_score_gemma":0.0014346268,"threshold_uncertainty_score":0.9995955},"labels":[],"label_agreement":null},{"id":"W4367603471","doi":"10.1016/j.leukres.2023.107239","title":"Topic: AS07-Singular Entities/Subtypes/AS07a-ARCH, CCUS, ICUS: THE IMPACT OF CHIP ON CHEMOTHERAPY-RELATED OUTCOMES AND CLONAL DYNAMICS IN OLDER LYMPHOMA PATIENTS","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; Kingston Health Sciences Centre; Queen's University; Ontario Institute for Cancer Research","funders":"","keywords":"Arch; Lymphoma; Medicine; Business; Intensive care medicine; Engineering; Structural engineering; Pathology","score_opus":0.02424807262812283,"score_gpt":0.3532056420237922,"score_spread":0.32895756939566934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367603471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951426,0.00015080866,3.1353198e-7,0.0011053111,0.00006692153,0.00080174574,0.000036431404,0.000035051264,0.0026608468],"genre_scores_gemma":[0.99735373,0.00038848422,0.000014489636,0.00010379709,0.000032891076,0.000066114764,0.00015314679,0.000033380988,0.0018539603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765843,0.00019033055,0.00035064243,0.0003515675,0.00088216877,0.0005668811],"domain_scores_gemma":[0.99858105,0.0005858635,0.00006611692,0.00046705935,0.00016102567,0.00013886424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067356904,0.00020644041,0.0003949922,0.00043375642,0.00013175812,0.000041425956,0.00017946385,0.00016127696,0.000104115075],"category_scores_gemma":[0.00021608033,0.0001205312,0.00017710337,0.0007722174,0.00024327371,0.000057975634,0.00012839175,0.0002651687,0.000053890708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028440735,0.0006748103,0.96538514,0.00005458352,0.00026469023,0.00009419984,0.0009259834,0.000019336112,0.000045226017,0.000994949,0.0012969564,0.029959736],"study_design_scores_gemma":[0.009281145,0.0006749361,0.9854921,0.00018561527,0.00001937598,0.0000071642085,0.0002321488,0.002762605,0.00054283364,0.00058994716,0.00010904355,0.000103078135],"about_ca_topic_score_codex":0.005476427,"about_ca_topic_score_gemma":0.00019777156,"teacher_disagreement_score":0.02985666,"about_ca_system_score_codex":0.0035256562,"about_ca_system_score_gemma":0.0005872326,"threshold_uncertainty_score":0.9219468},"labels":[],"label_agreement":null},{"id":"W4367604386","doi":"10.1016/j.leukres.2023.107164","title":"Topic: AS03-Health Economics &amp; Outcome Research/AS03a-Cost of care: ARE WE READY TO PERFORM NGS FOR ALL MDS PATIENTS ?","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Innovative concrete reinforcement materials","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Slab; Materials science; Polypropylene; Aggregate (composite); Ductility (Earth science); Mortar; Composite material; Deformation (meteorology); Structural engineering; Stiffness; Load bearing; Compressive strength; Building material; Engineering","score_opus":0.2964000057462181,"score_gpt":0.45964660385170747,"score_spread":0.16324659810548936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367604386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895924,0.00007858244,0.00013877242,0.0011938043,0.0005832864,0.0031018339,0.0005326667,0.00019513922,0.0045835385],"genre_scores_gemma":[0.9928954,0.0006460032,0.0006805741,0.00014526186,0.00034613218,0.0008971194,0.00081259815,0.0001389362,0.003437967],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99620926,0.00014984037,0.00086557027,0.00042551782,0.0008091733,0.0015406198],"domain_scores_gemma":[0.9969128,0.0005899709,0.00008999089,0.0007560649,0.0013837357,0.00026746021],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041820114,0.000233871,0.00053922413,0.0011107478,0.00025269383,0.000115478346,0.0006941616,0.0001913533,0.00012955547],"category_scores_gemma":[0.0008326426,0.00023810362,0.00008154024,0.0011132547,0.00011287041,0.00019178874,0.0004451963,0.00061538286,0.0006116646],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017193444,0.00008467839,0.03801687,0.025472509,0.00080333673,0.000019317884,0.030591853,0.040271807,0.02788227,0.036545783,0.690656,0.107936226],"study_design_scores_gemma":[0.0023038443,0.0008862041,0.006706839,0.00033217506,0.000007200313,7.0621167e-7,0.0017463163,0.0053819497,0.02312754,0.000470764,0.9585033,0.00053315685],"about_ca_topic_score_codex":0.00042331274,"about_ca_topic_score_gemma":0.00021713827,"teacher_disagreement_score":0.2678473,"about_ca_system_score_codex":0.004054157,"about_ca_system_score_gemma":0.00046072807,"threshold_uncertainty_score":0.9997691},"labels":[],"label_agreement":null},{"id":"W4367604542","doi":"10.1016/j.leukres.2023.107181","title":"Topic: AS04-MDS Biology and Pathogenesis/AS04c-MDS Mouse models (GEMMS, PDX): MAMMALIAN DIAPHANOUS-RELATED FORMIN 1 IS REQUIRED FOR MAINTAINING HEMATOPOIETIC STEM CELL QUIESCENCE AND SURVIVAL VIA REGULATING MITOCHONDRIA OXIDATIVE METABOLIC PATHWAY","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Biology; Genotype; Allele; Genotyping; SNP; Odds ratio; Single-nucleotide polymorphism; Pathogenesis; Genetics; Immunology; Internal medicine; Gene; Medicine","score_opus":0.058768967771025166,"score_gpt":0.3408956397664792,"score_spread":0.28212667199545405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367604542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99335027,0.0024841786,0.0011770823,0.00040828757,0.0001433757,0.001604597,0.00015007648,0.0001800985,0.0005020507],"genre_scores_gemma":[0.9872921,0.00034275855,0.0009471603,0.000119308956,0.00021636634,0.00035247745,0.00012132358,0.00010221923,0.010506285],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9958533,0.0005898817,0.0006808859,0.0009901709,0.00063534867,0.0012504],"domain_scores_gemma":[0.9974253,0.00082612195,0.0001686106,0.0006194367,0.00039575418,0.0005647741],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017063046,0.00039517597,0.0008041329,0.00067524664,0.0006186997,0.000091961,0.000262073,0.0003690134,0.000038768372],"category_scores_gemma":[0.00017197256,0.00033361875,0.00016787738,0.0010854031,0.0005460912,0.00026391944,0.00042326166,0.000487091,0.00002502311],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001672102,0.00021401102,0.016656116,0.0019869455,0.00030099196,0.00038757856,0.01022285,0.00017378901,0.84584576,0.010223832,0.0008711686,0.11144488],"study_design_scores_gemma":[0.026627872,0.004564927,0.020991987,0.0016476797,0.00059737574,0.00026598107,0.033891525,0.18501082,0.68165255,0.027323833,0.014381911,0.0030435647],"about_ca_topic_score_codex":0.00013065382,"about_ca_topic_score_gemma":0.00004609162,"teacher_disagreement_score":0.18483703,"about_ca_system_score_codex":0.00025250413,"about_ca_system_score_gemma":0.0006820657,"threshold_uncertainty_score":0.9999116},"labels":[],"label_agreement":null},{"id":"W4367604579","doi":"10.1016/j.leukres.2023.107270","title":"Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: RANDOMIZED PHASE 2 STUDY TO ASSESS SAFETY AND EFFICACY OF LOW-DOSE (LD) ORAL DECITABINE/CEDAZURIDINE (ASTX727) IN LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS) PATIENTS: INTERIM SAFETY ANALYSIS","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Ottawa Regional Cancer Foundation","funders":"","keywords":"Medicine; Internal medicine; Gynecology","score_opus":0.15669092100183316,"score_gpt":0.5137303052899491,"score_spread":0.357039384288116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367604579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919413,0.00021446543,0.00064387,0.0004474752,0.00055624003,0.0053593186,0.00045497835,0.00010595766,0.00027642216],"genre_scores_gemma":[0.99629647,0.0012369914,0.00022836578,0.00004800519,0.0002506347,0.00026126974,0.00056471943,0.00006292438,0.001050641],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9873269,0.0059134695,0.0029991937,0.0011939659,0.0015464673,0.001020004],"domain_scores_gemma":[0.96329254,0.03338727,0.00043989357,0.0011937324,0.00087087625,0.0008156961],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02233888,0.0005339051,0.004910931,0.0023699405,0.00028290253,0.00010909193,0.00033416555,0.00021130867,0.00031261359],"category_scores_gemma":[0.080754995,0.0004054467,0.0010713788,0.004426542,0.00049876596,0.00015184074,0.0006444196,0.0009663575,0.00006170299],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6830985,0.029608095,0.14746039,0.00024138506,0.008815153,0.0017680756,0.0035541542,0.0011311581,0.00039340576,0.00003305654,0.0029556698,0.120940946],"study_design_scores_gemma":[0.8168233,0.014353347,0.15250981,0.00049583946,0.0045498125,0.000010229574,0.0014153838,0.00818616,0.00027100192,0.000025391633,0.0009013138,0.00045839415],"about_ca_topic_score_codex":0.0017224662,"about_ca_topic_score_gemma":0.00024259521,"teacher_disagreement_score":0.1337248,"about_ca_system_score_codex":0.0010643175,"about_ca_system_score_gemma":0.001019772,"threshold_uncertainty_score":0.9998397},"labels":[],"label_agreement":null},{"id":"W4367604632","doi":"10.1016/j.leukres.2023.107278","title":"Topic: AS09-Quality of life-Disease experiences: LONGITUDINAL TRAJECTORY OF QUALITY OF LIFE IN MDS AND IMPACT OF PATIENT-RELATED FACTORS","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Graphite, nuclear technology, radiation studies","field":"Materials Science","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Vancouver General Hospital; Princess Margaret Cancer Centre; McGill University Health Centre; McGill University; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; University of British Columbia; CancerCare Manitoba; Saskatchewan Cancer Agency; University of Alberta Hospital; Capital District Health Authority; Health Sciences Centre; Ottawa Hospital; Jewish General Hospital; Juravinski Cancer Centre; Ontario Institute for Cancer Research; Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Pyrolysis; Thermogravimetric analysis; Charcoal; Chemistry; Inductively coupled plasma mass spectrometry; Yield (engineering); Residue (chemistry); Chromium; Inductively coupled plasma; Mass spectrometry; Boron; Metal; Nuclear chemistry; Materials science; Metallurgy; Chromatography; Organic chemistry; Plasma","score_opus":0.139468826652494,"score_gpt":0.4213634889614625,"score_spread":0.2818946623089685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367604632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99893796,0.00041110045,9.3475484e-7,0.00005445336,0.00006214953,0.00028688085,0.00013454408,0.000043463704,0.000068486785],"genre_scores_gemma":[0.99979424,0.000106793756,0.000029989014,0.0000036802353,0.0000059891177,0.000026000895,0.000005990445,0.000011273564,0.000016065947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963928,0.00076893566,0.0011253947,0.00036128005,0.000955475,0.0003961135],"domain_scores_gemma":[0.99766,0.0009638609,0.00043543018,0.00047034828,0.0003015036,0.00016886384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002380422,0.00014185507,0.00066627184,0.00082805933,0.00006992558,0.000009509218,0.00036862426,0.00015612859,0.00021694036],"category_scores_gemma":[0.004724522,0.00011805625,0.00014153763,0.0017117822,0.0016087685,0.00012803581,0.00029331865,0.0002530562,0.0000047272156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031460216,0.00011329542,0.87576234,0.0003435172,0.00004041234,0.0000016314086,0.009508349,0.00011309415,0.113137916,0.00040416463,0.00011258763,0.00014809046],"study_design_scores_gemma":[0.0007119779,0.00025085273,0.9689863,0.000046696852,0.0000038159274,9.027737e-8,0.013274318,0.00009357868,0.016087977,0.00044651414,0.0000028139332,0.00009509707],"about_ca_topic_score_codex":0.0049720006,"about_ca_topic_score_gemma":0.00016156101,"teacher_disagreement_score":0.097049944,"about_ca_system_score_codex":0.00019265684,"about_ca_system_score_gemma":0.0006209898,"threshold_uncertainty_score":0.75162107},"labels":[],"label_agreement":null},{"id":"W4367604905","doi":"10.1016/j.leukres.2023.107230","title":"Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: ACCELERATED FAILURE TIME MODELS AS A CLINICALLY PLAUSIBLE WAY TO DESCRIBE SURVIVAL IN MDS – AN ANALYSIS OF THE IWG-PM DATABASE","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Medicine; International Prognostic Scoring System; Myelodysplastic syndromes; Risk stratification; Prognostic model; Intensive care medicine; Internal medicine; Oncology; Overall survival","score_opus":0.17792482982712265,"score_gpt":0.44826791603131505,"score_spread":0.2703430862041924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367604905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952546,0.000028867602,0.00007921613,0.0010795317,0.00004718589,0.0019033265,0.00046648667,0.00008306709,0.0010577323],"genre_scores_gemma":[0.995955,0.0002020463,0.0013253029,0.00006813457,0.00006374985,0.00015484024,0.00042443213,0.00007490453,0.0017316215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9912407,0.0019942168,0.0014751164,0.0011184476,0.0028785819,0.001292985],"domain_scores_gemma":[0.99262595,0.003614525,0.0002536306,0.0015717525,0.001215952,0.0007181798],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.008322017,0.0003876464,0.0014392539,0.002518802,0.00025901053,0.00012231471,0.0012249112,0.0004188026,0.0004891435],"category_scores_gemma":[0.0057122484,0.00027735322,0.00031259385,0.010348481,0.0005502773,0.00038736488,0.0016847184,0.0024250105,0.00006115699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00063791336,0.00028271222,0.98030645,0.00022706077,0.00079978275,0.00009913653,0.0010222145,0.0026727533,0.01204442,0.0003443146,0.0006711098,0.00089212006],"study_design_scores_gemma":[0.0024407113,0.00090382196,0.79948145,0.00018893449,0.00051628606,0.0000039629863,0.0019096287,0.19196065,0.0020589223,0.00019436229,0.000094863484,0.00024639975],"about_ca_topic_score_codex":0.014502046,"about_ca_topic_score_gemma":0.0045491564,"teacher_disagreement_score":0.18928789,"about_ca_system_score_codex":0.0013476282,"about_ca_system_score_gemma":0.0022174416,"threshold_uncertainty_score":0.9999679},"labels":[],"label_agreement":null},{"id":"W4367605072","doi":"10.1016/j.leukres.2023.107160","title":"Topic: AS02-Epidemiology: EVALUATION OF INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES: A PROSPECTIVE COHORT STUDY FROM THE CANADIAN MDS REGISTRY","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Polymer Foaming and Composites","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; Vancouver General Hospital; Ontario Institute for Cancer Research; Dr. Georges-L.-Dumont University Hospital Centre; St. Paul's Hospital; University of British Columbia; University of Manitoba; Juravinski Cancer Centre; CancerCare Manitoba; Saskatchewan Cancer Agency; Ottawa Hospital; Université Laval; Dalhousie University; University of Winnipeg","funders":"","keywords":"Flexural strength; Photovoltaics; Renewable energy; Sunlight; Photovoltaic system; Ultimate tensile strength; Solar energy; Epoxy; Materials science; Environmental science; Composite material; Optics; Engineering; Electrical engineering; Physics","score_opus":0.08483279196042659,"score_gpt":0.37583843988746923,"score_spread":0.29100564792704264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367605072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969277,0.00004053935,0.0000060645198,0.00023218778,0.000074531104,0.001358156,0.000049721853,0.000035941906,0.0012751544],"genre_scores_gemma":[0.99917006,0.0000018602562,0.000020922735,0.000021962833,0.000024186109,0.0006133974,0.000054718912,0.000010093435,0.00008276684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967532,0.00133895,0.00026736342,0.0003847043,0.0008336096,0.00042217516],"domain_scores_gemma":[0.9971285,0.0016096857,0.000081736434,0.00059093494,0.00049640494,0.00009277268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047010058,0.00009498135,0.0002161656,0.00022544562,0.00039142076,0.00004433481,0.00040981814,0.00006749966,0.000051094976],"category_scores_gemma":[0.0016127204,0.00006578746,0.000018143057,0.00097604195,0.00027138545,0.00006778653,0.00010269653,0.0003295439,0.00011987097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023839631,0.000069334776,0.99761087,0.000004877096,0.000024260811,0.0000022000443,0.00084519247,0.0005446224,0.00024320414,0.00013437952,0.00022027083,0.00027696672],"study_design_scores_gemma":[0.00082076713,0.00022614535,0.995201,0.000050975003,0.000021945496,8.667856e-7,0.000323439,0.0017648995,0.0001913104,0.0013165085,0.000012170948,0.00006998584],"about_ca_topic_score_codex":0.43895268,"about_ca_topic_score_gemma":0.35438892,"teacher_disagreement_score":0.08456377,"about_ca_system_score_codex":0.0016434557,"about_ca_system_score_gemma":0.0014538198,"threshold_uncertainty_score":0.6573918},"labels":[],"label_agreement":null},{"id":"W4367605323","doi":"10.1016/j.leukres.2023.107206","title":"Topic: AS04-MDS Biology and Pathogenesis/AS04h-Immune deregulation/inflammation: NEPHROTIC SYNDROME IN MDS: A CASE REPORT AND REVIEW OF THE LITERATURE","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Tetanus; Diphtheria; Pillar; Humanities; Vaccination; Immunology; Art","score_opus":0.06468935058154511,"score_gpt":0.3882240475445291,"score_spread":0.323534696962984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367605323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834099,0.009143035,0.0000014420549,0.005720149,0.00006827561,0.0010443721,0.000007909445,0.0000277234,0.00057720754],"genre_scores_gemma":[0.9909495,0.007603957,0.00010698646,0.000099159006,0.000070547576,0.00010146401,0.000053228916,0.000019062287,0.0009960621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978984,0.0004436797,0.00057079276,0.00038248018,0.0003386941,0.00036593084],"domain_scores_gemma":[0.9985133,0.00030682262,0.00010076605,0.00068161567,0.0002813537,0.00011615744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021089837,0.00014544996,0.0005214045,0.00031206844,0.0001625636,0.000032586853,0.0001237909,0.00021298032,0.00005708872],"category_scores_gemma":[0.0010265314,0.0001012671,0.000070414804,0.0017333925,0.00024621742,0.00010069606,0.000300035,0.000511748,0.000012627673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031504862,0.0002408602,0.3326743,0.061123252,0.00067079696,0.20405817,0.006900471,0.000010529988,0.2820334,0.01499892,0.0018676802,0.09510659],"study_design_scores_gemma":[0.0015000409,0.00021634763,0.909498,0.009967673,0.00007592203,0.07045096,0.00022635753,0.00026244306,0.0033510572,0.0017007032,0.0025617813,0.00018872153],"about_ca_topic_score_codex":0.0003808961,"about_ca_topic_score_gemma":0.000107043925,"teacher_disagreement_score":0.5768237,"about_ca_system_score_codex":0.00023229195,"about_ca_system_score_gemma":0.00050656666,"threshold_uncertainty_score":0.41295522},"labels":[],"label_agreement":null},{"id":"W4367605563","doi":"10.1016/j.leukres.2023.107131","title":"EXCELLENT TRANSPLANT OUTCOMES WITH FLUDARABINE-TREOSULFAN (FT) REDUCED-TOXICITY CONDITIONING (RTC) IN COMBINATION WITH DUALT-CELL DEPLETION (TCD) IN MYELOABLATIVE CONDITIONING (MAC)-INELIGIBLE PATIENTS WITH MYELODYSPLASTIC SYNDROME (MDS)","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Vehicle emissions and performance","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Diesel fuel; Environmental science; Gasoline; Oxygenate; Waste management; Greenhouse gas; Truck; Fossil fuel; Automotive engineering; Engineering; Chemistry","score_opus":0.016846390854373304,"score_gpt":0.26135251437839274,"score_spread":0.24450612352401943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367605563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704117,0.00002740813,0.0005629362,0.000112782705,0.000062312036,0.00085249014,0.000059173875,0.00023706593,0.0010446826],"genre_scores_gemma":[0.9983465,0.000094605995,0.00023380239,0.000013387993,0.00001782163,0.00031124929,0.0005982433,0.000084913634,0.00029944992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686146,0.00017365835,0.00046981228,0.0005149979,0.0010638692,0.00091622473],"domain_scores_gemma":[0.9987728,0.00043715493,0.00007594825,0.00030669803,0.0002172355,0.000190152],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006786174,0.00034757837,0.00042998735,0.0011692311,0.00037265476,0.00010496342,0.00023310339,0.0001594795,0.00007974771],"category_scores_gemma":[0.000033021322,0.00027431687,0.000032328815,0.0024411136,0.0001587106,0.0005251774,0.000043684475,0.0010718531,0.00008221628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005517616,0.00024059325,0.58988637,0.0005583351,0.0000678096,0.00045338698,0.002567354,0.4020237,0.0028034917,0.00018211214,0.00030742295,0.0003576675],"study_design_scores_gemma":[0.008175694,0.0008726376,0.8600833,0.0014363407,0.000017495786,0.000023923405,0.0007072364,0.12249545,0.005487641,0.00010278911,0.00006393827,0.0005335536],"about_ca_topic_score_codex":0.00047428685,"about_ca_topic_score_gemma":0.0007549843,"teacher_disagreement_score":0.27952826,"about_ca_system_score_codex":0.0012032952,"about_ca_system_score_gemma":0.00028577444,"threshold_uncertainty_score":0.9999709},"labels":[],"label_agreement":null},{"id":"W4367605663","doi":"10.1016/j.leukres.2023.107226","title":"Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment: A STEP TOWARDS IDENTIFICATION AND CAUSAL INTERPRETATION OF THERAPY-RELATED MDS (T-MDS)","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Blood groups and transfusion","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Hospital Foundation","funders":"","keywords":"Peripheral blood mononuclear cell; CD8; Biology; In vitro; Immunology; Molecular biology; Cell growth; Red blood cell; Cytotoxic T cell; T lymphocyte; Lymphocyte; CD28; Andrology; Immune system; Medicine; Biochemistry","score_opus":0.06853498855850935,"score_gpt":0.39882189748701885,"score_spread":0.3302869089285095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367605663","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769825,0.00041381497,0.00022304134,0.0003071373,0.00008290055,0.0008143272,0.000030346017,0.000047281286,0.00038292116],"genre_scores_gemma":[0.9971865,0.0021492115,0.00013847905,0.0000064342926,0.000021239139,0.000044910863,0.000083516,0.000022688624,0.00034703224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979129,0.00026387247,0.0005255659,0.00033250955,0.0006988353,0.00026633238],"domain_scores_gemma":[0.9987036,0.00045468519,0.000125603,0.00025373866,0.0003472505,0.00011509397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014459873,0.0001320527,0.00034876433,0.00042804753,0.00010937353,0.00003687213,0.00009742803,0.0001734122,0.00004943616],"category_scores_gemma":[0.00034390335,0.00010343011,0.00006731833,0.00070193526,0.00023550208,0.000112011054,0.00008202446,0.00051457476,0.0000045657303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018727328,0.00010831598,0.89926165,0.0004527923,0.00018166663,0.000012924642,0.0016676312,0.000006491457,0.022496665,0.00032929628,0.000041840798,0.075253434],"study_design_scores_gemma":[0.0020940886,0.00066696055,0.97952145,0.00018253418,0.00010130809,0.00000584211,0.00074530806,0.009042104,0.0070831846,0.00042720203,0.00004693338,0.000083064886],"about_ca_topic_score_codex":0.0017152186,"about_ca_topic_score_gemma":0.00007917726,"teacher_disagreement_score":0.0802598,"about_ca_system_score_codex":0.00010536669,"about_ca_system_score_gemma":0.00016636397,"threshold_uncertainty_score":0.42177576},"labels":[],"label_agreement":null},{"id":"W4376869035","doi":"10.1016/j.leukres.2023.107315","title":"Elevated expression of interleukin 16 in chronic lymphocytic leukemia is associated with disease burden and abnormal immune microenvironment","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; Research Institute in Oncology and Hematology; University of Manitoba","funders":"Leukemia and Lymphoma Society of Canada","keywords":"Chronic lymphocytic leukemia; Immune system; Immunology; Disease; Medicine; Leukemia; Tumor microenvironment; Cancer research; Pathology","score_opus":0.029947984987117895,"score_gpt":0.3184048372239828,"score_spread":0.2884568522368649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376869035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562913,0.0017482192,0.000013327319,0.00034832838,0.00003850672,0.0015243026,0.000046246205,0.00013370084,0.0005182131],"genre_scores_gemma":[0.99137294,0.0016040677,0.000059529008,0.000049862825,0.00015403044,0.00026760515,0.00020895936,0.00012739224,0.006155612],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99319464,0.00052997697,0.00089127215,0.0010468089,0.0024962248,0.001841086],"domain_scores_gemma":[0.9966822,0.0009205491,0.00017534006,0.001218918,0.00028966472,0.00071332406],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002585995,0.00043681823,0.0008682662,0.0013633562,0.00020380603,0.000069342124,0.0005705469,0.00034114285,0.00041602395],"category_scores_gemma":[0.00085321907,0.00036145147,0.00014003854,0.0025894311,0.0011337305,0.00022829795,0.0010366589,0.001250721,0.00020515853],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.013557331,0.00018407816,0.008559765,0.0038789844,0.0005536278,0.008566004,0.0044324566,0.006556675,0.93684155,0.00014917168,0.007877596,0.008842777],"study_design_scores_gemma":[0.10214764,0.0030240468,0.0965984,0.0112830065,0.00017774093,0.00031914873,0.0019655067,0.32261738,0.45712528,0.00045672845,0.0031430272,0.001142092],"about_ca_topic_score_codex":0.0065237675,"about_ca_topic_score_gemma":0.00019761754,"teacher_disagreement_score":0.47971624,"about_ca_system_score_codex":0.29012898,"about_ca_system_score_gemma":0.049961638,"threshold_uncertainty_score":0.9998838},"labels":[],"label_agreement":null},{"id":"W4377695552","doi":"10.1016/j.leukres.2023.107324","title":"Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Multiple myeloma; Internal medicine; Confidence interval; Incidence (geometry); Meta-analysis; Randomized controlled trial; Odds ratio; Adverse effect; Oncology; Clinical endpoint; Clinical trial; Gastroenterology","score_opus":0.13460659739632136,"score_gpt":0.3991285932244679,"score_spread":0.26452199582814656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377695552","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0063716145,0.9831647,0.0000018669734,0.000036212077,0.000008658401,0.00973092,0.00052223465,0.000038172664,0.00012557222],"genre_scores_gemma":[0.00295854,0.9914063,0.00046889056,0.000037430935,0.000014016232,0.001842442,0.00067640265,0.000115764065,0.002480165],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9909501,0.001961658,0.0020221572,0.0012003882,0.0027523013,0.0011133755],"domain_scores_gemma":[0.99322164,0.0030651353,0.00072529423,0.0015300288,0.0010436856,0.0004142074],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044283005,0.0007372467,0.012342162,0.0026142213,0.00015976088,0.00007959507,0.0005979474,0.00033668833,0.00021734192],"category_scores_gemma":[0.0032121907,0.00043815243,0.0013888752,0.0052293083,0.00044102408,0.00020707832,0.00065576873,0.0013554773,0.000084167084],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006273744,0.00015714594,0.010557732,0.9065628,0.080999635,0.00034999178,0.00007134302,6.6632157e-7,9.793869e-7,0.0000035768526,0.00010265043,0.0011307292],"study_design_scores_gemma":[0.002717566,0.00072995416,0.079334795,0.39141655,0.5239489,0.00006580384,0.00007033155,0.000052534626,0.0000054701336,0.000009424979,0.0008814238,0.0007672596],"about_ca_topic_score_codex":0.0005460616,"about_ca_topic_score_gemma":0.0005356126,"teacher_disagreement_score":0.51514626,"about_ca_system_score_codex":0.0015024652,"about_ca_system_score_gemma":0.0020905803,"threshold_uncertainty_score":0.999807},"labels":[],"label_agreement":null},{"id":"W4384038204","doi":"10.1016/j.leukres.2023.107354","title":"Changing frontline AML treatment patterns from 2013 to 2022","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Myeloid leukemia; Internal medicine; Pediatrics","score_opus":0.08757382435923698,"score_gpt":0.39717534999691767,"score_spread":0.3096015256376807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384038204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784539,0.0002352915,0.00025191813,0.015604951,0.0002468881,0.0018351894,0.0003099589,0.00043527078,0.0026266437],"genre_scores_gemma":[0.85563743,0.001816821,0.00098306,0.00083499897,0.0024667997,0.0011883352,0.0011252098,0.00021452397,0.13573283],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99363804,0.0003754411,0.0004310505,0.0010679695,0.002153398,0.0023341195],"domain_scores_gemma":[0.99617606,0.00084076455,0.00003889291,0.0014335975,0.00043892927,0.0010717603],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0019413572,0.0003504209,0.00060787663,0.0023570997,0.00044393959,0.00012340587,0.00058471254,0.0002667613,0.0032679148],"category_scores_gemma":[0.00054224173,0.00029254146,0.00019788682,0.0031474319,0.00012977674,0.00012742088,0.00094371673,0.0012115354,0.018881198],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025763824,0.0004474563,0.038076993,0.00031638108,0.0008651164,0.0074410867,0.009708363,0.00036779323,0.10161701,0.00025573224,0.6422025,0.19612521],"study_design_scores_gemma":[0.01721419,0.005056798,0.13234745,0.00086311344,0.00013197892,0.000111727604,0.011293325,0.048344824,0.1059968,0.00097304594,0.67634046,0.0013262717],"about_ca_topic_score_codex":0.01461536,"about_ca_topic_score_gemma":0.0007911687,"teacher_disagreement_score":0.19479895,"about_ca_system_score_codex":0.008303955,"about_ca_system_score_gemma":0.0016382948,"threshold_uncertainty_score":0.9999527},"labels":[],"label_agreement":null},{"id":"W4385998043","doi":"10.1016/j.leukres.2023.107372","title":"Canadian evidence-based guideline for treatment of relapsed/refractory chronic lymphocytic leukemia","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Toronto; Spinal Cord Injury BC; Jewish General Hospital; Health Sciences Centre; CancerCare Manitoba; Leukemia & Lymphoma Society of Canada; Princess Margaret Cancer Centre; Ottawa Hospital; Foothills Medical Centre","funders":"","keywords":"Medicine; Chronic lymphocytic leukemia; Guideline; Refractory (planetary science); Internal medicine; Intensive care medicine; Oncology; Leukemia; Pathology","score_opus":0.15840194623129275,"score_gpt":0.4246529317459071,"score_spread":0.26625098551461435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385998043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745938,0.00836736,0.00022438185,0.004488182,0.00054663967,0.006921346,0.0002483909,0.00049448997,0.0041154074],"genre_scores_gemma":[0.97256225,0.0036381085,0.00097644114,0.0003101519,0.001209181,0.0014039127,0.00057048176,0.00022801296,0.019101454],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99175185,0.00040226147,0.0012832382,0.0011996735,0.0024921065,0.0028708722],"domain_scores_gemma":[0.9904965,0.0039712256,0.00012499558,0.0020973822,0.0017572304,0.0015526523],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004165977,0.00050304923,0.0010734532,0.0026817408,0.0005011168,0.0000816249,0.0007791575,0.0006017631,0.000684112],"category_scores_gemma":[0.003682536,0.00043506426,0.00053135527,0.0034515352,0.0006996294,0.0002349504,0.00016059152,0.00046655332,0.001214802],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.012068937,0.00039690023,0.0016231011,0.0079480605,0.0014461763,0.005374325,0.0018902343,0.046355132,0.10175506,0.0018594132,0.6414725,0.17781013],"study_design_scores_gemma":[0.045936294,0.007760217,0.0004695703,0.0015515194,0.00015787205,0.00011443812,0.0003319228,0.5735922,0.061834253,0.00028016727,0.30745336,0.00051818544],"about_ca_topic_score_codex":0.40809938,"about_ca_topic_score_gemma":0.055123318,"teacher_disagreement_score":0.52723706,"about_ca_system_score_codex":0.6780065,"about_ca_system_score_gemma":0.5143921,"threshold_uncertainty_score":0.9998101},"labels":[],"label_agreement":null},{"id":"W4386071245","doi":"10.1016/j.leukres.2023.107374","title":"Canadian real-world experience of asciminib treatment in heavily pre-treated chronic myeloid leukemia (CML) patients who failed multiple lines of tyrosine kinase inhibitor (TKI) therapy","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Jewish General Hospital; Juravinski Cancer Centre; Hôpital Maisonneuve-Rosemont; Dr. Georges-L.-Dumont University Hospital Centre; Ottawa Hospital; Princess Margaret Cancer Centre; Kingston General Hospital; London Health Sciences Centre; Brampton Civic Hospital; Université de Sherbrooke; Queen Elizabeth II Health Sciences Centre; Centre Hospitalier de l’Université de Montréal","funders":"Princess Margaret Cancer Foundation","keywords":"Tolerability; Medicine; Myeloid leukemia; Cumulative incidence; Internal medicine; Tyrosine-kinase inhibitor; Tyrosine kinase; Adverse effect; Gastroenterology; Oncology; Cohort; Cancer; Receptor","score_opus":0.05328367278869478,"score_gpt":0.3594598913470843,"score_spread":0.3061762185583895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386071245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365336,0.0006030586,4.0281668e-7,0.0002920944,0.00015795794,0.003502558,0.00025322597,0.00011920905,0.0014181184],"genre_scores_gemma":[0.98661894,0.003258515,0.00011483247,0.000032971504,0.0002278383,0.000962859,0.0007606176,0.00013707997,0.007886321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99365854,0.0004355904,0.0013063307,0.001137177,0.0016453742,0.001816984],"domain_scores_gemma":[0.99579686,0.0007772092,0.0002648877,0.0015253999,0.0008131615,0.0008224942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007806797,0.0006209023,0.0013006215,0.0025794855,0.00022516226,0.000040488256,0.00053927384,0.0003886526,0.00029354042],"category_scores_gemma":[0.0005547531,0.0005204537,0.000267007,0.0046514454,0.0005584386,0.00023965829,0.00020389208,0.00067274645,0.00011163896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0026337611,0.0007759371,0.92317486,0.00043345042,0.00025104877,0.0004826784,0.0053218203,0.000464265,0.039542954,0.000036773803,0.0022390399,0.02464341],"study_design_scores_gemma":[0.024041753,0.0033340196,0.70680124,0.0011447114,0.000037373244,0.0000043104988,0.0005455482,0.005149648,0.25498867,0.000021694976,0.0035376092,0.00039343062],"about_ca_topic_score_codex":0.6859839,"about_ca_topic_score_gemma":0.49023739,"teacher_disagreement_score":0.21637362,"about_ca_system_score_codex":0.05126601,"about_ca_system_score_gemma":0.014649854,"threshold_uncertainty_score":0.9997247},"labels":[],"label_agreement":null},{"id":"W4386258431","doi":"10.1016/j.leukres.2023.107376","title":"AML with CEBPA mutations: A comparison of ICC and WHO-HAEM5 criteria in patients with 20% or more blasts","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"CEBPA; Medicine; Internal medicine; Oncology; Mutation; Cohort; Hazard ratio; Genetics; Gene; Biology; Confidence interval","score_opus":0.06746631063902843,"score_gpt":0.4179117202482542,"score_spread":0.35044540960922577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386258431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958567,0.000067735564,0.000017284421,0.0013442843,0.000017939085,0.0015907586,0.000051477982,0.00006755371,0.0009862541],"genre_scores_gemma":[0.9947794,0.000054935477,0.00094545394,0.00006130237,0.000056153433,0.00022266139,0.00022344083,0.00007897964,0.0035776512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956105,0.0003182493,0.00047934108,0.00062061497,0.0019736052,0.000997724],"domain_scores_gemma":[0.99718934,0.00080805545,0.00008636331,0.00064187223,0.0009219861,0.00035240606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011473391,0.00024622816,0.0006773622,0.0014044471,0.00016684998,0.00006209856,0.00029698183,0.00018019798,0.00019156338],"category_scores_gemma":[0.0006695957,0.00016349157,0.000032447897,0.003523551,0.0009720042,0.000209242,0.00032215542,0.0012532717,0.00007998402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013849264,0.0004187301,0.9504008,0.0010925877,0.00017161951,0.0006653237,0.0070894314,0.00022800147,0.0013595783,0.00007926556,0.018408516,0.006236869],"study_design_scores_gemma":[0.016348042,0.0046228752,0.9508993,0.0011650743,0.00003865494,0.000035586756,0.0057062474,0.016821735,0.0025214334,0.00006508848,0.0014857842,0.00029016365],"about_ca_topic_score_codex":0.00078261597,"about_ca_topic_score_gemma":0.00066882704,"teacher_disagreement_score":0.016922733,"about_ca_system_score_codex":0.0012253025,"about_ca_system_score_gemma":0.0021824248,"threshold_uncertainty_score":0.66669923},"labels":[],"label_agreement":null},{"id":"W4386574131","doi":"10.1016/j.leukres.2023.107387","title":"Single centre retrospective analysis of extracorporeal photopheresis (ECP) therapy in patients heavily pre-treated for chronic graft-versus-host disease (cGvHD) with steroid failure","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Extracorporeal Photopheresis; Medicine; Photopheresis; Immunosuppression; Graft-versus-host disease; Refractory (planetary science); Surgery; Internal medicine; Complication; Retrospective cohort study; Gastroenterology; Disease","score_opus":0.04202740629419695,"score_gpt":0.33033963935682126,"score_spread":0.2883122330626243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386574131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99670374,0.000061283274,0.00003513274,0.00021567466,0.00003126179,0.0023008634,0.00033257462,0.00007292387,0.00024651407],"genre_scores_gemma":[0.9975149,0.00010411427,0.0001459893,0.000010460126,0.000042862328,0.00020963434,0.0012246324,0.000057658992,0.0006897157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968137,0.00021095196,0.00045020253,0.0006142205,0.0012220158,0.0006888979],"domain_scores_gemma":[0.99786437,0.00054137263,0.00011661383,0.00054310844,0.00065788184,0.00027668112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054155913,0.00022716958,0.00057891256,0.0010329755,0.00009576018,0.00003055912,0.00018181323,0.00014620739,0.00017251744],"category_scores_gemma":[0.00011354903,0.00018391648,0.00018788548,0.004052212,0.00018223653,0.00010854375,0.000029836037,0.00032365296,0.000014927868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020358909,0.0006065236,0.9583262,0.00059108087,0.001134894,0.000121192534,0.0014132921,0.00021560723,0.015641091,0.000034062705,0.0007446837,0.00081241794],"study_design_scores_gemma":[0.0144969225,0.0025113754,0.9647889,0.0003710613,0.00040699492,4.0941276e-7,0.00042333608,0.002844817,0.013892596,0.0000253353,0.00006844478,0.00016979786],"about_ca_topic_score_codex":0.0006314884,"about_ca_topic_score_gemma":0.0027706597,"teacher_disagreement_score":0.0064626634,"about_ca_system_score_codex":0.0020018467,"about_ca_system_score_gemma":0.00067663094,"threshold_uncertainty_score":0.7499896},"labels":[],"label_agreement":null},{"id":"W4386886967","doi":"10.1016/j.leukres.2023.107390","title":"Phase 1 study of JNJ-64619178, a protein arginine methyltransferase 5 inhibitor, in patients with lower-risk myelodysplastic syndromes","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Cancer-related gene regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"Janssen Pharmaceuticals; Janssen Research and Development","keywords":"Myelodysplastic syndromes; Methyltransferase; Arginine; Medicine; Internal medicine; Oncology; Chemistry; Methylation; Biochemistry; Gene; Amino acid","score_opus":0.020881035359742617,"score_gpt":0.3224272566979904,"score_spread":0.30154622133824777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386886967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99791783,0.00007401182,0.000051591145,0.000036738802,0.00006531744,0.0017328326,0.00004350782,0.00002199804,0.000056161247],"genre_scores_gemma":[0.9988757,0.000033117172,0.00004528524,0.0000021139067,0.00007559266,0.00026433522,0.0001795886,0.000046064102,0.00047821517],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974432,0.00039843656,0.0003243997,0.00054816005,0.0007929921,0.00049278745],"domain_scores_gemma":[0.99892515,0.00005965482,0.00007280741,0.00051887915,0.0003143674,0.00010916285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008633235,0.00018326982,0.000248885,0.00047740762,0.000093496106,0.000020771504,0.00022921644,0.00017446736,0.000023378629],"category_scores_gemma":[0.00026492574,0.00016310287,0.000046037356,0.0014487266,0.00013774917,0.000009779663,0.0001285028,0.0004223952,0.000021803731],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021776102,0.009008141,0.14922252,0.00047571253,0.0007890042,0.00020263405,0.002061729,0.024318963,0.7593962,0.000026316318,0.002761136,0.029961552],"study_design_scores_gemma":[0.11061703,0.08015133,0.27435917,0.0007345182,0.00014374299,0.000008705636,0.0018540611,0.0059216637,0.5223505,0.00014035859,0.0023163897,0.0014025717],"about_ca_topic_score_codex":0.00040387665,"about_ca_topic_score_gemma":0.00055761,"teacher_disagreement_score":0.23704572,"about_ca_system_score_codex":0.00021928997,"about_ca_system_score_gemma":0.0005149109,"threshold_uncertainty_score":0.6651142},"labels":[],"label_agreement":null},{"id":"W4386987507","doi":"10.1016/j.leukres.2023.107401","title":"Deep immunophenotypic analysis of the bone marrow progenitor cells in myelodysplastic syndromes","year":2023,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Calgary Laboratory Services; University of Calgary","funders":"","keywords":"Myelodysplastic syndromes; Immunophenotyping; Cytopenia; Chronic myelomonocytic leukemia; Medicine; Myeloid; Bone marrow; Population; Progenitor cell; International Prognostic Scoring System; Leukocytosis; Pathology; Internal medicine; Oncology; Immunology; Stem cell; Flow cytometry; Biology; Genetics","score_opus":0.044005983657383944,"score_gpt":0.3429631793028866,"score_spread":0.29895719564550266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386987507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450004,0.00039801275,0.000019691131,0.0010491884,0.00015414876,0.0012960352,0.000025580008,0.00008584861,0.002471479],"genre_scores_gemma":[0.9888769,0.00022482737,0.00021401592,0.0000628775,0.00010185007,0.00024655857,0.000055608947,0.00006827181,0.010149124],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99392635,0.0007698725,0.0007298917,0.0006658463,0.0024861281,0.0014219396],"domain_scores_gemma":[0.99593765,0.0015707546,0.00010600679,0.0015403891,0.00057563547,0.0002695846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035123802,0.00025542447,0.00085159886,0.0035756219,0.00023537707,0.000051447045,0.00090911146,0.00029664385,0.0004620916],"category_scores_gemma":[0.0016168958,0.00018326919,0.0003982734,0.020189501,0.00072077085,0.00010187714,0.0008903367,0.0019136283,0.0007099321],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002917071,0.00059021375,0.1754797,0.001892234,0.0046424503,0.0027918576,0.0039618425,0.0104297595,0.76847845,0.0014170357,0.016908722,0.010490679],"study_design_scores_gemma":[0.0052979784,0.0005657428,0.75097805,0.00043874432,0.0008683251,0.000087568784,0.0026471177,0.18152164,0.053591892,0.00056717766,0.002952086,0.00048368046],"about_ca_topic_score_codex":0.001110286,"about_ca_topic_score_gemma":0.0003349366,"teacher_disagreement_score":0.71488655,"about_ca_system_score_codex":0.0030481375,"about_ca_system_score_gemma":0.0024636104,"threshold_uncertainty_score":0.97003865},"labels":[],"label_agreement":null},{"id":"W4392888281","doi":"10.1016/j.leukres.2024.107485","title":"Mathematical modelling of clonal reduction therapeutic strategies in acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Centre Hospitalier Universitaire Sainte-Justine; McGill University Health Centre; Université de Montréal","funders":"Natural Sciences and Engineering Research Council of Canada; CHU Sainte-Justine Foundation; Cole Foundation; Fonds de Recherche du Québec - Santé; Fondation de l'Hôpital de Montréal pour enfants; Leukemia and Lymphoma Society of Canada","keywords":"Myeloid leukemia; Population; Medicine; Stem cell; Haematopoiesis; Cytarabine; Oncology; Pharmacology; Myeloid; Internal medicine; Cancer research; Biology","score_opus":0.10147604319015943,"score_gpt":0.3924380663267607,"score_spread":0.29096202313660124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392888281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96025985,0.0028936698,0.010095154,0.0018892211,0.00017371075,0.0013036008,0.000019074378,0.00020960638,0.023156118],"genre_scores_gemma":[0.9889497,0.0014536859,0.003915856,0.000030614192,0.00038807976,0.00017294478,0.000046146342,0.00011372491,0.00492925],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9943993,0.00041337628,0.0008565899,0.0008434936,0.0022206146,0.0012666449],"domain_scores_gemma":[0.9975941,0.00076007325,0.000037553054,0.00080108526,0.0004940971,0.00031305326],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0035612471,0.00032716338,0.00068384025,0.0016712265,0.00013546653,0.00021243378,0.00049335574,0.00045438114,0.00052108965],"category_scores_gemma":[0.00012717616,0.0002734797,0.00023390383,0.00256045,0.0008064051,0.0004957115,0.00026208346,0.0032713732,0.00047961817],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0047629187,0.0005392742,0.00041862266,0.007913609,0.0015611725,0.0041720616,0.00918544,0.02643081,0.59634644,0.2904743,0.009033025,0.04916233],"study_design_scores_gemma":[0.002933597,0.0010228624,0.000698221,0.0021713641,0.00015444796,0.0014791238,0.005096447,0.84602654,0.054576293,0.08221448,0.0031152475,0.00051135547],"about_ca_topic_score_codex":0.00062457635,"about_ca_topic_score_gemma":0.000013980019,"teacher_disagreement_score":0.81959575,"about_ca_system_score_codex":0.0068434216,"about_ca_system_score_gemma":0.009814833,"threshold_uncertainty_score":0.99997175},"labels":[],"label_agreement":null},{"id":"W4393230660","doi":"10.1016/j.leukres.2024.107497","title":"Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML","year":2024,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Medical Research Council; Bristol-Myers Squibb","keywords":"IDH2; Neuroblastoma RAS viral oncogene homolog; Internal medicine; Medicine; Oncology; Mutation; Myeloid; IDH1; Biology; Gene; Genetics; KRAS","score_opus":0.03134948617511376,"score_gpt":0.35570727734812685,"score_spread":0.3243577911730131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393230660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341387,0.0009355138,0.000083347215,0.0031214512,0.00005027372,0.0013280278,0.000019966366,0.00020018301,0.00084738224],"genre_scores_gemma":[0.9946986,0.00043339253,0.00062450516,0.0001371694,0.0001432383,0.0002796374,0.00007019257,0.00011263455,0.00350062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950857,0.00046780377,0.0005626713,0.00088952616,0.0018744459,0.0011198445],"domain_scores_gemma":[0.99688554,0.0015039681,0.000049974322,0.00070325215,0.0004245295,0.00043271255],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002037314,0.00033227837,0.0005459165,0.001555266,0.00016757907,0.00027492893,0.00032824953,0.00029318882,0.00015719574],"category_scores_gemma":[0.0010178034,0.00024859371,0.0000685911,0.0016844508,0.0004441576,0.0004091555,0.00027959063,0.0025174755,0.00037190097],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032184653,0.0003597243,0.6197294,0.008051394,0.0010828308,0.059691247,0.02062031,0.0017776891,0.2164554,0.0004901025,0.0033389595,0.06518449],"study_design_scores_gemma":[0.011149256,0.002145091,0.9032673,0.0035419737,0.00011436204,0.0021046873,0.0037867443,0.045464147,0.025156772,0.0010623313,0.0014081674,0.00079914933],"about_ca_topic_score_codex":0.0055457177,"about_ca_topic_score_gemma":0.00044599676,"teacher_disagreement_score":0.28353795,"about_ca_system_score_codex":0.0039287363,"about_ca_system_score_gemma":0.0029745034,"threshold_uncertainty_score":0.9999966},"labels":[],"label_agreement":null},{"id":"W4401752195","doi":"10.1016/j.leukres.2024.107560","title":"Cost-effectiveness of blinatumomab for the treatment of B‑precursor acute lymphoblastic leukemia pediatric patients with high‑risk first‑relapse in Mexico","year":2024,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Blinatumomab; Lymphoblastic Leukemia; Medicine; Oncology; Leukemia; Internal medicine","score_opus":0.03311726518485927,"score_gpt":0.34277513827120726,"score_spread":0.309657873086348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401752195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714316,0.0022907353,0.0014196867,0.00016828188,0.0002969305,0.007877849,0.00054322125,0.000069617134,0.0001905056],"genre_scores_gemma":[0.9926537,0.0031296406,0.0005611018,0.000009125596,0.00022983388,0.0024525076,0.00016338466,0.0001540811,0.000646589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938919,0.0006757491,0.0008306448,0.0010047843,0.0022702292,0.001326719],"domain_scores_gemma":[0.980421,0.016638422,0.00017313306,0.0011264462,0.0013120084,0.00032898324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002464648,0.00049483276,0.0010540873,0.0014952455,0.00024271912,0.0000692918,0.0006187375,0.00037864177,0.000061870836],"category_scores_gemma":[0.0012140408,0.00029598936,0.00031778583,0.003393969,0.0007626861,0.00019056891,0.0001961663,0.0008301206,0.000060881237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.12829345,0.008441341,0.71059424,0.022905342,0.007763211,0.0021953476,0.008074737,0.017901566,0.00204715,0.004654286,0.011450803,0.07567855],"study_design_scores_gemma":[0.103340976,0.040524375,0.67556375,0.0038608997,0.0033439037,0.00011251542,0.0005895524,0.12257357,0.041621972,0.001506481,0.005849382,0.0011125926],"about_ca_topic_score_codex":0.0018924393,"about_ca_topic_score_gemma":0.00022250193,"teacher_disagreement_score":0.10467201,"about_ca_system_score_codex":0.017270975,"about_ca_system_score_gemma":0.008444964,"threshold_uncertainty_score":0.9999492},"labels":[],"label_agreement":null},{"id":"W4402731040","doi":"10.1016/j.leukres.2024.107586","title":"Outcome of adolescents and young adult acute myeloid leukemia patients compared with middle-aged patients: A single centre retrospective experience","year":2024,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Myeloid leukemia; Medicine; Retrospective cohort study; Pediatrics; Young adult; Internal medicine","score_opus":0.038281070651816275,"score_gpt":0.3206665925156642,"score_spread":0.2823855218638479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402731040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940158,0.00025287608,0.000051535753,0.00021518777,0.00024792674,0.0022847163,0.00019345144,0.00019356675,0.0025449437],"genre_scores_gemma":[0.99472475,0.00016580448,0.00071039126,0.00012557366,0.00015147188,0.00013297312,0.00020703558,0.00016074858,0.0036212269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99189496,0.00043420526,0.0009608311,0.001473821,0.0035858862,0.0016502725],"domain_scores_gemma":[0.9949484,0.00026990418,0.00015281982,0.0010561983,0.0027921698,0.00078050996],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00065208395,0.00057306315,0.0010091581,0.0009941206,0.00036692357,0.00024273038,0.0006303854,0.0003568923,0.00012555592],"category_scores_gemma":[0.0009956348,0.00045121732,0.00017888984,0.0022977607,0.0013453903,0.0005545863,0.00071152695,0.0024167888,0.00012402688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002953134,0.00047170155,0.9767399,0.001392152,0.00033187823,0.00039400713,0.0071591134,0.0000029957987,0.005433783,0.00013176611,0.0031845148,0.0018050958],"study_design_scores_gemma":[0.0131381275,0.0025389283,0.9627875,0.0038730088,0.00017362104,0.00006104931,0.0030413955,0.0025219664,0.010696494,0.000070036614,0.00044506765,0.00065279193],"about_ca_topic_score_codex":0.0014725934,"about_ca_topic_score_gemma":0.00033801395,"teacher_disagreement_score":0.013952346,"about_ca_system_score_codex":0.011119808,"about_ca_system_score_gemma":0.001492419,"threshold_uncertainty_score":0.99988467},"labels":[],"label_agreement":null},{"id":"W4407687743","doi":"10.1016/j.leukres.2025.107665","title":"Molecular genetic characterization of mixed-phenotype acute leukemia (MPAL) with BCR::ABL1 fusion","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"breakpoint cluster region; Phenotype; Fusion gene; Cancer research; Genetics; Biology; Gene","score_opus":0.018717936051413576,"score_gpt":0.3272520593277069,"score_spread":0.3085341232762933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407687743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824452,0.00031862417,0.003842666,0.0015618026,0.00012542418,0.0017728095,0.00003508132,0.00012285355,0.00977557],"genre_scores_gemma":[0.98618907,0.0006890351,0.002710955,0.00033294474,0.00015309572,0.00020746994,0.00028525395,0.000113065566,0.009319125],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99421483,0.00054043264,0.0007265036,0.00096940383,0.0022372613,0.0013115797],"domain_scores_gemma":[0.9957729,0.00031971867,0.00015402028,0.001574541,0.0017582524,0.0004205607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013916497,0.0004071858,0.0007885723,0.0014832515,0.00030986956,0.00009101196,0.000766583,0.00046564708,0.00027059333],"category_scores_gemma":[0.00043605856,0.00033735018,0.00016664476,0.0035998113,0.0007350021,0.00018496116,0.0006553969,0.0017854586,0.00020467471],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0028525256,0.00013431128,0.007400294,0.00074971357,0.0004859712,0.0008080886,0.0002320543,0.000112969334,0.96191573,0.0019606669,0.0022969889,0.021050675],"study_design_scores_gemma":[0.009515041,0.0022614663,0.2230101,0.0014486592,0.00039694362,0.00019056322,0.00031067815,0.012148821,0.7376854,0.0007552256,0.011652959,0.0006241414],"about_ca_topic_score_codex":0.00068530877,"about_ca_topic_score_gemma":0.000043179385,"teacher_disagreement_score":0.22423033,"about_ca_system_score_codex":0.0050269975,"about_ca_system_score_gemma":0.00933123,"threshold_uncertainty_score":0.99990785},"labels":[],"label_agreement":null},{"id":"W4409174715","doi":"10.1016/j.leukres.2025.107690","title":"Safety, tolerability, and pharmacokinetics of ASP1235 in relapsed or refractory acute myeloid leukemia: A phase 1 study","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Astellas Pharma; Astellas Pharma US","keywords":"Tolerability; Pharmacokinetics; Myeloid leukemia; Medicine; Refractory (planetary science); Pharmacology; Oncology; Internal medicine; Adverse effect; Materials science","score_opus":0.05871529485145651,"score_gpt":0.4337909477996639,"score_spread":0.3750756529482074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409174715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98039085,0.0007811345,0.000046061377,0.0020882722,0.00013960025,0.004206766,0.000058774447,0.00007780096,0.012210722],"genre_scores_gemma":[0.98123604,0.002023634,0.00059515936,0.00028477743,0.00014141655,0.00032316952,0.000040861607,0.00008372752,0.015271192],"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9920676,0.0014349862,0.0015650572,0.0013350274,0.0021002614,0.0014970948],"domain_scores_gemma":[0.99365366,0.002985348,0.00015707473,0.0016312614,0.0010389541,0.00053373084],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006261548,0.00048537375,0.0014296665,0.0023012774,0.00027761655,0.000077445,0.00085960963,0.0005013465,0.0006052846],"category_scores_gemma":[0.003011911,0.00040143347,0.00015190459,0.0042697196,0.0011272115,0.0001949114,0.0015004083,0.0042037554,0.000054313972],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.13790226,0.014954589,0.1515673,0.00514738,0.0032574236,0.009669834,0.0106024565,0.00020007495,0.33627564,0.0012218864,0.049760647,0.27944052],"study_design_scores_gemma":[0.388778,0.04892095,0.27238068,0.0043202573,0.0017576033,0.00080434134,0.02394273,0.04985229,0.11274832,0.0023116965,0.09142465,0.0027584855],"about_ca_topic_score_codex":0.0018522555,"about_ca_topic_score_gemma":0.00043186796,"teacher_disagreement_score":0.27668205,"about_ca_system_score_codex":0.009077617,"about_ca_system_score_gemma":0.010252786,"threshold_uncertainty_score":0.9998438},"labels":[],"label_agreement":null},{"id":"W4413389037","doi":"10.1016/j.leukres.2025.108087","title":"Pilot study: A prospective, real-world, feasibility study testing a decreased frequency paradigm in treatment free remission in chronic myeloid leukemia","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Windsor Regional Hospital","funders":"","keywords":"Myeloid leukemia; Medicine; Oncology; Internal medicine; Leukemia; Complete remission; Prospective cohort study; Chemotherapy","score_opus":0.12377204351037173,"score_gpt":0.4169045640463377,"score_spread":0.29313252053596595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413389037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9574747,0.0007870226,0.0000035822018,0.00029923458,0.00012100629,0.017155303,0.000020034546,0.00026572548,0.023873407],"genre_scores_gemma":[0.9905799,0.00016693323,0.0005506595,0.000032794633,0.00019686662,0.0038687207,0.000046376535,0.00011447861,0.0044432683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98936194,0.0020696335,0.0016991463,0.0026597993,0.0020353016,0.0021741688],"domain_scores_gemma":[0.9928367,0.0023631437,0.00016258976,0.0035789693,0.00043973746,0.0006188233],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0044074096,0.00088400766,0.00165334,0.0026902263,0.00047642319,0.00014105724,0.00096914184,0.000203018,0.00017758275],"category_scores_gemma":[0.0043383488,0.0007608905,0.00016155408,0.0078778155,0.00035693683,0.0002883527,0.00073548197,0.0024127604,0.00008511465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.004090351,0.0113767935,0.96501744,0.00031567007,0.00029326478,0.0033524667,0.001534391,0.00014310218,0.00783446,0.00017320174,0.00025690766,0.005611946],"study_design_scores_gemma":[0.062685914,0.01992253,0.907919,0.0015232543,0.00015152234,0.000024050161,0.0015593285,0.0019843257,0.0013826905,0.002340274,0.000054828157,0.00045230406],"about_ca_topic_score_codex":0.27820495,"about_ca_topic_score_gemma":0.26437312,"teacher_disagreement_score":0.22903948,"about_ca_system_score_codex":0.2675933,"about_ca_system_score_gemma":0.038553838,"threshold_uncertainty_score":0.9998887},"labels":[],"label_agreement":null},{"id":"W4414096472","doi":"10.1016/j.leukres.2025.107905","title":"TREATMENT - CURRENT TREATMENT OPTIONS - HIGHER RISK MDS","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Current (fluid); MEDLINE; Risk assessment; Clinical trial","score_opus":0.5899221020561286,"score_gpt":0.564459568485141,"score_spread":0.0254625335709876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414096472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67351794,0.058907837,0.0019538268,0.095653705,0.0048434027,0.005438349,0.0017978171,0.00038570873,0.15750143],"genre_scores_gemma":[0.8587207,0.019322306,0.0020962183,0.0012505976,0.0014964914,0.0031298217,0.00022479503,0.00008975822,0.11366927],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.994898,0.0009647541,0.0022705914,0.00085598935,0.00017470491,0.0008359303],"domain_scores_gemma":[0.996222,0.0018253454,0.0005053172,0.0010564447,0.00012538547,0.00026548165],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008322633,0.0002556038,0.0008310884,0.00093531184,0.00072899536,0.0001809727,0.00036180275,0.00017952314,0.0011755957],"category_scores_gemma":[0.0011063637,0.0002674435,0.0002240504,0.00067287014,0.00016441457,0.00024105624,0.00009682083,0.00037311716,0.00838054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006628635,0.00079216115,0.07755264,0.00022504888,0.0004125083,0.0000056669287,0.0016031077,0.0006717084,0.00000463681,0.8014459,0.10011383,0.017106514],"study_design_scores_gemma":[0.0021098102,0.0003200827,0.027947756,0.00006161899,0.000014610478,0.000001089675,0.00030292306,0.003452748,0.000025742547,0.038222034,0.92730725,0.00023436327],"about_ca_topic_score_codex":0.010440383,"about_ca_topic_score_gemma":0.00045733195,"teacher_disagreement_score":0.8271934,"about_ca_system_score_codex":0.016930731,"about_ca_system_score_gemma":0.0013372493,"threshold_uncertainty_score":0.99997777},"labels":[],"label_agreement":null},{"id":"W4414096542","doi":"10.1016/j.leukres.2025.107876","title":"OUTCOME RESEARCH (INCLUDING QUALITY OF LIFE) AND HEALTH ECONOMICS - PATIENT-REPORTED OUTCOMES &amp; QUALITY OF LIFE","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada)","funders":"","keywords":"Outcome (game theory); Health economics; Quality of life (healthcare); Quality (philosophy); Quality-adjusted life year; Health related quality of life; Outcomes research","score_opus":0.6938777666991559,"score_gpt":0.6695954740101862,"score_spread":0.024282292688969753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414096542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9714149,0.0019753072,0.000028835726,0.014965557,0.00059380004,0.0027209024,0.00016596558,0.00007947615,0.008055258],"genre_scores_gemma":[0.9936063,0.0008456196,0.0008083808,0.0015879435,0.00009686248,0.00018635188,0.000041652955,0.000041797935,0.002785074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9765512,0.0126747405,0.005612532,0.00096557295,0.0020047012,0.002191266],"domain_scores_gemma":[0.9775829,0.01472247,0.0013333419,0.0019226193,0.00337661,0.00106211],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.058497813,0.00030466105,0.0019896722,0.0011776756,0.0017556819,0.000029637555,0.0007847711,0.0005958799,0.00016277228],"category_scores_gemma":[0.03402237,0.00028283175,0.00018759469,0.0016740799,0.00092314515,0.0001942849,0.0020998514,0.003409706,0.00011678368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00063976104,0.00014252972,0.9424785,0.0072339796,0.000114372655,9.987517e-7,0.0039748526,0.000014615592,0.00009499822,0.02465597,0.019511035,0.0011384324],"study_design_scores_gemma":[0.002641964,0.00019135296,0.965505,0.0005271263,0.000004763022,2.0453199e-7,0.011345032,0.000041881496,0.000033627497,0.005866869,0.013640937,0.00020125235],"about_ca_topic_score_codex":0.14509326,"about_ca_topic_score_gemma":0.023331484,"teacher_disagreement_score":0.12176178,"about_ca_system_score_codex":0.005094277,"about_ca_system_score_gemma":0.01830242,"threshold_uncertainty_score":0.9999624},"labels":[],"label_agreement":null},{"id":"W4414096581","doi":"10.1016/j.leukres.2025.107906","title":"TREATMENT - CURRENT TREATMENT OPTIONS - HIGHER RISK MDS","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Current (fluid); MEDLINE; Risk assessment; Clinical trial","score_opus":0.5899221020561286,"score_gpt":0.564459568485141,"score_spread":0.0254625335709876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414096581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.67351794,0.058907837,0.0019538268,0.095653705,0.0048434027,0.005438349,0.0017978171,0.00038570873,0.15750143],"genre_scores_gemma":[0.8587207,0.019322306,0.0020962183,0.0012505976,0.0014964914,0.0031298217,0.00022479503,0.00008975822,0.11366927],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.994898,0.0009647541,0.0022705914,0.00085598935,0.00017470491,0.0008359303],"domain_scores_gemma":[0.996222,0.0018253454,0.0005053172,0.0010564447,0.00012538547,0.00026548165],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.008322633,0.0002556038,0.0008310884,0.00093531184,0.00072899536,0.0001809727,0.00036180275,0.00017952314,0.0011755957],"category_scores_gemma":[0.0011063637,0.0002674435,0.0002240504,0.00067287014,0.00016441457,0.00024105624,0.00009682083,0.00037311716,0.00838054],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006628635,0.00079216115,0.07755264,0.00022504888,0.0004125083,0.0000056669287,0.0016031077,0.0006717084,0.00000463681,0.8014459,0.10011383,0.017106514],"study_design_scores_gemma":[0.0021098102,0.0003200827,0.027947756,0.00006161899,0.000014610478,0.000001089675,0.00030292306,0.003452748,0.000025742547,0.038222034,0.92730725,0.00023436327],"about_ca_topic_score_codex":0.010440383,"about_ca_topic_score_gemma":0.00045733195,"teacher_disagreement_score":0.8271934,"about_ca_system_score_codex":0.016930731,"about_ca_system_score_gemma":0.0013372493,"threshold_uncertainty_score":0.99997777},"labels":[],"label_agreement":null},{"id":"W4414570461","doi":"10.1016/j.leukres.2025.108113","title":"Evaluating complete response/remission rate as a surrogate endpoint in relapsed/refractory chronic lymphocytic leukemia","year":2025,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Bristol-Myers Squibb","keywords":"Chronic lymphocytic leukemia; Surrogate endpoint; Clinical endpoint; Confidence interval; Randomized controlled trial; Odds ratio; Proportional hazards model","score_opus":0.22145760030301562,"score_gpt":0.5080526382068011,"score_spread":0.2865950379037855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414570461","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011515195,0.968971,0.000007935276,0.00015046031,0.00056166993,0.008868483,0.00013417547,0.0003866195,0.009404426],"genre_scores_gemma":[0.0012743212,0.94048846,0.00027788422,0.00014897529,0.0008706784,0.002177898,0.000690692,0.00051453424,0.05355656],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9645501,0.015797952,0.0040594693,0.0041067167,0.0063233213,0.0051624835],"domain_scores_gemma":[0.9667235,0.024573851,0.0006100945,0.005019257,0.0014667729,0.001606547],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"category_scores_codex":[0.034974188,0.0020089848,0.006462894,0.0065397397,0.0008413622,0.00039517938,0.0028301547,0.0028584676,0.001847943],"category_scores_gemma":[0.029113486,0.0017433263,0.0017007991,0.008118455,0.0013791079,0.00027046574,0.003248973,0.01061725,0.0046941554],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011545314,0.00019042063,0.000002561156,0.15335825,0.0007728074,0.0121528255,0.000528461,0.0007243453,0.0012131585,0.0002808395,0.008917097,0.81031394],"study_design_scores_gemma":[0.029814146,0.002343414,0.000016767473,0.13429154,0.0006176597,0.0011964745,0.00015047824,0.029995859,0.00016723892,0.00024013712,0.79987127,0.001295026],"about_ca_topic_score_codex":0.0069872458,"about_ca_topic_score_gemma":0.00028986848,"teacher_disagreement_score":0.8090189,"about_ca_system_score_codex":0.75965875,"about_ca_system_score_gemma":0.68199646,"threshold_uncertainty_score":0.9996253},"labels":[],"label_agreement":null},{"id":"W7115707592","doi":"10.1016/j.leukres.2025.108155","title":"Frequency and prognostic significance of RAS pathway alterations in adult acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Leukemia Research","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Science and Technology Planning Project of Guangdong Province; National Natural Science Foundation of China; Saint Mary’s University","keywords":"PTPN11; KRAS; Clinical significance; Multivariate analysis; Survival analysis; Lymphoblastic Leukemia","score_opus":0.02401054487492874,"score_gpt":0.33368733018252633,"score_spread":0.30967678530759757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7115707592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767339,0.000579243,0.0014240688,0.0014292184,0.00012449546,0.002383677,0.000061881845,0.000081066966,0.0171824],"genre_scores_gemma":[0.99098086,0.00046585,0.0024474752,0.0002574459,0.00010703812,0.0006212785,0.00005303963,0.000054925025,0.0050121024],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99475616,0.0005298004,0.00095407537,0.000954388,0.0015292412,0.0012763492],"domain_scores_gemma":[0.99435616,0.0028178424,0.00008034997,0.00094427605,0.0014070712,0.00039427576],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016031648,0.0003516871,0.00076176896,0.0016347333,0.00024793035,0.00009300539,0.0005170992,0.0003847827,0.00010642202],"category_scores_gemma":[0.0047210758,0.00031713332,0.00011270668,0.003135541,0.0011415133,0.00023426859,0.00042583796,0.0013202892,0.0000804635],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0035424693,0.00092700106,0.16547155,0.005177076,0.00091083226,0.0030893304,0.0029195792,0.0004016449,0.7173294,0.067580424,0.0131507795,0.019499922],"study_design_scores_gemma":[0.0558757,0.004548071,0.36387074,0.01220199,0.00063481723,0.0008986791,0.0037921618,0.13816452,0.38996914,0.02584587,0.0021674822,0.0020308308],"about_ca_topic_score_codex":0.0028159923,"about_ca_topic_score_gemma":0.0004030389,"teacher_disagreement_score":0.32736024,"about_ca_system_score_codex":0.008211201,"about_ca_system_score_gemma":0.017310387,"threshold_uncertainty_score":0.99992806},"labels":[],"label_agreement":null}]}